,type,age_at_initial_pathologic_diagnosis,gender,race,ajcc_pathologic_tumor_stage,clinical_stage,histological_type,histological_grade,initial_pathologic_dx_year,menopause_status,birth_days_to,vital_status,tumor_status,last_contact_days_to,death_days_to,cause_of_death,new_tumor_event_type,new_tumor_event_site,new_tumor_event_site_other,new_tumor_event_dx_days_to,treatment_outcome_first_course,margin_status,residual_tumor,OS,OS.time,DSS,DSS.time,DFI,DFI.time,PFI,PFI.time,Redaction
TCGA-E9-A1NI-01A-11R-A14D-07,BRCA,51.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18985.0,Alive,TUMOR FREE,300.0,,[Not Available],,,,,[Not Available],Negative,,0.0,300.0,0.0,300.0,0.0,300.0,0.0,300.0,
TCGA-E2-A1LK-01A-21R-A14D-07,BRCA,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30757.0,Dead,WITH TUMOR,,266.0,[Not Available],Locoregional Disease,"Other, specify",Left axilla,155.0,[Not Available],Negative,,1.0,266.0,1.0,266.0,1.0,155.0,1.0,155.0,
TCGA-BH-A0B2-01A-11R-A10J-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-E2-A107-01A-11R-A10J-07,BRCA,54.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20065.0,Alive,TUMOR FREE,1047.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1047.0,0.0,1047.0,0.0,1047.0,0.0,1047.0,
TCGA-LL-A5YN-01A-11R-A28M-07,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16884.0,Alive,TUMOR FREE,447.0,,[Not Available],,,,,[Not Available],Negative,,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,
TCGA-BH-A0DQ-01A-11R-A084-07,BRCA,42.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15533.0,Alive,TUMOR FREE,98.0,,[Not Available],,,,,[Not Available],Negative,,0.0,98.0,0.0,98.0,0.0,98.0,0.0,98.0,
TCGA-D8-A73X-01A-11R-A32P-07,BRCA,53.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19607.0,Alive,TUMOR FREE,767.0,,[Not Available],,,,,[Not Available],Negative,,0.0,767.0,0.0,767.0,0.0,767.0,0.0,767.0,
TCGA-AR-A0TP-01A-11R-A084-07,BRCA,43.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15812.0,Alive,TUMOR FREE,4275.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4275.0,0.0,4275.0,0.0,4275.0,0.0,4275.0,
TCGA-E2-A1IF-01A-11R-A144-07,BRCA,74.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27341.0,Alive,TUMOR FREE,1138.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1138.0,0.0,1138.0,0.0,1138.0,0.0,1138.0,
TCGA-EW-A6SD-01A-12R-A33J-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-AO-A03T-01A-21R-A034-07,BRCA,42.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15540.0,Alive,TUMOR FREE,2124.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2124.0,0.0,2124.0,0.0,2124.0,0.0,2124.0,
TCGA-OL-A5D8-01A-11R-A27Q-07,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14853.0,Alive,TUMOR FREE,973.0,,[Not Available],,,,,[Not Available],[Unknown],,0.0,973.0,0.0,973.0,,,0.0,973.0,
TCGA-AR-A24X-01A-11R-A169-07,BRCA,52.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19030.0,Alive,TUMOR FREE,3004.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3004.0,0.0,3004.0,0.0,3004.0,0.0,3004.0,
TCGA-B6-A0WV-01A-11R-A109-07,BRCA,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24803.0,Dead,TUMOR FREE,,2417.0,[Not Available],,,,,[Not Available],Negative,,1.0,2417.0,0.0,2417.0,0.0,2417.0,0.0,2417.0,
TCGA-A8-A09W-01A-11R-A00Z-07,BRCA,70.0,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25659.0,Alive,,30.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-C8-A8HQ-01A-11R-A36F-07,BRCA,53.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Mucinous Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19432.0,Alive,TUMOR FREE,380.0,,[Not Available],,,,,[Not Available],Negative,,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,
TCGA-B6-A0RU-01A-11R-A084-07,BRCA,40.0,FEMALE,WHITE,Stage IA,[Not Applicable],"Other, specify",[Not Available],1990.0,Indeterminate (neither Pre or Postmenopausal),-14920.0,Alive,TUMOR FREE,8605.0,,[Not Available],New Primary Tumor,"Other, specify",Right Breast,3076.0,[Not Available],Negative,,0.0,8605.0,0.0,8605.0,1.0,3076.0,1.0,3076.0,
TCGA-A8-A09E-01A-11R-A00Z-07,BRCA,73.0,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26724.0,Alive,WITH TUMOR,1492.0,,[Not Available],,,,,[Not Available],Positive,,0.0,1492.0,0.0,1492.0,,,0.0,1492.0,
TCGA-A7-A6VX-01A-12R-A33J-07,BRCA,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25066.0,Alive,TUMOR FREE,317.0,,[Not Available],,,,,[Not Available],Negative,,0.0,317.0,0.0,317.0,0.0,317.0,0.0,317.0,
TCGA-E2-A14O-01A-31R-A115-07,BRCA,76.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27837.0,Alive,TUMOR FREE,1359.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1359.0,0.0,1359.0,0.0,1359.0,0.0,1359.0,
TCGA-A2-A1G6-01A-11R-A13Q-07,BRCA,50.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18514.0,Alive,TUMOR FREE,501.0,,[Not Available],,,,,[Not Available],Negative,,0.0,501.0,0.0,501.0,0.0,501.0,0.0,501.0,
TCGA-E2-A1LA-01A-11R-A144-07,BRCA,59.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21773.0,Alive,TUMOR FREE,748.0,,[Not Available],,,,,[Not Available],Negative,,0.0,748.0,0.0,748.0,0.0,748.0,0.0,748.0,
TCGA-BH-A0GZ-01A-11R-A056-07,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22714.0,Alive,TUMOR FREE,328.0,,[Not Available],,,,,[Not Available],Negative,,0.0,328.0,0.0,328.0,0.0,328.0,0.0,328.0,
TCGA-D8-A1JG-01B-11R-A13Q-07,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22878.0,Alive,TUMOR FREE,1612.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1612.0,0.0,1612.0,0.0,1612.0,0.0,1612.0,
TCGA-A7-A13G-01B-04R-A22O-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-B6-A400-01A-11R-A239-07,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,[Unknown],-16022.0,Alive,TUMOR FREE,215.0,,[Not Available],,,,,[Not Available],Negative,,0.0,215.0,0.0,215.0,0.0,215.0,0.0,215.0,
TCGA-MS-A51U-01A-31R-A266-07,BRCA,44.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,[Not Available],-16213.0,Alive,TUMOR FREE,681.0,,[Not Available],,,,,[Not Available],Negative,,0.0,681.0,0.0,681.0,0.0,681.0,0.0,681.0,
TCGA-BH-A0EB-01A-11R-A034-07,BRCA,69.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25259.0,Alive,TUMOR FREE,745.0,,[Not Available],,,,,[Not Available],Negative,,0.0,745.0,0.0,745.0,0.0,745.0,0.0,745.0,
TCGA-AR-A2LR-01A-12R-A18M-07,BRCA,49.0,FEMALE,WHITE,Stage I,[Not Applicable],Metaplastic Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18214.0,Alive,TUMOR FREE,1742.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1742.0,0.0,1742.0,0.0,1742.0,0.0,1742.0,
TCGA-BH-A0AZ-01A-21R-A12P-07,BRCA,47.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17465.0,Alive,TUMOR FREE,1919.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1919.0,0.0,1919.0,0.0,1919.0,0.0,1919.0,
TCGA-BH-A18K-01A-11R-A12D-07,BRCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999.0,[Not Available],-16824.0,Dead,WITH TUMOR,,2763.0,[Not Available],,,,,[Not Available],Negative,,1.0,2763.0,1.0,2763.0,,,1.0,2763.0,
TCGA-AO-A0J7-01A-11R-A034-07,BRCA,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26281.0,Alive,TUMOR FREE,618.0,,[Not Available],,,,,[Not Available],Negative,,0.0,618.0,0.0,618.0,0.0,618.0,0.0,618.0,
TCGA-A2-A0YH-01A-11R-A109-07,BRCA,53.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19596.0,Alive,TUMOR FREE,659.0,,[Not Available],,,,,[Not Available],Negative,,0.0,659.0,0.0,659.0,0.0,659.0,0.0,659.0,
TCGA-BH-A42V-01A-11R-A24H-07,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15158.0,Alive,TUMOR FREE,635.0,,[Not Available],,,,,[Not Available],Negative,,0.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,
TCGA-AR-A5QN-01A-12R-A28M-07,BRCA,68.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25089.0,Alive,TUMOR FREE,1013.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,1013.0,0.0,1013.0,,,0.0,1013.0,
TCGA-B6-A0X1-01A-11R-A109-07,BRCA,48.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1994.0,Indeterminate (neither Pre or Postmenopausal),-17624.0,Dead,TUMOR FREE,,7455.0,[Not Available],Distant Metastasis,Brain,,490.0,[Not Available],Negative,,1.0,7455.0,0.0,7455.0,1.0,490.0,1.0,490.0,
TCGA-S3-A6ZG-01A-22R-A32P-07,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Mixed Histology (please specify),[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26141.0,Alive,TUMOR FREE,562.0,,[Not Available],,,,,[Not Available],Negative,,0.0,562.0,0.0,562.0,0.0,562.0,0.0,562.0,
TCGA-A8-A085-01A-11R-A00Z-07,BRCA,44.0,MALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,[Not Available],-16377.0,Alive,TUMOR FREE,1124.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1124.0,0.0,1124.0,0.0,1124.0,0.0,1124.0,
TCGA-D8-A1J9-01A-11R-A13Q-07,BRCA,48.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17879.0,Alive,TUMOR FREE,532.0,,[Not Available],,,,,[Not Available],Negative,,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,
TCGA-A7-A0DC-01B-04R-A22O-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-AR-A24S-01A-11R-A169-07,BRCA,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22587.0,Alive,,2976.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2976.0,0.0,2976.0,0.0,2976.0,0.0,2976.0,
TCGA-BH-A0BA-01A-11R-A056-07,BRCA,51.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Mixed Histology (please specify),[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18839.0,Alive,TUMOR FREE,1132.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1132.0,0.0,1132.0,0.0,1132.0,0.0,1132.0,
TCGA-A2-A0YM-01A-11R-A109-07,BRCA,67.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24831.0,Alive,TUMOR FREE,965.0,,[Not Available],,,,,[Not Available],Negative,,0.0,965.0,0.0,965.0,0.0,965.0,0.0,965.0,
TCGA-D8-A27N-01A-11R-A16F-07,BRCA,36.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13243.0,Alive,TUMOR FREE,519.0,,[Not Available],,,,,[Not Available],Negative,,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,
TCGA-EW-A1PH-01A-11R-A14M-07,BRCA,52.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19073.0,Alive,TUMOR FREE,607.0,,[Not Available],,,,,[Not Available],Negative,,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,
TCGA-EW-A1OZ-01A-11R-A144-07,BRCA,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20664.0,Alive,TUMOR FREE,1229.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1229.0,0.0,1229.0,0.0,1229.0,0.0,1229.0,
TCGA-AO-A12G-01A-11R-A10J-07,BRCA,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27705.0,Alive,TUMOR FREE,1639.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0,
TCGA-AR-A1AK-01A-21R-A12P-07,BRCA,70.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25825.0,Alive,TUMOR FREE,3159.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3159.0,0.0,3159.0,0.0,3159.0,0.0,3159.0,
TCGA-AC-A5EH-01A-11R-A28M-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-D8-A27I-01A-11R-A16F-07,BRCA,58.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21327.0,Alive,TUMOR FREE,439.0,,[Not Available],,,,,[Not Available],Negative,,0.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,
TCGA-D8-A1JP-01A-11R-A13Q-07,BRCA,73.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26862.0,Alive,TUMOR FREE,639.0,,[Not Available],,,,,[Not Available],Negative,,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,
TCGA-E2-A14R-01A-11R-A115-07,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22686.0,Alive,TUMOR FREE,1174.0,,[Not Available],New Primary Tumor,"Other, specify",Endometrial,971.0,[Not Available],Negative,,0.0,1174.0,0.0,1174.0,0.0,1174.0,1.0,971.0,
TCGA-A2-A0SW-01A-11R-A084-07,BRCA,82.0,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30085.0,Dead,WITH TUMOR,,1365.0,[Not Available],,,,653.0,[Not Available],Negative,,1.0,1365.0,1.0,1365.0,,,1.0,653.0,
TCGA-AQ-A0Y5-01A-11R-A14M-07,BRCA,70.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25793.0,Dead,TUMOR FREE,,172.0,[Not Available],,,,,[Not Available],Negative,,1.0,172.0,0.0,172.0,0.0,172.0,0.0,172.0,
TCGA-AO-A125-01A-11R-A10J-07,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26466.0,Alive,TUMOR FREE,3456.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3456.0,0.0,3456.0,0.0,3456.0,0.0,3456.0,
TCGA-A2-A0T2-01A-11R-A084-07,BRCA,66.0,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24235.0,Dead,WITH TUMOR,,255.0,[Not Available],,,,,[Not Available],Close,,1.0,255.0,1.0,255.0,,,1.0,255.0,
TCGA-A2-A1FW-01A-11R-A13Q-07,BRCA,62.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22779.0,Alive,TUMOR FREE,528.0,,[Not Available],,,,,[Not Available],Negative,,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,
TCGA-B6-A0I9-01A-11R-A034-07,BRCA,62.0,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1992.0,Indeterminate (neither Pre or Postmenopausal),-22798.0,Dead,WITH TUMOR,,362.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,362.0,1.0,362.0,,,1.0,362.0,
TCGA-GM-A2DK-01A-21R-A180-07,BRCA,58.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21198.0,Alive,TUMOR FREE,2645.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2645.0,0.0,2645.0,0.0,2645.0,0.0,2645.0,
TCGA-E2-A159-01A-11R-A115-07,BRCA,50.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18621.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,[Not Available],Negative,,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,
TCGA-A8-A084-01A-21R-A00Z-07,BRCA,81.0,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29858.0,Alive,WITH TUMOR,458.0,,[Not Available],,,,,[Not Available],Positive,,0.0,458.0,0.0,458.0,,,0.0,458.0,
TCGA-BH-A42U-01A-12R-A24H-07,BRCA,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29330.0,Alive,TUMOR FREE,3364.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3364.0,0.0,3364.0,0.0,3364.0,0.0,3364.0,
TCGA-D8-A1JH-01A-11R-A13Q-07,BRCA,56.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20497.0,Alive,TUMOR FREE,426.0,,[Not Available],,,,,[Not Available],Negative,,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,
TCGA-E2-A14P-01A-31R-A12D-07,BRCA,79.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28923.0,Alive,TUMOR FREE,1246.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0,
TCGA-E2-A1L7-01A-11R-A144-07,BRCA,40.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14854.0,Alive,TUMOR FREE,1836.0,,[Not Available],New Primary Tumor,"Other, specify",left breast,1619.0,[Not Available],Negative,,0.0,1836.0,0.0,1836.0,1.0,1619.0,1.0,1619.0,
TCGA-E2-A1IL-01A-11R-A14D-07,BRCA,78.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28495.0,Alive,TUMOR FREE,118.0,,[Not Available],,,,,[Not Available],Negative,,0.0,118.0,0.0,118.0,0.0,118.0,0.0,118.0,
TCGA-BH-A6R8-01A-21R-A33J-07,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,[Unknown],-16829.0,Alive,TUMOR FREE,293.0,,[Not Available],,,,,[Not Available],Negative,,0.0,293.0,0.0,293.0,0.0,293.0,0.0,293.0,
TCGA-A7-A4SD-01A-11R-A266-07,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19131.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,[Not Available],Negative,,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,
TCGA-A8-A083-01A-21R-A00Z-07,BRCA,67.0,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24746.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],Negative,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-B6-A0I5-01A-11R-A034-07,BRCA,49.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1988.0,Indeterminate (neither Pre or Postmenopausal),-18038.0,Alive,TUMOR FREE,8556.0,,[Not Available],,,,,[Not Available],Negative,,0.0,8556.0,0.0,8556.0,0.0,8556.0,0.0,8556.0,
TCGA-D8-A1JA-01A-11R-A13Q-07,BRCA,60.0,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21918.0,Alive,WITH TUMOR,502.0,,[Not Available],Locoregional Disease,,,431.0,[Not Available],Negative,,0.0,502.0,0.0,502.0,1.0,431.0,1.0,431.0,
TCGA-A2-A0D0-01A-11R-A00Z-07,BRCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22115.0,Alive,TUMOR FREE,2048.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2048.0,0.0,2048.0,0.0,2048.0,0.0,2048.0,
TCGA-A8-A07B-01A-11R-A00Z-07,BRCA,69.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25475.0,Alive,TUMOR FREE,1308.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1308.0,0.0,1308.0,0.0,1308.0,0.0,1308.0,
TCGA-C8-A275-01A-21R-A16F-07,BRCA,56.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20774.0,Alive,TUMOR FREE,1.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,
TCGA-AO-A1KQ-01A-11R-A13Q-07,BRCA,84.0,MALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,[Not Available],-30859.0,Alive,TUMOR FREE,1882.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1882.0,0.0,1882.0,0.0,1882.0,0.0,1882.0,
TCGA-E9-A5UP-01A-11R-A28M-07,BRCA,63.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23371.0,Alive,TUMOR FREE,803.0,,[Not Available],,,,,[Not Available],Negative,,0.0,803.0,0.0,803.0,0.0,803.0,0.0,803.0,
TCGA-AR-A24T-01A-11R-A169-07,BRCA,46.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17135.0,Alive,TUMOR FREE,3202.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3202.0,0.0,3202.0,0.0,3202.0,0.0,3202.0,
TCGA-D8-A1XB-01A-11R-A14D-07,BRCA,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22976.0,Alive,TUMOR FREE,552.0,,[Not Available],,,,,[Not Available],Negative,,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,
TCGA-E9-A245-01A-22R-A16F-07,BRCA,47.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17363.0,Alive,TUMOR FREE,26.0,,[Not Available],,,,,[Not Available],Negative,,0.0,26.0,0.0,26.0,0.0,26.0,0.0,26.0,
TCGA-WT-AB44-01A-11R-A41B-07,BRCA,77.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,883.0,,[Not Available],,,,,[Not Available],Negative,,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,
TCGA-SL-A6J9-01A-11R-A31O-07,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26701.0,Alive,,2.0,,[Not Available],,,,,[Unknown],,,0.0,2.0,0.0,2.0,,,0.0,2.0,
TCGA-AX-A3G9-01A-11R-A22K-07,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010.0,[Not Available],-23361.0,Alive,,558.0,,[Not Available],,,,,[Not Available],,,0.0,558.0,0.0,558.0,,,0.0,558.0,
TCGA-AJ-A3BH-01A-11R-A19W-07,UCEC,,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-EY-A212-01A-11R-A14M-07,UCEC,83.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30680.0,Dead,WITH TUMOR,,310.0,[Not Available],,,,,Partial Remission/Response,,,1.0,310.0,1.0,310.0,,,1.0,310.0,
TCGA-AJ-A8CV-01A-11R-A37O-07,UCEC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21336.0,Alive,TUMOR FREE,1068.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1068.0,0.0,1068.0,0.0,1068.0,0.0,1068.0,
TCGA-BG-A0LW-01A-11R-A16W-07,UCEC,47.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Indeterminate (neither Pre or Postmenopausal),-17369.0,Alive,TUMOR FREE,566.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,566.0,0.0,566.0,0.0,566.0,0.0,566.0,
TCGA-AX-A1C4-01A-11R-A137-07,UCEC,52.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Indeterminate (neither Pre or Postmenopausal),-19209.0,Alive,TUMOR FREE,404.0,,[Not Available],,,,,[Not Applicable],,,0.0,404.0,0.0,404.0,,,0.0,404.0,
TCGA-AX-A3FV-01A-11R-A22K-07,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,[Not Available],-22752.0,Alive,,-6.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-B5-A1MZ-01A-11R-A144-07,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Indeterminate (neither Pre or Postmenopausal),-19955.0,Alive,TUMOR FREE,1598.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,613.0,Complete Remission/Response,,,0.0,1598.0,0.0,1598.0,1.0,613.0,1.0,613.0,
TCGA-A5-A3LO-01A-11R-A22K-07,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23401.0,Alive,TUMOR FREE,776.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,776.0,0.0,776.0,0.0,776.0,0.0,776.0,
TCGA-AX-A3G6-01A-11R-A213-07,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G2,2010.0,[Not Available],-24681.0,Alive,,8.0,,[Not Available],,,,,[Not Available],,,0.0,8.0,0.0,8.0,,,0.0,8.0,
TCGA-DI-A2QT-01A-12R-A19W-07,UCEC,51.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18835.0,Dead,WITH TUMOR,,377.0,[Not Available],,,,,[Not Available],,,1.0,377.0,1.0,377.0,,,1.0,377.0,
TCGA-AX-A2HD-01A-21R-A17B-07,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2008.0,[Not Available],-25499.0,Alive,WITH TUMOR,1414.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1414.0,0.0,1414.0,,,0.0,1414.0,
TCGA-QS-A744-01A-11R-A34R-07,UCEC,86.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31520.0,Alive,TUMOR FREE,451.0,,[Not Available],,,,,[Not Applicable],,,0.0,451.0,0.0,451.0,,,0.0,451.0,
TCGA-B5-A11M-01A-11R-A118-07,UCEC,43.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16063.0,Alive,TUMOR FREE,1362.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1362.0,0.0,1362.0,0.0,1362.0,0.0,1362.0,
TCGA-B5-A1MS-01B-11R-A22K-07,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IC,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22068.0,Dead,WITH TUMOR,,3112.0,[Not Available],Locoregional Recurrence,"Other, specify",Supraclavicular Fossa,2706.0,Partial Remission/Response,,,1.0,3112.0,1.0,3112.0,,,1.0,2706.0,
TCGA-AJ-A3OK-01A-12R-A22K-07,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26851.0,Alive,TUMOR FREE,485.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,
TCGA-BG-A0MK-01A-51R-A19W-07,UCEC,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19034.0,Dead,WITH TUMOR,,1317.0,[Not Available],,,,,Progressive Disease,,,1.0,1317.0,1.0,1317.0,,,1.0,1317.0,
TCGA-AJ-A3IA-01A-11R-A213-07,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28470.0,Alive,TUMOR FREE,633.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,633.0,0.0,633.0,0.0,633.0,0.0,633.0,
TCGA-D1-A16E-01A-22R-A12I-07,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26859.0,Alive,TUMOR FREE,1119.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1119.0,0.0,1119.0,0.0,1119.0,0.0,1119.0,
TCGA-AX-A3G1-01A-11R-A22K-07,UCEC,84.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31037.0,Dead,,,624.0,[Not Available],,,,,[Not Available],,,1.0,624.0,,624.0,,,0.0,624.0,
TCGA-A5-A2K5-01A-11R-A180-07,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28057.0,Alive,TUMOR FREE,752.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,
TCGA-E6-A2P8-01A-11R-A19W-07,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IV,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19448.0,Dead,WITH TUMOR,,72.0,[Not Available],Metastatic,Lung,,60.0,Progressive Disease,,,1.0,72.0,1.0,72.0,,,1.0,60.0,
TCGA-AX-A1CP-01A-11R-A137-07,UCEC,84.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30737.0,Alive,,1107.0,,[Not Available],,,,722.0,[Not Available],,,0.0,1107.0,0.0,1107.0,,,1.0,722.0,
TCGA-D1-A16J-01A-11R-A12I-07,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22319.0,Alive,TUMOR FREE,910.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,
TCGA-AJ-A5DW-01A-11R-A27V-07,UCEC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20711.0,Alive,TUMOR FREE,390.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,390.0,0.0,390.0,0.0,390.0,0.0,390.0,
TCGA-EY-A2ON-01A-21R-A18M-07,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22624.0,Dead,WITH TUMOR,,610.0,[Not Available],,,,226.0,Progressive Disease,,,1.0,610.0,1.0,610.0,,,1.0,226.0,
TCGA-KP-A3VZ-01A-11R-A22K-07,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous endometrial adenocarcinoma,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25366.0,Alive,WITH TUMOR,722.0,,[Not Available],,,,,[Not Available],,,0.0,722.0,0.0,722.0,,,0.0,722.0,
TCGA-D1-A16N-01A-11R-A12I-07,UCEC,51.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Peri (6-12 months since last menstrual period),-18787.0,Alive,TUMOR FREE,945.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,945.0,0.0,945.0,0.0,945.0,0.0,945.0,
TCGA-EY-A547-01A-11R-A27V-07,UCEC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27686.0,Alive,TUMOR FREE,545.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,545.0,0.0,545.0,0.0,545.0,0.0,545.0,
TCGA-B5-A11P-01B-11R-A14D-07,UCEC,87.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32047.0,Alive,TUMOR FREE,1583.0,,[Not Available],,,,,[Not Available],,,0.0,1583.0,0.0,1583.0,,,0.0,1583.0,
TCGA-AX-A2HF-01A-11R-A17B-07,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24689.0,Alive,WITH TUMOR,848.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,848.0,0.0,848.0,0.0,848.0,0.0,848.0,
TCGA-B5-A0JT-01A-21R-A118-07,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041.0,Alive,TUMOR FREE,1682.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1682.0,0.0,1682.0,0.0,1682.0,0.0,1682.0,
TCGA-AX-A2H8-01A-11R-A17B-07,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23448.0,Alive,TUMOR FREE,1861.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1861.0,0.0,1861.0,0.0,1861.0,0.0,1861.0,
TCGA-BS-A0V6-01A-11R-A118-07,UCEC,55.0,FEMALE,ASIAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20369.0,Alive,TUMOR FREE,2725.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2725.0,0.0,2725.0,0.0,2725.0,0.0,2725.0,
TCGA-AX-A06J-01A-11R-A00V-07,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26000.0,Alive,TUMOR FREE,913.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,913.0,0.0,913.0,0.0,913.0,0.0,913.0,
TCGA-D1-A0ZO-01A-11R-A118-07,UCEC,75.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27482.0,Alive,TUMOR FREE,602.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,
TCGA-D1-A165-01A-11R-A12I-07,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23526.0,Alive,TUMOR FREE,20.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,20.0,0.0,20.0,0.0,20.0,0.0,20.0,
TCGA-EY-A1GM-01A-12R-A14D-07,UCEC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22010.0,Dead,WITH TUMOR,,995.0,[Not Available],Locoregional Recurrence,,,791.0,Complete Remission/Response,,,1.0,995.0,1.0,995.0,1.0,791.0,1.0,791.0,
TCGA-AX-A3GB-01A-11R-A22K-07,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26724.0,Alive,,440.0,,[Not Available],,,,,[Not Available],,,0.0,440.0,0.0,440.0,,,0.0,440.0,
TCGA-BG-A2L7-01A-11R-A18M-07,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,[Not Available],-25091.0,Alive,TUMOR FREE,612.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,
TCGA-BK-A6W3-01A-12R-A34R-07,UCEC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12590.0,Alive,TUMOR FREE,305.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,305.0,0.0,305.0,0.0,305.0,0.0,305.0,
TCGA-B5-A3FB-01A-11R-A19W-07,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26779.0,Alive,TUMOR FREE,2844.0,,[Not Available],,,,,[Not Available],,,0.0,2844.0,0.0,2844.0,,,0.0,2844.0,
TCGA-D1-A179-01A-11R-A12I-07,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28037.0,Dead,WITH TUMOR,,448.0,[Not Available],Metastatic,Lung,,427.0,Complete Remission/Response,,,1.0,448.0,1.0,448.0,1.0,427.0,1.0,427.0,
TCGA-AP-A05O-01A-12R-A118-07,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24978.0,Alive,TUMOR FREE,384.0,,[Not Available],,,,340.0,Complete Remission/Response,,,0.0,384.0,0.0,384.0,1.0,340.0,1.0,340.0,
TCGA-D1-A161-01A-11R-A118-07,UCEC,78.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28695.0,Alive,TUMOR FREE,892.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,892.0,0.0,892.0,0.0,892.0,0.0,892.0,
TCGA-D1-A17K-01A-11R-A12I-07,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27283.0,Alive,TUMOR FREE,854.0,,[Not Available],Locoregional Disease,"Other, specify","Vagina, apex",815.0,Complete Remission/Response,,,0.0,854.0,0.0,854.0,1.0,815.0,1.0,815.0,
TCGA-EY-A1GC-01A-11R-A13S-07,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22656.0,Alive,TUMOR FREE,1647.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1647.0,0.0,1647.0,0.0,1647.0,0.0,1647.0,
TCGA-D1-A0ZV-01A-11R-A10J-07,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21374.0,Alive,TUMOR FREE,728.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,728.0,0.0,728.0,0.0,728.0,0.0,728.0,
TCGA-B5-A3S1-01A-11R-A22K-07,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26031.0,Alive,WITH TUMOR,902.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,902.0,0.0,902.0,0.0,902.0,0.0,902.0,
TCGA-D1-A2G5-01A-11R-A17B-07,UCEC,50.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18322.0,Alive,WITH TUMOR,1455.0,,[Not Available],Distant Metastasis,"Other, specify",omentum,1122.0,Complete Remission/Response,,,0.0,1455.0,0.0,1455.0,1.0,1122.0,1.0,1122.0,
TCGA-AJ-A5DV-01A-11R-A27V-07,UCEC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23892.0,Alive,TUMOR FREE,679.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,
TCGA-B5-A3FA-01A-11R-A19W-07,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26850.0,Alive,TUMOR FREE,2929.0,,[Not Available],,,,,[Not Available],,,0.0,2929.0,0.0,2929.0,,,0.0,2929.0,
TCGA-BS-A0WQ-01A-21R-A109-07,UCEC,55.0,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20131.0,Alive,TUMOR FREE,2022.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2022.0,0.0,2022.0,0.0,2022.0,0.0,2022.0,
TCGA-H5-A2HR-01A-11R-A180-07,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25986.0,Alive,TUMOR FREE,53.0,,[Not Available],,,,,[Not Available],,,0.0,53.0,0.0,53.0,,,0.0,53.0,
TCGA-AX-A062-01A-11R-A00V-07,UCEC,53.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2005.0,Indeterminate (neither Pre or Postmenopausal),-19643.0,Alive,TUMOR FREE,1399.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1399.0,0.0,1399.0,0.0,1399.0,0.0,1399.0,
TCGA-D1-A0ZU-01A-11R-A10J-07,UCEC,34.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12458.0,Alive,TUMOR FREE,872.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,872.0,0.0,872.0,0.0,872.0,0.0,872.0,
TCGA-D1-A16O-01A-11R-A12I-07,UCEC,44.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16114.0,Alive,TUMOR FREE,1023.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1023.0,0.0,1023.0,0.0,1023.0,0.0,1023.0,
TCGA-AX-A063-01A-11R-A00V-07,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23045.0,Alive,TUMOR FREE,2417.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2417.0,0.0,2417.0,0.0,2417.0,0.0,2417.0,
TCGA-EY-A1GU-01A-11R-A13S-07,UCEC,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24304.0,Dead,TUMOR FREE,,997.0,[Not Available],,,,,Complete Remission/Response,,,1.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,
TCGA-A5-A0GD-01A-11R-A16W-07,UCEC,75.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27399.0,Dead,TUMOR FREE,,3423.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3423.0,0.0,3423.0,0.0,3423.0,0.0,3423.0,
TCGA-A5-A0GB-01A-11R-A040-07,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23883.0,Alive,TUMOR FREE,997.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,
TCGA-AP-A0LN-01A-11R-A040-07,UCEC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20704.0,Alive,TUMOR FREE,2510.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2510.0,0.0,2510.0,0.0,2510.0,0.0,2510.0,
TCGA-AX-A1CI-01A-11R-A137-07,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22582.0,Alive,TUMOR FREE,2600.0,,[Not Available],,,,,[Not Available],,,0.0,2600.0,0.0,2600.0,,,0.0,2600.0,
TCGA-EO-A3KW-01A-11R-A22K-07,UCEC,72.0,FEMALE,[Not Available],[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26492.0,Alive,TUMOR FREE,497.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,497.0,0.0,497.0,0.0,497.0,0.0,497.0,
TCGA-EO-A3AZ-01A-12R-A19W-07,UCEC,80.0,FEMALE,[Not Available],[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29234.0,Alive,TUMOR FREE,826.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,826.0,0.0,826.0,0.0,826.0,0.0,826.0,
TCGA-BK-A26L-01A-11R-A16F-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-BK-A139-01A-11R-A118-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-A5-A2K7-01A-11R-A180-07,UCEC,41.0,FEMALE,[Not Available],[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14980.0,Alive,TUMOR FREE,1063.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0,
TCGA-BK-A26L-01C-04R-A277-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-EO-A3KU-01A-11R-A22K-07,UCEC,68.0,FEMALE,[Not Available],[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25116.0,Alive,TUMOR FREE,677.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,677.0,0.0,677.0,0.0,677.0,0.0,677.0,
TCGA-AP-A1DQ-01A-11R-A137-07,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,High Grade,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27815.0,Dead,WITH TUMOR,,1423.0,[Not Available],Metastatic,"Other, specify","Lymph nodes, lung, bone",905.0,Complete Remission/Response,,,1.0,1423.0,1.0,1423.0,1.0,905.0,1.0,905.0,
TCGA-D1-A17A-01A-11R-A12I-07,UCEC,59.0,FEMALE,WHITE,[Not Applicable],Stage IIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21560.0,Alive,TUMOR FREE,48.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,48.0,0.0,48.0,0.0,48.0,0.0,48.0,
TCGA-D1-A17B-01A-22R-A12I-07,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25504.0,Alive,TUMOR FREE,213.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,213.0,0.0,213.0,0.0,213.0,0.0,213.0,
TCGA-D1-A17M-01A-21R-A12I-07,UCEC,56.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20685.0,Alive,TUMOR FREE,311.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,311.0,0.0,311.0,0.0,311.0,0.0,311.0,
TCGA-FI-A2F4-01A-11R-A17B-07,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23621.0,Alive,TUMOR FREE,2230.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2230.0,0.0,2230.0,0.0,2230.0,0.0,2230.0,
TCGA-AX-A1C7-01A-11R-A137-07,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28198.0,Alive,,1054.0,,[Not Available],,,,390.0,[Not Applicable],,,0.0,1054.0,0.0,1054.0,,,1.0,390.0,
TCGA-B5-A1MR-01A-31R-A14D-07,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24017.0,Alive,TUMOR FREE,6859.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,6859.0,0.0,6859.0,0.0,6859.0,0.0,6859.0,
TCGA-AJ-A23O-01A-11R-A157-07,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25433.0,Dead,TUMOR FREE,,312.0,[Not Available],,,,,[Not Available],,,1.0,312.0,0.0,312.0,,,0.0,312.0,
TCGA-D1-A1NX-01A-11R-A16F-07,UCEC,66.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24441.0,Alive,WITH TUMOR,555.0,,[Not Available],Metastatic,"Other, specify",Supraclavicular lymphnodes,476.0,Complete Remission/Response,,,0.0,555.0,0.0,555.0,1.0,476.0,1.0,476.0,
TCGA-A3-3347-01A-02R-1325-07,KIRC,76.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-27966.0,Dead,WITH TUMOR,,1610.0,[Not Available],,,,610.0,[Not Available],,,1.0,1610.0,1.0,1610.0,,,1.0,610.0,
TCGA-A3-3329-01A-01R-0864-07,KIRC,75.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-27650.0,Alive,TUMOR FREE,1624.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1624.0,0.0,1624.0,0.0,1624.0,0.0,1624.0,
TCGA-CZ-5457-01A-01R-1503-07,KIRC,62.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-22763.0,Alive,WITH TUMOR,2754.0,,[Not Available],,,,174.0,[Not Available],,,0.0,2754.0,0.0,2754.0,,,1.0,174.0,
TCGA-B8-A54E-01A-11R-A266-07,KIRC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2011.0,[Not Available],-22900.0,Alive,TUMOR FREE,909.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,909.0,0.0,909.0,0.0,909.0,0.0,909.0,
TCGA-B4-5838-01A-11R-1672-07,KIRC,52.0,MALE,WHITE,[Discrepancy],[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-19242.0,Alive,WITH TUMOR,166.0,,[Not Available],,,,,[Not Applicable],,,0.0,166.0,0.0,166.0,,,0.0,166.0,
TCGA-CJ-5683-01A-11R-1541-07,KIRC,78.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-28745.0,Alive,TUMOR FREE,1889.0,,[Not Available],,,,,[Not Available],,,0.0,1889.0,0.0,1889.0,,,0.0,1889.0,
TCGA-B0-5088-01A-01R-1334-07,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-19677.0,Dead,TUMOR FREE,,563.0,[Not Available],,,,,[Not Available],,,1.0,563.0,0.0,563.0,,,0.0,563.0,
TCGA-B2-4099-01A-02R-1188-07,KIRC,83.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-30355.0,Alive,TUMOR FREE,972.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,
TCGA-CZ-4865-01A-02R-1503-07,KIRC,70.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-25709.0,Dead,TUMOR FREE,,166.0,[Not Available],,,,,[Not Available],,,1.0,166.0,0.0,166.0,,,0.0,166.0,
TCGA-B0-4701-01A-01R-1277-07,KIRC,66.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-24232.0,Dead,WITH TUMOR,,238.0,[Not Available],,,,,[Not Available],,,1.0,238.0,1.0,238.0,,,1.0,238.0,
TCGA-A3-3322-01A-02R-1325-07,KIRC,51.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-18754.0,Alive,TUMOR FREE,1478.0,,[Not Available],,,,,[Not Available],,,0.0,1478.0,0.0,1478.0,,,0.0,1478.0,
TCGA-B0-5400-01A-01R-1503-07,KIRC,59.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2008.0,[Not Available],-21819.0,Alive,TUMOR FREE,1733.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1733.0,0.0,1733.0,0.0,1733.0,0.0,1733.0,
TCGA-A3-A8OU-01A-11R-A37O-07,KIRC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2011.0,[Not Available],-27377.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-B0-4847-01A-01R-1277-07,KIRC,60.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-22147.0,Dead,[Discrepancy],,793.0,[Not Available],,,,,[Not Available],,,1.0,793.0,,793.0,,,0.0,793.0,
TCGA-CJ-6031-01A-11R-1672-07,KIRC,54.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-19905.0,Alive,TUMOR FREE,1906.0,,[Not Available],,,,,[Not Available],,,0.0,1906.0,0.0,1906.0,,,0.0,1906.0,
TCGA-CJ-5689-01A-11R-1541-07,KIRC,90.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2005.0,[Not Available],-32872.0,Dead,TUMOR FREE,,1620.0,[Not Available],,,,,[Not Available],,,1.0,1620.0,0.0,1620.0,,,0.0,1620.0,
TCGA-EU-5907-01A-11R-1672-07,KIRC,81.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-29863.0,Alive,TUMOR FREE,127.0,,[Not Available],,,,,[Not Available],,,0.0,127.0,0.0,127.0,,,0.0,127.0,
TCGA-B0-4718-01A-01R-1277-07,KIRC,57.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-20910.0,Alive,WITH TUMOR,1778.0,,[Not Available],,,,768.0,Progressive Disease,,,0.0,1778.0,0.0,1778.0,,,1.0,768.0,
TCGA-B0-5107-01A-01R-1420-07,KIRC,65.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-23929.0,Dead,WITH TUMOR,,927.0,[Not Available],,,,549.0,[Not Available],,,1.0,927.0,1.0,927.0,,,1.0,549.0,
TCGA-B8-4154-01A-01R-1188-07,KIRC,73.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-26882.0,Alive,TUMOR FREE,1380.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1380.0,0.0,1380.0,0.0,1380.0,0.0,1380.0,
TCGA-B0-5703-01A-11R-1541-07,KIRC,73.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2009.0,[Not Available],-26897.0,Alive,TUMOR FREE,2246.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2246.0,0.0,2246.0,0.0,2246.0,0.0,2246.0,
TCGA-CJ-6033-01A-11R-1672-07,KIRC,54.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-19919.0,Dead,WITH TUMOR,,224.0,[Not Available],,,,144.0,[Not Available],,,1.0,224.0,1.0,224.0,,,1.0,144.0,
TCGA-BP-4161-01A-02R-1325-07,KIRC,74.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-27119.0,Alive,WITH TUMOR,2746.0,,[Not Available],,,,2685.0,[Not Available],,,0.0,2746.0,0.0,2746.0,,,1.0,2685.0,
TCGA-B0-5104-01A-01R-1420-07,KIRC,90.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2002.0,[Not Available],-32873.0,Dead,TUMOR FREE,,2752.0,[Not Available],,,,,[Not Available],,,1.0,2752.0,0.0,2752.0,,,0.0,2752.0,
TCGA-A3-3373-01A-02R-1420-07,KIRC,54.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-19964.0,Alive,TUMOR FREE,1621.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0,
TCGA-BP-4170-01A-02R-1289-07,KIRC,72.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-26596.0,Dead,TUMOR FREE,,2343.0,[Not Available],,,,,[Not Available],,,1.0,2343.0,0.0,2343.0,,,0.0,2343.0,
TCGA-BP-4961-01A-01R-1334-07,KIRC,47.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-17284.0,Alive,TUMOR FREE,1935.0,,[Not Available],,,,,[Not Available],,,0.0,1935.0,0.0,1935.0,,,0.0,1935.0,
TCGA-CJ-5675-01A-11R-1541-07,KIRC,70.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-25617.0,Alive,WITH TUMOR,3936.0,,[Not Available],,,,900.0,Complete Remission/Response,,,0.0,3936.0,0.0,3936.0,1.0,900.0,1.0,900.0,
TCGA-CZ-5462-01A-01R-1503-07,KIRC,83.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-30659.0,Dead,WITH TUMOR,,311.0,[Not Available],,,,,[Not Available],,,1.0,311.0,1.0,311.0,,,1.0,311.0,
TCGA-A3-A6NJ-01A-12R-A33J-07,KIRC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2012.0,[Not Available],-20918.0,Alive,TUMOR FREE,468.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,468.0,0.0,468.0,0.0,468.0,0.0,468.0,
TCGA-BP-5195-01A-02R-1426-07,KIRC,75.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2008.0,[Not Available],-27547.0,Alive,TUMOR FREE,749.0,,[Not Available],,,,,[Not Available],,,0.0,749.0,0.0,749.0,,,0.0,749.0,
TCGA-B0-5699-01A-11R-1541-07,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-19647.0,Alive,TUMOR FREE,3841.0,,[Not Available],,,,94.0,Complete Remission/Response,,,0.0,3841.0,0.0,3841.0,1.0,94.0,1.0,94.0,
TCGA-CW-5581-01A-02R-1541-07,KIRC,44.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-16195.0,Alive,TUMOR FREE,2799.0,,[Not Available],,,,,[Not Available],,,0.0,2799.0,0.0,2799.0,,,0.0,2799.0,
TCGA-AK-3433-01A-02R-1277-07,KIRC,48.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,GX,2004.0,[Not Available],-17853.0,Alive,TUMOR FREE,3409.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3409.0,0.0,3409.0,0.0,3409.0,0.0,3409.0,
TCGA-BP-5201-01A-01R-1426-07,KIRC,63.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2008.0,[Not Available],-23125.0,Alive,WITH TUMOR,951.0,,[Not Available],,,,-19.0,[Not Available],,,0.0,951.0,0.0,951.0,,,1.0,,
TCGA-BP-4325-01A-02R-1289-07,KIRC,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2001.0,[Not Available],-23588.0,Alive,TUMOR FREE,2964.0,,[Not Available],,,,,[Not Available],,,0.0,2964.0,0.0,2964.0,,,0.0,2964.0,
TCGA-AK-3445-01A-02R-1277-07,KIRC,69.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-25494.0,Alive,TUMOR FREE,2392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2392.0,0.0,2392.0,0.0,2392.0,0.0,2392.0,
TCGA-B2-5633-01A-01R-A277-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-A3-3328-01A-01R-0864-07,KIRC,79.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-29168.0,Alive,TUMOR FREE,1385.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1385.0,0.0,1385.0,0.0,1385.0,0.0,1385.0,
TCGA-A3-A8OV-01A-11R-A37O-07,KIRC,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2011.0,[Not Available],-27526.0,Alive,TUMOR FREE,340.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,340.0,0.0,340.0,0.0,340.0,0.0,340.0,
TCGA-AK-3461-01A-02R-1277-07,KIRC,72.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-26464.0,Alive,TUMOR FREE,2217.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2217.0,0.0,2217.0,0.0,2217.0,0.0,2217.0,
TCGA-B0-5096-01A-01R-1420-07,KIRC,72.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,GX,1998.0,[Not Available],-26574.0,Dead,TUMOR FREE,,68.0,[Not Available],,,,,[Not Available],,,1.0,68.0,0.0,68.0,,,0.0,68.0,
TCGA-CZ-5988-01A-11R-1672-07,KIRC,38.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-14131.0,Alive,TUMOR FREE,693.0,,[Not Available],,,,,[Not Available],,,0.0,693.0,0.0,693.0,,,0.0,693.0,
TCGA-B0-5110-01A-01R-1420-07,KIRC,71.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2009.0,[Not Available],-25976.0,Alive,TUMOR FREE,2009.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0,
TCGA-CJ-4901-01A-01R-1426-07,KIRC,47.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-17396.0,Alive,TUMOR FREE,1450.0,,[Not Available],,,,,[Not Available],,,0.0,1450.0,0.0,1450.0,,,0.0,1450.0,
TCGA-CZ-5459-01A-01R-1503-07,KIRC,63.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-23318.0,Alive,TUMOR FREE,1683.0,,[Not Available],,,,,[Not Available],,,0.0,1683.0,0.0,1683.0,,,0.0,1683.0,
TCGA-B0-5106-01A-01R-1420-07,KIRC,64.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-23547.0,Dead,TUMOR FREE,,1598.0,[Not Available],,,,,[Not Available],,,1.0,1598.0,0.0,1598.0,,,0.0,1598.0,
TCGA-BP-4354-01A-02R-1289-07,KIRC,40.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-14973.0,Dead,WITH TUMOR,,1034.0,[Not Available],,,,685.0,[Not Available],,,1.0,1034.0,1.0,1034.0,,,1.0,685.0,
TCGA-B8-4146-01B-11R-1672-07,KIRC,41.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2009.0,[Not Available],-15063.0,Alive,TUMOR FREE,511.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,
TCGA-CZ-5455-01A-01R-1503-07,KIRC,63.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-23150.0,Dead,WITH TUMOR,,561.0,[Not Available],,,,,[Not Available],,,1.0,561.0,1.0,561.0,,,1.0,561.0,
TCGA-BP-5187-01A-01R-1426-07,KIRC,54.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-19999.0,Alive,TUMOR FREE,406.0,,[Not Available],,,,,[Not Available],,,0.0,406.0,0.0,406.0,,,0.0,406.0,
TCGA-B0-4833-01A-01R-1305-07,KIRC,82.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-30190.0,Dead,WITH TUMOR,,2386.0,[Not Available],,,,,[Not Available],,,1.0,2386.0,1.0,2386.0,,,1.0,2386.0,
TCGA-CZ-4853-01A-01R-1426-07,KIRC,82.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-30191.0,Alive,TUMOR FREE,774.0,,[Not Available],,,,,[Not Available],,,0.0,774.0,0.0,774.0,,,0.0,774.0,
TCGA-B0-4819-01A-01R-1277-07,KIRC,60.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2002.0,[Not Available],-22220.0,Dead,TUMOR FREE,183.0,183.0,[Not Available],,,,,[Not Available],,,1.0,183.0,0.0,183.0,,,0.0,183.0,
TCGA-G6-A8L6-01A-11R-A37O-07,KIRC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2013.0,[Not Available],-20306.0,Dead,WITH TUMOR,,313.0,[Not Available],,,,304.0,Progressive Disease,,,1.0,313.0,1.0,313.0,,,1.0,304.0,
TCGA-A3-3306-01A-01R-0864-07,KIRC,67.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-24569.0,Alive,,1120.0,,[Not Available],,,,,[Not Available],,,0.0,1120.0,0.0,1120.0,,,0.0,1120.0,
TCGA-CJ-5680-01A-11R-1541-07,KIRC,65.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2003.0,[Not Available],-23778.0,Dead,WITH TUMOR,,768.0,[Not Available],,,,153.0,[Not Available],,,1.0,768.0,1.0,768.0,,,1.0,153.0,
TCGA-BP-4985-01A-01R-1334-07,KIRC,72.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-26611.0,Dead,WITH TUMOR,,952.0,[Not Available],,,,205.0,[Not Available],,,1.0,952.0,1.0,952.0,,,1.0,205.0,
TCGA-CW-5580-01A-01R-1672-07,KIRC,73.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-26696.0,Dead,,,1964.0,[Not Available],,,,,[Not Available],,,1.0,1964.0,,1964.0,,,0.0,1964.0,
TCGA-BP-5200-01A-01R-1426-07,KIRC,44.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2008.0,[Not Available],-16197.0,Alive,TUMOR FREE,1063.0,,[Not Available],,,,,[Not Available],,,0.0,1063.0,0.0,1063.0,,,0.0,1063.0,
TCGA-B0-4822-01A-01R-1277-07,KIRC,78.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2002.0,[Not Available],-28774.0,Dead,WITH TUMOR,,1111.0,[Not Available],,,,,[Not Available],,,1.0,1111.0,1.0,1111.0,,,1.0,1111.0,
TCGA-B2-5633-01B-04R-A277-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-CJ-4900-01A-01R-1334-07,KIRC,69.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-25508.0,Dead,WITH TUMOR,,1714.0,[Not Available],,,,,[Not Available],,,1.0,1714.0,1.0,1714.0,,,1.0,1714.0,
TCGA-BP-5006-01A-01R-1334-07,KIRC,61.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-22324.0,Alive,TUMOR FREE,840.0,,[Not Available],,,,,[Not Available],,,0.0,840.0,0.0,840.0,,,0.0,840.0,
TCGA-B0-4827-01A-02R-1420-07,KIRC,77.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2002.0,[Not Available],-28467.0,Dead,WITH TUMOR,,885.0,[Not Available],,,,668.0,[Not Available],,,1.0,885.0,1.0,885.0,,,1.0,668.0,
TCGA-CW-5584-01A-01R-1541-07,KIRC,74.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-27352.0,Dead,,,164.0,[Not Available],,,,102.0,[Not Available],,,1.0,164.0,,164.0,,,1.0,102.0,
TCGA-CJ-4640-01A-02R-1325-07,KIRC,49.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-18178.0,Alive,TUMOR FREE,3480.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3480.0,0.0,3480.0,0.0,3480.0,0.0,3480.0,
TCGA-BP-4177-01A-02R-1420-07,KIRC,65.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-23955.0,Alive,TUMOR FREE,1670.0,,[Not Available],,,,,[Not Available],,,0.0,1670.0,0.0,1670.0,,,0.0,1670.0,
TCGA-CJ-4908-01A-01R-1426-07,KIRC,38.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-14226.0,Alive,TUMOR FREE,1531.0,,[Not Available],,,,,[Not Available],,,0.0,1531.0,0.0,1531.0,,,0.0,1531.0,
TCGA-B0-4849-01A-01R-1277-07,KIRC,51.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-18843.0,Dead,WITH TUMOR,,69.0,[Not Available],,,,4.0,[Not Available],,,1.0,69.0,1.0,69.0,,,1.0,4.0,
TCGA-AK-3447-01A-01R-1766-07,KIRC,83.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-30676.0,Alive,TUMOR FREE,1217.0,,[Not Available],,,,,[Not Available],,,0.0,1217.0,0.0,1217.0,,,0.0,1217.0,
TCGA-B0-4691-01A-01R-1277-07,KIRC,55.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2009.0,[Not Available],-20176.0,Dead,WITH TUMOR,,139.0,[Not Available],,,,,[Not Available],,,1.0,139.0,1.0,139.0,,,1.0,139.0,
TCGA-B0-4714-01A-01R-1277-07,KIRC,81.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-29873.0,Dead,WITH TUMOR,,99.0,[Not Available],,,,,[Not Available],,,1.0,99.0,1.0,99.0,,,1.0,99.0,
TCGA-CZ-4862-01A-01R-1305-07,KIRC,46.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-17077.0,Alive,[Discrepancy],3271.0,,[Not Available],,,,,[Not Available],,,0.0,3271.0,0.0,3271.0,,,0.0,3271.0,
TCGA-CJ-4643-01A-02R-1325-07,KIRC,67.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-24477.0,Alive,TUMOR FREE,1793.0,,[Not Available],,,,,[Not Available],,,0.0,1793.0,0.0,1793.0,,,0.0,1793.0,
TCGA-A3-3351-01A-02R-1325-07,KIRC,42.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-15562.0,Alive,TUMOR FREE,910.0,,[Not Available],,,,,[Not Available],,,0.0,910.0,0.0,910.0,,,0.0,910.0,
TCGA-BP-5202-01A-02R-1426-07,KIRC,75.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2008.0,[Not Available],-27556.0,Alive,TUMOR FREE,29.0,,[Not Available],,,,,[Not Available],,,0.0,29.0,0.0,29.0,,,0.0,29.0,
TCGA-CW-6090-01A-11R-1672-07,KIRC,68.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-24909.0,Alive,TUMOR FREE,2552.0,,[Not Available],,,,2780.0,[Not Available],,,0.0,2552.0,0.0,2552.0,,,1.0,2780.0,
TCGA-BP-4774-01A-01R-1289-07,KIRC,57.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-20827.0,Alive,TUMOR FREE,1885.0,,[Not Available],,,,,[Not Available],,,0.0,1885.0,0.0,1885.0,,,0.0,1885.0,
TCGA-BP-4782-01A-02R-1420-07,KIRC,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-20102.0,Alive,[Discrepancy],354.0,,[Not Available],,,,,[Not Available],,,0.0,354.0,0.0,354.0,,,0.0,354.0,
TCGA-44-8117-01A-11R-2241-07,LUAD,54.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-19855.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-50-5936-01A-11R-1628-07,LUAD,58.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-21238.0,Dead,WITH TUMOR,,257.0,[Not Available],,,,150.0,Progressive Disease,,,1.0,257.0,1.0,257.0,,,1.0,150.0,
TCGA-55-A494-01A-11R-A24X-07,LUAD,61.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22540.0,Alive,TUMOR FREE,481.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,
TCGA-78-7160-01A-11R-2039-07,LUAD,61.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-22385.0,Dead,,,697.0,[Not Available],,,,,Complete Remission/Response,,,1.0,697.0,,697.0,,,0.0,697.0,
TCGA-78-7158-01A-11R-2039-07,LUAD,59.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-21742.0,Dead,WITH TUMOR,,179.0,[Not Available],,,,132.0,Progressive Disease,,,1.0,179.0,1.0,179.0,,,1.0,132.0,
TCGA-78-7149-01A-11R-2039-07,LUAD,71.0,MALE,WHITE,Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-26285.0,Alive,,3940.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3940.0,0.0,3940.0,0.0,3940.0,0.0,3940.0,
TCGA-64-5775-01A-01R-1628-07,LUAD,71.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-26058.0,Dead,WITH TUMOR,,62.0,[Not Available],,,,,Progressive Disease,,,1.0,62.0,1.0,62.0,,,1.0,62.0,
TCGA-78-7147-01A-11R-2039-07,LUAD,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-24809.0,Dead,WITH TUMOR,,586.0,[Not Available],,,,578.0,[Not Available],,,1.0,586.0,1.0,586.0,,,1.0,578.0,
TCGA-44-6777-01A-11R-1858-07,LUAD,85.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-31234.0,Dead,TUMOR FREE,,987.0,[Not Available],,,,,Complete Remission/Response,,,1.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,
TCGA-49-4490-01A-21R-1858-07,LUAD,45.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1993.0,[Not Available],-16634.0,Dead,WITH TUMOR,,385.0,[Not Available],,,,,[Not Available],,,1.0,385.0,1.0,385.0,,,1.0,385.0,
TCGA-NJ-A4YF-01A-12R-A262-07,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-18584.0,Alive,TUMOR FREE,2161.0,,[Not Available],,,,,Stable Disease,,,0.0,2161.0,0.0,2161.0,,,0.0,2161.0,
TCGA-44-5643-01A-01R-1628-07,LUAD,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-19426.0,Alive,TUMOR FREE,1013.0,,[Not Available],,,,,[Not Available],,,0.0,1013.0,0.0,1013.0,,,0.0,1013.0,
TCGA-86-8674-01A-21R-2403-07,LUAD,50.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-18479.0,Alive,TUMOR FREE,806.0,,[Not Available],Locoregional Recurrence,,,334.0,Complete Remission/Response,,,0.0,806.0,0.0,806.0,1.0,334.0,1.0,334.0,
TCGA-99-8033-01A-11R-2241-07,LUAD,74.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27342.0,Dead,WITH TUMOR,,656.0,[Not Available],,,,,Progressive Disease,,,1.0,656.0,1.0,656.0,,,1.0,656.0,
TCGA-91-8497-01A-11R-2403-07,LUAD,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27632.0,Dead,TUMOR FREE,,434.0,[Not Available],,,,,Complete Remission/Response,,,1.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,
TCGA-86-7711-01A-11R-2066-07,LUAD,70.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25719.0,Dead,WITH TUMOR,,1046.0,[Not Available],,,,,Progressive Disease,,,1.0,1046.0,1.0,1046.0,,,1.0,1046.0,
TCGA-55-7724-01A-11R-2170-07,LUAD,76.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27891.0,Alive,TUMOR FREE,705.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,705.0,0.0,705.0,0.0,705.0,0.0,705.0,
TCGA-67-3774-01A-01R-0946-07,LUAD,73.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-26704.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],,,0.0,385.0,0.0,385.0,,,0.0,385.0,
TCGA-67-3773-01A-01R-0946-07,LUAD,84.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-30706.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,[Not Available],,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-50-8460-01A-11R-2326-07,LUAD,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27270.0,Alive,TUMOR FREE,829.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,829.0,0.0,829.0,0.0,829.0,0.0,829.0,
TCGA-44-6146-01A-11R-1755-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-86-8280-01A-11R-2287-07,LUAD,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-19977.0,Alive,TUMOR FREE,701.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,701.0,0.0,701.0,0.0,701.0,0.0,701.0,
TCGA-55-8615-01A-11R-2403-07,LUAD,67.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-24786.0,Alive,WITH TUMOR,446.0,,[Not Available],Distant Metastasis,,,224.0,Complete Remission/Response,,,0.0,446.0,0.0,446.0,1.0,224.0,1.0,224.0,
TCGA-50-5930-01A-11R-1755-07,LUAD,47.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-17238.0,Dead,WITH TUMOR,,282.0,[Not Available],Distant Metastasis,,,177.0,Progressive Disease,,,1.0,282.0,1.0,282.0,,,1.0,177.0,
TCGA-44-2662-01A-01R-A278-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-62-A46V-01A-11R-A24H-07,LUAD,78.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-28495.0,Alive,TUMOR FREE,2199.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2199.0,0.0,2199.0,0.0,2199.0,0.0,2199.0,
TCGA-55-7281-01A-11R-2039-07,LUAD,70.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25870.0,Alive,WITH TUMOR,872.0,,[Not Available],Distant Metastasis,,,339.0,Complete Remission/Response,,,0.0,872.0,0.0,872.0,1.0,339.0,1.0,339.0,
TCGA-44-5644-01A-21R-2039-07,LUAD,51.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-18644.0,Alive,TUMOR FREE,863.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,863.0,0.0,863.0,0.0,863.0,0.0,863.0,
TCGA-MN-A4N5-01A-11R-A24X-07,LUAD,63.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23257.0,Alive,TUMOR FREE,84.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,84.0,0.0,84.0,0.0,84.0,0.0,84.0,
TCGA-78-7145-01A-11R-2039-07,LUAD,52.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2000.0,[Not Available],-19080.0,Dead,WITH TUMOR,,826.0,[Not Available],,,,422.0,[Not Available],,,1.0,826.0,1.0,826.0,,,1.0,422.0,
TCGA-05-5420-01A-01R-1628-07,LUAD,67.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-24472.0,Alive,WITH TUMOR,457.0,,[Not Available],,,,245.0,Progressive Disease,,,0.0,457.0,0.0,457.0,,,1.0,245.0,
TCGA-55-7911-01A-11R-2170-07,LUAD,70.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25746.0,Alive,TUMOR FREE,537.0,,[Not Available],New Primary Tumor,,,515.0,Complete Remission/Response,,,0.0,537.0,0.0,537.0,0.0,537.0,1.0,515.0,
TCGA-44-7661-01A-11R-2066-07,LUAD,69.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25483.0,Dead,WITH TUMOR,,557.0,[Not Available],Locoregional Recurrence,,,335.0,Complete Remission/Response,,,1.0,557.0,1.0,557.0,1.0,335.0,1.0,335.0,
TCGA-97-7941-01A-11R-2187-07,LUAD,72.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26298.0,Alive,TUMOR FREE,484.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,484.0,0.0,484.0,0.0,484.0,0.0,484.0,
TCGA-97-7554-01A-11R-2039-07,LUAD,83.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-30327.0,Alive,TUMOR FREE,775.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,
TCGA-55-7815-01A-11R-2170-07,LUAD,76.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-28119.0,Alive,WITH TUMOR,773.0,,[Not Available],Locoregional Recurrence,,,466.0,Complete Remission/Response,,,0.0,773.0,0.0,773.0,1.0,466.0,1.0,466.0,
TCGA-55-6985-01A-11R-1949-07,LUAD,58.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-21381.0,Alive,TUMOR FREE,1233.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1233.0,0.0,1233.0,0.0,1233.0,0.0,1233.0,
TCGA-91-7771-01A-11R-2170-07,LUAD,62.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22926.0,Alive,TUMOR FREE,492.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,
TCGA-69-7764-01A-11R-2170-07,LUAD,75.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-27693.0,Alive,TUMOR FREE,414.0,,[Not Available],,,,,[Not Available],,,0.0,414.0,0.0,414.0,,,0.0,414.0,
TCGA-55-8092-01A-11R-2241-07,LUAD,75.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27597.0,Dead,WITH TUMOR,,154.0,[Not Available],Locoregional Recurrence,,,127.0,Complete Remission/Response,,,1.0,154.0,1.0,154.0,1.0,127.0,1.0,127.0,
TCGA-62-A46O-01A-11R-A24H-07,LUAD,65.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-24050.0,Dead,WITH TUMOR,,1454.0,[Not Available],Locoregional Recurrence|Distant Metastasis,,,943.0,Complete Remission/Response,,,1.0,1454.0,1.0,1454.0,1.0,943.0,1.0,943.0,
TCGA-99-8032-01A-11R-2241-07,LUAD,61.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22635.0,Alive,TUMOR FREE,44.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,44.0,0.0,44.0,0.0,44.0,0.0,44.0,
TCGA-91-6828-01A-11R-1858-07,LUAD,70.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25870.0,Alive,TUMOR FREE,323.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,
TCGA-L9-A50W-01A-12R-A39D-07,LUAD,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27414.0,Dead,WITH TUMOR,,442.0,[Not Available],Distant Metastasis,,,389.0,Complete Remission/Response,,,1.0,442.0,1.0,442.0,1.0,389.0,1.0,389.0,
TCGA-55-8505-01A-11R-2403-07,LUAD,62.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22676.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,
TCGA-97-7937-01A-11R-2170-07,LUAD,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23919.0,Alive,TUMOR FREE,564.0,,[Not Available],,,,,Stable Disease,,,0.0,564.0,0.0,564.0,,,0.0,564.0,
TCGA-97-8179-01A-11R-2287-07,LUAD,72.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26305.0,Alive,TUMOR FREE,435.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,
TCGA-05-5715-01A-01R-1628-07,LUAD,69.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-25383.0,Alive,TUMOR FREE,62.0,,[Not Available],,,,,[Not Available],,,0.0,62.0,0.0,62.0,,,0.0,62.0,
TCGA-50-6592-01A-11R-1755-07,LUAD,71.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-26191.0,Dead,WITH TUMOR,,777.0,[Not Available],,,,,Progressive Disease,,,1.0,777.0,1.0,777.0,,,1.0,777.0,
TCGA-78-8640-01A-11R-2403-07,LUAD,59.0,MALE,[Not Evaluated],Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1994.0,[Not Available],-21832.0,Alive,TUMOR FREE,7062.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,7062.0,0.0,7062.0,0.0,7062.0,0.0,7062.0,
TCGA-86-8585-01A-11R-2403-07,LUAD,57.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-20918.0,Alive,TUMOR FREE,353.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,353.0,0.0,353.0,0.0,353.0,0.0,353.0,
TCGA-50-5931-01A-11R-1755-07,LUAD,75.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-27733.0,Dead,WITH TUMOR,,434.0,[Not Available],Distant Metastasis,,,425.0,Progressive Disease,,,1.0,434.0,1.0,434.0,,,1.0,425.0,
TCGA-93-8067-01A-11R-2287-07,LUAD,77.0,MALE,ASIAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-28453.0,Alive,TUMOR FREE,186.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,186.0,0.0,186.0,0.0,186.0,0.0,186.0,
TCGA-44-2656-01A-02R-0946-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-44-2665-01A-01R-A278-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-86-8668-01A-11R-2403-07,LUAD,61.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22383.0,Alive,TUMOR FREE,423.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,
TCGA-MP-A4T8-01A-11R-A24X-07,LUAD,68.0,MALE,[Unknown],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-25069.0,Dead,,,161.0,[Not Available],,,,,[Unknown],,,1.0,161.0,,161.0,,,0.0,161.0,
TCGA-44-A4SS-01A-11R-A24X-07,LUAD,73.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26991.0,Alive,TUMOR FREE,415.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,415.0,0.0,415.0,0.0,415.0,0.0,415.0,
TCGA-97-8172-01A-11R-2287-07,LUAD,75.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27416.0,Alive,TUMOR FREE,545.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,545.0,0.0,545.0,0.0,545.0,0.0,545.0,
TCGA-49-6744-01A-11R-1858-07,LUAD,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-23484.0,Alive,TUMOR FREE,1683.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1683.0,0.0,1683.0,0.0,1683.0,0.0,1683.0,
TCGA-4B-A93V-01A-11R-A39D-07,LUAD,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2013.0,[Not Available],-19035.0,Dead,WITH TUMOR,,300.0,[Not Available],Distant Metastasis,,,251.0,Progressive Disease,,,1.0,300.0,1.0,300.0,,,1.0,251.0,
TCGA-44-2661-01A-01R-1107-07,LUAD,69.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-25313.0,Alive,TUMOR FREE,1159.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1159.0,0.0,1159.0,0.0,1159.0,0.0,1159.0,
TCGA-05-4396-01A-21R-1858-07,LUAD,76.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-28094.0,Dead,,,303.0,[Not Available],,,,,[Not Available],,,1.0,303.0,,303.0,,,0.0,303.0,
TCGA-91-A4BD-01A-11R-A24H-07,LUAD,78.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28544.0,Alive,TUMOR FREE,603.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,603.0,0.0,603.0,0.0,603.0,0.0,603.0,
TCGA-55-6975-01A-11R-1949-07,LUAD,61.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],,Dead,WITH TUMOR,,118.0,[Not Available],,,,,Progressive Disease,,,1.0,118.0,1.0,118.0,,,1.0,118.0,
TCGA-49-6761-01A-31R-1949-07,LUAD,68.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-24849.0,Alive,TUMOR FREE,354.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,354.0,0.0,354.0,0.0,354.0,0.0,354.0,
TCGA-MP-A4TF-01A-11R-A262-07,LUAD,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-21387.0,Dead,WITH TUMOR,,336.0,[Not Available],Distant Metastasis,,,195.0,Partial Remission/Response,,,1.0,336.0,1.0,336.0,,,1.0,195.0,
TCGA-44-2656-01B-06R-A277-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-44-3918-01A-01R-A278-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-55-A57B-01A-12R-A39D-07,LUAD,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-29452.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-62-A46Y-01A-11R-A24H-07,LUAD,70.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-25905.0,Dead,WITH TUMOR,,414.0,[Not Available],Distant Metastasis,,,314.0,Complete Remission/Response,,,1.0,414.0,1.0,414.0,1.0,314.0,1.0,314.0,
TCGA-49-AAR2-01A-11R-A39D-07,LUAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-23479.0,Alive,TUMOR FREE,2224.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2224.0,0.0,2224.0,0.0,2224.0,0.0,2224.0,
TCGA-05-5423-01A-01R-1628-07,LUAD,65.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-23863.0,Alive,TUMOR FREE,151.0,,[Not Available],,,,,[Not Available],,,0.0,151.0,0.0,151.0,,,0.0,151.0,
TCGA-91-A4BC-01A-11R-A24H-07,LUAD,59.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-21565.0,Alive,,44.0,,[Not Available],,,,,[Unknown],,,0.0,44.0,0.0,44.0,,,0.0,44.0,
TCGA-86-8056-01A-11R-2241-07,LUAD,63.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23369.0,Alive,TUMOR FREE,139.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,139.0,0.0,139.0,0.0,139.0,0.0,139.0,
TCGA-49-6745-01A-11R-1858-07,LUAD,82.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-30133.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,[Not Available],,,0.0,522.0,0.0,522.0,,,0.0,522.0,
TCGA-55-8096-01A-11R-2241-07,LUAD,67.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-24684.0,Dead,WITH TUMOR,,719.0,[Not Available],Distant Metastasis,,,566.0,Complete Remission/Response,,,1.0,719.0,1.0,719.0,1.0,566.0,1.0,566.0,
TCGA-44-6774-01A-21R-1858-07,LUAD,56.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-20462.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,
TCGA-05-4402-01A-01R-1206-07,LUAD,57.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-20819.0,Dead,TUMOR FREE,,244.0,[Not Available],,,,,Complete Remission/Response,,,1.0,244.0,0.0,244.0,,,0.0,244.0,
TCGA-69-7761-01A-11R-2170-07,LUAD,84.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-31041.0,Alive,TUMOR FREE,186.0,,[Not Available],,,,,[Not Available],,,0.0,186.0,0.0,186.0,,,0.0,186.0,
TCGA-HT-8011-01A-11R-2403-07,LGG,55.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-20175.0,Alive,WITH TUMOR,494.0,,[Not Available],,,,278.0,Stable Disease,,,0.0,494.0,0.0,494.0,,,1.0,278.0,
TCGA-RY-A83Y-01A-11R-A36H-07,LGG,45.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-16470.0,Alive,TUMOR FREE,166.0,,[Not Available],,,,,[Not Available],,,0.0,166.0,0.0,166.0,,,0.0,166.0,
TCGA-HT-7616-01A-11R-2256-07,LGG,75.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2007.0,[Not Available],-27685.0,Dead,WITH TUMOR,,7.0,[Not Available],,,,,Progressive Disease,,,1.0,7.0,1.0,7.0,,,1.0,7.0,
TCGA-P5-A737-01A-11R-A32Q-07,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-17390.0,Alive,TUMOR FREE,372.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,
TCGA-HT-7884-01B-11R-2403-07,LGG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-16280.0,Alive,[Discrepancy],343.0,,[Not Available],,,,,Stable Disease,,,0.0,343.0,0.0,343.0,,,0.0,343.0,
TCGA-KT-A7W1-01A-11R-A34F-07,LGG,45.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-16560.0,Alive,TUMOR FREE,438.0,,[Not Available],,,,84.0,Progressive Disease,,,0.0,438.0,0.0,438.0,,,1.0,84.0,
TCGA-TQ-A7RN-01A-11R-A33Z-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-TM-A84J-01A-11R-A36H-07,LGG,63.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-23091.0,Alive,WITH TUMOR,735.0,,[Not Available],,,,454.0,Progressive Disease,,,0.0,735.0,0.0,735.0,,,1.0,454.0,
TCGA-HT-8106-01A-11R-2404-07,LGG,53.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-19555.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,Stable Disease,,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-W9-A837-01A-11R-A36H-07,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],,Alive,WITH TUMOR,1553.0,,[Not Available],,,,,Stable Disease,,,0.0,1553.0,0.0,1553.0,,,0.0,1553.0,
TCGA-HT-7882-01A-11R-2403-07,LGG,66.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2010.0,[Not Available],-24450.0,Dead,WITH TUMOR,,113.0,[Not Available],,,,,Progressive Disease,,,1.0,113.0,1.0,113.0,,,1.0,113.0,
TCGA-RY-A843-01A-11R-A36H-07,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-11083.0,Alive,WITH TUMOR,63.0,,[Not Available],,,,,[Not Available],,,0.0,63.0,0.0,63.0,,,0.0,63.0,
TCGA-HT-7855-01A-11R-2403-07,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-14496.0,Alive,TUMOR FREE,585.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,
TCGA-DU-8166-01A-11R-2256-07,LGG,29.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-10641.0,Alive,WITH TUMOR,516.0,,[Not Available],,,,193.0,Progressive Disease,,,0.0,516.0,0.0,516.0,,,1.0,193.0,
TCGA-DU-A76O-01A-11R-A32Q-07,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-10960.0,Alive,WITH TUMOR,522.0,,[Not Available],,,,,[Unknown],,,0.0,522.0,0.0,522.0,,,0.0,522.0,
TCGA-DB-A4XE-01A-11R-A27Q-07,LGG,27.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-10150.0,Alive,TUMOR FREE,1139.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1139.0,0.0,1139.0,0.0,1139.0,0.0,1139.0,
TCGA-TM-A84S-01A-11R-A36H-07,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-13424.0,Alive,TUMOR FREE,454.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,454.0,0.0,454.0,0.0,454.0,0.0,454.0,
TCGA-DB-A64W-01A-11R-A29R-07,LGG,65.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2012.0,[Not Available],-23936.0,Dead,TUMOR FREE,,438.0,[Not Available],,,,,Stable Disease,,,1.0,438.0,0.0,438.0,,,0.0,438.0,
TCGA-IK-8125-01A-11R-2256-07,LGG,62.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2009.0,[Not Available],-22745.0,Alive,TUMOR FREE,1301.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0,
TCGA-CS-4944-01A-01R-1470-07,LGG,50.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-18494.0,Alive,WITH TUMOR,1828.0,,[Not Available],,,,,Stable Disease,,,0.0,1828.0,0.0,1828.0,,,0.0,1828.0,
TCGA-QH-A6CV-01A-11R-A31N-07,LGG,51.0,MALE,ASIAN,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-18955.0,Alive,WITH TUMOR,442.0,,[Not Available],,,,,Stable Disease,,,0.0,442.0,0.0,442.0,,,0.0,442.0,
TCGA-HW-A5KL-01A-11R-A27Q-07,LGG,42.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-15513.0,Alive,WITH TUMOR,878.0,,[Not Available],,,,,Stable Disease,,,0.0,878.0,0.0,878.0,,,0.0,878.0,
TCGA-HW-8319-01A-11R-2404-07,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-12557.0,Dead,WITH TUMOR,,1209.0,[Not Available],,,,997.0,Partial Remission/Response,,,1.0,1209.0,1.0,1209.0,,,1.0,997.0,
TCGA-DU-7008-01A-11R-2027-07,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1998.0,[Not Available],-15289.0,Alive,TUMOR FREE,4752.0,,[Not Available],,,,330.0,Progressive Disease,,,0.0,4752.0,0.0,4752.0,,,1.0,330.0,
TCGA-DU-6400-01A-12R-1708-07,LGG,66.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1998.0,[Not Available],-24122.0,Dead,WITH TUMOR,,37.0,[Not Available],,,,,[Not Available],,,1.0,37.0,1.0,37.0,,,1.0,37.0,
TCGA-DU-6404-02A-21R-A36H-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-HT-7684-01A-11R-2256-07,LGG,58.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2008.0,[Not Available],-21352.0,Alive,TUMOR FREE,184.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,184.0,0.0,184.0,0.0,184.0,0.0,184.0,
TCGA-DU-8161-01A-11R-2256-07,LGG,63.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2009.0,[Not Available],-23064.0,Dead,WITH TUMOR,,722.0,[Not Available],,,,111.0,Progressive Disease,,,1.0,722.0,1.0,722.0,,,1.0,111.0,
TCGA-QH-A6CU-01A-11R-A31N-07,LGG,52.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-19149.0,Alive,TUMOR FREE,451.0,,[Not Available],,,,,Stable Disease,,,0.0,451.0,0.0,451.0,,,0.0,451.0,
TCGA-WY-A859-01A-12R-A36H-07,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-12631.0,Alive,WITH TUMOR,1213.0,,[Not Available],,,,,Stable Disease,,,0.0,1213.0,0.0,1213.0,,,0.0,1213.0,
TCGA-DU-6395-01A-13R-1708-07,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,1994.0,[Not Available],-11584.0,Dead,WITH TUMOR,,1491.0,[Not Available],,,,1197.0,Progressive Disease,,,1.0,1491.0,1.0,1491.0,,,1.0,1197.0,
TCGA-HT-7475-01A-11R-2027-07,LGG,67.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2010.0,[Not Available],-24686.0,Alive,TUMOR FREE,530.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,530.0,0.0,530.0,0.0,530.0,0.0,530.0,
TCGA-HT-7470-01A-12R-2090-07,LGG,37.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-13611.0,Dead,TUMOR FREE,,1220.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,
TCGA-S9-A6WN-01A-12R-A33Z-07,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-13961.0,Alive,WITH TUMOR,805.0,,[Not Available],,,,303.0,Progressive Disease,,,0.0,805.0,0.0,805.0,,,1.0,303.0,
TCGA-DB-A75L-01A-11R-A32Q-07,LGG,36.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-13338.0,Alive,TUMOR FREE,342.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,342.0,0.0,342.0,0.0,342.0,0.0,342.0,
TCGA-QH-A6X5-01A-12R-A32Q-07,LGG,58.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-21239.0,Alive,,497.0,,[Not Available],,,,,[Unknown],,,0.0,497.0,0.0,497.0,,,0.0,497.0,
TCGA-QH-A6X4-01A-51R-A32Q-07,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-17258.0,Alive,TUMOR FREE,442.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,
TCGA-HT-8015-01B-11R-A28M-07,LGG,21.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2008.0,[Not Available],-7760.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3.0,0.0,3.0,0.0,3.0,0.0,3.0,
TCGA-FG-A4MX-01A-11R-A26U-07,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-17381.0,Alive,TUMOR FREE,569.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,569.0,0.0,569.0,0.0,569.0,0.0,569.0,
TCGA-HT-A618-01A-11R-A29R-07,LGG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-13595.0,Alive,TUMOR FREE,512.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,
TCGA-P5-A72Z-01A-11R-A32Q-07,LGG,64.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-23482.0,Alive,TUMOR FREE,354.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,354.0,0.0,354.0,0.0,354.0,0.0,354.0,
TCGA-DU-A5TP-01A-11R-A28M-07,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-12111.0,Alive,TUMOR FREE,1012.0,,[Not Available],,,,203.0,[Discrepancy],,,0.0,1012.0,0.0,1012.0,,,1.0,203.0,
TCGA-P5-A5F0-01A-11R-A28M-07,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-12157.0,Alive,[Discrepancy],287.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,287.0,0.0,287.0,,,0.0,287.0,
TCGA-S9-A6U5-01A-12R-A33Z-07,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-12417.0,Alive,TUMOR FREE,992.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,992.0,0.0,992.0,0.0,992.0,0.0,992.0,
TCGA-DH-A7UU-01A-12R-A34F-07,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-16037.0,Alive,WITH TUMOR,417.0,,[Not Available],,,,,Stable Disease,,,0.0,417.0,0.0,417.0,,,0.0,417.0,
TCGA-DU-6397-02A-12R-A36H-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-FG-A4MT-02A-11R-A29R-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-HT-7472-01A-11R-2027-07,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-13968.0,Alive,TUMOR FREE,1.0,,[Not Available],,,,,Stable Disease,,,0.0,1.0,0.0,1.0,,,0.0,1.0,
TCGA-HT-8013-01A-11R-2403-07,LGG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2005.0,[Not Available],-13753.0,Dead,WITH TUMOR,,1933.0,[Not Available],,,,1306.0,Stable Disease,,,1.0,1933.0,1.0,1933.0,,,1.0,1306.0,
TCGA-CS-6668-01A-11R-1896-07,LGG,57.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-20836.0,Alive,WITH TUMOR,1519.0,,[Not Available],,,,,Stable Disease,,,0.0,1519.0,0.0,1519.0,,,0.0,1519.0,
TCGA-QH-A6X8-01A-12R-A32Q-07,LGG,56.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-20771.0,Alive,WITH TUMOR,509.0,,[Not Available],,,,,Stable Disease,,,0.0,509.0,0.0,509.0,,,0.0,509.0,
TCGA-TQ-A7RU-01A-21R-A34F-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-FG-A60L-01A-12R-A31N-07,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-12580.0,Alive,TUMOR FREE,655.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,655.0,0.0,655.0,0.0,655.0,0.0,655.0,
TCGA-S9-A7R2-01A-21R-A34R-07,LGG,69.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-25419.0,Dead,WITH TUMOR,,316.0,[Not Available],,,,,Progressive Disease,,,1.0,316.0,1.0,316.0,,,1.0,316.0,
TCGA-S9-A6TW-01A-12R-A32Q-07,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-14679.0,Alive,TUMOR FREE,1250.0,,[Not Available],,,,861.0,Partial Remission/Response,,,0.0,1250.0,0.0,1250.0,,,1.0,861.0,
TCGA-DH-A7UV-01A-12R-A34F-07,LGG,49.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-18161.0,Alive,WITH TUMOR,566.0,,[Not Available],,,,,Stable Disease,,,0.0,566.0,0.0,566.0,,,0.0,566.0,
TCGA-TQ-A7RR-01A-21R-A34F-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-HT-7601-01A-11R-2090-07,LGG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-10989.0,Alive,TUMOR FREE,153.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,153.0,0.0,153.0,,,0.0,153.0,
TCGA-HT-7478-01A-11R-2027-07,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-13216.0,Alive,TUMOR FREE,194.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,
TCGA-S9-A7R3-01A-11R-A34R-07,LGG,28.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2006.0,[Not Available],-10342.0,Alive,TUMOR FREE,3013.0,,[Not Available],,,,970.0,Partial Remission/Response,,,0.0,3013.0,0.0,3013.0,,,1.0,970.0,
TCGA-HT-7854-01A-11R-2256-07,LGG,62.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-22738.0,Alive,TUMOR FREE,1201.0,,[Not Available],,,,1147.0,Stable Disease,,,0.0,1201.0,0.0,1201.0,,,1.0,1147.0,
TCGA-S9-A6WO-01A-21R-A34F-07,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-10933.0,Alive,WITH TUMOR,566.0,,[Not Available],,,,187.0,Progressive Disease,,,0.0,566.0,0.0,566.0,,,1.0,187.0,
TCGA-HT-8558-01A-21R-2404-07,LGG,29.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-10950.0,Alive,TUMOR FREE,418.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,418.0,0.0,418.0,0.0,418.0,0.0,418.0,
TCGA-TQ-A8XE-02A-11R-A36H-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-DU-6406-01A-11R-1708-07,LGG,59.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2001.0,[Not Available],-21634.0,Dead,,,512.0,[Not Available],,,,,[Not Available],,,1.0,512.0,,512.0,,,0.0,512.0,
TCGA-TQ-A7RO-01A-11R-A33Z-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-IK-7675-01A-11R-2090-07,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2009.0,[Not Available],-15900.0,Dead,WITH TUMOR,,578.0,[Not Available],,,,123.0,Progressive Disease,,,1.0,578.0,1.0,578.0,,,1.0,123.0,
TCGA-DH-A7UR-01A-11R-A33Z-07,LGG,59.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2008.0,[Not Available],-21803.0,Alive,TUMOR FREE,1650.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1650.0,0.0,1650.0,0.0,1650.0,0.0,1650.0,
TCGA-QH-A65X-01A-11R-A32Q-07,LGG,28.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-10440.0,Alive,TUMOR FREE,482.0,,[Not Available],,,,,Stable Disease,,,0.0,482.0,0.0,482.0,,,0.0,482.0,
TCGA-FG-6691-01A-11R-1896-07,LGG,23.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-8403.0,Alive,WITH TUMOR,1257.0,,[Not Available],,,,913.0,Complete Remission/Response,,,0.0,1257.0,0.0,1257.0,1.0,913.0,1.0,913.0,
TCGA-HT-7476-01A-11R-2027-07,LGG,26.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-9614.0,Alive,TUMOR FREE,199.0,,[Not Available],,,,,Stable Disease,,,0.0,199.0,0.0,199.0,,,0.0,199.0,
TCGA-TM-A7CF-01A-11R-A32Q-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-HW-A5KJ-01A-12R-A27Q-07,LGG,68.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-24966.0,Dead,WITH TUMOR,,962.0,[Not Available],,,,615.0,Progressive Disease,,,1.0,962.0,1.0,962.0,,,1.0,615.0,
TCGA-DB-5278-01A-01R-1470-07,LGG,17.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2007.0,[Not Available],-6480.0,Alive,WITH TUMOR,2772.0,,[Not Available],,,,507.0,Stable Disease,,,0.0,2772.0,0.0,2772.0,,,1.0,507.0,
TCGA-HT-7875-01A-11R-2403-07,LGG,56.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-20613.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,Stable Disease,,,0.0,10.0,0.0,10.0,,,0.0,10.0,
TCGA-FG-8182-01A-11R-2256-07,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-12972.0,Alive,WITH TUMOR,416.0,,[Not Available],,,,,Stable Disease,,,0.0,416.0,0.0,416.0,,,0.0,416.0,
TCGA-TM-A84G-01A-11R-A36H-07,LGG,54.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2010.0,[Not Available],-20014.0,Alive,TUMOR FREE,1236.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1236.0,0.0,1236.0,0.0,1236.0,0.0,1236.0,
TCGA-HT-7603-01A-21R-2090-07,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-10883.0,Alive,TUMOR FREE,705.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,705.0,0.0,705.0,0.0,705.0,0.0,705.0,
TCGA-TQ-A7RF-01A-11R-A33Z-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-DB-A64Q-01A-11R-A29R-07,LGG,31.0,FEMALE,[Unknown],[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-11637.0,Alive,TUMOR FREE,182.0,,[Not Available],,,,,Stable Disease,,,0.0,182.0,0.0,182.0,,,0.0,182.0,
TCGA-EM-A2P2-01A-11R-A206-07,THCA,46.0,MALE,[Not Available],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-16895.0,Alive,TUMOR FREE,526.0,,[Not Available],,,,,[Not Available],,R0,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,
TCGA-EM-A2P3-01A-11R-A206-07,THCA,47.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-17495.0,Alive,TUMOR FREE,444.0,,[Not Available],,,,,[Not Available],,R0,0.0,444.0,0.0,444.0,0.0,444.0,0.0,444.0,
TCGA-ET-A3DT-01A-11R-A19O-07,THCA,23.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-8761.0,Alive,TUMOR FREE,1330.0,,[Not Available],,,,,[Not Available],,R0,0.0,1330.0,0.0,1330.0,0.0,1330.0,0.0,1330.0,
TCGA-BJ-A4O9-01A-11R-A250-07,THCA,51.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-18938.0,Alive,TUMOR FREE,714.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,714.0,0.0,714.0,,,0.0,714.0,
TCGA-EM-A2CK-01A-11R-A180-07,THCA,28.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-10485.0,Alive,TUMOR FREE,544.0,,[Not Available],,,,,[Not Available],,R0,0.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,
TCGA-J8-A3YE-01A-12R-A23N-07,THCA,31.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-11446.0,Alive,TUMOR FREE,847.0,,[Not Available],,,,,[Not Available],,R0,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,
TCGA-ET-A3DO-01A-11R-A19O-07,THCA,33.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-12158.0,Alive,TUMOR FREE,3552.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,570.0,[Not Available],,R0,0.0,3552.0,0.0,3552.0,1.0,570.0,1.0,570.0,
TCGA-BJ-A190-01A-11R-A13Y-07,THCA,55.0,MALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20407.0,Alive,TUMOR FREE,626.0,,[Not Available],,,,,[Not Available],,R0,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,
TCGA-BJ-A0ZF-01A-11R-A10U-07,THCA,54.0,FEMALE,WHITE,Stage II,[Not Applicable],"Other, specify",[Not Available],2010.0,[Not Available],-19978.0,Alive,WITH TUMOR,1217.0,,[Not Available],Locoregional Recurrence,,,735.0,[Not Available],,R0,0.0,1217.0,0.0,1217.0,1.0,735.0,1.0,735.0,
TCGA-DE-A4MB-01A-11R-A250-07,THCA,79.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-29011.0,Alive,WITH TUMOR,352.0,,[Not Available],,,,,[Not Available],,R1,0.0,352.0,0.0,352.0,,,0.0,352.0,
TCGA-H2-A26U-01A-11R-A16R-07,THCA,54.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19927.0,Alive,TUMOR FREE,517.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,517.0,0.0,517.0,,,0.0,517.0,
TCGA-EM-A4FU-01A-11R-A250-07,THCA,35.0,MALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2009.0,[Not Available],-12912.0,Alive,TUMOR FREE,1840.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,781.0,[Not Available],,R0,0.0,1840.0,0.0,1840.0,1.0,781.0,1.0,781.0,
TCGA-EM-A2CU-01A-12R-A180-07,THCA,47.0,FEMALE,[Not Available],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-17231.0,Alive,WITH TUMOR,400.0,,[Not Available],,,,,[Not Available],,R0,0.0,400.0,0.0,400.0,0.0,400.0,0.0,400.0,
TCGA-BJ-A0Z0-01A-11R-A10U-07,THCA,55.0,MALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20361.0,Alive,TUMOR FREE,419.0,,[Not Available],,,,,[Not Available],,R0,0.0,419.0,0.0,419.0,0.0,419.0,0.0,419.0,
TCGA-EM-A3SX-01A-11R-A22U-07,THCA,28.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-10447.0,Alive,WITH TUMOR,908.0,,[Not Available],,,,,[Not Available],,R1,0.0,908.0,0.0,908.0,,,0.0,908.0,
TCGA-DE-A2OL-01A-11R-A18C-07,THCA,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-16253.0,Alive,TUMOR FREE,1145.0,,[Not Available],,,,,[Not Available],,R0,0.0,1145.0,0.0,1145.0,0.0,1145.0,0.0,1145.0,
TCGA-FK-A3SH-01A-11R-A22L-07,THCA,50.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-18609.0,Alive,TUMOR FREE,1463.0,,[Not Available],,,,,[Not Available],,R0,0.0,1463.0,0.0,1463.0,0.0,1463.0,0.0,1463.0,
TCGA-ET-A3DP-01A-11R-A21D-07,THCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-15876.0,Alive,TUMOR FREE,2877.0,,[Not Available],,,,,[Not Available],,R0,0.0,2877.0,0.0,2877.0,0.0,2877.0,0.0,2877.0,
TCGA-EM-A4FK-01A-11R-A250-07,THCA,33.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-12383.0,Alive,TUMOR FREE,649.0,,[Not Available],,,,,[Not Available],,R0,0.0,649.0,0.0,649.0,0.0,649.0,0.0,649.0,
TCGA-ET-A3DU-01A-11R-A19O-07,THCA,21.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-7869.0,Alive,TUMOR FREE,1911.0,,[Not Available],,,,,[Not Available],,R1,0.0,1911.0,0.0,1911.0,,,0.0,1911.0,
TCGA-DJ-A3V6-01A-11R-A22U-07,THCA,54.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-19870.0,Alive,TUMOR FREE,818.0,,[Not Available],,,,,[Not Available],,R0,0.0,818.0,0.0,818.0,0.0,818.0,0.0,818.0,
TCGA-EL-A3H2-01A-11R-A20F-07,THCA,58.0,MALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-21266.0,Dead,WITH TUMOR,,1019.0,[Not Available],,,,,[Not Available],,R0,1.0,1019.0,1.0,1019.0,,,1.0,1019.0,
TCGA-BJ-A0Z5-01A-11R-A10U-07,THCA,58.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-21369.0,Alive,TUMOR FREE,448.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,448.0,0.0,448.0,,,0.0,448.0,
TCGA-DJ-A2PT-01A-11R-A18C-07,THCA,70.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-25837.0,Alive,TUMOR FREE,1181.0,,[Not Available],,,,,[Not Available],,R0,0.0,1181.0,0.0,1181.0,0.0,1181.0,0.0,1181.0,
TCGA-DE-A0Y2-01A-11R-A10U-07,THCA,30.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-11227.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,[Not Available],,R0,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,
TCGA-EL-A3D6-01A-12R-A206-07,THCA,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1999.0,[Not Available],-18640.0,Alive,,3296.0,,[Not Available],,,,,[Not Available],,R1,0.0,3296.0,0.0,3296.0,,,0.0,3296.0,
TCGA-BJ-A28X-01A-11R-A22L-07,THCA,32.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-11735.0,Alive,TUMOR FREE,942.0,,[Not Available],,,,494.0,[Not Available],,R0,0.0,942.0,0.0,942.0,1.0,494.0,1.0,494.0,
TCGA-BJ-A0Z9-01A-11R-A10U-07,THCA,57.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-21061.0,Alive,TUMOR FREE,1257.0,,[Not Available],,,,,[Not Available],,R1,0.0,1257.0,0.0,1257.0,,,0.0,1257.0,
TCGA-BJ-A192-01A-31R-A13Y-07,THCA,54.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-19878.0,Alive,TUMOR FREE,1349.0,,[Not Available],,,,,[Not Available],,RX,0.0,1349.0,0.0,1349.0,,,0.0,1349.0,
TCGA-EM-A2CP-01A-11R-A180-07,THCA,26.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-9759.0,Alive,TUMOR FREE,91.0,,[Not Available],,,,,[Not Available],,R0,0.0,91.0,0.0,91.0,0.0,91.0,0.0,91.0,
TCGA-EL-A3H3-01A-11R-A206-07,THCA,19.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-7000.0,Alive,TUMOR FREE,1319.0,,[Not Available],,,,,[Not Available],,R0,0.0,1319.0,0.0,1319.0,0.0,1319.0,0.0,1319.0,
TCGA-FE-A23A-01A-11R-A16R-07,THCA,27.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-10177.0,Alive,TUMOR FREE,2489.0,,[Not Available],,,,,[Not Available],,R0,0.0,2489.0,0.0,2489.0,0.0,2489.0,0.0,2489.0,
TCGA-FY-A3R7-01A-11R-A220-07,THCA,50.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-18403.0,Alive,TUMOR FREE,495.0,,[Not Available],,,,,[Not Available],,[Unknown],0.0,495.0,0.0,495.0,,,0.0,495.0,
TCGA-EM-A4FM-01A-11R-A250-07,THCA,59.0,FEMALE,[Unknown],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-21595.0,Alive,WITH TUMOR,162.0,,[Not Available],,,,,[Not Available],,R1,0.0,162.0,0.0,162.0,,,0.0,162.0,
TCGA-CE-A485-01A-11R-A23W-07,THCA,32.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-11997.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],,R0,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-BJ-A4O8-01A-11R-A250-07,THCA,47.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-17430.0,Alive,TUMOR FREE,591.0,,[Not Available],,,,,[Not Available],,R0,0.0,591.0,0.0,591.0,0.0,591.0,0.0,591.0,
TCGA-EM-A3FK-01A-11R-A21D-07,THCA,30.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-10992.0,Alive,TUMOR FREE,723.0,,[Not Available],,,,,[Not Available],,R0,0.0,723.0,0.0,723.0,0.0,723.0,0.0,723.0,
TCGA-EM-A22L-01A-11R-A180-07,THCA,33.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-12092.0,Alive,TUMOR FREE,318.0,,[Not Available],,,,,[Not Available],,R0,0.0,318.0,0.0,318.0,0.0,318.0,0.0,318.0,
TCGA-FY-A40K-01A-11R-A23N-07,THCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-17092.0,Alive,TUMOR FREE,461.0,,[Not Available],,,,,[Not Available],,R0,0.0,461.0,0.0,461.0,0.0,461.0,0.0,461.0,
TCGA-FY-A3W9-01A-11R-A22L-07,THCA,66.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-24136.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,[Not Available],,R1,0.0,658.0,0.0,658.0,,,0.0,658.0,
TCGA-FY-A40N-01A-11R-A23N-07,THCA,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-20320.0,Alive,TUMOR FREE,579.0,,[Not Available],,,,,[Not Available],,R0,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,
TCGA-ET-A39O-01A-11R-A19O-07,THCA,39.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2006.0,[Not Available],-14295.0,Alive,TUMOR FREE,3059.0,,[Not Available],,,,,[Not Available],,R0,0.0,3059.0,0.0,3059.0,0.0,3059.0,0.0,3059.0,
TCGA-ET-A3BV-01A-11R-A19O-07,THCA,47.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-17441.0,Alive,TUMOR FREE,2294.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,1204.0,[Not Available],,R0,0.0,2294.0,0.0,2294.0,1.0,1204.0,1.0,1204.0,
TCGA-EL-A3MW-01A-11R-A20F-07,THCA,55.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2003.0,[Not Available],-20186.0,Alive,TUMOR FREE,3305.0,,[Not Available],,,,,[Not Available],,R0,0.0,3305.0,0.0,3305.0,0.0,3305.0,0.0,3305.0,
TCGA-J8-A3O1-01A-11R-A21D-07,THCA,33.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-12113.0,Alive,TUMOR FREE,827.0,,[Not Available],,,,,[Not Available],,R0,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,
TCGA-ET-A3BS-01A-11R-A206-07,THCA,42.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-15421.0,Alive,TUMOR FREE,176.0,,[Not Available],,,,,[Not Available],,R0,0.0,176.0,0.0,176.0,0.0,176.0,0.0,176.0,
TCGA-KS-A4I5-01A-11R-A250-07,THCA,49.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-17963.0,Alive,TUMOR FREE,567.0,,[Not Available],,,,,[Not Available],,R0,0.0,567.0,0.0,567.0,,,0.0,567.0,
TCGA-ET-A3DV-01A-12R-A206-07,THCA,68.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2001.0,[Not Available],-24905.0,Alive,TUMOR FREE,5068.0,,[Not Available],,,,,[Not Available],,R0,0.0,5068.0,0.0,5068.0,0.0,5068.0,0.0,5068.0,
TCGA-ET-A39K-01A-11R-A19O-07,THCA,48.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-17789.0,Alive,TUMOR FREE,3267.0,,[Not Available],Locoregional Recurrence,,,711.0,[Not Available],,R1,0.0,3267.0,0.0,3267.0,,,1.0,711.0,
TCGA-DJ-A2Q6-01A-11R-A18C-07,THCA,38.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-14193.0,Alive,TUMOR FREE,1109.0,,[Not Available],,,,,[Not Available],,R0,0.0,1109.0,0.0,1109.0,0.0,1109.0,0.0,1109.0,
TCGA-EM-A2CS-06A-11R-A180-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-DJ-A3UK-01A-11R-A22L-07,THCA,35.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-13145.0,Alive,TUMOR FREE,1123.0,,[Not Available],,,,,[Not Available],,R0,0.0,1123.0,0.0,1123.0,0.0,1123.0,0.0,1123.0,
TCGA-ET-A4KQ-01A-12R-A250-07,THCA,45.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-16685.0,Alive,TUMOR FREE,955.0,,[Not Available],,,,,[Not Available],,R0,0.0,955.0,0.0,955.0,0.0,955.0,0.0,955.0,
TCGA-EL-A3CP-01A-11R-A19O-07,THCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],1999.0,[Not Available],-18298.0,Alive,TUMOR FREE,4831.0,,[Not Available],,,,,[Not Available],,RX,0.0,4831.0,0.0,4831.0,,,0.0,4831.0,
TCGA-DJ-A3US-01A-11R-A22L-07,THCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-13634.0,Alive,TUMOR FREE,998.0,,[Not Available],,,,,[Not Available],,R0,0.0,998.0,0.0,998.0,0.0,998.0,0.0,998.0,
TCGA-BJ-A0ZH-01A-11R-A10U-07,THCA,52.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-19114.0,Alive,TUMOR FREE,460.0,,[Not Available],,,,,[Not Available],,RX,0.0,460.0,0.0,460.0,,,0.0,460.0,
TCGA-E8-A44K-01A-21R-A23W-07,THCA,50.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-18472.0,Alive,TUMOR FREE,943.0,,[Not Available],,,,,[Not Available],,R0,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,
TCGA-ET-A39T-01A-11R-A19O-07,THCA,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2006.0,[Not Available],-20164.0,Alive,TUMOR FREE,2987.0,,[Not Available],,,,,[Not Available],,R0,0.0,2987.0,0.0,2987.0,0.0,2987.0,0.0,2987.0,
TCGA-BJ-A45E-01A-11R-A32Y-07,THCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-17115.0,Alive,TUMOR FREE,639.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,639.0,0.0,639.0,,,0.0,639.0,
TCGA-DJ-A2Q4-01A-21R-A18C-07,THCA,53.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19689.0,Alive,TUMOR FREE,1032.0,,[Not Available],,,,,[Not Available],,R0,0.0,1032.0,0.0,1032.0,0.0,1032.0,0.0,1032.0,
TCGA-EM-A3FP-01A-11R-A21D-07,THCA,71.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-26158.0,Alive,TUMOR FREE,529.0,,[Not Available],,,,,[Not Available],,R0,0.0,529.0,0.0,529.0,0.0,529.0,0.0,529.0,
TCGA-FE-A234-01A-11R-A14Y-07,THCA,26.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-9724.0,Alive,WITH TUMOR,2075.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,483.0,[Not Available],,R0,0.0,2075.0,0.0,2075.0,1.0,483.0,1.0,483.0,
TCGA-FE-A239-01A-11R-A16R-07,THCA,82.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-30259.0,Dead,WITH TUMOR,,1023.0,[Not Available],Locoregional Recurrence,Lymph Node Only,,933.0,[Not Available],,R0,1.0,1023.0,1.0,1023.0,1.0,933.0,1.0,933.0,
TCGA-DJ-A3V3-01A-11R-A22U-07,THCA,57.0,FEMALE,ASIAN,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20997.0,Alive,TUMOR FREE,931.0,,[Not Available],,,,,[Not Available],,R0,0.0,931.0,0.0,931.0,0.0,931.0,0.0,931.0,
TCGA-BJ-A28R-01A-11R-A16R-07,THCA,38.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-14044.0,Alive,TUMOR FREE,1282.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,1282.0,0.0,1282.0,,,0.0,1282.0,
TCGA-EM-A2OW-01A-11R-A206-07,THCA,37.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-13761.0,Alive,TUMOR FREE,1227.0,,[Not Available],,,,,[Not Available],,R0,0.0,1227.0,0.0,1227.0,0.0,1227.0,0.0,1227.0,
TCGA-FE-A236-01A-11R-A16R-07,THCA,33.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-12348.0,Alive,TUMOR FREE,2031.0,,[Not Available],,,,,[Not Available],,R0,0.0,2031.0,0.0,2031.0,0.0,2031.0,0.0,2031.0,
TCGA-E3-A3E3-01A-11R-A20F-07,THCA,49.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-18140.0,Alive,TUMOR FREE,1595.0,,[Not Available],Distant Metastasis,Lymph Node Only,,445.0,[Not Available],,R0,0.0,1595.0,0.0,1595.0,1.0,445.0,1.0,445.0,
TCGA-DJ-A3V2-01A-11R-A22U-07,THCA,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-16382.0,Alive,TUMOR FREE,615.0,,[Not Available],,,,,[Not Available],,R0,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,
TCGA-DJ-A13M-01A-11R-A10U-07,THCA,28.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-10530.0,Alive,TUMOR FREE,1484.0,,[Not Available],,,,,[Not Available],,R0,0.0,1484.0,0.0,1484.0,0.0,1484.0,0.0,1484.0,
TCGA-IM-A3U3-01A-11R-A22L-07,THCA,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012.0,[Not Available],-20117.0,Alive,TUMOR FREE,514.0,,[Not Available],,,,,[Not Available],,RX,0.0,514.0,0.0,514.0,,,0.0,514.0,
TCGA-EL-A3T6-01A-11R-A220-07,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2003.0,[Not Available],-12777.0,Alive,TUMOR FREE,2988.0,,[Not Available],,,,,[Not Available],,R0,0.0,2988.0,0.0,2988.0,0.0,2988.0,0.0,2988.0,
TCGA-FE-A233-01A-11R-A14Y-07,THCA,18.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-6770.0,Alive,TUMOR FREE,751.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,567.0,[Not Available],,R0,0.0,751.0,0.0,751.0,1.0,567.0,1.0,567.0,
TCGA-BJ-A291-01A-11R-A16R-07,THCA,56.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20682.0,Alive,TUMOR FREE,696.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,696.0,0.0,696.0,,,0.0,696.0,
TCGA-DJ-A3UW-01A-11R-A22L-07,THCA,50.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-18487.0,Alive,TUMOR FREE,1812.0,,[Not Available],,,,,[Not Available],,R0,0.0,1812.0,0.0,1812.0,0.0,1812.0,0.0,1812.0,
TCGA-FY-A2QD-01A-11R-A19O-07,THCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-22491.0,Alive,TUMOR FREE,38.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,38.0,0.0,38.0,,,0.0,38.0,
TCGA-DE-A3KN-01A-11R-A20F-07,THCA,49.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18098.0,Alive,TUMOR FREE,831.0,,[Not Available],,,,,[Not Available],,R0,0.0,831.0,0.0,831.0,,,0.0,831.0,
TCGA-DJ-A2Q9-01A-21R-A18C-07,THCA,65.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-23951.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,[Not Available],,R0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,
TCGA-DJ-A1QO-01A-11R-A14Y-07,THCA,69.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-25232.0,Alive,TUMOR FREE,1442.0,,[Not Available],New Primary Tumor,"Other, specify",Cecum,1062.0,[Not Available],,R0,0.0,1442.0,0.0,1442.0,0.0,1442.0,1.0,1062.0,
TCGA-ET-A25P-01A-11R-A16R-07,THCA,24.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-8787.0,Alive,TUMOR FREE,559.0,,[Not Available],,,,,[Not Available],,R0,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,
TCGA-MZ-A7D7-01A-21R-A34R-07,HNSC,51.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,[Not Available],2013.0,[Not Available],-18974.0,Alive,WITH TUMOR,547.0,,[Not Available],Distant Metastasis,Distant Metastasis,lung,339.0,Complete Remission/Response,,,0.0,547.0,0.0,547.0,,,1.0,339.0,
TCGA-CN-6022-01A-21R-1686-07,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-17971.0,Dead,WITH TUMOR,,281.0,[Not Available],,Cervical Lymph Nodes,,101.0,Progressive Disease,,,1.0,281.0,1.0,281.0,,,1.0,101.0,
TCGA-CQ-A4C9-01A-11R-A24Z-07,HNSC,56.0,MALE,[Not Evaluated],Stage III,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-20732.0,Alive,WITH TUMOR,707.0,,[Not Available],Locoregional Disease,Oral Cavity,,287.0,Complete Remission/Response,,,0.0,707.0,0.0,707.0,1.0,287.0,1.0,287.0,
TCGA-CR-6477-01A-11R-1873-07,HNSC,56.0,FEMALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-20815.0,Alive,TUMOR FREE,514.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,514.0,0.0,514.0,,,0.0,514.0,
TCGA-CR-6471-01A-11R-1873-07,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-21315.0,Dead,WITH TUMOR,,1202.0,[Not Available],,Oropharynx,,498.0,Complete Remission/Response,,,1.0,1202.0,1.0,1202.0,,,1.0,498.0,
TCGA-CQ-A4CH-01A-11R-A266-07,HNSC,58.0,MALE,ASIAN,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21455.0,Dead,WITH TUMOR,,379.0,[Not Available],,,trachea,210.0,Complete Remission/Response,,,1.0,379.0,1.0,379.0,,,1.0,210.0,
TCGA-CV-6953-01A-11R-1915-07,HNSC,80.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1997.0,[Not Available],-29465.0,Dead,WITH TUMOR,,1641.0,[Not Available],Locoregional Recurrence,Oral Cavity,oral tongue,1521.0,Complete Remission/Response,,,1.0,1641.0,1.0,1641.0,1.0,1521.0,1.0,1521.0,
TCGA-CN-4739-01A-02R-1514-07,HNSC,71.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-26081.0,Dead,WITH TUMOR,,1394.0,[Not Available],Locoregional Recurrence,Oropharynx,"OROPHARYNX, OVERLAPPING",1302.0,Complete Remission/Response,,,1.0,1394.0,1.0,1394.0,,,1.0,1302.0,
TCGA-IQ-7631-01A-11R-2081-07,HNSC,60.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-22151.0,Alive,TUMOR FREE,1172.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1172.0,0.0,1172.0,0.0,1172.0,0.0,1172.0,
TCGA-CV-6942-01A-21R-2016-07,HNSC,73.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-26941.0,Alive,TUMOR FREE,4282.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4282.0,0.0,4282.0,0.0,4282.0,0.0,4282.0,
TCGA-BA-A6DB-01A-11R-A30B-07,HNSC,24.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-8967.0,Alive,WITH TUMOR,216.0,,[Not Available],Locoregional Disease,Cervical Lymph Nodes,,208.0,Complete Remission/Response,,,0.0,216.0,0.0,216.0,1.0,208.0,1.0,208.0,
TCGA-CV-6955-01A-11R-2016-07,HNSC,74.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-27261.0,Dead,WITH TUMOR,,334.0,[Not Available],,,,,[Not Available],,,1.0,334.0,1.0,334.0,,,1.0,334.0,
TCGA-CQ-6223-01A-11R-1915-07,HNSC,69.0,MALE,WHITE,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-25266.0,Alive,TUMOR FREE,1428.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1428.0,0.0,1428.0,,,0.0,1428.0,
TCGA-HD-8224-01A-11R-2403-07,HNSC,63.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-23069.0,Dead,WITH TUMOR,,446.0,[Not Available],Distant Metastasis,Distant Metastasis,Lung,171.0,Progressive Disease,,,1.0,446.0,1.0,446.0,,,1.0,171.0,
TCGA-CV-7091-01A-11R-2016-07,HNSC,54.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2001.0,[Not Available],-19938.0,Alive,TUMOR FREE,3381.0,,[Not Available],,,,,[Not Available],,,0.0,3381.0,0.0,3381.0,,,0.0,3381.0,
TCGA-CV-A6K2-01A-11R-A31N-07,HNSC,79.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-29114.0,Dead,WITH TUMOR,,317.0,[Not Available],Locoregional Recurrence,,Infratemporal fossa,134.0,Progressive Disease,,,1.0,317.0,1.0,317.0,,,1.0,134.0,
TCGA-CV-6945-01A-11R-1915-07,HNSC,41.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1993.0,[Not Available],-15158.0,Dead,WITH TUMOR,,366.0,[Not Available],,,,,[Not Available],,,1.0,366.0,1.0,366.0,,,1.0,366.0,
TCGA-CN-4734-01A-01R-1436-07,HNSC,70.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-25753.0,Alive,TUMOR FREE,1690.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0,
TCGA-CV-6939-01A-11R-1915-07,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1994.0,[Not Available],-21947.0,Dead,WITH TUMOR,,666.0,[Not Available],,,,,[Not Available],,,1.0,666.0,1.0,666.0,,,1.0,666.0,
TCGA-CN-A63V-01A-11R-A466-07,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21734.0,Alive,TUMOR FREE,679.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,679.0,0.0,679.0,,,0.0,679.0,
TCGA-CV-6940-01A-11R-1915-07,HNSC,80.0,FEMALE,WHITE,Stage III,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2002.0,[Not Available],-29382.0,Dead,TUMOR FREE,,804.0,[Not Available],,,,,Complete Remission/Response,,,1.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0,
TCGA-CR-7388-01A-11R-2016-07,HNSC,70.0,FEMALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-25728.0,Dead,WITH TUMOR,,823.0,[Not Available],,Cervical Lymph Nodes,Right neck,334.0,Complete Remission/Response,,,1.0,823.0,1.0,823.0,,,1.0,334.0,
TCGA-KU-A6H7-06A-21R-A31N-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-CV-7089-01A-11R-2016-07,HNSC,74.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,[Not Available],-27149.0,Dead,TUMOR FREE,,1972.0,[Not Available],,,,,[Not Available],,,1.0,1972.0,0.0,1972.0,,,0.0,1972.0,
TCGA-CV-7103-01A-21R-2016-07,HNSC,49.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2000.0,[Not Available],-18219.0,Dead,WITH TUMOR,,1591.0,[Not Available],,,,,[Not Available],,,1.0,1591.0,1.0,1591.0,,,1.0,1591.0,
TCGA-BB-4217-01A-11R-2081-07,HNSC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-25020.0,Alive,WITH TUMOR,187.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,187.0,0.0,187.0,,,0.0,187.0,
TCGA-F7-A50I-01A-11R-A28V-07,HNSC,72.0,MALE,WHITE,Stage IVA,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-26373.0,Alive,TUMOR FREE,92.0,,[Not Available],,,,,[Not Available],,,0.0,92.0,0.0,92.0,,,0.0,92.0,
TCGA-BB-4225-01A-01R-1436-07,HNSC,73.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,[Not Available],-26687.0,Alive,WITH TUMOR,146.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,146.0,0.0,146.0,,,0.0,146.0,
TCGA-CQ-A4CG-01A-11R-A266-07,HNSC,78.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-28637.0,Dead,WITH TUMOR,,430.0,[Not Available],,Distant Metastasis,new primary in left upper lung lobe with metastasis to brain,350.0,Complete Remission/Response,,,1.0,430.0,1.0,430.0,1.0,350.0,1.0,350.0,
TCGA-CQ-6224-01A-11R-1915-07,HNSC,52.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2009.0,[Not Available],-19051.0,Alive,TUMOR FREE,1721.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1721.0,0.0,1721.0,,,0.0,1721.0,
TCGA-CX-7219-01A-11R-2016-07,HNSC,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-17222.0,Alive,TUMOR FREE,1045.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1045.0,0.0,1045.0,,,0.0,1045.0,
TCGA-DQ-7592-01A-11R-2081-07,HNSC,57.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21041.0,Alive,TUMOR FREE,1143.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1143.0,0.0,1143.0,,,0.0,1143.0,
TCGA-CV-6936-01A-11R-1915-07,HNSC,68.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2004.0,[Not Available],-25020.0,Dead,WITH TUMOR,,166.0,[Not Available],Locoregional Recurrence,Oral Cavity,mandibular,157.0,Progressive Disease,,,1.0,166.0,1.0,166.0,,,1.0,157.0,
TCGA-T3-A92M-01A-31R-A39I-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-CR-6472-01A-11R-1873-07,HNSC,59.0,MALE,WHITE,[Not Available],Stage IVB,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-21654.0,Alive,TUMOR FREE,1050.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1050.0,0.0,1050.0,,,0.0,1050.0,
TCGA-CV-6935-01A-11R-1915-07,HNSC,67.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,1999.0,[Not Available],-24799.0,Dead,WITH TUMOR,,295.0,[Not Available],,,,,[Not Available],,,1.0,295.0,1.0,295.0,,,1.0,295.0,
TCGA-CN-6019-01A-11R-1686-07,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-22485.0,Alive,TUMOR FREE,1038.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1038.0,0.0,1038.0,,,0.0,1038.0,
TCGA-CV-7446-01A-11R-2232-07,HNSC,66.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1998.0,[Not Available],-24170.0,Dead,WITH TUMOR,,1093.0,[Not Available],,,,,[Not Available],,,1.0,1093.0,1.0,1093.0,,,1.0,1093.0,
TCGA-CN-4740-01A-01R-1436-07,HNSC,79.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-29186.0,Dead,WITH TUMOR,,839.0,[Not Available],,,PTERYGOID FOSSA,224.0,Complete Remission/Response,,,1.0,839.0,1.0,839.0,,,1.0,224.0,
TCGA-CR-7401-01A-11R-2016-07,HNSC,64.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-23420.0,Alive,TUMOR FREE,1077.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1077.0,0.0,1077.0,0.0,1077.0,0.0,1077.0,
TCGA-CN-6994-01A-11R-1915-07,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-24778.0,Alive,TUMOR FREE,1183.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1183.0,0.0,1183.0,,,0.0,1183.0,
TCGA-HD-8634-01A-11R-2403-07,HNSC,51.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-18718.0,Dead,TUMOR FREE,,385.0,[Not Available],,,,,Complete Remission/Response,,,1.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-D6-A4Z9-01A-11R-A24Z-07,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21659.0,Alive,TUMOR FREE,539.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,539.0,0.0,539.0,,,0.0,539.0,
TCGA-UF-A7JJ-01A-11R-A34R-07,HNSC,68.0,MALE,[Unknown],Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2013.0,[Not Available],-25201.0,Alive,TUMOR FREE,549.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,549.0,0.0,549.0,,,0.0,549.0,
TCGA-CV-A464-01A-11R-A266-07,HNSC,48.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-17669.0,Alive,TUMOR FREE,1722.0,,[Not Available],Locoregional Disease,,pterygoid,28.0,Complete Remission/Response,,,0.0,1722.0,0.0,1722.0,,,1.0,28.0,
TCGA-BA-6869-01A-11R-1873-07,HNSC,62.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-22765.0,Alive,TUMOR FREE,644.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,
TCGA-CV-7099-01A-41R-2016-07,HNSC,85.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2002.0,[Not Available],-31134.0,Dead,TUMOR FREE,,243.0,[Not Available],,,,,Complete Remission/Response,,,1.0,243.0,0.0,243.0,0.0,243.0,0.0,243.0,
TCGA-CQ-5331-01A-02R-1873-07,HNSC,73.0,FEMALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-26901.0,Alive,TUMOR FREE,1399.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1399.0,0.0,1399.0,,,0.0,1399.0,
TCGA-CR-7399-01A-11R-2016-07,HNSC,60.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-22182.0,Alive,TUMOR FREE,181.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,181.0,0.0,181.0,,,0.0,181.0,
TCGA-CV-6952-01A-11R-1915-07,HNSC,65.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1996.0,[Not Available],-23892.0,Dead,TUMOR FREE,,185.0,[Not Available],,,,,[Not Available],,,1.0,185.0,0.0,185.0,,,0.0,185.0,
TCGA-D6-8569-01A-11R-2403-07,HNSC,52.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-19212.0,Alive,TUMOR FREE,770.0,,[Not Available],,,,,Stable Disease,,,0.0,770.0,0.0,770.0,,,0.0,770.0,
TCGA-BA-7269-01A-11R-2016-07,HNSC,61.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2010.0,[Not Available],-22609.0,Alive,TUMOR FREE,1273.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1273.0,0.0,1273.0,0.0,1273.0,0.0,1273.0,
TCGA-QK-A6IJ-01A-11R-A31N-07,HNSC,71.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-25966.0,Alive,TUMOR FREE,387.0,,[Not Available],,,,,[Unknown],,,0.0,387.0,0.0,387.0,,,0.0,387.0,
TCGA-CV-7263-01A-11R-2016-07,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1997.0,[Not Available],-23513.0,Dead,WITH TUMOR,,560.0,[Not Available],,,,,[Not Available],,,1.0,560.0,1.0,560.0,,,1.0,560.0,
TCGA-CR-7367-01A-11R-2016-07,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVB,Head & Neck Squamous Cell Carcinoma,G1,2008.0,[Not Available],-19116.0,Alive,TUMOR FREE,1440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1440.0,0.0,1440.0,,,0.0,1440.0,
TCGA-P3-A6T2-01A-11R-A34R-07,HNSC,45.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-16588.0,Alive,TUMOR FREE,2298.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2298.0,0.0,2298.0,,,0.0,2298.0,
TCGA-CN-4729-01A-01R-1436-07,HNSC,73.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-26713.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,392.0,0.0,392.0,,,0.0,392.0,
TCGA-CN-6012-01A-11R-1686-07,HNSC,66.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-24286.0,Alive,TUMOR FREE,1460.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1460.0,0.0,1460.0,,,0.0,1460.0,
TCGA-CV-6950-01A-11R-1915-07,HNSC,64.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1994.0,[Not Available],-23549.0,Dead,WITH TUMOR,,459.0,[Not Available],Locoregional Recurrence,Oral Cavity,Tonsil,258.0,Complete Remission/Response,,,1.0,459.0,1.0,459.0,,,1.0,258.0,
TCGA-IQ-7632-01A-11R-2081-07,HNSC,68.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-24986.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,441.0,0.0,441.0,,,0.0,441.0,
TCGA-D6-A6EN-01A-11R-A31N-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-CV-7414-01A-11R-2081-07,HNSC,78.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1995.0,[Not Available],-28603.0,Dead,,,14.0,[Not Available],,,,,Complete Remission/Response,,,1.0,14.0,,14.0,,,0.0,14.0,
TCGA-BB-8601-01A-11R-2403-07,HNSC,84.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-30721.0,Alive,WITH TUMOR,624.0,,[Not Available],Locoregional Disease,Oral Cavity,,440.0,Progressive Disease,,,0.0,624.0,0.0,624.0,,,1.0,440.0,
TCGA-CV-7243-01A-11R-2016-07,HNSC,50.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-18466.0,Alive,TUMOR FREE,954.0,,[Not Available],,,,,[Not Available],,,0.0,954.0,0.0,954.0,,,0.0,954.0,
TCGA-CR-6484-01A-11R-1873-07,HNSC,67.0,FEMALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-24569.0,Alive,TUMOR FREE,354.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,354.0,0.0,354.0,,,0.0,354.0,
TCGA-P3-A6T6-01A-11R-A34R-07,HNSC,53.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2009.0,[Not Available],-19694.0,Dead,WITH TUMOR,,395.0,[Not Available],Distant Metastasis,Distant Metastasis,lung,273.0,Complete Remission/Response,,,1.0,395.0,1.0,395.0,,,1.0,273.0,
TCGA-CV-6941-01A-11R-1915-07,HNSC,51.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-18812.0,Dead,TUMOR FREE,,342.0,[Not Available],,,,,Complete Remission/Response,,,1.0,342.0,0.0,342.0,0.0,342.0,0.0,342.0,
TCGA-CQ-5333-01A-01R-2403-07,HNSC,74.0,MALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-27110.0,Dead,WITH TUMOR,,341.0,[Not Available],,Oropharynx,,176.0,Complete Remission/Response,,,1.0,341.0,1.0,341.0,1.0,176.0,1.0,176.0,
TCGA-HD-A6I0-01A-11R-A31N-07,HNSC,56.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2013.0,[Not Available],-20491.0,Alive,TUMOR FREE,210.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,210.0,0.0,210.0,,,0.0,210.0,
TCGA-IQ-A61I-01A-11R-A30B-07,HNSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,[Not Available],-23035.0,Dead,TUMOR FREE,,2.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2.0,0.0,2.0,,,0.0,2.0,
TCGA-CV-7095-01A-21R-2016-07,HNSC,87.0,FEMALE,[Not Available],Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,[Not Available],-32022.0,Dead,TUMOR FREE,,572.0,[Not Available],,,,,[Not Available],,,1.0,572.0,0.0,572.0,,,0.0,572.0,
TCGA-CV-7410-01A-21R-2081-07,HNSC,61.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,GX,1993.0,[Not Available],-22302.0,Dead,WITH TUMOR,,6417.0,[Not Available],,,,,[Not Available],,,1.0,6417.0,1.0,6417.0,,,1.0,6417.0,
TCGA-CV-7245-01A-11R-2016-07,HNSC,62.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-22646.0,Alive,TUMOR FREE,797.0,,[Not Available],,,,,[Not Available],,,0.0,797.0,0.0,797.0,,,0.0,797.0,
TCGA-HD-8314-01A-11R-2403-07,HNSC,58.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma Basaloid Type,G4,2012.0,[Not Available],-21517.0,Alive,TUMOR FREE,670.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,
TCGA-CR-7369-01A-11R-2132-07,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-21897.0,Dead,TUMOR FREE,,1090.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1090.0,0.0,1090.0,,,0.0,1090.0,
TCGA-CQ-7063-01A-11R-2403-07,HNSC,59.0,FEMALE,WHITE,Stage I,[Not Available],Head & Neck Squamous Cell Carcinoma,G1,2008.0,[Not Available],-21723.0,Alive,TUMOR FREE,2133.0,,[Not Available],Locoregional Disease,Oral Cavity,left oral tongue,1160.0,Complete Remission/Response,,,0.0,2133.0,0.0,2133.0,1.0,1160.0,1.0,1160.0,
TCGA-CV-6961-01A-21R-1915-07,HNSC,61.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,1999.0,[Not Available],-22532.0,Dead,WITH TUMOR,,76.0,[Not Available],,,,,Complete Remission/Response,,,1.0,76.0,1.0,76.0,,,1.0,76.0,
TCGA-UF-A7JH-01A-21R-A34R-07,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-21558.0,Alive,TUMOR FREE,896.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,896.0,0.0,896.0,,,0.0,896.0,
TCGA-CN-A6V1-01A-12R-A34R-07,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2013.0,[Not Available],-21730.0,Alive,TUMOR FREE,603.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,603.0,0.0,603.0,,,0.0,603.0,
TCGA-CR-6487-01A-11R-1873-07,HNSC,50.0,MALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-18331.0,Alive,TUMOR FREE,234.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,234.0,0.0,234.0,0.0,234.0,0.0,234.0,
TCGA-21-1078-01A-01R-0692-07,LUSC,77.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-28125.0,Dead,WITH TUMOR,469.0,474.0,[Not Available],,,,257.0,[Not Available],,,1.0,474.0,1.0,474.0,,,1.0,257.0,
TCGA-NK-A7XE-01A-12R-A405-07,LUSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2013.0,[Not Available],-24319.0,Alive,TUMOR FREE,13.0,,[Not Available],,,,,Stable Disease,,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-52-7811-01A-11R-2125-07,LUSC,67.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-24782.0,Dead,WITH TUMOR,,266.0,[Not Available],Distant Metastasis,,,153.0,Progressive Disease,,,1.0,266.0,1.0,266.0,,,1.0,153.0,
TCGA-18-3409-01A-01R-0980-07,LUSC,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-27154.0,Alive,TUMOR FREE,3747.0,,[Not Available],New Primary Tumor,,,2291.0,Complete Remission/Response,,,0.0,3747.0,0.0,3747.0,0.0,3747.0,1.0,2291.0,
TCGA-56-7579-01A-11R-2045-07,LUSC,61.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22632.0,Dead,WITH TUMOR,,951.0,[Not Available],Locoregional Recurrence,,,149.0,Progressive Disease,,,1.0,951.0,1.0,951.0,,,1.0,149.0,
TCGA-63-A5MM-01A-11R-A26W-07,LUSC,69.0,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-25348.0,Dead,WITH TUMOR,,456.0,[Not Available],,,,218.0,Complete Remission/Response,,,1.0,456.0,1.0,456.0,1.0,218.0,1.0,218.0,
TCGA-18-3411-01A-01R-0980-07,LUSC,63.0,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-23370.0,Alive,TUMOR FREE,3576.0,,[Not Available],,,,,[Unknown],,,0.0,3576.0,0.0,3576.0,,,0.0,3576.0,
TCGA-85-8070-01A-11R-2247-07,LUSC,71.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26183.0,Alive,TUMOR FREE,960.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,960.0,0.0,960.0,0.0,960.0,0.0,960.0,
TCGA-56-8625-01A-11R-2403-07,LUSC,66.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24188.0,Dead,WITH TUMOR,,315.0,[Not Available],Distant Metastasis,,,272.0,Progressive Disease,,,1.0,315.0,1.0,315.0,,,1.0,272.0,
TCGA-NC-A5HG-01A-11R-A26W-07,LUSC,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-21608.0,Alive,TUMOR FREE,1963.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1963.0,0.0,1963.0,0.0,1963.0,0.0,1963.0,
TCGA-63-A5MN-01A-22R-A27Q-07,LUSC,78.0,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-28677.0,Dead,WITH TUMOR,,345.0,[Not Available],,,,320.0,Complete Remission/Response,,,1.0,345.0,1.0,345.0,1.0,320.0,1.0,320.0,
TCGA-46-6026-01A-11R-1820-07,LUSC,81.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-29890.0,Alive,TUMOR FREE,423.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,
TCGA-60-2720-01A-01R-0851-07,LUSC,60.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-22238.0,Alive,TUMOR FREE,97.0,,[Not Available],,,,,[Not Available],,,0.0,97.0,0.0,97.0,,,0.0,97.0,
TCGA-77-8156-01A-11R-2247-07,LUSC,60.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-22198.0,Alive,,1106.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,
TCGA-77-8133-01A-12R-2247-07,LUSC,74.0,MALE,[Not Evaluated],Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-27139.0,Dead,,,1640.0,[Not Available],,,,,[Not Available],,,1.0,1640.0,,1640.0,,,0.0,1640.0,
TCGA-43-6647-01A-11R-1820-07,LUSC,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-25378.0,Alive,TUMOR FREE,757.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,757.0,0.0,757.0,0.0,757.0,0.0,757.0,
TCGA-85-A53L-01A-21R-A26W-07,LUSC,63.0,MALE,ASIAN,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-23065.0,Alive,TUMOR FREE,377.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,
TCGA-43-6773-01A-41R-1949-07,LUSC,76.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-28036.0,Dead,TUMOR FREE,,116.0,[Not Available],,,,,[Not Available],,,1.0,116.0,0.0,116.0,,,0.0,116.0,
TCGA-60-2712-01A-01R-0851-07,LUSC,79.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-29131.0,Dead,,274.0,274.0,[Not Available],,,,,Complete Remission/Response,,,1.0,274.0,,274.0,0.0,274.0,0.0,274.0,
TCGA-60-2710-01A-01R-0851-07,LUSC,67.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-24669.0,Alive,TUMOR FREE,2024.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2024.0,0.0,2024.0,0.0,2024.0,0.0,2024.0,
TCGA-98-8020-01A-11R-2247-07,LUSC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20509.0,Dead,WITH TUMOR,,84.0,[Not Available],Distant Metastasis,,,11.0,[Unknown],,,1.0,84.0,1.0,84.0,,,1.0,11.0,
TCGA-37-4130-01A-01R-1100-07,LUSC,56.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-20652.0,Alive,TUMOR FREE,247.0,,[Not Available],,,,,[Not Available],,,0.0,247.0,0.0,247.0,,,0.0,247.0,
TCGA-39-5016-01A-01R-1443-07,LUSC,44.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-16306.0,Alive,TUMOR FREE,3850.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3850.0,0.0,3850.0,0.0,3850.0,0.0,3850.0,
TCGA-60-2709-01A-21R-1820-07,LUSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-25453.0,Alive,TUMOR FREE,1505.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1505.0,0.0,1505.0,0.0,1505.0,0.0,1505.0,
TCGA-21-A5DI-01A-31R-A26W-07,LUSC,77.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-28374.0,Alive,TUMOR FREE,979.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,
TCGA-22-4607-01A-01R-1201-07,LUSC,75.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-27601.0,Dead,TUMOR FREE,587.0,587.0,[Not Available],,,,,[Not Available],,,1.0,587.0,0.0,587.0,,,0.0,587.0,
TCGA-56-A62T-01A-11R-A405-07,LUSC,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2013.0,[Not Available],-28522.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,
TCGA-85-8287-01A-11R-2296-07,LUSC,72.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26401.0,Dead,TUMOR FREE,,23.0,[Not Available],,,,,Complete Remission/Response,,,1.0,23.0,0.0,23.0,0.0,23.0,0.0,23.0,
TCGA-77-6844-01A-11R-1949-07,LUSC,74.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-27220.0,Dead,,,2284.0,[Not Available],,,,1788.0,Complete Remission/Response,,,1.0,2284.0,,2284.0,1.0,1788.0,1.0,1788.0,
TCGA-63-A5MU-01A-11R-A26W-07,LUSC,48.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-17801.0,Dead,WITH TUMOR,,,[Not Available],Distant Metastasis,,,420.0,Complete Remission/Response,,,1.0,,1.0,,1.0,420.0,1.0,420.0,
TCGA-85-A511-01A-21R-A262-07,LUSC,62.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-22759.0,Dead,WITH TUMOR,,455.0,[Not Available],Distant Metastasis,,,390.0,Complete Remission/Response,,,1.0,455.0,1.0,455.0,1.0,390.0,1.0,390.0,
TCGA-58-A46N-01A-11R-A24H-07,LUSC,52.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-19050.0,Alive,WITH TUMOR,910.0,,[Not Available],Locoregional Recurrence,,,630.0,Complete Remission/Response,,,0.0,910.0,0.0,910.0,1.0,630.0,1.0,630.0,
TCGA-66-2737-01A-01R-0980-07,LUSC,72.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-26390.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,[Not Available],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-33-4587-01A-11R-2125-07,LUSC,63.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-23062.0,Dead,WITH TUMOR,,1656.0,[Not Available],,,,,Progressive Disease,,,1.0,1656.0,1.0,1656.0,,,1.0,1656.0,
TCGA-34-5928-01A-11R-1820-07,LUSC,83.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-30334.0,Alive,TUMOR FREE,1196.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1196.0,0.0,1196.0,0.0,1196.0,0.0,1196.0,
TCGA-66-2777-01A-01R-1201-07,LUSC,71.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-26085.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,[Not Available],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-37-A5EM-01A-21R-A27Q-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-77-A5GB-01B-11R-A27Q-07,LUSC,90.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-32872.0,Dead,,,937.0,[Not Available],New Primary Tumor,,,229.0,Complete Remission/Response,,,1.0,937.0,,937.0,0.0,937.0,1.0,229.0,
TCGA-43-A56V-01A-11R-A26W-07,LUSC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-22475.0,Alive,WITH TUMOR,366.0,,[Not Available],Locoregional Recurrence|Distant Metastasis,,,355.0,Complete Remission/Response,,,0.0,366.0,0.0,366.0,1.0,355.0,1.0,355.0,
TCGA-85-A510-01A-11R-A26W-07,LUSC,74.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-27067.0,Alive,TUMOR FREE,482.0,,[Not Available],Distant Metastasis,,,363.0,Complete Remission/Response,,,0.0,482.0,0.0,482.0,1.0,363.0,1.0,363.0,
TCGA-46-3765-01A-01R-0980-07,LUSC,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-21762.0,Alive,TUMOR FREE,405.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,405.0,0.0,405.0,0.0,405.0,0.0,405.0,
TCGA-85-7698-01A-11R-2125-07,LUSC,48.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-17651.0,Alive,TUMOR FREE,952.0,,[Not Available],Distant Metastasis,,,650.0,Complete Remission/Response,,,0.0,952.0,0.0,952.0,1.0,650.0,1.0,650.0,
TCGA-66-2791-01A-01R-0980-07,LUSC,66.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-24138.0,Dead,,,153.0,[Not Available],,,,,[Not Available],,,1.0,153.0,,153.0,,,0.0,153.0,
TCGA-77-A5G1-01A-11R-A27Q-07,LUSC,75.0,MALE,[Not Evaluated],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-27555.0,Alive,,4026.0,,[Not Available],New Primary Tumor,,,2197.0,Complete Remission/Response,,,0.0,4026.0,0.0,4026.0,0.0,4026.0,1.0,2197.0,
TCGA-66-2771-01A-01R-0980-07,LUSC,60.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-22219.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,
TCGA-22-5489-01A-01R-1635-07,LUSC,64.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-23618.0,Dead,WITH TUMOR,1912.0,1912.0,[Not Available],,,,428.0,Complete Remission/Response,,,1.0,1912.0,1.0,1912.0,1.0,428.0,1.0,428.0,
TCGA-66-2785-01A-01R-0851-07,LUSC,65.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-23772.0,Alive,TUMOR FREE,60.0,,[Not Available],,,,,[Not Available],,,0.0,60.0,0.0,60.0,,,0.0,60.0,
TCGA-43-8118-01A-11R-2403-07,LUSC,55.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20224.0,Dead,,,89.0,[Not Available],,,,,[Unknown],,,1.0,89.0,,89.0,,,0.0,89.0,
TCGA-77-7140-01A-41R-2045-07,LUSC,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-25303.0,Dead,,,632.0,[Not Available],,,,250.0,[Not Available],,,1.0,632.0,,632.0,,,1.0,250.0,
TCGA-56-A5DS-01A-11R-A27Q-07,LUSC,72.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-26355.0,Alive,TUMOR FREE,8.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,8.0,0.0,8.0,0.0,8.0,0.0,8.0,
TCGA-O2-A52W-01A-11R-A26W-07,LUSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-23156.0,Dead,TUMOR FREE,,261.0,[Not Available],,,,,[Not Applicable],,,1.0,261.0,0.0,261.0,,,0.0,261.0,
TCGA-XC-AA0X-01A-32R-A405-07,LUSC,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2013.0,[Not Available],-28211.0,Dead,TUMOR FREE,,6.0,[Not Available],,,,,[Not Applicable],,,1.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-18-3421-01A-01R-0980-07,LUSC,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23972.0,Alive,TUMOR FREE,2645.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2645.0,0.0,2645.0,0.0,2645.0,0.0,2645.0,
TCGA-68-7757-01B-11R-2296-07,LUSC,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-27272.0,Alive,,211.0,,[Not Available],,,,,[Not Available],,,0.0,211.0,0.0,211.0,,,0.0,211.0,
TCGA-NK-A5CR-01A-11R-A26W-07,LUSC,77.0,MALE,[Unknown],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-28126.0,Alive,TUMOR FREE,2542.0,,[Not Available],,,,,Stable Disease,,,0.0,2542.0,0.0,2542.0,,,0.0,2542.0,
TCGA-39-5037-01A-01R-1443-07,LUSC,65.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23868.0,Alive,TUMOR FREE,1690.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0,
TCGA-66-2727-01A-01R-0980-07,LUSC,55.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-20150.0,Dead,,,516.0,[Not Available],,,,,[Not Available],,,1.0,516.0,,516.0,,,0.0,516.0,
TCGA-56-8629-01A-11R-2403-07,LUSC,63.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-23346.0,Alive,TUMOR FREE,481.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,
TCGA-60-2719-01A-01R-0851-07,LUSC,83.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-30379.0,Alive,TUMOR FREE,1297.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1297.0,0.0,1297.0,0.0,1297.0,0.0,1297.0,
TCGA-22-4595-01A-01R-1201-07,LUSC,57.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-21146.0,Dead,WITH TUMOR,734.0,734.0,[Not Available],,,,250.0,Complete Remission/Response,,,1.0,734.0,1.0,734.0,1.0,250.0,1.0,250.0,
TCGA-43-6771-01A-11R-1820-07,LUSC,85.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-31052.0,Dead,WITH TUMOR,,166.0,[Not Available],,,,154.0,Progressive Disease,,,1.0,166.0,1.0,166.0,,,1.0,154.0,
TCGA-60-2696-01A-01R-0851-07,LUSC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-27991.0,Dead,,109.0,109.0,[Not Available],,,,,[Not Available],,,1.0,109.0,,109.0,,,0.0,109.0,
TCGA-56-8305-01A-11R-2296-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-66-2767-01A-01R-0851-07,LUSC,62.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-22888.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,[Not Available],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-66-2765-01A-01R-0851-07,LUSC,64.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23465.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,[Not Available],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-L3-A4E7-01A-11R-A24Z-07,LUSC,71.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-26232.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,
TCGA-56-8624-01A-11R-2403-07,LUSC,84.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-30798.0,Alive,TUMOR FREE,420.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,420.0,0.0,420.0,0.0,420.0,0.0,420.0,
TCGA-18-3410-01A-01R-0980-07,LUSC,81.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-29827.0,Dead,TUMOR FREE,,146.0,[Not Available],,,,,[Not Applicable],,,1.0,146.0,0.0,146.0,,,0.0,146.0,
TCGA-85-8288-01A-11R-2296-07,LUSC,70.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25629.0,Dead,TUMOR FREE,,402.0,[Not Available],,,,,Complete Remission/Response,,,1.0,402.0,0.0,402.0,0.0,402.0,0.0,402.0,
TCGA-18-3417-01A-01R-1443-07,LUSC,65.0,MALE,[Not Available],Stage IV,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-24019.0,Dead,TUMOR FREE,,1097.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1097.0,0.0,1097.0,,,0.0,1097.0,
TCGA-77-7142-01A-11R-2045-07,LUSC,59.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-21796.0,Alive,TUMOR FREE,2227.0,,[Not Available],,,,,[Not Available],,,0.0,2227.0,0.0,2227.0,,,0.0,2227.0,
TCGA-98-8021-01A-11R-2247-07,LUSC,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-27738.0,Alive,TUMOR FREE,937.0,,[Not Available],Locoregional Recurrence,,,918.0,Complete Remission/Response,,,0.0,937.0,0.0,937.0,1.0,918.0,1.0,918.0,
TCGA-33-AASL-01A-11R-A405-07,LUSC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-20940.0,Dead,WITH TUMOR,,826.0,[Not Available],Locoregional Recurrence,,,149.0,Progressive Disease,,,1.0,826.0,1.0,826.0,,,1.0,149.0,
TCGA-52-7812-01A-11R-2125-07,LUSC,68.0,MALE,WHITE,[Discrepancy],[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-24887.0,Dead,WITH TUMOR,,835.0,[Not Available],Distant Metastasis,,,791.0,Progressive Disease,,,1.0,835.0,1.0,835.0,,,1.0,791.0,
TCGA-33-6738-01A-11R-1949-07,LUSC,80.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-29368.0,Alive,TUMOR FREE,1927.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1927.0,0.0,1927.0,0.0,1927.0,0.0,1927.0,
TCGA-O2-A52Q-01A-11R-A26W-07,LUSC,44.0,FEMALE,WHITE,Stage III,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-16429.0,Dead,WITH TUMOR,,113.0,[Not Available],Distant Metastasis,,,87.0,[Unknown],,,1.0,113.0,1.0,113.0,,,1.0,87.0,
TCGA-56-7582-01A-11R-2045-07,LUSC,83.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-30678.0,Alive,TUMOR FREE,601.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,
TCGA-85-8352-01A-31R-2326-07,LUSC,67.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24788.0,Dead,WITH TUMOR,,161.0,[Not Available],Distant Metastasis,,,128.0,Complete Remission/Response,,,1.0,161.0,1.0,161.0,1.0,128.0,1.0,128.0,
TCGA-39-5040-01A-21R-2125-07,LUSC,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-21790.0,Dead,WITH TUMOR,,519.0,[Not Available],,,,442.0,Stable Disease,,,1.0,519.0,1.0,519.0,,,1.0,442.0,
TCGA-94-7033-01A-11R-1949-07,LUSC,73.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26948.0,Alive,TUMOR FREE,640.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,
TCGA-KC-A7FA-01A-21R-A33R-07,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23208.0,Alive,TUMOR FREE,598.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,598.0,0.0,598.0,0.0,598.0,0.0,598.0,
TCGA-HC-8257-01A-11R-2263-07,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25629.0,Alive,TUMOR FREE,726.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,726.0,0.0,726.0,0.0,726.0,0.0,726.0,
TCGA-KK-A6E4-01A-11R-A30B-07,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2004.0,[Not Available],-25338.0,Dead,TUMOR FREE,,3502.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3502.0,0.0,3502.0,0.0,3502.0,0.0,3502.0,
TCGA-HC-7745-01A-11R-2118-07,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24078.0,Alive,TUMOR FREE,721.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,721.0,0.0,721.0,0.0,721.0,0.0,721.0,
TCGA-KK-A5A1-01A-11R-A29R-07,PRAD,72.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2003.0,[Not Available],-26415.0,Dead,,,2469.0,[Not Available],Locoregional Recurrence,,,203.0,Partial Remission/Response,,,1.0,2469.0,,2469.0,,,1.0,203.0,
TCGA-KK-A8IH-01A-11R-A36G-07,PRAD,50.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-18560.0,Alive,TUMOR FREE,2013.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2013.0,0.0,2013.0,0.0,2013.0,0.0,2013.0,
TCGA-J4-A6G1-01A-11R-A311-07,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24945.0,Alive,TUMOR FREE,769.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,769.0,0.0,769.0,0.0,769.0,0.0,769.0,
TCGA-KK-A7AU-01A-11R-A32O-07,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-23118.0,Alive,TUMOR FREE,1775.0,,[Not Available],Biochemical evidence of disease,,,207.0,Progressive Disease,,,0.0,1775.0,0.0,1775.0,,,1.0,207.0,
TCGA-EJ-5495-01A-01R-1580-07,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-24904.0,Alive,TUMOR FREE,1760.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1760.0,0.0,1760.0,0.0,1760.0,0.0,1760.0,
TCGA-FC-A66V-01A-21R-A30B-07,PRAD,74.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-27282.0,Alive,TUMOR FREE,524.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,
TCGA-G9-7523-01A-11R-2263-07,PRAD,44.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-16269.0,Alive,TUMOR FREE,857.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,857.0,0.0,857.0,0.0,857.0,0.0,857.0,
TCGA-HC-7230-01A-11R-2118-07,PRAD,50.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-18577.0,Alive,TUMOR FREE,1001.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,
TCGA-YL-A8SL-01B-21R-A37L-07,PRAD,74.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-27033.0,Alive,TUMOR FREE,987.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,
TCGA-KK-A7AQ-01A-11R-A33R-07,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-22731.0,Alive,TUMOR FREE,1610.0,,[Not Available],Biochemical evidence of disease,,,1217.0,Complete Remission/Response,,,0.0,1610.0,0.0,1610.0,1.0,1217.0,1.0,1217.0,
TCGA-EJ-A46I-01A-12R-A26U-07,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21046.0,Alive,TUMOR FREE,668.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,668.0,0.0,668.0,0.0,668.0,0.0,668.0,
TCGA-EJ-A7NJ-01A-22R-A352-07,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-21748.0,Alive,TUMOR FREE,197.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,197.0,0.0,197.0,0.0,197.0,0.0,197.0,
TCGA-HI-7169-01A-11R-2118-07,PRAD,55.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-20133.0,Alive,TUMOR FREE,2684.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2684.0,0.0,2684.0,0.0,2684.0,0.0,2684.0,
TCGA-WW-A8ZI-01A-11R-A37L-07,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-25593.0,Alive,TUMOR FREE,449.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,449.0,0.0,449.0,0.0,449.0,0.0,449.0,
TCGA-EJ-7793-01A-31R-2263-07,PRAD,49.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-17982.0,Alive,TUMOR FREE,114.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,114.0,0.0,114.0,0.0,114.0,0.0,114.0,
TCGA-J4-A83N-01A-11R-A352-07,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20841.0,Alive,TUMOR FREE,992.0,,[Not Available],New Primary Tumor,,,433.0,Complete Remission/Response,,,0.0,992.0,0.0,992.0,0.0,992.0,1.0,433.0,
TCGA-HC-7738-01A-11R-2118-07,PRAD,58.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21195.0,Alive,WITH TUMOR,964.0,,[Not Available],Biochemical evidence of disease,"Other, specify",biochemical recurrence only,420.0,Partial Remission/Response,,,0.0,964.0,0.0,964.0,,,1.0,420.0,
TCGA-ZG-A9L6-01A-11R-A41O-07,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23681.0,Alive,WITH TUMOR,687.0,,[Not Available],Biochemical evidence of disease,,,664.0,Partial Remission/Response,,,0.0,687.0,0.0,687.0,,,1.0,664.0,
TCGA-2A-A8VV-01A-11R-A37L-07,PRAD,52.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-19065.0,Alive,TUMOR FREE,671.0,,[Not Available],,,,,[Not Available],,,0.0,671.0,0.0,671.0,,,0.0,671.0,
TCGA-KC-A7FE-01A-12R-A33R-07,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22718.0,Alive,TUMOR FREE,352.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,
TCGA-H9-7775-01A-11R-2118-07,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24898.0,Alive,TUMOR FREE,185.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,185.0,0.0,185.0,0.0,185.0,0.0,185.0,
TCGA-SU-A7E7-01A-22R-A33R-07,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22185.0,Alive,TUMOR FREE,551.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,551.0,0.0,551.0,0.0,551.0,0.0,551.0,
TCGA-VN-A88N-01A-11R-A36G-07,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22695.0,Alive,TUMOR FREE,766.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,
TCGA-EJ-5510-01A-01R-1580-07,PRAD,48.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-17895.0,Alive,TUMOR FREE,1887.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1887.0,0.0,1887.0,0.0,1887.0,0.0,1887.0,
TCGA-J4-A6M7-01A-11R-A31N-07,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-19640.0,Alive,TUMOR FREE,512.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,
TCGA-HC-7209-01A-11R-2118-07,PRAD,60.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22129.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,
TCGA-ZG-A9LU-01A-11R-A41O-07,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24742.0,Alive,WITH TUMOR,579.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,579.0,0.0,579.0,,,0.0,579.0,
TCGA-CH-5791-01A-11R-1580-07,PRAD,72.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-26390.0,Alive,,1004.0,,[Not Available],New Primary Tumor,,,396.0,Complete Remission/Response,,,0.0,1004.0,0.0,1004.0,0.0,1004.0,1.0,396.0,
TCGA-XJ-A83H-01A-11R-A352-07,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],,Alive,,1280.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1280.0,0.0,1280.0,,,0.0,1280.0,
TCGA-V1-A9OY-01A-11R-A41O-07,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-21170.0,Alive,,1067.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1067.0,0.0,1067.0,0.0,1067.0,0.0,1067.0,
TCGA-EJ-8472-01A-11R-2403-07,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23104.0,Alive,TUMOR FREE,756.0,,[Not Available],Biochemical evidence of disease,,,196.0,Partial Remission/Response,,,0.0,756.0,0.0,756.0,,,1.0,196.0,
TCGA-VP-A87K-01A-11R-A352-07,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2010.0,[Not Available],-23030.0,Alive,TUMOR FREE,1306.0,,[Not Available],Biochemical evidence of disease,,,533.0,Complete Remission/Response,,,0.0,1306.0,0.0,1306.0,1.0,533.0,1.0,533.0,
TCGA-QU-A6IL-01A-11R-A31N-07,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2002.0,[Not Available],-23710.0,Alive,TUMOR FREE,97.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,97.0,0.0,97.0,0.0,97.0,0.0,97.0,
TCGA-KK-A6E6-01A-11R-A311-07,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2002.0,[Not Available],-25320.0,Alive,TUMOR FREE,3447.0,,[Not Available],,,,,[Not Available],,,0.0,3447.0,0.0,3447.0,,,0.0,3447.0,
TCGA-VN-A943-01A-11R-A41O-07,PRAD,71.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-26162.0,Alive,TUMOR FREE,496.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-VP-A87D-01A-11R-A352-07,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-19818.0,Alive,TUMOR FREE,1853.0,,[Not Available],Biochemical evidence of disease,,,1194.0,Complete Remission/Response,,,0.0,1853.0,0.0,1853.0,1.0,1194.0,1.0,1194.0,
TCGA-2A-A8VO-01A-11R-A37L-07,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20958.0,Alive,TUMOR FREE,1701.0,,[Not Available],,,,,[Not Available],,,0.0,1701.0,0.0,1701.0,,,0.0,1701.0,
TCGA-G9-6365-01A-11R-1789-07,PRAD,71.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-26207.0,Alive,TUMOR FREE,1363.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1363.0,0.0,1363.0,0.0,1363.0,0.0,1363.0,
TCGA-EJ-5505-01A-01R-1580-07,PRAD,57.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-21164.0,Alive,TUMOR FREE,922.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,922.0,0.0,922.0,0.0,922.0,0.0,922.0,
TCGA-HC-A9TE-01A-11R-A41O-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-G9-6363-01A-21R-1789-07,PRAD,64.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-23480.0,Alive,TUMOR FREE,1378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1378.0,0.0,1378.0,0.0,1378.0,0.0,1378.0,
TCGA-KC-A7F6-01A-11R-A33R-07,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23367.0,Alive,TUMOR FREE,263.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,263.0,0.0,263.0,0.0,263.0,0.0,263.0,
TCGA-KK-A8II-01A-11R-A36G-07,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2004.0,[Not Available],-22460.0,Dead,WITH TUMOR,,3467.0,[Unknown],Biochemical evidence of disease,,,626.0,Progressive Disease,,,1.0,3467.0,1.0,3467.0,,,1.0,626.0,
TCGA-XK-AAJA-01A-11R-A41O-07,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-22771.0,Alive,,930.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,
TCGA-EJ-AB27-01A-11R-A41O-07,PRAD,51.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-18648.0,Alive,TUMOR FREE,145.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,145.0,0.0,145.0,0.0,145.0,0.0,145.0,
TCGA-KC-A4BN-01A-61R-A250-07,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20392.0,Alive,TUMOR FREE,1815.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1815.0,0.0,1815.0,0.0,1815.0,0.0,1815.0,
TCGA-V1-A9Z8-01A-11R-A41O-07,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-21900.0,Alive,TUMOR FREE,827.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,
TCGA-HC-A9TH-01A-11R-A41O-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-KK-A8IC-01A-11R-A36G-07,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-19902.0,Alive,WITH TUMOR,2051.0,,[Not Available],Biochemical evidence of disease,,,1060.0,Progressive Disease,,,0.0,2051.0,0.0,2051.0,,,1.0,1060.0,
TCGA-CH-5739-01A-11R-1580-07,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-23953.0,Alive,TUMOR FREE,671.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,671.0,0.0,671.0,0.0,671.0,0.0,671.0,
TCGA-YL-A8SI-01A-11R-A41O-07,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-25292.0,Alive,TUMOR FREE,1614.0,,[Not Available],Biochemical evidence of disease,,,1423.0,Complete Remission/Response,,,0.0,1614.0,0.0,1614.0,1.0,1423.0,1.0,1423.0,
TCGA-EJ-7328-01A-31R-2118-07,PRAD,70.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25756.0,Alive,TUMOR FREE,842.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,
TCGA-ZG-A9L2-01A-31R-A41O-07,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25573.0,Alive,WITH TUMOR,1154.0,,[Not Available],Biochemical evidence of disease,,,180.0,Stable Disease,,,0.0,1154.0,0.0,1154.0,,,1.0,180.0,
TCGA-VP-A87E-01A-31R-A352-07,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-21811.0,Alive,TUMOR FREE,2037.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2037.0,0.0,2037.0,0.0,2037.0,0.0,2037.0,
TCGA-EJ-5521-01A-01R-1580-07,PRAD,63.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23304.0,Alive,TUMOR FREE,2279.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2279.0,0.0,2279.0,0.0,2279.0,0.0,2279.0,
TCGA-CH-5765-01A-11R-1580-07,PRAD,55.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-20364.0,Alive,TUMOR FREE,700.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,700.0,0.0,700.0,0.0,700.0,0.0,700.0,
TCGA-HC-7079-01A-11R-1965-07,PRAD,51.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-18734.0,Alive,WITH TUMOR,1184.0,,[Not Available],Biochemical evidence of disease,,,380.0,Partial Remission/Response,,,0.0,1184.0,0.0,1184.0,,,1.0,380.0,
TCGA-YL-A9WX-01A-21R-A41O-07,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-25008.0,Alive,WITH TUMOR,1518.0,,[Not Available],Biochemical evidence of disease,,,1506.0,Stable Disease,,,0.0,1518.0,0.0,1518.0,,,1.0,1506.0,
TCGA-ZG-A9NI-01A-11R-A41O-07,PRAD,73.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-26697.0,Alive,TUMOR FREE,132.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,132.0,0.0,132.0,0.0,132.0,0.0,132.0,
TCGA-V1-A9OL-01A-11R-A41O-07,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-24090.0,Alive,,1913.0,,[Not Available],Biochemical evidence of disease,,,105.0,Complete Remission/Response,,,0.0,1913.0,0.0,1913.0,1.0,105.0,1.0,105.0,
TCGA-G9-7509-01A-11R-A41O-07,PRAD,48.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-17538.0,Alive,TUMOR FREE,1610.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1610.0,0.0,1610.0,0.0,1610.0,0.0,1610.0,
TCGA-V1-A8WS-01A-11R-A37L-07,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-20805.0,Alive,,474.0,,[Not Available],,,,,Progressive Disease,,,0.0,474.0,0.0,474.0,,,0.0,474.0,
TCGA-J4-AATZ-01A-11R-A41O-07,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24226.0,Alive,WITH TUMOR,412.0,,[Not Available],Biochemical evidence of disease,,,79.0,Complete Remission/Response,,,0.0,412.0,0.0,412.0,1.0,79.0,1.0,79.0,
TCGA-V1-A9OT-01A-11R-A41O-07,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-22630.0,Alive,,476.0,,[Not Available],Biochemical evidence of disease,,,292.0,Progressive Disease,,,0.0,476.0,0.0,476.0,,,1.0,292.0,
TCGA-CH-5750-01A-11R-1580-07,PRAD,72.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-26389.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,
TCGA-EJ-A65B-01A-12R-A30B-07,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012.0,[Not Available],-20204.0,Alive,TUMOR FREE,710.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,
TCGA-J4-A83J-01A-11R-A36G-07,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24960.0,Alive,TUMOR FREE,696.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,696.0,0.0,696.0,0.0,696.0,0.0,696.0,
TCGA-KK-A7B2-01A-12R-A32O-07,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24845.0,Alive,WITH TUMOR,1099.0,,[Not Available],Biochemical evidence of disease,,,692.0,Stable Disease,,,0.0,1099.0,0.0,1099.0,,,1.0,692.0,
TCGA-KK-A8IK-01A-11R-A36G-07,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-20594.0,Alive,TUMOR FREE,2052.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2052.0,0.0,2052.0,0.0,2052.0,0.0,2052.0,
TCGA-V1-A8MJ-01A-11R-A36G-07,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-21535.0,Alive,,1791.0,,[Not Available],,,,,Progressive Disease,,,0.0,1791.0,0.0,1791.0,,,0.0,1791.0,
TCGA-G9-6370-01A-11R-1789-07,PRAD,52.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-19149.0,Alive,TUMOR FREE,1156.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1156.0,0.0,1156.0,0.0,1156.0,0.0,1156.0,
TCGA-HC-8264-01B-11R-2403-07,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22177.0,Alive,WITH TUMOR,48.0,,[Not Available],,,,,[Not Applicable],,,0.0,48.0,0.0,48.0,,,0.0,48.0,
TCGA-HC-A48F-01A-11R-A250-07,PRAD,47.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-17434.0,Alive,TUMOR FREE,680.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,680.0,0.0,680.0,0.0,680.0,0.0,680.0,
TCGA-J4-A67S-01A-11R-A30B-07,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23332.0,Alive,WITH TUMOR,833.0,,[Not Available],Biochemical evidence of disease,,,708.0,Complete Remission/Response,,,0.0,833.0,0.0,833.0,1.0,708.0,1.0,708.0,
TCGA-EJ-7781-01A-11R-2118-07,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23937.0,Alive,TUMOR FREE,1073.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1073.0,0.0,1073.0,0.0,1073.0,0.0,1073.0,
TCGA-G9-6356-01A-11R-1789-07,PRAD,60.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-22010.0,Alive,TUMOR FREE,1434.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1434.0,0.0,1434.0,0.0,1434.0,0.0,1434.0,
TCGA-AA-3532-01A-01R-0821-07,COAD,63.0,MALE,[Not Available],Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-23133.0,Alive,WITH TUMOR,882.0,,[Not Available],,,,,[Unknown],,,0.0,882.0,0.0,882.0,,,0.0,882.0,
TCGA-AA-3842-01A-01R-1022-07,COAD,51.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-18842.0,Alive,TUMOR FREE,1126.0,,[Not Available],,,,396.0,Complete Remission/Response,,,0.0,1126.0,0.0,1126.0,1.0,396.0,1.0,396.0,
TCGA-G4-6310-01A-11R-1723-07,COAD,69.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-25243.0,Alive,TUMOR FREE,1935.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0,
TCGA-AA-3975-01A-01R-1022-07,COAD,80.0,MALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-29310.0,Alive,TUMOR FREE,1036.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1036.0,0.0,1036.0,0.0,1036.0,0.0,1036.0,
TCGA-AM-5820-01A-01R-1653-07,COAD,59.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-21902.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,[Not Available],,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-AA-A02W-01A-01R-A00A-07,COAD,73.0,FEMALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-26693.0,Alive,TUMOR FREE,1247.0,,[Not Available],,,,1005.0,Complete Remission/Response,,,0.0,1247.0,0.0,1247.0,1.0,1005.0,1.0,1005.0,
TCGA-CA-6719-01A-11R-1839-07,COAD,77.0,MALE,ASIAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-28343.0,Alive,WITH TUMOR,435.0,,[Not Available],,,,354.0,Progressive Disease,,,0.0,435.0,0.0,435.0,,,1.0,354.0,
TCGA-G4-6295-01A-11R-1723-07,COAD,70.0,FEMALE,WHITE,Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2004.0,[Not Available],-25758.0,Alive,TUMOR FREE,254.0,,[Not Available],,,,,[Not Available],,,0.0,254.0,0.0,254.0,,,0.0,254.0,
TCGA-AA-3949-01A-01R-1022-07,COAD,87.0,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-32081.0,Alive,TUMOR FREE,791.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,
TCGA-AA-3815-01A-01R-1022-07,COAD,65.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-23922.0,Alive,TUMOR FREE,1005.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1005.0,0.0,1005.0,0.0,1005.0,0.0,1005.0,
TCGA-AD-6890-01A-11R-1928-07,COAD,65.0,MALE,WHITE,[Not Available],[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23769.0,Alive,TUMOR FREE,746.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,746.0,0.0,746.0,0.0,746.0,0.0,746.0,
TCGA-AA-A01I-01A-02R-A089-07,COAD,76.0,MALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-27759.0,Alive,TUMOR FREE,943.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,
TCGA-AA-3527-01A-01R-0821-07,COAD,90.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-32871.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-DM-A1D0-01A-11R-A155-07,COAD,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-28875.0,Alive,,3974.0,,[Not Available],,,,,[Not Available],,,0.0,3974.0,0.0,3974.0,,,0.0,3974.0,
TCGA-DM-A0XD-01A-12R-A155-07,COAD,65.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2000.0,[Not Available],-23966.0,Dead,,,743.0,[Not Available],,,,484.0,[Not Available],,,1.0,743.0,,743.0,,,1.0,484.0,
TCGA-AY-A71X-01A-12R-A37K-07,COAD,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-19904.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,
TCGA-AA-A01F-01A-01R-A002-07,COAD,72.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-26298.0,Alive,WITH TUMOR,974.0,,[Not Available],,,,,[Unknown],,,0.0,974.0,0.0,974.0,,,0.0,974.0,
TCGA-G4-6294-01A-11R-1774-07,COAD,75.0,MALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2004.0,[Not Available],-27755.0,Dead,WITH TUMOR,,858.0,[Not Available],,,,517.0,[Not Available],,,1.0,858.0,1.0,858.0,,,1.0,517.0,
TCGA-NH-A8F7-06A-31R-A41B-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-AA-A00W-01A-01R-A002-07,COAD,80.0,MALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-29311.0,Alive,TUMOR FREE,456.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,456.0,0.0,456.0,,,0.0,456.0,
TCGA-CM-4747-01A-01R-1410-07,COAD,47.0,MALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-17198.0,Alive,[Discrepancy],761.0,,[Not Available],,,,,[Discrepancy],,,0.0,761.0,0.0,761.0,,,0.0,761.0,
TCGA-AA-3511-01A-21R-1839-07,COAD,64.0,MALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-23407.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,59.0,Complete Remission/Response,,,0.0,212.0,0.0,212.0,1.0,59.0,1.0,59.0,
TCGA-A6-2684-01A-01R-A278-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-A6-2675-01A-02R-1723-07,COAD,78.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-28813.0,Alive,TUMOR FREE,1321.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1321.0,0.0,1321.0,0.0,1321.0,0.0,1321.0,
TCGA-3L-AA1B-01A-11R-A37K-07,COAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-22379.0,Alive,TUMOR FREE,475.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,
TCGA-D5-5540-01A-01R-1653-07,COAD,73.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-26972.0,Alive,TUMOR FREE,1706.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1706.0,0.0,1706.0,0.0,1706.0,0.0,1706.0,
TCGA-DM-A28M-01A-12R-A16W-07,COAD,63.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2003.0,[Not Available],-23043.0,Alive,,2895.0,,[Not Available],,,,,[Not Available],,,0.0,2895.0,0.0,2895.0,,,0.0,2895.0,
TCGA-DM-A28G-01A-11R-A16W-07,COAD,75.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-27641.0,Dead,,1849.0,1849.0,[Not Available],,,,,[Not Available],,,1.0,1849.0,,1849.0,,,0.0,1849.0,
TCGA-CM-5864-01A-01R-1653-07,COAD,60.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-22219.0,Alive,TUMOR FREE,457.0,,[Not Available],,,,,[Not Available],,,0.0,457.0,0.0,457.0,,,0.0,457.0,
TCGA-AA-3672-01A-01R-0905-07,COAD,90.0,FEMALE,[Not Available],Stage III,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-32873.0,Alive,TUMOR FREE,28.0,,[Not Available],,,,,[Unknown],,,0.0,28.0,0.0,28.0,,,0.0,28.0,
TCGA-CK-5916-01A-11R-1653-07,COAD,71.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2003.0,[Not Available],-26024.0,Dead,WITH TUMOR,,643.0,[Not Available],,,,292.0,Progressive Disease,,,1.0,643.0,1.0,643.0,,,1.0,292.0,
TCGA-AA-A00R-01A-01R-A002-07,COAD,64.0,FEMALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-23528.0,Alive,WITH TUMOR,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-G4-6321-01A-11R-1723-07,COAD,60.0,FEMALE,WHITE,Stage III,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-21921.0,Alive,TUMOR FREE,672.0,,[Not Available],,,,,[Not Available],,,0.0,672.0,0.0,672.0,,,0.0,672.0,
TCGA-AA-3970-01A-01R-1022-07,COAD,65.0,MALE,[Not Available],Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-23741.0,Alive,TUMOR FREE,1096.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,
TCGA-A6-2679-01A-02R-1410-07,COAD,73.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-26820.0,Alive,TUMOR FREE,1366.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1366.0,0.0,1366.0,0.0,1366.0,0.0,1366.0,
TCGA-AA-3950-01A-02R-1022-07,COAD,79.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-29130.0,Alive,TUMOR FREE,730.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,730.0,0.0,730.0,0.0,730.0,0.0,730.0,
TCGA-DM-A1DA-01A-11R-A155-07,COAD,71.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],1999.0,[Not Available],-26169.0,Dead,,228.0,228.0,[Not Available],,,,,[Not Available],,,1.0,228.0,,228.0,,,0.0,228.0,
TCGA-AA-A02F-01A-01R-A089-07,COAD,68.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-25051.0,Alive,WITH TUMOR,1216.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1216.0,0.0,1216.0,,,0.0,1216.0,
TCGA-AA-3977-01A-01R-1022-07,COAD,65.0,MALE,[Not Available],[Not Available],[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-23832.0,Alive,TUMOR FREE,761.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,
TCGA-A6-5661-01A-01R-1653-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-D5-6927-01A-21R-1928-07,COAD,34.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-12737.0,Alive,TUMOR FREE,287.0,,[Not Available],,,,,[Unknown],,,0.0,287.0,0.0,287.0,,,0.0,287.0,
TCGA-AA-3663-01A-01R-1723-07,COAD,42.0,MALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-15675.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,212.0,0.0,212.0,0.0,212.0,0.0,212.0,
TCGA-A6-2680-01A-01R-1410-07,COAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-26533.0,Alive,TUMOR FREE,1068.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1068.0,0.0,1068.0,0.0,1068.0,0.0,1068.0,
TCGA-A6-5664-01A-21R-1839-07,COAD,80.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-29426.0,Alive,WITH TUMOR,672.0,,[Not Available],,,,183.0,[Not Available],,,0.0,672.0,0.0,672.0,,,1.0,183.0,
TCGA-AA-3679-01A-02R-0905-07,COAD,59.0,MALE,[Not Available],Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-21611.0,Alive,WITH TUMOR,457.0,,[Not Available],,,,,Progressive Disease,,,0.0,457.0,0.0,457.0,,,0.0,457.0,
TCGA-AA-3526-01A-02R-A32Z-07,COAD,57.0,MALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-21123.0,Alive,TUMOR FREE,580.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,580.0,0.0,580.0,0.0,580.0,0.0,580.0,
TCGA-G4-6626-01A-11R-1774-07,COAD,90.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-32871.0,Dead,TUMOR FREE,,1422.0,[Not Available],,,,,[Not Available],,,1.0,1422.0,0.0,1422.0,,,0.0,1422.0,
TCGA-AA-3544-01A-01R-1873-07,COAD,68.0,MALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-24959.0,Alive,TUMOR FREE,426.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,
TCGA-A6-5656-01A-21R-A278-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-AA-3870-01A-01R-1022-07,COAD,71.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-26086.0,Alive,TUMOR FREE,912.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,912.0,0.0,912.0,,,0.0,912.0,
TCGA-A6-2685-01A-01R-1410-07,COAD,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-17757.0,Alive,TUMOR FREE,1133.0,,[Not Available],Locoregional Disease,,,948.0,[Not Available],,,0.0,1133.0,0.0,1133.0,,,1.0,948.0,
TCGA-A6-2681-01A-01R-1410-07,COAD,73.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-26929.0,Alive,TUMOR FREE,1387.0,,[Not Available],,,,1150.0,Complete Remission/Response,,,0.0,1387.0,0.0,1387.0,1.0,1150.0,1.0,1150.0,
TCGA-G4-6299-01A-11R-1774-07,COAD,69.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-25318.0,Alive,TUMOR FREE,2268.0,,[Not Available],,,,,[Not Available],,,0.0,2268.0,0.0,2268.0,,,0.0,2268.0,
TCGA-AA-A01D-01A-01R-A00A-07,COAD,47.0,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-17318.0,Dead,WITH TUMOR,,334.0,[Not Available],,,,183.0,Progressive Disease,,,1.0,334.0,1.0,334.0,,,1.0,183.0,
TCGA-AA-3955-01A-02R-1022-07,COAD,38.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-14186.0,Alive,TUMOR FREE,638.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,638.0,0.0,638.0,0.0,638.0,0.0,638.0,
TCGA-AA-3819-01A-01R-0905-07,COAD,41.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-15280.0,Alive,TUMOR FREE,761.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,
TCGA-AA-3866-01A-01R-1022-07,COAD,78.0,FEMALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-28672.0,Alive,TUMOR FREE,518.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,
TCGA-NH-A8F7-01A-11R-A41B-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-G4-6588-01A-11R-1774-07,COAD,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-21532.0,Alive,TUMOR FREE,796.0,,[Not Available],,,,,[Not Available],,,0.0,796.0,0.0,796.0,,,0.0,796.0,
TCGA-A6-6781-01A-22R-A278-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-AA-3861-01A-01R-1022-07,COAD,72.0,MALE,[Not Available],Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-26602.0,Alive,TUMOR FREE,914.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,914.0,0.0,914.0,0.0,914.0,0.0,914.0,
TCGA-G4-6625-01A-21R-1774-07,COAD,77.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2004.0,[Not Available],-28163.0,Alive,TUMOR FREE,2792.0,,[Not Available],,,,2564.0,[Not Available],,,0.0,2792.0,0.0,2792.0,,,1.0,2564.0,
TCGA-A6-6654-01A-21R-1839-07,COAD,65.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-23953.0,Alive,TUMOR FREE,726.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,726.0,0.0,726.0,0.0,726.0,0.0,726.0,
TCGA-D5-7000-01A-11R-A32Z-07,COAD,79.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-28913.0,Alive,TUMOR FREE,312.0,,[Not Available],,,,,[Not Available],,,0.0,312.0,0.0,312.0,,,0.0,312.0,
TCGA-A6-2677-01A-01R-A278-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-AZ-4323-01A-21R-1839-07,COAD,37.0,MALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-13755.0,Dead,WITH TUMOR,,43.0,[Not Available],,,,,[Not Available],,,1.0,43.0,1.0,43.0,,,1.0,43.0,
TCGA-CA-6717-01A-11R-1839-07,COAD,57.0,MALE,ASIAN,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-20984.0,Alive,TUMOR FREE,388.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,388.0,0.0,388.0,0.0,388.0,0.0,388.0,
TCGA-AA-A00E-01A-01R-A002-07,COAD,65.0,MALE,[Not Available],Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-23741.0,Alive,TUMOR FREE,913.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,913.0,0.0,913.0,0.0,913.0,0.0,913.0,
TCGA-A6-6140-01A-11R-1774-07,COAD,62.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-22835.0,Alive,TUMOR FREE,734.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,734.0,0.0,734.0,0.0,734.0,0.0,734.0,
TCGA-A6-6653-01A-11R-1774-07,COAD,82.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-29996.0,Alive,TUMOR FREE,742.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,742.0,0.0,742.0,0.0,742.0,0.0,742.0,
TCGA-A6-2674-01B-04R-A277-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-D5-6533-01A-11R-1723-07,COAD,68.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-24971.0,Alive,TUMOR FREE,775.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,
TCGA-AA-3549-01A-02R-0821-07,COAD,69.0,MALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-25415.0,Alive,TUMOR FREE,639.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,
TCGA-AA-3667-01A-01R-0905-07,COAD,36.0,FEMALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-13302.0,Alive,TUMOR FREE,426.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,
TCGA-AA-3854-01A-01R-0905-07,COAD,71.0,FEMALE,[Not Available],Stage I,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-26022.0,Alive,TUMOR FREE,1096.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,
TCGA-AA-3562-01A-02R-0821-07,COAD,82.0,MALE,[Not Available],Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-30254.0,Alive,WITH TUMOR,608.0,,[Not Available],,,,,[Unknown],,,0.0,608.0,0.0,608.0,,,0.0,608.0,
TCGA-AA-3655-01A-02R-1723-07,COAD,68.0,MALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-24896.0,Alive,TUMOR FREE,1856.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1856.0,0.0,1856.0,0.0,1856.0,0.0,1856.0,
TCGA-F4-6463-01A-11R-1723-07,COAD,51.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-18804.0,Alive,TUMOR FREE,1087.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1087.0,0.0,1087.0,0.0,1087.0,0.0,1087.0,
TCGA-AA-A01R-01A-21R-A083-07,COAD,47.0,MALE,[Not Available],Stage III,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2004.0,[Not Available],-17289.0,Alive,WITH TUMOR,1065.0,,[Not Available],,,,608.0,Partial Remission/Response,,,0.0,1065.0,0.0,1065.0,,,1.0,608.0,
TCGA-A6-5657-01A-01R-A32Z-07,COAD,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23920.0,Alive,TUMOR FREE,962.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,962.0,0.0,962.0,0.0,962.0,0.0,962.0,
TCGA-W3-A828-06A-11R-A352-07,SKCM,66.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1997.0,[Not Available],-24258.0,Dead,,,3683.0,[Not Available],,,,,[Not Available],,,1.0,3683.0,,3683.0,,,0.0,3683.0,
TCGA-FW-A5DX-01A-11R-A27Q-07,SKCM,71.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-26056.0,Alive,TUMOR FREE,640.0,,[Not Available],,,,,[Not Available],,,0.0,640.0,0.0,640.0,,,0.0,640.0,
TCGA-D3-A5GU-06A-11R-A27Q-07,SKCM,36.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2002.0,[Not Available],-13296.0,Alive,WITH TUMOR,3808.0,,[Not Available],Distant Metastasis,Bone,,3074.0,[Not Available],,,0.0,3808.0,0.0,3808.0,,,1.0,3074.0,
TCGA-BF-AAP7-01A-11R-A40A-07,SKCM,76.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-28073.0,Alive,TUMOR FREE,318.0,,[Not Available],,,,,[Not Available],,,0.0,318.0,0.0,318.0,,,0.0,318.0,
TCGA-IH-A3EA-01A-11R-A20F-07,SKCM,61.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-22577.0,Alive,WITH TUMOR,524.0,,[Not Available],Distant Metastasis,Brain,,314.0,[Not Available],,,0.0,524.0,0.0,524.0,,,1.0,314.0,
TCGA-EE-A3JD-06A-11R-A20F-07,SKCM,70.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-25930.0,Dead,WITH TUMOR,,832.0,[Not Available],Distant Metastasis,Lung,,364.0,[Not Available],,,1.0,832.0,1.0,832.0,,,1.0,364.0,
TCGA-EE-A2GH-06A-11R-A18T-07,SKCM,34.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1996.0,[Not Available],-12727.0,Alive,TUMOR FREE,6699.0,,[Not Available],,,,,[Not Available],,,0.0,6699.0,0.0,6699.0,,,0.0,6699.0,
TCGA-BF-A1Q0-01A-21R-A18S-07,SKCM,80.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-29380.0,Alive,TUMOR FREE,831.0,,[Not Available],,,,,[Not Available],,,0.0,831.0,0.0,831.0,,,0.0,831.0,
TCGA-EE-A2MM-06A-11R-A18S-07,SKCM,63.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],1993.0,[Not Available],-23132.0,Dead,WITH TUMOR,,5107.0,[Not Available],New primary melanoma,,,1357.0,[Not Available],,,1.0,5107.0,1.0,5107.0,,,1.0,1357.0,
TCGA-EE-A3AH-06A-11R-A18S-07,SKCM,30.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1998.0,[Not Available],-10988.0,Dead,WITH TUMOR,,4222.0,[Not Available],Locoregional Recurrence,,,1981.0,[Not Available],,,1.0,4222.0,1.0,4222.0,,,1.0,1981.0,
TCGA-ER-A2NB-01A-12R-A18S-07,SKCM,57.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2010.0,[Not Available],-20938.0,Dead,WITH TUMOR,,857.0,[Not Available],,,,461.0,[Not Available],,,1.0,857.0,1.0,857.0,,,1.0,461.0,
TCGA-FW-A3R5-06A-11R-A239-07,SKCM,68.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2010.0,[Not Available],-24868.0,Alive,TUMOR FREE,1124.0,,[Not Available],,,,,[Not Available],,,0.0,1124.0,0.0,1124.0,,,0.0,1124.0,
TCGA-DA-A95W-06A-11R-A37K-07,SKCM,52.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-19105.0,Alive,TUMOR FREE,1136.0,,[Not Available],,,,,[Not Available],,,0.0,1136.0,0.0,1136.0,,,0.0,1136.0,
TCGA-FR-A7U8-06A-21R-A352-07,SKCM,50.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-18346.0,Alive,WITH TUMOR,847.0,,[Not Available],Distant Metastasis,Brain,,567.0,[Not Available],,,0.0,847.0,0.0,847.0,,,1.0,567.0,
TCGA-EE-A2GR-06A-11R-A18S-07,SKCM,78.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],2009.0,[Not Available],-28510.0,Dead,WITH TUMOR,,1301.0,[Not Available],,,,,[Not Available],,,1.0,1301.0,1.0,1301.0,,,1.0,1301.0,
TCGA-RP-A694-06A-11R-A311-07,SKCM,71.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2009.0,[Not Available],-26044.0,Alive,TUMOR FREE,21.0,,[Not Available],,,,,[Not Available],,,0.0,21.0,0.0,21.0,,,0.0,21.0,
TCGA-D3-A2JK-06A-11R-A18S-07,SKCM,24.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2005.0,[Not Available],-8952.0,Dead,WITH TUMOR,,368.0,[Not Available],Distant Metastasis,Lung,,261.0,[Not Available],,,1.0,368.0,1.0,368.0,,,1.0,261.0,
TCGA-EE-A3AC-06A-11R-A18S-07,SKCM,47.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-17319.0,Alive,TUMOR FREE,1948.0,,[Not Available],,,,,[Not Available],,,0.0,1948.0,0.0,1948.0,,,0.0,1948.0,
TCGA-EE-A2GO-06A-11R-A18S-07,SKCM,66.0,FEMALE,WHITE,Stage II,[Not Applicable],,[Not Available],2002.0,[Not Available],-24159.0,Alive,TUMOR FREE,3857.0,,[Not Available],Regional lymph node,,,2216.0,[Not Available],,,0.0,3857.0,0.0,3857.0,,,1.0,2216.0,
TCGA-FS-A1ZJ-06A-12R-A18S-07,SKCM,75.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],2001.0,[Not Available],-27476.0,Dead,WITH TUMOR,,1441.0,[Not Available],,,,1225.0,[Not Available],,,1.0,1441.0,1.0,1441.0,,,1.0,1225.0,
TCGA-HR-A2OH-06A-11R-A18U-07,SKCM,46.0,FEMALE,[Not Evaluated],Stage IIIB,[Not Applicable],,[Not Available],,[Not Available],-16910.0,Dead,WITH TUMOR,,2004.0,[Not Available],,,,,[Not Available],,,1.0,2004.0,1.0,2004.0,,,1.0,2004.0,
TCGA-FS-A4F2-06A-11R-A24X-07,SKCM,46.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2003.0,[Not Available],-16944.0,Dead,WITH TUMOR,,1525.0,[Not Available],,,,,[Not Available],,,1.0,1525.0,1.0,1525.0,,,1.0,1525.0,
TCGA-EE-A3J8-06A-11R-A20F-07,SKCM,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2006.0,[Not Available],-21688.0,Dead,TUMOR FREE,,1044.0,[Not Available],,,,1035.0,[Not Available],,,1.0,1044.0,0.0,1044.0,,,1.0,1035.0,
TCGA-EB-A41B-01A-11R-A24X-07,SKCM,76.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-27998.0,Alive,TUMOR FREE,291.0,,[Not Available],,,,,[Not Available],,,0.0,291.0,0.0,291.0,,,0.0,291.0,
TCGA-ER-A42L-06A-11R-A24X-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-3N-A9WC-06A-11R-A38C-07,SKCM,82.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2009.0,[Not Available],-30286.0,Alive,WITH TUMOR,2022.0,,[Not Available],Distant Metastasis,Lung,,1705.0,[Not Available],,,0.0,2022.0,0.0,2022.0,,,1.0,1705.0,
TCGA-D3-A2JL-06A-11R-A18S-07,SKCM,43.0,FEMALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1999.0,[Not Available],-15710.0,Alive,TUMOR FREE,5219.0,,[Not Available],Distant Metastasis,Lung,,2638.0,[Not Available],,,0.0,5219.0,0.0,5219.0,,,1.0,2638.0,
TCGA-EE-A2M6-06A-12R-A18S-07,SKCM,61.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1997.0,[Not Available],-22564.0,Alive,TUMOR FREE,3932.0,,[Not Available],,,,,[Not Available],,,0.0,3932.0,0.0,3932.0,,,0.0,3932.0,
TCGA-EB-A5VV-06A-11R-A32P-07,SKCM,74.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-27364.0,Alive,TUMOR FREE,214.0,,[Not Available],,,,,[Not Available],,,0.0,214.0,0.0,214.0,,,0.0,214.0,
TCGA-GN-A266-06A-11R-A18T-07,SKCM,45.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2004.0,[Not Available],-16456.0,Dead,WITH TUMOR,,308.0,[Not Available],Distant Metastasis,Brain,,109.0,[Not Available],,,1.0,308.0,1.0,308.0,,,1.0,109.0,
TCGA-D3-A3C8-06A-12R-A18S-07,SKCM,58.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-21281.0,Alive,WITH TUMOR,1409.0,,[Not Available],Distant Metastasis,"Other, Specify","Lymph nodes, neck",55.0,[Not Available],,,0.0,1409.0,0.0,1409.0,,,1.0,55.0,
TCGA-EE-A2GD-06A-11R-A18T-07,SKCM,58.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],1984.0,[Not Available],-21526.0,Dead,WITH TUMOR,,10346.0,[Not Available],Locoregional Recurrence,,,3689.0,[Not Available],,,1.0,10346.0,1.0,10346.0,,,1.0,3689.0,
TCGA-FR-A3R1-01A-11R-A239-07,SKCM,69.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-25271.0,Alive,WITH TUMOR,685.0,,[Not Available],Locoregional Recurrence,,,678.0,[Not Available],,,0.0,685.0,0.0,685.0,,,1.0,678.0,
TCGA-D3-A3C7-06A-11R-A18U-07,SKCM,57.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-20979.0,Alive,TUMOR FREE,1429.0,,[Not Available],,,,,[Not Available],,,0.0,1429.0,0.0,1429.0,,,0.0,1429.0,
TCGA-D3-A8GB-06A-11R-A37K-07,SKCM,48.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2003.0,[Not Available],-17871.0,Dead,WITH TUMOR,,938.0,[Not Available],Distant Metastasis,"Other, Specify",Soft tissue,347.0,[Not Available],,,1.0,938.0,1.0,938.0,,,1.0,347.0,
TCGA-D9-A6EG-06A-12R-A32P-07,SKCM,56.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2012.0,[Not Available],-20570.0,Dead,,,698.0,[Not Available],Distant Metastasis,Bone,,398.0,[Not Available],,,1.0,698.0,,698.0,,,1.0,398.0,
TCGA-EE-A3AA-06A-11R-A18S-07,SKCM,47.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-17196.0,Alive,TUMOR FREE,3781.0,,[Not Available],,,,,[Not Available],,,0.0,3781.0,0.0,3781.0,,,0.0,3781.0,
TCGA-D3-A51F-06A-11R-A266-07,SKCM,51.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-18776.0,Alive,TUMOR FREE,1695.0,,[Not Available],,,,,[Not Available],,,0.0,1695.0,0.0,1695.0,,,0.0,1695.0,
TCGA-BF-AAP2-01A-11R-A40A-07,SKCM,62.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2013.0,[Not Available],-22734.0,Alive,TUMOR FREE,405.0,,[Not Available],,,,,[Not Available],,,0.0,405.0,0.0,405.0,,,0.0,405.0,
TCGA-ER-A2NC-06A-11R-A18T-07,SKCM,50.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2006.0,[Not Available],-18582.0,Dead,WITH TUMOR,,1333.0,[Not Available],Distant Metastasis,Bone,,1157.0,[Not Available],,,1.0,1333.0,1.0,1333.0,,,1.0,1157.0,
TCGA-D3-A5GN-06A-11R-A27Q-07,SKCM,15.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],2001.0,[Not Available],-5684.0,Alive,TUMOR FREE,4129.0,,[Not Available],New primary melanoma,,,1279.0,[Not Available],,,0.0,4129.0,0.0,4129.0,,,1.0,1279.0,
TCGA-DA-A1I0-06A-11R-A20F-07,SKCM,63.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2008.0,[Not Available],-23157.0,Dead,WITH TUMOR,,620.0,[Not Available],Distant Metastasis,Brain,,599.0,[Not Available],,,1.0,620.0,1.0,620.0,,,1.0,599.0,
TCGA-D3-A2JP-06A-11R-A18S-07,SKCM,37.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-13552.0,Alive,WITH TUMOR,1812.0,,[Not Available],Distant Metastasis,Liver,,227.0,[Not Available],,,0.0,1812.0,0.0,1812.0,,,1.0,227.0,
TCGA-FS-A4FC-06A-11R-A24X-07,SKCM,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2007.0,[Not Available],-27482.0,Dead,WITH TUMOR,,1655.0,[Not Available],,,,,[Not Available],,,1.0,1655.0,1.0,1655.0,,,1.0,1655.0,
TCGA-WE-A8ZT-06A-11R-A37K-07,SKCM,25.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2013.0,[Not Available],-9379.0,Alive,TUMOR FREE,359.0,,[Not Available],Locoregional Recurrence,,,69.0,[Not Available],,,0.0,359.0,0.0,359.0,,,1.0,69.0,
TCGA-D3-A2J7-06A-11R-A18T-07,SKCM,67.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2003.0,[Not Available],-24692.0,Dead,WITH TUMOR,,3136.0,[Not Available],Regional lymph node,,,13.0,[Not Available],,,1.0,3136.0,1.0,3136.0,,,1.0,13.0,
TCGA-EE-A3JA-06A-11R-A20F-07,SKCM,44.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2006.0,[Not Available],-16430.0,Dead,WITH TUMOR,,1618.0,[Not Available],Regional lymph node,,,539.0,[Not Available],,,1.0,1618.0,1.0,1618.0,,,1.0,539.0,
TCGA-GF-A3OT-06A-23R-A239-07,SKCM,58.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-21359.0,Alive,WITH TUMOR,301.0,,[Not Available],Distant Metastasis,Lung,,248.0,[Not Available],,,0.0,301.0,0.0,301.0,,,1.0,248.0,
TCGA-DA-A3F3-06A-11R-A20F-07,SKCM,52.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2010.0,[Not Available],-19330.0,Dead,WITH TUMOR,,319.0,[Not Available],,,,,[Not Available],,,1.0,319.0,1.0,319.0,,,1.0,319.0,
TCGA-DA-A1IA-06A-11R-A18S-07,SKCM,32.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2005.0,[Not Available],-11744.0,Dead,WITH TUMOR,,2005.0,[Not Available],,,,,[Not Available],,,1.0,2005.0,1.0,2005.0,,,1.0,2005.0,
TCGA-DA-A1HY-06A-11R-A18T-07,SKCM,42.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2002.0,[Not Available],-15357.0,Alive,TUMOR FREE,4407.0,,[Not Available],,,,,[Not Available],,,0.0,4407.0,0.0,4407.0,,,0.0,4407.0,
TCGA-D3-A8GP-06A-11R-A37K-07,SKCM,77.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2002.0,[Not Available],-28234.0,Alive,TUMOR FREE,4646.0,,[Not Available],Locoregional Recurrence,,,535.0,[Not Available],,,0.0,4646.0,0.0,4646.0,,,1.0,535.0,
TCGA-ER-A193-06A-12R-A18S-07,SKCM,62.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2006.0,[Not Available],-22702.0,Dead,WITH TUMOR,,955.0,[Not Available],Distant Metastasis,Brain,,806.0,[Not Available],,,1.0,955.0,1.0,955.0,,,1.0,806.0,
TCGA-BF-AAP4-01A-11R-A40A-07,SKCM,61.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-22303.0,Alive,TUMOR FREE,335.0,,[Not Available],,,,,[Not Available],,,0.0,335.0,0.0,335.0,,,0.0,335.0,
TCGA-EE-A2M7-06A-11R-A18U-07,SKCM,66.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1999.0,[Not Available],-24371.0,Dead,WITH TUMOR,,877.0,[Not Available],Distant Metastasis,"Other, Specify",mediastinal lymph nodes,799.0,[Not Available],,,1.0,877.0,1.0,877.0,,,1.0,799.0,
TCGA-FR-A69P-06A-21R-A311-07,SKCM,34.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-12679.0,Alive,TUMOR FREE,478.0,,[Not Available],Regional lymph node,,,274.0,[Not Available],,,0.0,478.0,0.0,478.0,,,1.0,274.0,
TCGA-GN-A8LL-06A-21R-A37K-07,SKCM,68.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-25000.0,Dead,WITH TUMOR,,650.0,[Not Available],,,,,[Not Available],,,1.0,650.0,1.0,650.0,,,1.0,650.0,
TCGA-EB-A4OZ-01A-12R-A266-07,SKCM,41.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-15337.0,Alive,TUMOR FREE,620.0,,[Not Available],,,,,[Not Available],,,0.0,620.0,0.0,620.0,,,0.0,620.0,
TCGA-EE-A180-06A-11R-A21D-07,SKCM,69.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-25523.0,Dead,WITH TUMOR,,2889.0,[Not Available],New primary melanoma,,,850.0,[Not Available],,,1.0,2889.0,1.0,2889.0,,,1.0,850.0,
TCGA-W3-AA21-06A-11R-A38C-07,SKCM,26.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1994.0,[Not Available],-9527.0,Dead,WITH TUMOR,,3195.0,[Not Available],Distant Metastasis,"Other, Specify",Chest,2952.0,[Not Available],,,1.0,3195.0,1.0,3195.0,,,1.0,2952.0,
TCGA-D3-A3ML-06A-11R-A21D-07,SKCM,70.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2003.0,[Not Available],-25643.0,Dead,WITH TUMOR,,422.0,[Not Available],Regional lymph node,,,32.0,[Not Available],,,1.0,422.0,1.0,422.0,,,1.0,32.0,
TCGA-FS-A1Z3-06A-11R-A18T-07,SKCM,72.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2002.0,[Not Available],-26435.0,Dead,WITH TUMOR,,636.0,[Not Available],,,,276.0,[Not Available],,,1.0,636.0,1.0,636.0,,,1.0,276.0,
TCGA-D3-A51G-06A-11R-A266-07,SKCM,,MALE,WHITE,Stage 0,[Not Applicable],,[Not Available],1990.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,,,,,,,,,
TCGA-EE-A29E-06A-11R-A18T-07,SKCM,54.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2008.0,[Not Available],-19961.0,Alive,TUMOR FREE,1940.0,,[Not Available],,,,,[Not Available],,,0.0,1940.0,0.0,1940.0,,,0.0,1940.0,
TCGA-RP-A690-06A-11R-A311-07,SKCM,66.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2005.0,[Not Available],-24450.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,,0.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-EE-A3JH-06A-11R-A21D-07,SKCM,54.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2003.0,[Not Available],-19852.0,Alive,TUMOR FREE,4086.0,,[Not Available],Regional lymph node,,,537.0,[Not Available],,,0.0,4086.0,0.0,4086.0,,,1.0,537.0,
TCGA-EE-A2MP-06A-11R-A18S-07,SKCM,34.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],1991.0,[Not Available],-12474.0,Alive,WITH TUMOR,7563.0,,[Not Available],Locoregional Recurrence,,,365.0,[Not Available],,,0.0,7563.0,0.0,7563.0,,,1.0,365.0,
TCGA-EB-A3Y6-01A-21R-A239-07,SKCM,56.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-20605.0,Alive,TUMOR FREE,126.0,,[Not Available],,,,,[Not Available],,,0.0,126.0,0.0,126.0,,,0.0,126.0,
TCGA-EE-A3JI-06A-11R-A21D-07,SKCM,48.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1999.0,[Not Available],-17835.0,Dead,WITH TUMOR,,4648.0,[Not Available],New primary melanoma,,,725.0,[Not Available],,,1.0,4648.0,1.0,4648.0,,,1.0,725.0,
TCGA-D9-A1JX-06A-11R-A18S-07,SKCM,80.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2010.0,[Not Available],-29323.0,Dead,WITH TUMOR,,216.0,[Not Available],Distant Metastasis,"Other, Specify",iliac nymph nodes,195.0,[Not Available],,,1.0,216.0,1.0,216.0,,,1.0,195.0,
TCGA-EE-A2GT-06A-12R-A18S-07,SKCM,77.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2009.0,[Not Available],-28364.0,Alive,WITH TUMOR,1365.0,,[Not Available],Locoregional Recurrence,,,281.0,[Not Available],,,0.0,1365.0,0.0,1365.0,,,1.0,281.0,
TCGA-FW-A3TV-06A-11R-A239-07,SKCM,57.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-20972.0,Alive,WITH TUMOR,411.0,,[Not Available],Locoregional Recurrence,,,139.0,[Not Available],,,0.0,411.0,0.0,411.0,,,1.0,139.0,
TCGA-D9-A4Z5-01A-11R-A266-07,SKCM,68.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-24979.0,Alive,TUMOR FREE,218.0,,[Not Available],,,,,[Not Available],,,0.0,218.0,0.0,218.0,,,0.0,218.0,
TCGA-ER-A19B-06A-11R-A18S-07,SKCM,42.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2000.0,[Not Available],-15437.0,Dead,WITH TUMOR,,2993.0,[Not Available],Regional lymph node,,,829.0,[Not Available],,,1.0,2993.0,1.0,2993.0,,,1.0,829.0,
TCGA-EE-A2MG-06A-11R-A18T-07,SKCM,23.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1997.0,[Not Available],-8405.0,Dead,WITH TUMOR,,3139.0,[Not Available],Distant Metastasis,Lung,,2585.0,[Not Available],,,1.0,3139.0,1.0,3139.0,,,1.0,2585.0,
TCGA-WE-A8ZO-06A-11R-A37K-07,SKCM,73.0,FEMALE,[Not Evaluated],Stage IIIB,[Not Applicable],,[Not Available],2009.0,[Not Available],-26946.0,Alive,TUMOR FREE,2145.0,,[Not Available],Regional lymph node,,,1371.0,[Not Available],,,0.0,2145.0,0.0,2145.0,,,1.0,1371.0,
TCGA-WE-A8K1-06A-21R-A37K-07,SKCM,74.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-27191.0,Alive,TUMOR FREE,1492.0,,[Not Available],,,,,[Not Available],,,0.0,1492.0,0.0,1492.0,,,0.0,1492.0,
TCGA-ER-A2ND-06A-11R-A18T-07,SKCM,57.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2004.0,[Not Available],-20867.0,Dead,WITH TUMOR,,710.0,[Not Available],,,,,[Not Available],,,1.0,710.0,1.0,710.0,,,1.0,710.0,
TCGA-EB-A5UL-06A-11R-A311-07,SKCM,71.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2012.0,[Not Available],-26058.0,Alive,TUMOR FREE,891.0,,[Not Available],,,,,[Not Available],,,0.0,891.0,0.0,891.0,,,0.0,891.0,
TCGA-BF-A3DJ-01A-11R-A20F-07,SKCM,36.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-13332.0,Alive,TUMOR FREE,464.0,,[Not Available],Distant Metastasis,Liver,,217.0,[Not Available],,,0.0,464.0,0.0,464.0,,,1.0,217.0,
TCGA-23-1032-01A-02R-1564-13,OV,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G3,2002.0,[Not Available],-26715.0,Dead,WITH TUMOR,68.0,84.0,[Not Available],,,,,[Not Available],,,1.0,84.0,1.0,84.0,,,1.0,84.0,Redacted
TCGA-30-1860-01A-01R-1568-13,OV,58.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,[Not Available],-21406.0,Dead,WITH TUMOR,1366.0,1366.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],397.0,Complete Remission/Response,,,1.0,1366.0,1.0,1366.0,1.0,397.0,1.0,397.0,
TCGA-20-0991-01A-01R-1564-13,OV,78.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Serous Cystadenocarcinoma,G3,2006.0,[Not Available],-28694.0,Alive,TUMOR FREE,797.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,797.0,0.0,797.0,0.0,797.0,0.0,797.0,Redacted
TCGA-24-2290-01A-01R-1568-13,OV,56.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,[Not Available],-20530.0,Dead,WITH TUMOR,1102.0,1102.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],324.0,Complete Remission/Response,,,1.0,1102.0,1.0,1102.0,1.0,324.0,1.0,324.0,
TCGA-13-1403-01A-01R-1565-13,OV,48.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-17697.0,Dead,WITH TUMOR,,2345.0,[Not Available],,[Not Applicable],[Not Applicable],418.0,Complete Remission/Response,,,1.0,2345.0,1.0,2345.0,1.0,418.0,1.0,418.0,
TCGA-13-0804-01A-01R-1564-13,OV,73.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,[Not Available],-27021.0,Dead,WITH TUMOR,1073.0,1073.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],329.0,Complete Remission/Response,,,1.0,1073.0,1.0,1073.0,1.0,329.0,1.0,329.0,
TCGA-10-0926-01A-01R-1564-13,OV,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,[Not Available],-23307.0,Dead,WITH TUMOR,788.0,788.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],287.0,Complete Remission/Response,,,1.0,788.0,1.0,788.0,1.0,287.0,1.0,287.0,
TCGA-04-1338-01A-01R-1564-13,OV,78.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,[Not Available],-28789.0,Alive,WITH TUMOR,1418.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],380.0,[Not Available],,,0.0,1418.0,0.0,1418.0,,,1.0,380.0,Redacted
TCGA-61-1741-01A-02R-1567-13,OV,76.0,FEMALE,WHITE,[Not Applicable],Stage IIIB,Serous Cystadenocarcinoma,G3,2004.0,[Not Available],-27762.0,Dead,WITH TUMOR,1024.0,1024.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],488.0,Complete Remission/Response,,,1.0,1024.0,1.0,1024.0,1.0,488.0,1.0,488.0,
TCGA-24-1103-01A-01R-1565-13,OV,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,[Not Available],-18583.0,Dead,WITH TUMOR,1646.0,1646.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],678.0,Complete Remission/Response,,,1.0,1646.0,1.0,1646.0,1.0,678.0,1.0,678.0,Redacted
TCGA-24-1431-01A-01R-1566-13,OV,67.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,[Not Available],-24758.0,Dead,WITH TUMOR,583.0,567.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],199.0,[Not Available],,,1.0,567.0,1.0,567.0,,,1.0,199.0,
TCGA-13-1512-01A-01R-1565-13,OV,49.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-18134.0,Alive,WITH TUMOR,442.0,,[Not Available],,[Not Applicable],[Not Applicable],427.0,[Not Available],,,0.0,442.0,0.0,442.0,,,1.0,427.0,
TCGA-59-2351-01A-01R-1569-13,OV,51.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,[Not Available],,Alive,TUMOR FREE,3532.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],2139.0,Complete Remission/Response,,,0.0,3532.0,0.0,3532.0,1.0,2139.0,1.0,2139.0,
TCGA-23-1030-01A-02R-1564-13,OV,64.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,[Not Available],-23416.0,Alive,TUMOR FREE,886.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],544.0,Complete Remission/Response,,,0.0,886.0,0.0,886.0,1.0,544.0,1.0,544.0,Redacted
TCGA-29-1707-02A-01R-1567-13,OV,41.0,FEMALE,WHITE,[Not Applicable],Stage IIC,Serous Cystadenocarcinoma,G3,2006.0,[Not Available],-15017.0,Alive,,1277.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1201.0,Complete Remission/Response,,,0.0,1277.0,0.0,1277.0,1.0,1201.0,1.0,1201.0,
TCGA-24-1923-01A-01R-1567-13,OV,51.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,[Not Available],-18628.0,Dead,WITH TUMOR,690.0,690.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],343.0,Complete Remission/Response,,,1.0,690.0,1.0,690.0,1.0,343.0,1.0,343.0,
TCGA-04-1530-01A-02R-1569-13,OV,68.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1995.0,[Not Available],-25013.0,Dead,WITH TUMOR,,3622.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],350.0,Complete Remission/Response,,,1.0,3622.0,1.0,3622.0,1.0,350.0,1.0,350.0,
TCGA-20-1685-01A-01R-1566-13,OV,45.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-16745.0,Alive,TUMOR FREE,508.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,508.0,0.0,508.0,0.0,508.0,0.0,508.0,
TCGA-29-1770-02A-01R-1567-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-61-2094-01A-01R-1568-13,OV,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,[Not Available],-23273.0,Alive,TUMOR FREE,2182.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2182.0,0.0,2182.0,0.0,2182.0,0.0,2182.0,
TCGA-13-0720-01A-01R-1564-13,OV,48.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,[Not Available],-17799.0,Dead,WITH TUMOR,1355.0,1355.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],292.0,Complete Remission/Response,,,1.0,1355.0,1.0,1355.0,1.0,292.0,1.0,292.0,
TCGA-09-1670-01A-01R-1566-13,OV,57.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous Cystadenocarcinoma,G3,2005.0,[Not Available],-21147.0,Alive,WITH TUMOR,547.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],547.0,Complete Remission/Response,,,0.0,547.0,0.0,547.0,1.0,547.0,1.0,547.0,
TCGA-3P-A9WA-01A-11R-A406-31,OV,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIB,Serous Cystadenocarcinoma,G3,2013.0,[Not Available],-20211.0,Alive,TUMOR FREE,420.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,420.0,0.0,420.0,0.0,420.0,0.0,420.0,
TCGA-61-1917-01A-01R-1568-13,OV,60.0,FEMALE,WHITE,[Not Applicable],Stage IIIB,Serous Cystadenocarcinoma,G3,2002.0,[Not Available],-21972.0,Dead,,1321.0,1321.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1321.0,,1321.0,0.0,1321.0,0.0,1321.0,
TCGA-61-2102-01A-01R-1568-13,OV,74.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,[Not Available],-27256.0,Dead,WITH TUMOR,197.0,197.0,[Not Available],,,,,[Not Available],,,1.0,197.0,1.0,197.0,,,1.0,197.0,
TCGA-24-1425-01A-02R-1566-13,OV,45.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-16764.0,Alive,TUMOR FREE,181.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,181.0,0.0,181.0,0.0,181.0,0.0,181.0,
TCGA-25-1633-01A-01R-1566-13,OV,64.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,[Not Available],-23407.0,Dead,WITH TUMOR,1843.0,1891.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],616.0,Complete Remission/Response,,,1.0,1891.0,1.0,1891.0,1.0,616.0,1.0,616.0,
TCGA-20-0987-01A-02R-1564-13,OV,61.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,[Not Available],-22287.0,Dead,WITH TUMOR,,701.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],442.0,[Not Available],,,1.0,701.0,1.0,701.0,,,1.0,442.0,Redacted
TCGA-23-1022-01A-01R-1564-13,OV,67.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,[Not Available],-24798.0,Dead,WITH TUMOR,,1511.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],450.0,Complete Remission/Response,,,1.0,1511.0,1.0,1511.0,1.0,450.0,1.0,450.0,Redacted
TCGA-24-1843-01A-01R-1567-13,OV,66.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-24469.0,Alive,,106.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,106.0,0.0,106.0,0.0,106.0,0.0,106.0,
TCGA-61-2092-01A-01R-1568-13,OV,57.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,[Not Available],-21072.0,Alive,TUMOR FREE,1573.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1573.0,0.0,1573.0,0.0,1573.0,0.0,1573.0,
TCGA-25-1320-01A-01R-1565-13,OV,65.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,[Not Available],-24018.0,Dead,WITH TUMOR,1124.0,1155.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],424.0,Progressive Disease,,,1.0,1155.0,1.0,1155.0,,,1.0,424.0,
TCGA-13-1485-01A-02R-1565-13,OV,48.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G2,2001.0,[Not Available],-17642.0,Dead,WITH TUMOR,629.0,629.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],170.0,Partial Remission/Response,,,1.0,629.0,1.0,629.0,,,1.0,170.0,
TCGA-30-1866-01A-02R-1568-13,OV,61.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G2,2003.0,[Not Available],-22562.0,Dead,WITH TUMOR,1114.0,1114.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],285.0,Complete Remission/Response,,,1.0,1114.0,1.0,1114.0,,,1.0,285.0,
TCGA-61-1733-01A-01R-1567-13,OV,71.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,[Not Available],-26180.0,Alive,WITH TUMOR,967.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],175.0,Stable Disease,,,0.0,967.0,0.0,967.0,,,1.0,175.0,
TCGA-13-1407-01A-01R-1565-13,OV,51.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-18896.0,Alive,WITH TUMOR,2534.0,,[Not Available],,[Not Applicable],[Not Applicable],1333.0,Complete Remission/Response,,,0.0,2534.0,0.0,2534.0,1.0,1333.0,1.0,1333.0,
TCGA-57-1586-01A-02R-1567-13,OV,66.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,[Not Available],-24304.0,Alive,WITH TUMOR,679.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],259.0,[Not Available],,,0.0,679.0,0.0,679.0,,,1.0,259.0,
TCGA-13-1509-01A-01R-1565-13,OV,64.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-23481.0,Alive,WITH TUMOR,2438.0,,[Not Available],,[Not Applicable],[Not Applicable],578.0,Complete Remission/Response,,,0.0,2438.0,0.0,2438.0,,,1.0,578.0,
TCGA-25-2400-01A-01R-1569-13,OV,76.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,[Not Available],-27789.0,Dead,WITH TUMOR,1278.0,1278.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],577.0,Complete Remission/Response,,,1.0,1278.0,1.0,1278.0,1.0,577.0,1.0,577.0,
TCGA-04-1651-01A-01R-1567-13,OV,53.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,[Not Available],-19628.0,Dead,,,1102.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],990.0,[Not Available],,,1.0,1102.0,,1102.0,,,1.0,990.0,
TCGA-29-1778-01A-01R-1567-13,OV,77.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-28147.0,Alive,TUMOR FREE,454.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,454.0,0.0,454.0,0.0,454.0,0.0,454.0,
TCGA-61-1743-01A-01R-1568-13,OV,53.0,FEMALE,WHITE,[Not Applicable],Stage IIC,Serous Cystadenocarcinoma,G2,2004.0,[Not Available],-19365.0,Dead,WITH TUMOR,1329.0,1329.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],809.0,Complete Remission/Response,,,1.0,1329.0,1.0,1329.0,1.0,809.0,1.0,809.0,
TCGA-24-1470-01A-01R-1566-13,OV,54.0,FEMALE,WHITE,[Not Applicable],Stage IIIB,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-20007.0,Alive,TUMOR FREE,105.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,105.0,0.0,105.0,0.0,105.0,0.0,105.0,
TCGA-61-1724-01A-01R-1568-13,OV,47.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,[Not Available],-17168.0,Dead,WITH TUMOR,637.0,637.0,[Not Available],,,,,Progressive Disease,,,1.0,637.0,1.0,637.0,,,1.0,637.0,
TCGA-13-0886-01A-01R-1569-13,OV,67.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,[Not Available],-24724.0,Alive,TUMOR FREE,4665.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4665.0,0.0,4665.0,0.0,4665.0,0.0,4665.0,
TCGA-24-1427-01A-01R-1565-13,OV,58.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-21423.0,Alive,WITH TUMOR,147.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,147.0,0.0,147.0,,,0.0,147.0,
TCGA-25-1631-01A-01R-1569-13,OV,73.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,[Not Available],-26687.0,Dead,TUMOR FREE,9.0,9.0,[Not Available],,,,,[Not Available],,,1.0,9.0,0.0,9.0,,,0.0,9.0,
TCGA-61-2003-01A-01R-1568-13,OV,53.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G2,2008.0,[Not Available],-19605.0,Alive,WITH TUMOR,122.0,,[Not Available],,,,,Progressive Disease,,,0.0,122.0,0.0,122.0,,,0.0,122.0,
TCGA-24-1436-01A-01R-1566-13,OV,57.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,[Not Available],-20881.0,Dead,WITH TUMOR,260.0,260.0,[Not Available],,,,,Partial Remission/Response,,,1.0,260.0,1.0,260.0,,,1.0,260.0,
TCGA-13-0920-01A-01R-1564-13,OV,65.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,[Not Available],-24064.0,Dead,WITH TUMOR,,1484.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],297.0,Complete Remission/Response,,,1.0,1484.0,1.0,1484.0,1.0,297.0,1.0,297.0,
TCGA-10-0931-01A-01R-1564-13,OV,44.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,[Not Available],-16262.0,Dead,WITH TUMOR,982.0,1000.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],300.0,Complete Remission/Response,,,1.0,1000.0,1.0,1000.0,1.0,300.0,1.0,300.0,
TCGA-09-2056-01B-01R-1568-13,OV,62.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-22864.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-09-0366-01A-01R-1564-13,OV,55.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,[Not Available],-20440.0,Dead,WITH TUMOR,,1757.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],190.0,Stable Disease,,,1.0,1757.0,1.0,1757.0,,,1.0,190.0,
TCGA-13-0891-01A-01R-1564-13,OV,73.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G3,2003.0,[Not Available],-26886.0,Dead,WITH TUMOR,,3128.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],762.0,Complete Remission/Response,,,1.0,3128.0,1.0,3128.0,,,1.0,762.0,
TCGA-29-1783-01A-01R-1567-13,OV,58.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-21284.0,Alive,TUMOR FREE,220.0,,[Not Available],,,,,[Not Available],,,0.0,220.0,0.0,220.0,,,0.0,220.0,
TCGA-24-1603-01A-01R-1566-13,OV,53.0,FEMALE,WHITE,[Not Applicable],Stage IIIB,Serous Cystadenocarcinoma,G3,1996.0,[Not Available],-19681.0,Dead,WITH TUMOR,2742.0,2742.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],992.0,Complete Remission/Response,,,1.0,2742.0,1.0,2742.0,1.0,992.0,1.0,992.0,
TCGA-25-1326-01A-01R-1565-13,OV,61.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,[Not Available],-22339.0,Dead,WITH TUMOR,945.0,1249.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],396.0,Partial Remission/Response,,,1.0,1249.0,1.0,1249.0,,,1.0,396.0,
TCGA-24-1604-01A-01R-1566-13,OV,66.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1996.0,[Not Available],-24471.0,Dead,WITH TUMOR,2688.0,2688.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2688.0,1.0,2688.0,,,1.0,2688.0,
TCGA-23-1023-01A-02R-1564-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-24-1551-01A-01R-1566-13,OV,53.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,[Not Available],-19661.0,Dead,WITH TUMOR,1579.0,1579.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],764.0,Complete Remission/Response,,,1.0,1579.0,1.0,1579.0,1.0,764.0,1.0,764.0,
TCGA-04-1519-01A-01R-1565-13,OV,48.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,[Not Available],-17671.0,Alive,,24.0,,[Not Available],,,,,[Unknown],,,0.0,24.0,0.0,24.0,,,0.0,24.0,
TCGA-04-1356-01A-01R-1569-13,OV,62.0,FEMALE,WHITE,[Not Applicable],Stage IIC,Serous Cystadenocarcinoma,G3,2004.0,[Not Available],-22855.0,Dead,WITH TUMOR,,1499.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],156.0,Progressive Disease,,,1.0,1499.0,1.0,1499.0,,,1.0,156.0,
TCGA-25-2393-01A-01R-1569-13,OV,81.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,[Not Available],-29585.0,Dead,WITH TUMOR,1157.0,1157.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],305.0,Partial Remission/Response,,,1.0,1157.0,1.0,1157.0,,,1.0,305.0,
TCGA-24-1426-01A-01R-1565-13,OV,43.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-15949.0,Alive,TUMOR FREE,163.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,163.0,0.0,163.0,0.0,163.0,0.0,163.0,
TCGA-13-0884-01B-01R-1565-13,OV,39.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,[Not Available],-14538.0,Dead,WITH TUMOR,3260.0,3260.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1251.0,Complete Remission/Response,,,1.0,3260.0,1.0,3260.0,1.0,1251.0,1.0,1251.0,
TCGA-10-0934-01A-02R-1564-13,OV,50.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,[Not Available],-18602.0,Dead,WITH TUMOR,119.0,204.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],111.0,Progressive Disease,,,1.0,204.0,1.0,204.0,,,1.0,111.0,
TCGA-13-1477-01A-01R-1565-13,OV,49.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G2,2000.0,[Not Available],-18111.0,Dead,WITH TUMOR,1662.0,1662.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],235.0,Progressive Disease,,,1.0,1662.0,1.0,1662.0,,,1.0,235.0,
TCGA-13-1489-02A-01R-1565-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-13-1496-01A-01R-1565-13,OV,65.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,[Not Available],-23993.0,Dead,,129.0,129.0,[Not Available],,,,,[Not Available],,,1.0,129.0,,129.0,,,0.0,129.0,
TCGA-09-1674-01A-01R-1566-13,OV,79.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-28878.0,Alive,WITH TUMOR,260.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,260.0,0.0,260.0,0.0,260.0,0.0,260.0,
TCGA-24-1557-01A-01R-1566-13,OV,49.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,[Not Available],-17943.0,Dead,WITH TUMOR,1213.0,1213.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],447.0,Partial Remission/Response,,,1.0,1213.0,1.0,1213.0,,,1.0,447.0,
TCGA-13-1510-01A-02R-1565-13,OV,62.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-22708.0,Dead,WITH TUMOR,,1359.0,[Not Available],,[Not Applicable],[Not Applicable],1189.0,[Not Available],,,1.0,1359.0,1.0,1359.0,,,1.0,1189.0,
TCGA-61-2098-01A-01R-1568-13,OV,62.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G2,2003.0,[Not Available],-22876.0,Alive,TUMOR FREE,1993.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1993.0,0.0,1993.0,0.0,1993.0,0.0,1993.0,
TCGA-24-1556-01A-01R-1566-13,OV,50.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Serous Cystadenocarcinoma,G3,2000.0,[Not Available],-18517.0,Dead,WITH TUMOR,2148.0,2148.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],539.0,Complete Remission/Response,,,1.0,2148.0,1.0,2148.0,1.0,539.0,1.0,539.0,
TCGA-25-1316-01A-01R-1565-13,OV,55.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,[Not Available],-20331.0,Dead,WITH TUMOR,1126.0,1279.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],276.0,Progressive Disease,,,1.0,1279.0,1.0,1279.0,,,1.0,276.0,
TCGA-24-1844-01A-01R-1567-13,OV,64.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-23542.0,Alive,,113.0,,[Not Available],,,,,[Not Available],,,0.0,113.0,0.0,113.0,,,0.0,113.0,
TCGA-24-1434-01A-01R-1566-13,OV,59.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,[Not Available],-21810.0,Dead,WITH TUMOR,568.0,568.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],337.0,Partial Remission/Response,,,1.0,568.0,1.0,568.0,,,1.0,337.0,
TCGA-61-2111-01A-01R-1568-13,OV,61.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G3,1998.0,[Not Available],-22517.0,Alive,WITH TUMOR,3825.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],2205.0,Complete Remission/Response,,,0.0,3825.0,0.0,3825.0,,,1.0,2205.0,
TCGA-13-0730-01A-01R-1564-13,OV,71.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,[Not Available],-26086.0,Dead,,,542.0,[Not Available],,,,,[Unknown],,,1.0,542.0,,542.0,,,0.0,542.0,
TCGA-61-2109-01A-01R-1568-13,OV,40.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,[Not Available],-14900.0,Dead,WITH TUMOR,629.0,629.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],465.0,[Not Available],,,1.0,629.0,1.0,629.0,,,1.0,465.0,
TCGA-R5-A7ZE-01B-11R-A354-31,STAD,66.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-24328.0,Dead,WITH TUMOR,,554.0,[Unknown],,,,,Progressive Disease,,,1.0,554.0,1.0,554.0,,,1.0,554.0,
TCGA-BR-4369-01A-01R-1157-13,STAD,75.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-27509.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-CG-4444-01A-01R-1157-13,STAD,76.0,MALE,[Not Available],Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,[Not Available],-27912.0,Alive,TUMOR FREE,1431.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1431.0,0.0,1431.0,0.0,1431.0,0.0,1431.0,
TCGA-BR-4367-01A-01R-1157-13,STAD,78.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-28817.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-VQ-A91U-01A-11R-A414-31,STAD,78.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-28791.0,Dead,,,52.0,[Unknown],,,,,[Unknown],,,1.0,52.0,,52.0,,,0.0,52.0,
TCGA-RD-A8N5-01A-12R-A36D-31,STAD,78.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2006.0,[Not Available],-28589.0,Dead,TUMOR FREE,,1747.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,1747.0,0.0,1747.0,0.0,1747.0,0.0,1747.0,
TCGA-HU-A4GY-01A-21R-A24K-31,STAD,76.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-28113.0,Alive,TUMOR FREE,8.0,,[Not Available],,,,,Stable Disease,,,0.0,8.0,0.0,8.0,,,0.0,8.0,
TCGA-CG-4449-01A-01R-1157-13,STAD,81.0,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2007.0,[Not Available],-29705.0,Alive,WITH TUMOR,580.0,,[Not Available],,,,336.0,Partial Remission/Response,,,0.0,580.0,0.0,580.0,,,1.0,336.0,
TCGA-BR-7716-01A-21R-2055-13,STAD,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-22829.0,Alive,TUMOR FREE,1210.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1210.0,0.0,1210.0,0.0,1210.0,0.0,1210.0,
TCGA-BR-6802-01A-11R-1884-13,STAD,65.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-23915.0,Alive,TUMOR FREE,940.0,,[Not Available],Distant Metastasis,Non-regional / Distant Lymph Nodes,,807.0,Complete Remission/Response,,,0.0,940.0,0.0,940.0,1.0,807.0,1.0,807.0,
TCGA-SW-A7EA-01A-12R-A354-31,STAD,61.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",GX,2013.0,[Not Available],-22294.0,Alive,TUMOR FREE,579.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,
TCGA-BR-7901-01A-11R-2203-13,STAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-27031.0,Dead,TUMOR FREE,,105.0,[Not Available],Locoregional Recurrence,,,91.0,Complete Remission/Response,,,1.0,105.0,0.0,105.0,1.0,91.0,1.0,91.0,
TCGA-D7-8578-01A-21R-2343-13,STAD,72.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-26620.0,Alive,WITH TUMOR,643.0,,[Not Available],Locoregional Recurrence|Distant Metastasis,Lung,,451.0,Complete Remission/Response,,,0.0,643.0,0.0,643.0,1.0,451.0,1.0,451.0,
TCGA-CD-8536-01A-11R-2343-13,STAD,74.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-27328.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,
TCGA-BR-4357-01A-01R-1157-13,STAD,58.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-21295.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-MX-A666-01A-11R-A31P-31,STAD,61.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,[Not Available],-22288.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,Stable Disease,,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-HF-7136-01A-11R-2055-13,STAD,,MALE,[Not Available],Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],,Alive,WITH TUMOR,,,[Not Available],,,,,Progressive Disease,,,0.0,,0.0,,,,0.0,,
TCGA-D7-6519-01A-11R-1802-13,STAD,64.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-23413.0,Alive,WITH TUMOR,625.0,,[Not Available],Distant Metastasis,Liver,cervix,429.0,Progressive Disease,,,0.0,625.0,0.0,625.0,,,1.0,429.0,
TCGA-BR-A4QM-01A-12R-A251-31,STAD,65.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23999.0,Alive,WITH TUMOR,156.0,,[Not Available],Locoregional Recurrence,,,127.0,Complete Remission/Response,,,0.0,156.0,0.0,156.0,1.0,127.0,1.0,127.0,
TCGA-CD-8532-01A-11R-2343-13,STAD,52.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-19284.0,Dead,WITH TUMOR,,354.0,[Not Available],Locoregional Recurrence,,,282.0,Complete Remission/Response,,,1.0,354.0,1.0,354.0,1.0,282.0,1.0,282.0,
TCGA-CG-4472-01A-01R-1157-13,STAD,49.0,MALE,[Not Available],Stage IV,[Not Applicable],[Not Available],G3,2009.0,[Not Available],-18110.0,Alive,WITH TUMOR,365.0,,[Not Available],,,,122.0,Partial Remission/Response,,,0.0,365.0,0.0,365.0,,,1.0,122.0,
TCGA-RD-A7BS-01A-11R-A32D-31,STAD,46.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2001.0,[Not Available],-16847.0,Dead,WITH TUMOR,,336.0,Stomach Cancer,Distant Metastasis,Liver,,244.0,Complete Remission/Response,,,1.0,336.0,1.0,336.0,1.0,244.0,1.0,244.0,
TCGA-VQ-A91S-01A-11R-A414-31,STAD,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",GX,2012.0,[Not Available],-23187.0,Alive,TUMOR FREE,1000.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,
TCGA-CD-5803-01A-11R-1602-13,STAD,78.0,FEMALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-28608.0,Dead,WITH TUMOR,,341.0,[Not Available],Distant Metastasis,Liver,,300.0,Progressive Disease,,,1.0,341.0,1.0,341.0,,,1.0,300.0,
TCGA-VQ-A8PQ-01A-11R-A414-31,STAD,50.0,FEMALE,WHITE,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008.0,[Not Available],-18318.0,Dead,WITH TUMOR,,476.0,Stomach Cancer,Locoregional Recurrence,,,91.0,Progressive Disease,,,1.0,476.0,1.0,476.0,,,1.0,91.0,
TCGA-VQ-A8PZ-01A-11R-A414-31,STAD,56.0,FEMALE,WHITE,Stage II,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2008.0,[Not Available],-20735.0,Alive,TUMOR FREE,2233.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2233.0,0.0,2233.0,0.0,2233.0,0.0,2233.0,
TCGA-HU-A4HD-01A-11R-A251-31,STAD,73.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-26699.0,Alive,TUMOR FREE,1016.0,,[Not Available],,,,,Stable Disease,,,0.0,1016.0,0.0,1016.0,,,0.0,1016.0,
TCGA-FP-8210-01A-11R-2343-13,STAD,48.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,[Not Available],-17562.0,Dead,WITH TUMOR,,153.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,153.0,1.0,153.0,,,1.0,153.0,
TCGA-3M-AB46-01A-11R-A414-31,STAD,70.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],,Alive,TUMOR FREE,1765.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1765.0,0.0,1765.0,0.0,1765.0,0.0,1765.0,
TCGA-HU-8604-01A-11R-2402-13,STAD,82.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-30178.0,Alive,TUMOR FREE,694.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,
TCGA-IP-7968-01A-11R-2203-13,STAD,74.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-27114.0,Alive,TUMOR FREE,77.0,,[Not Available],,,,,[Not Available],,,0.0,77.0,0.0,77.0,,,0.0,77.0,
TCGA-VQ-A8E3-01A-11R-A39E-31,STAD,79.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-28919.0,Dead,,,661.0,[Unknown],Locoregional Recurrence,,,538.0,[Unknown],,,1.0,661.0,,661.0,,,1.0,538.0,
TCGA-BR-7851-01A-11R-2203-13,STAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-27091.0,Dead,TUMOR FREE,574.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,,0.0,,0.0,,0.0,,
TCGA-HF-7132-01A-11R-2055-13,STAD,,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2006.0,[Not Available],,Alive,TUMOR FREE,2351.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2351.0,0.0,2351.0,0.0,2351.0,0.0,2351.0,
TCGA-CG-4440-01A-01R-1157-13,STAD,68.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,[Not Available],-25171.0,Dead,,,122.0,[Not Available],,,,,[Not Available],,,1.0,122.0,,122.0,,,0.0,122.0,
TCGA-D7-A4YY-01A-11R-A251-31,STAD,61.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-22287.0,Alive,TUMOR FREE,419.0,,[Not Available],,,,,Stable Disease,,,0.0,419.0,0.0,419.0,,,0.0,419.0,
TCGA-BR-8687-01A-11R-2402-13,STAD,67.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-24472.0,Dead,WITH TUMOR,,250.0,[Not Available],,,,,Stable Disease,,,1.0,250.0,1.0,250.0,,,1.0,250.0,
TCGA-VQ-AA6B-01A-11R-A414-31,STAD,48.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-17852.0,Alive,TUMOR FREE,1002.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1002.0,0.0,1002.0,0.0,1002.0,0.0,1002.0,
TCGA-CG-4476-01A-01R-1157-13,STAD,69.0,MALE,[Not Available],Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-25506.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-VQ-A8PK-01A-12R-A414-31,STAD,58.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-21419.0,Dead,WITH TUMOR,,543.0,Stomach Cancer,Locoregional Recurrence|Distant Metastasis,Liver,,263.0,Progressive Disease,,,1.0,543.0,1.0,543.0,,,1.0,263.0,
TCGA-BR-7723-01A-11R-2055-13,STAD,59.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21839.0,Dead,WITH TUMOR,,874.0,[Not Available],Distant Metastasis,Liver,,559.0,Complete Remission/Response,,,1.0,874.0,1.0,874.0,1.0,559.0,1.0,559.0,
TCGA-RD-A8N9-01A-12R-A39E-31,STAD,63.0,FEMALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2009.0,[Not Available],-23059.0,Alive,TUMOR FREE,1083.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1083.0,0.0,1083.0,0.0,1083.0,0.0,1083.0,
TCGA-BR-8058-01A-31R-2343-13,STAD,53.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-19658.0,Alive,TUMOR FREE,1133.0,,[Not Available],New Primary Tumor,"Other, specify",Rectum,89.0,Complete Remission/Response,,,0.0,1133.0,0.0,1133.0,0.0,1133.0,1.0,89.0,
TCGA-IN-7806-01A-11R-2055-13,STAD,50.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-18404.0,Alive,TUMOR FREE,1106.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,
TCGA-VQ-A92D-01A-11R-A414-31,STAD,67.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,[Not Available],-24595.0,Alive,TUMOR FREE,2032.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2032.0,0.0,2032.0,0.0,2032.0,0.0,2032.0,
TCGA-VQ-A8E0-01A-11R-A414-31,STAD,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-24848.0,Dead,WITH TUMOR,,562.0,Stomach Cancer,Distant Metastasis,Liver,,531.0,Progressive Disease,,,1.0,562.0,1.0,562.0,,,1.0,531.0,
TCGA-BR-8296-01A-11R-2343-13,STAD,58.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21527.0,Dead,WITH TUMOR,,474.0,[Not Available],Distant Metastasis,Liver,,390.0,Stable Disease,,,1.0,474.0,1.0,474.0,,,1.0,390.0,
TCGA-HU-A4GU-01A-11R-A251-31,STAD,73.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-27024.0,Alive,TUMOR FREE,200.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,200.0,0.0,200.0,0.0,200.0,0.0,200.0,
TCGA-VQ-A923-01A-11R-A414-31,STAD,90.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2008.0,[Not Available],-32873.0,Dead,TUMOR FREE,,61.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,61.0,0.0,61.0,0.0,61.0,0.0,61.0,
TCGA-BR-4253-01A-01R-1131-13,STAD,80.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-29397.0,Dead,,,124.0,[Not Available],,,,,[Not Available],,,1.0,124.0,,124.0,,,0.0,124.0,
TCGA-CD-8525-01A-11R-2343-13,STAD,82.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010.0,[Not Available],-30004.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-IN-A6RN-01A-12R-A33Y-31,STAD,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-26409.0,Alive,TUMOR FREE,594.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,
TCGA-BR-8372-01A-11R-2343-13,STAD,63.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23346.0,Alive,TUMOR FREE,951.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,951.0,0.0,951.0,0.0,951.0,0.0,951.0,
TCGA-MX-A5UJ-01A-11R-A31P-31,STAD,86.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-31517.0,Alive,TUMOR FREE,600.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,
TCGA-FP-8211-01A-11R-2343-13,STAD,62.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-22957.0,Alive,TUMOR FREE,413.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,413.0,0.0,413.0,0.0,413.0,0.0,413.0,
TCGA-R5-A7ZI-01A-11R-A354-31,STAD,44.0,FEMALE,WHITE,Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2009.0,[Not Available],-16396.0,Alive,TUMOR FREE,2267.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2267.0,0.0,2267.0,,,0.0,2267.0,
TCGA-BR-6454-01A-11R-1802-13,STAD,58.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21501.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-BR-A4QL-01A-31R-A251-31,STAD,75.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-27668.0,Dead,TUMOR FREE,,491.0,[Not Available],,,,,Complete Remission/Response,,,1.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,
TCGA-BR-6709-01A-11R-1884-13,STAD,57.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-20935.0,Dead,WITH TUMOR,,370.0,[Not Available],,,,,Partial Remission/Response,,,1.0,370.0,1.0,370.0,,,1.0,370.0,
TCGA-BR-4362-01A-01R-1157-13,STAD,74.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-27179.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-CG-4306-01A-01R-1157-13,STAD,90.0,MALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,[Not Available],-32871.0,Dead,,,31.0,[Not Available],,,,,[Not Available],,,1.0,31.0,,31.0,,,0.0,31.0,
TCGA-VQ-A94T-01A-11R-A414-31,STAD,73.0,MALE,[Unknown],Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-26702.0,Dead,WITH TUMOR,,342.0,[Not Available],Locoregional Recurrence,,,296.0,Progressive Disease,,,1.0,342.0,1.0,342.0,,,1.0,296.0,
TCGA-BR-8486-01A-31R-2402-13,STAD,90.0,FEMALE,WHITE,Stage IA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-32872.0,Alive,TUMOR FREE,615.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,
TCGA-BR-8286-01A-12R-2343-13,STAD,49.0,MALE,WHITE,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-17966.0,Alive,TUMOR FREE,895.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,895.0,0.0,895.0,0.0,895.0,0.0,895.0,
TCGA-D7-5578-01A-01R-1602-13,STAD,80.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2010.0,[Not Available],-29390.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],,,0.0,385.0,0.0,385.0,,,0.0,385.0,
TCGA-BR-7704-01A-11R-2055-13,STAD,69.0,FEMALE,WHITE,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25300.0,Alive,TUMOR FREE,1072.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1072.0,0.0,1072.0,0.0,1072.0,0.0,1072.0,
TCGA-3M-AB47-01A-22R-A414-31,STAD,51.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],,Dead,WITH TUMOR,,,Stomach Cancer,Locoregional Recurrence,,,395.0,Stable Disease,,,1.0,,1.0,,,,1.0,395.0,
TCGA-CG-4474-01A-02R-1157-13,STAD,67.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-24686.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-CD-5799-01A-11R-1602-13,STAD,45.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-16533.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,
TCGA-BR-6710-01A-11R-1884-13,STAD,41.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-15316.0,Alive,TUMOR FREE,273.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,273.0,0.0,273.0,0.0,273.0,0.0,273.0,
TCGA-BR-4363-01A-01R-1157-13,STAD,60.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-22196.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-VQ-A8PX-01A-12R-A414-31,STAD,51.0,MALE,[Unknown],Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],-18902.0,Alive,TUMOR FREE,1964.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1964.0,0.0,1964.0,0.0,1964.0,0.0,1964.0,
TCGA-BR-4255-01A-01R-1131-13,STAD,76.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-27893.0,Dead,,,124.0,[Not Available],,,,,[Not Available],,,1.0,124.0,,124.0,,,0.0,124.0,
TCGA-KB-A93H-01A-11R-A39E-31,STAD,79.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G1,2011.0,[Not Available],-28966.0,Alive,TUMOR FREE,1145.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1145.0,0.0,1145.0,0.0,1145.0,0.0,1145.0,
TCGA-CD-8533-01A-11R-2343-13,STAD,48.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-17821.0,Alive,WITH TUMOR,468.0,,[Not Available],Distant Metastasis,"Other, specify",liver and lung,226.0,Complete Remission/Response,,,0.0,468.0,0.0,468.0,1.0,226.0,1.0,226.0,
TCGA-RD-A8N2-01A-12R-A36D-31,STAD,59.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2002.0,[Not Available],-21749.0,Alive,TUMOR FREE,3540.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3540.0,0.0,3540.0,0.0,3540.0,0.0,3540.0,
TCGA-BR-8384-01A-21R-2402-13,STAD,69.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25281.0,Alive,TUMOR FREE,113.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,113.0,0.0,113.0,0.0,113.0,0.0,113.0,
TCGA-BR-A4IV-01A-31R-A251-31,STAD,47.0,MALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-17515.0,Dead,WITH TUMOR,,869.0,[Not Available],Locoregional Recurrence,,,737.0,Complete Remission/Response,,,1.0,869.0,1.0,869.0,1.0,737.0,1.0,737.0,
TCGA-HU-8238-01A-11R-2343-13,STAD,56.0,MALE,ASIAN,[Discrepancy],[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-20708.0,Alive,TUMOR FREE,46.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,
TCGA-BR-A4J6-01A-11R-A251-31,STAD,69.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-25279.0,Alive,TUMOR FREE,20.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,20.0,0.0,20.0,0.0,20.0,0.0,20.0,
TCGA-UY-A9PB-01A-11R-A38B-07,BLCA,49.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-17885.0,Alive,TUMOR FREE,899.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,899.0,0.0,899.0,0.0,899.0,0.0,899.0,
TCGA-UY-A78N-01A-12R-A33J-07,BLCA,80.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-29132.0,Dead,WITH TUMOR,,2641.0,[Not Available],Distant Metastasis,Renal Pelvis,,2472.0,Complete Remission/Response,,,1.0,2641.0,1.0,2641.0,,,1.0,2472.0,
TCGA-CF-A27C-01A-11R-A16R-07,BLCA,52.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-19270.0,Alive,TUMOR FREE,425.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,425.0,0.0,425.0,0.0,425.0,0.0,425.0,
TCGA-XF-A8HI-01A-11R-A38B-07,BLCA,57.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-21059.0,Dead,WITH TUMOR,,544.0,[Not Available],Distant Metastasis,Lung,,468.0,Progressive Disease,,,1.0,544.0,1.0,544.0,,,1.0,468.0,
TCGA-DK-A3X2-01A-11R-A22U-07,BLCA,85.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-31160.0,Dead,WITH TUMOR,,547.0,[Not Available],Distant Metastasis,Liver,,533.0,Complete Remission/Response,,,1.0,547.0,1.0,547.0,,,1.0,533.0,
TCGA-XF-AAMY-01A-11R-A42T-07,BLCA,78.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-28509.0,Alive,TUMOR FREE,3011.0,,[Not Available],Distant Metastasis,Lung,,637.0,Complete Remission/Response,,,0.0,3011.0,0.0,3011.0,1.0,637.0,1.0,637.0,
TCGA-DK-A3IV-01A-22R-A21D-07,BLCA,60.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-22237.0,Dead,WITH TUMOR,,294.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,212.0,Stable Disease,,,1.0,294.0,1.0,294.0,,,1.0,212.0,
TCGA-DK-A3IS-01A-21R-A21D-07,BLCA,68.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-25098.0,Alive,TUMOR FREE,1529.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1529.0,0.0,1529.0,0.0,1529.0,0.0,1529.0,
TCGA-XF-A9SV-01A-21R-A42T-07,BLCA,82.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-30265.0,Dead,WITH TUMOR,,388.0,[Not Available],Distant Metastasis,Lung,,237.0,Progressive Disease,,,1.0,388.0,1.0,388.0,,,1.0,237.0,
TCGA-FJ-A3Z9-01A-11R-A26T-07,BLCA,72.0,MALE,WHITE,[Not Available],[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26515.0,Dead,TUMOR FREE,,385.0,[Not Available],,,,,Complete Remission/Response,,,1.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-DK-A6B5-01A-11R-A31N-07,BLCA,45.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-16453.0,Alive,TUMOR FREE,1542.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1542.0,0.0,1542.0,,,0.0,1542.0,
TCGA-DK-A1AG-01A-11R-A13Y-07,BLCA,65.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-24095.0,Alive,TUMOR FREE,475.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,
TCGA-BT-A20X-01A-11R-A16R-07,BLCA,56.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-20519.0,Dead,WITH TUMOR,,251.0,[Not Available],,,,,Progressive Disease,,,1.0,251.0,1.0,251.0,,,1.0,251.0,
TCGA-BL-A0C8-01A-11R-A277-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-4Z-AA7Q-01A-11R-A39I-07,BLCA,79.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28981.0,Dead,TUMOR FREE,,510.0,[Not Available],,,,,[Not Applicable],,,1.0,510.0,0.0,510.0,,,0.0,510.0,
TCGA-ZF-AA53-01A-11R-A39I-07,BLCA,60.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-22035.0,Alive,TUMOR FREE,1761.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1761.0,0.0,1761.0,0.0,1761.0,0.0,1761.0,
TCGA-XF-A9SW-01A-11R-A42T-07,BLCA,85.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-31049.0,Dead,WITH TUMOR,,362.0,[Not Available],,,,,Partial Remission/Response,,,1.0,362.0,1.0,362.0,,,1.0,362.0,
TCGA-G2-AA3C-01A-21R-A39I-07,BLCA,66.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-24267.0,Dead,WITH TUMOR,,211.0,[Not Available],,,,,[Unknown],,,1.0,211.0,1.0,211.0,,,1.0,211.0,
TCGA-DK-A2I4-01A-11R-A21D-07,BLCA,79.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001.0,[Not Available],-29037.0,Alive,TUMOR FREE,4343.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4343.0,0.0,4343.0,0.0,4343.0,0.0,4343.0,
TCGA-XF-AAN8-01A-11R-A42T-07,BLCA,74.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-27309.0,Dead,,,118.0,[Not Available],,,,,[Unknown],,,1.0,118.0,,118.0,,,0.0,118.0,
TCGA-DK-AA75-01A-11R-A39I-07,BLCA,82.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-30090.0,Dead,WITH TUMOR,,340.0,[Not Available],Distant Metastasis,Bone,,328.0,Stable Disease,,,1.0,340.0,1.0,340.0,,,1.0,328.0,
TCGA-BT-A20W-01A-21R-A14Y-07,BLCA,71.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-26078.0,Dead,TUMOR FREE,,254.0,[Not Available],,,,,Complete Remission/Response,,,1.0,254.0,0.0,254.0,0.0,254.0,0.0,254.0,
TCGA-GC-A4ZW-01A-11R-A26T-07,BLCA,71.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25964.0,Alive,TUMOR FREE,15.0,,[Not Available],,,,,[Unknown],,,0.0,15.0,0.0,15.0,,,0.0,15.0,
TCGA-DK-AA71-01A-31R-A39I-07,BLCA,71.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-25950.0,Alive,WITH TUMOR,415.0,,[Not Available],,,,,Stable Disease,,,0.0,415.0,0.0,415.0,,,0.0,415.0,
TCGA-XF-A9SM-01A-11R-A42T-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-LC-A66R-01A-41R-A30C-07,BLCA,78.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28793.0,Alive,TUMOR FREE,466.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,466.0,0.0,466.0,,,0.0,466.0,
TCGA-CF-A7I0-01A-22R-A352-07,BLCA,54.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,[Not Available],-20059.0,Alive,TUMOR FREE,368.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,
TCGA-FJ-A3ZE-01A-11R-A23N-07,BLCA,65.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-23866.0,Dead,WITH TUMOR,,324.0,[Not Available],Distant Metastasis,Bone,,152.0,Progressive Disease,,,1.0,324.0,1.0,324.0,,,1.0,152.0,
TCGA-FD-A6TA-01A-12R-A33J-07,BLCA,58.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-21196.0,Alive,TUMOR FREE,1912.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1912.0,0.0,1912.0,,,0.0,1912.0,
TCGA-GD-A3OP-01A-21R-A220-07,BLCA,84.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-30956.0,Alive,,64.0,,[Not Available],,,,,[Unknown],,,0.0,64.0,0.0,64.0,,,0.0,64.0,
TCGA-E7-A6MF-01A-12R-A32O-07,BLCA,37.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,[Not Available],-13867.0,Alive,TUMOR FREE,750.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,750.0,0.0,750.0,0.0,750.0,0.0,750.0,
TCGA-CF-A47X-01A-31R-A23W-07,BLCA,60.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-22200.0,Alive,TUMOR FREE,384.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,
TCGA-HQ-A5NE-01A-12R-A28M-07,BLCA,57.0,MALE,[Not Evaluated],Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-20647.0,Dead,WITH TUMOR,,370.0,[Not Available],Distant Metastasis,Renal Pelvis,,211.0,Complete Remission/Response,,,1.0,370.0,1.0,370.0,1.0,211.0,1.0,211.0,
TCGA-GC-A3BM-01A-11R-A22U-07,BLCA,70.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-25609.0,Dead,WITH TUMOR,,651.0,[Not Available],,,,,Progressive Disease,,,1.0,651.0,1.0,651.0,,,1.0,651.0,
TCGA-E7-A7PW-01A-11R-A352-07,BLCA,63.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23057.0,Alive,TUMOR FREE,416.0,,[Not Available],Distant Metastasis,Bone,,174.0,Complete Remission/Response,,,0.0,416.0,0.0,416.0,1.0,174.0,1.0,174.0,
TCGA-BL-A13J-01B-04R-A277-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-K4-A4AB-01B-12R-A28M-07,BLCA,76.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27922.0,Alive,,84.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,84.0,0.0,84.0,,,0.0,84.0,
TCGA-FD-A3NA-01A-11R-A21D-07,BLCA,60.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-21936.0,Alive,TUMOR FREE,1845.0,,[Not Available],New Primary Tumor,Lung,,1338.0,Complete Remission/Response,,,0.0,1845.0,0.0,1845.0,0.0,1845.0,1.0,1338.0,
TCGA-G2-A3IB-01A-11R-A20F-07,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-24149.0,Dead,WITH TUMOR,,220.0,[Not Available],,,,,Progressive Disease,,,1.0,220.0,1.0,220.0,,,1.0,220.0,
TCGA-E7-A519-01A-11R-A26T-07,BLCA,72.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26427.0,Alive,TUMOR FREE,508.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,508.0,0.0,508.0,0.0,508.0,0.0,508.0,
TCGA-KQ-A41O-01A-12R-A352-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-GV-A3QG-01A-11R-A220-07,BLCA,65.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-23847.0,Dead,WITH TUMOR,,,[Not Available],Distant Metastasis,"Other, specify",Brain,84.0,[Not Applicable],,,1.0,,1.0,,,,1.0,84.0,
TCGA-ZF-AA4W-01A-12R-A38B-07,BLCA,56.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-20611.0,Alive,,1830.0,,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",penile urethra,1679.0,Complete Remission/Response,,,0.0,1830.0,0.0,1830.0,1.0,1679.0,1.0,1679.0,
TCGA-HQ-A5ND-01A-11R-A26T-07,BLCA,78.0,MALE,[Not Evaluated],Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-28555.0,Dead,WITH TUMOR,,274.0,[Not Available],Distant Metastasis,Lymph Node Only,,84.0,Progressive Disease,,,1.0,274.0,1.0,274.0,,,1.0,84.0,
TCGA-C4-A0F0-01A-12R-A10U-07,BLCA,60.0,MALE,[Not Available],Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-22068.0,Alive,TUMOR FREE,59.0,,[Not Available],,,,,[Not Available],,,0.0,59.0,0.0,59.0,,,0.0,59.0,
TCGA-CU-A3YL-01A-11R-A22U-07,BLCA,67.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-24524.0,Alive,TUMOR FREE,906.0,,[Not Available],Distant Metastasis,Lung,,370.0,Complete Remission/Response,,,0.0,906.0,0.0,906.0,1.0,370.0,1.0,370.0,
TCGA-CU-A5W6-01A-11R-A28M-07,BLCA,70.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25706.0,Dead,TUMOR FREE,,56.0,[Not Available],,,,,Complete Remission/Response,,,1.0,56.0,0.0,56.0,0.0,56.0,0.0,56.0,
TCGA-DK-A3IK-01A-32R-A21D-07,BLCA,87.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-32076.0,Dead,TUMOR FREE,,146.0,[Not Available],,,,,Complete Remission/Response,,,1.0,146.0,0.0,146.0,,,0.0,146.0,
TCGA-UY-A78K-01A-11R-A33J-07,BLCA,60.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-22020.0,Dead,,,536.0,[Not Available],,,,,Complete Remission/Response,,,1.0,536.0,,536.0,,,0.0,536.0,
TCGA-ZF-A9RF-01A-11R-A38B-07,BLCA,74.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-27281.0,Alive,TUMOR FREE,1949.0,,[Not Available],Locoregional (Urothelial tumor event),Bladder,,1565.0,Complete Remission/Response,,,0.0,1949.0,0.0,1949.0,1.0,1565.0,1.0,1565.0,
TCGA-DK-AA6U-01A-11R-A39I-07,BLCA,64.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2013.0,[Not Available],-23611.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,
TCGA-K4-A3WV-01A-11R-A22U-07,BLCA,77.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-28444.0,Alive,TUMOR FREE,646.0,,[Not Available],,,,,[Not Applicable],,,0.0,646.0,0.0,646.0,,,0.0,646.0,
TCGA-BT-A20T-01A-11R-A14Y-07,BLCA,63.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-23220.0,Dead,WITH TUMOR,,453.0,[Not Available],Distant Metastasis,Liver,,314.0,Progressive Disease,,,1.0,453.0,1.0,453.0,,,1.0,314.0,
TCGA-K4-A3WU-01B-11R-A23N-07,BLCA,87.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-32134.0,Alive,TUMOR FREE,105.0,,[Not Available],,,,,[Not Applicable],,,0.0,105.0,0.0,105.0,,,0.0,105.0,
TCGA-E7-A4IJ-01A-31R-A26T-07,BLCA,56.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-20723.0,Dead,WITH TUMOR,,674.0,[Not Available],Distant Metastasis,Bone,,620.0,Complete Remission/Response,,,1.0,674.0,1.0,674.0,1.0,620.0,1.0,620.0,
TCGA-DK-A2I2-01A-11R-A180-07,BLCA,63.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-23116.0,Dead,WITH TUMOR,,237.0,[Not Available],Distant Metastasis,Liver,,163.0,Complete Remission/Response,,,1.0,237.0,1.0,237.0,,,1.0,163.0,
TCGA-DK-A3IN-01A-11R-A20F-07,BLCA,72.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-26562.0,Dead,TUMOR FREE,,250.0,[Not Available],,,,,Complete Remission/Response,,,1.0,250.0,0.0,250.0,0.0,250.0,0.0,250.0,
TCGA-GV-A40G-01A-11R-A23N-07,BLCA,77.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28204.0,Alive,TUMOR FREE,580.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,580.0,0.0,580.0,0.0,580.0,0.0,580.0,
TCGA-G2-A2EK-01A-22R-A18C-07,BLCA,57.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-20995.0,Alive,WITH TUMOR,485.0,,[Not Available],Distant Metastasis,Renal Pelvis,,485.0,Stable Disease,,,0.0,485.0,0.0,485.0,,,1.0,485.0,
TCGA-FD-A6TB-01A-12R-A33J-07,BLCA,82.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-30185.0,Alive,TUMOR FREE,572.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,
TCGA-GU-A763-01A-11R-A32O-07,BLCA,72.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26527.0,Alive,WITH TUMOR,997.0,,[Not Available],Distant Metastasis,Lung,,303.0,Stable Disease,,,0.0,997.0,0.0,997.0,,,1.0,303.0,
TCGA-K4-A5RJ-01A-11R-A28M-07,BLCA,75.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27518.0,Alive,TUMOR FREE,539.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,539.0,0.0,539.0,0.0,539.0,0.0,539.0,
TCGA-GC-A6I1-01A-12R-A31N-07,BLCA,90.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-32873.0,Dead,TUMOR FREE,,272.0,[Not Available],,,,,Complete Remission/Response,,,1.0,272.0,0.0,272.0,0.0,272.0,0.0,272.0,
TCGA-DK-A1AE-01A-11R-A13Y-07,BLCA,84.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-30707.0,Alive,WITH TUMOR,491.0,,[Not Available],Metastatic,Bone,,211.0,Progressive Disease,,,0.0,491.0,0.0,491.0,,,1.0,211.0,
TCGA-CF-A47V-01A-11R-A23W-07,BLCA,52.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-19265.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-G2-AA3B-01A-11R-A39I-07,BLCA,75.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-27646.0,Alive,TUMOR FREE,2008.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2008.0,0.0,2008.0,0.0,2008.0,0.0,2008.0,
TCGA-XF-AAN0-01A-11R-A42T-07,BLCA,68.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-24877.0,Dead,WITH TUMOR,,1718.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Scrotum and Perineum,603.0,Complete Remission/Response,,,1.0,1718.0,1.0,1718.0,,,1.0,603.0,
TCGA-4Z-AA7N-01A-11R-A39I-07,BLCA,65.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-24090.0,Dead,TUMOR FREE,,1367.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1367.0,0.0,1367.0,0.0,1367.0,0.0,1367.0,
TCGA-ZF-A9R9-01A-11R-A38B-07,BLCA,58.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-21491.0,Dead,WITH TUMOR,,864.0,[Not Available],Distant Metastasis,"Other, specify",penis,629.0,Complete Remission/Response,,,1.0,864.0,1.0,864.0,,,1.0,629.0,
TCGA-GU-A42P-01A-11R-A23W-07,BLCA,72.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26546.0,Dead,TUMOR FREE,,332.0,[Not Available],,,,,Stable Disease,,,1.0,332.0,0.0,332.0,,,0.0,332.0,
TCGA-GV-A3QK-01B-11R-A23N-07,BLCA,56.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-20802.0,Alive,WITH TUMOR,832.0,,[Not Available],,,,,Stable Disease,,,0.0,832.0,0.0,832.0,,,0.0,832.0,
TCGA-CF-A1HS-01A-11R-A13Y-07,BLCA,75.0,FEMALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-27565.0,Alive,WITH TUMOR,382.0,,[Not Available],Distant Metastasis,"Other, specify",Pelvis,133.0,Complete Remission/Response,,,0.0,382.0,0.0,382.0,1.0,133.0,1.0,133.0,
TCGA-FD-A6TD-01A-51R-A33J-07,BLCA,77.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28328.0,Dead,TUMOR FREE,,386.0,[Not Available],,,,,Complete Remission/Response,,,1.0,386.0,0.0,386.0,0.0,386.0,0.0,386.0,
TCGA-BT-A3PH-01A-11R-A220-07,BLCA,76.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-28030.0,Dead,WITH TUMOR,,142.0,[Not Available],,,,,Progressive Disease,,,1.0,142.0,1.0,142.0,,,1.0,142.0,
TCGA-ZF-A9R7-01A-11R-A38B-07,BLCA,76.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-28063.0,Alive,TUMOR FREE,665.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,665.0,0.0,665.0,0.0,665.0,0.0,665.0,
TCGA-DK-A3WW-01A-22R-A23N-07,BLCA,57.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-20909.0,Alive,TUMOR FREE,633.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,633.0,0.0,633.0,0.0,633.0,0.0,633.0,
TCGA-K4-A54R-01A-11R-A26T-07,BLCA,59.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-21601.0,Alive,TUMOR FREE,842.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,
TCGA-FD-A3SP-01A-31R-A22U-07,BLCA,60.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-22005.0,Alive,TUMOR FREE,783.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,783.0,0.0,783.0,0.0,783.0,0.0,783.0,
TCGA-E7-A7DU-01A-11R-A32O-07,BLCA,73.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,[Not Available],-27000.0,Alive,TUMOR FREE,28.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,28.0,0.0,28.0,0.0,28.0,0.0,28.0,
TCGA-XF-A9T8-01A-11R-A39I-07,BLCA,64.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-23403.0,Dead,,,418.0,[Not Available],,,,,[Unknown],,,1.0,418.0,,418.0,,,0.0,418.0,
TCGA-PD-A5DF-01A-11R-A27V-07,LIHC,58.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-21414.0,Dead,WITH TUMOR,,639.0,[Not Available],,,,,[Not Available],,[Not Available],1.0,639.0,1.0,639.0,,,1.0,639.0,
TCGA-BC-A10Q-01A-11R-A131-07,LIHC,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,[Not Available],1998.0,[Not Available],-26400.0,Dead,WITH TUMOR,,1135.0,[Not Available],Intrahepatic Recurrence,,,340.0,[Not Available],,R1,1.0,1135.0,1.0,1135.0,,,1.0,340.0,
TCGA-DD-AAW1-01A-11R-A41C-07,LIHC,55.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-20288.0,Alive,TUMOR FREE,1989.0,,[Not Available],,,,,[Not Available],,R0,0.0,1989.0,0.0,1989.0,0.0,1989.0,0.0,1989.0,
TCGA-MR-A8JO-01A-12R-A36F-07,LIHC,34.0,MALE,WHITE,Stage I,[Not Applicable],Fibrolamellar Carcinoma,G3,2013.0,[Not Available],-12669.0,Alive,TUMOR FREE,330.0,,[Not Available],,,,,[Not Available],,RX,0.0,330.0,0.0,330.0,,,0.0,330.0,
TCGA-DD-AA3A-01A-11R-A37K-07,LIHC,81.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocholangiocarcinoma (Mixed),G4,2009.0,[Not Available],-29712.0,Dead,TUMOR FREE,,410.0,[Not Available],,,,,[Not Available],,R0,1.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,
TCGA-BC-A10Z-01A-11R-A131-07,LIHC,62.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2003.0,[Not Available],-22913.0,Dead,TUMOR FREE,,34.0,[Not Available],,,,,[Not Available],,R0,1.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,
TCGA-WX-AA47-01A-11R-A39D-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-O8-A75V-01A-11R-A32O-07,LIHC,54.0,MALE,[Unknown],Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-19850.0,Alive,TUMOR FREE,538.0,,[Not Available],,,,,[Not Available],,R1,0.0,538.0,0.0,538.0,,,0.0,538.0,
TCGA-G3-AAUZ-01A-11R-A38B-07,LIHC,48.0,MALE,[Unknown],Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-17760.0,Alive,TUMOR FREE,480.0,,[Not Available],,,,,[Not Available],,R0,0.0,480.0,0.0,480.0,0.0,480.0,0.0,480.0,
TCGA-ES-A2HT-01A-12R-A180-07,LIHC,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-20023.0,Dead,TUMOR FREE,,438.0,[Not Available],,,,,[Not Available],,R0,1.0,438.0,0.0,438.0,0.0,438.0,0.0,438.0,
TCGA-CC-5262-01A-01R-A131-07,LIHC,67.0,MALE,ASIAN,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G1,2010.0,[Not Available],-24787.0,Dead,TUMOR FREE,,103.0,[Not Available],,,,,[Not Available],,[Not Available],1.0,103.0,0.0,103.0,,,0.0,103.0,
TCGA-DD-A39Y-01A-11R-A213-07,LIHC,67.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2002.0,[Not Available],-24769.0,Dead,TUMOR FREE,,171.0,[Not Available],,,,,[Not Available],,R0,1.0,171.0,0.0,171.0,0.0,171.0,0.0,171.0,
TCGA-2Y-A9GY-01A-11R-A38B-07,LIHC,64.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2007.0,[Not Available],-23435.0,Dead,WITH TUMOR,,757.0,[Not Available],Extrahepatic Recurrence,Lung,,637.0,[Not Available],,R0,1.0,757.0,1.0,757.0,1.0,637.0,1.0,637.0,
TCGA-2V-A95S-01A-11R-A37K-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-BC-A10U-01A-11R-A131-07,LIHC,69.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G2,2000.0,[Not Available],-25305.0,Dead,WITH TUMOR,,837.0,[Not Available],Intrahepatic Recurrence,,,586.0,[Not Available],,R1,1.0,837.0,1.0,837.0,,,1.0,586.0,
TCGA-CC-5263-01A-01R-A131-07,LIHC,35.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2010.0,[Not Available],-12863.0,Dead,TUMOR FREE,,129.0,[Not Available],,,,,[Not Available],,RX,1.0,129.0,0.0,129.0,,,0.0,129.0,
TCGA-WX-AA46-01A-11R-A39D-07,LIHC,61.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-22639.0,Alive,TUMOR FREE,756.0,,[Not Available],,,,,[Not Available],,R0,0.0,756.0,0.0,756.0,0.0,756.0,0.0,756.0,
TCGA-UB-A7MB-01A-11R-A33R-07,LIHC,24.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-8951.0,Alive,WITH TUMOR,601.0,,[Not Available],Intrahepatic Recurrence,Liver,,48.0,[Not Available],,R0,0.0,601.0,0.0,601.0,1.0,48.0,1.0,48.0,
TCGA-DD-A3A9-01A-11R-A266-07,LIHC,64.0,FEMALE,WHITE,Stage IVB,[Not Applicable],Hepatocellular Carcinoma,G2,2001.0,[Not Available],-23526.0,Dead,WITH TUMOR,,931.0,[Not Available],Extrahepatic Recurrence,Lung,,289.0,[Not Available],,R0,1.0,931.0,1.0,931.0,,,1.0,289.0,
TCGA-CC-A9FS-01A-11R-A37K-07,LIHC,55.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-20157.0,Alive,WITH TUMOR,211.0,,[Not Available],New Primary Tumor,Lung,,109.0,[Not Available],,R0,0.0,211.0,0.0,211.0,0.0,211.0,1.0,109.0,
TCGA-G3-A25S-01A-11R-A16W-07,LIHC,64.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-23571.0,Dead,WITH TUMOR,,416.0,[Not Available],Extrahepatic Recurrence,"Other, specify",Bone and Lung,37.0,[Not Available],,R1,1.0,416.0,1.0,416.0,,,1.0,37.0,
TCGA-DD-AACY-01A-11R-A41C-07,LIHC,61.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-22332.0,Alive,WITH TUMOR,1450.0,,[Not Available],Intrahepatic Recurrence,Liver,,776.0,[Not Available],,R0,0.0,1450.0,0.0,1450.0,1.0,776.0,1.0,776.0,
TCGA-FV-A3R3-01A-11R-A22L-07,LIHC,38.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-14231.0,Dead,TUMOR FREE,,366.0,[Not Available],,,,,[Not Available],,R0,1.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,
TCGA-DD-A4NL-01A-11R-A28V-07,LIHC,46.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2007.0,[Not Available],-16874.0,Alive,TUMOR FREE,1711.0,,[Not Available],,,,,[Not Available],,R0,0.0,1711.0,0.0,1711.0,0.0,1711.0,0.0,1711.0,
TCGA-2Y-A9H1-01A-11R-A38B-07,LIHC,58.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-21222.0,Dead,WITH TUMOR,,1229.0,[Not Available],Locoregional Recurrence,Liver,,321.0,[Not Available],,R0,1.0,1229.0,1.0,1229.0,1.0,321.0,1.0,321.0,
TCGA-DD-AAD1-01A-11R-A41C-07,LIHC,51.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2010.0,[Not Available],-18794.0,Alive,WITH TUMOR,564.0,,[Not Available],Intrahepatic Recurrence,Liver,,127.0,[Not Available],,R1,0.0,564.0,0.0,564.0,,,1.0,127.0,
TCGA-DD-A1EA-01A-11R-A131-07,LIHC,68.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2002.0,[Not Available],-24925.0,Alive,WITH TUMOR,2415.0,,[Not Available],Locoregional Recurrence,Liver,,754.0,[Not Available],,R0,0.0,2415.0,0.0,2415.0,1.0,754.0,1.0,754.0,
TCGA-DD-A1EK-01A-11R-A213-07,LIHC,64.0,FEMALE,WHITE,Stage IVB,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-23437.0,Dead,WITH TUMOR,,558.0,[Not Available],Locoregional Recurrence,Liver,,167.0,[Not Available],,R0,1.0,558.0,1.0,558.0,,,1.0,167.0,
TCGA-DD-A3A1-01A-11R-A213-07,LIHC,65.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2001.0,[Not Available],-24046.0,Dead,TUMOR FREE,,233.0,[Not Available],,,,,[Not Available],,R0,1.0,233.0,0.0,233.0,0.0,233.0,0.0,233.0,
TCGA-T1-A6J8-01A-11R-A32O-07,LIHC,68.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-24853.0,Alive,TUMOR FREE,23.0,,[Not Available],,,,,[Not Available],,RX,0.0,23.0,0.0,23.0,,,0.0,23.0,
TCGA-CC-A8HU-01A-11R-A36F-07,LIHC,39.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-14367.0,Dead,WITH TUMOR,,344.0,[Not Available],Locoregional Recurrence,,,301.0,[Not Available],,R0,1.0,344.0,1.0,344.0,1.0,301.0,1.0,301.0,
TCGA-WQ-AB4B-01A-11R-A41C-07,LIHC,62.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-22769.0,Alive,WITH TUMOR,395.0,,[Not Available],Intrahepatic Recurrence,,,273.0,[Not Available],,R0,0.0,395.0,0.0,395.0,1.0,273.0,1.0,273.0,
TCGA-DD-AADY-01A-11R-A41C-07,LIHC,55.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-20233.0,Alive,TUMOR FREE,555.0,,[Not Available],,,,,[Not Available],,R0,0.0,555.0,0.0,555.0,0.0,555.0,0.0,555.0,
TCGA-RC-A6M6-01A-11R-A32O-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-ZS-A9CG-01A-11R-A37K-07,LIHC,55.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-20100.0,Alive,TUMOR FREE,341.0,,[Not Available],,,,,[Not Available],,R0,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,
TCGA-RC-A7SK-01A-11R-A352-07,LIHC,59.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-21814.0,Alive,TUMOR FREE,472.0,,[Not Available],Intrahepatic Recurrence,Liver,,312.0,[Not Available],,R0,0.0,472.0,0.0,472.0,1.0,312.0,1.0,312.0,
TCGA-DD-AAVP-01A-11R-A41C-07,LIHC,48.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2007.0,[Not Available],-17833.0,Alive,TUMOR FREE,2752.0,,[Not Available],Locoregional Recurrence,Liver,,903.0,[Not Available],,R0,0.0,2752.0,0.0,2752.0,1.0,903.0,1.0,903.0,
TCGA-BC-A112-01A-11R-A131-07,LIHC,80.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-29511.0,Dead,TUMOR FREE,,153.0,[Not Available],,,,,[Not Available],,R0,1.0,153.0,0.0,153.0,0.0,153.0,0.0,153.0,
TCGA-MI-A75I-01A-11R-A32O-07,LIHC,61.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G1,2011.0,[Not Available],-22341.0,Alive,,630.0,,[Not Available],,Liver,,265.0,[Not Available],,R0,0.0,630.0,0.0,630.0,1.0,265.0,1.0,265.0,
TCGA-G3-A25T-01A-11R-A16W-07,LIHC,45.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-16461.0,Alive,WITH TUMOR,1553.0,,[Not Available],Intrahepatic Recurrence,Liver,,452.0,[Not Available],,R0,0.0,1553.0,0.0,1553.0,1.0,452.0,1.0,452.0,
TCGA-CC-A7II-01A-11R-A33J-07,LIHC,54.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-20079.0,Alive,WITH TUMOR,399.0,,[Not Available],Locoregional Recurrence,,,278.0,[Not Available],,R0,0.0,399.0,0.0,399.0,1.0,278.0,1.0,278.0,
TCGA-DD-A4NE-01A-11R-A27V-07,LIHC,75.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-27549.0,Dead,WITH TUMOR,,660.0,[Not Available],Locoregional Recurrence,Liver,,190.0,[Not Available],,R0,1.0,660.0,1.0,660.0,1.0,190.0,1.0,190.0,
TCGA-DD-AAE7-01A-11R-A41C-07,LIHC,72.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-26568.0,Alive,TUMOR FREE,644.0,,[Not Available],,,,,[Not Available],,R0,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,
TCGA-NI-A8LF-01A-11R-A36F-07,LIHC,74.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-27162.0,Alive,TUMOR FREE,799.0,,[Not Available],,,,,[Not Available],,R0,0.0,799.0,0.0,799.0,0.0,799.0,0.0,799.0,
TCGA-BC-A10T-01A-11R-A131-07,LIHC,76.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G1,2000.0,[Not Available],-27944.0,Dead,WITH TUMOR,,837.0,[Not Available],Extrahepatic Recurrence,Pulmonary,,598.0,[Not Available],,R1,1.0,837.0,1.0,837.0,,,1.0,598.0,
TCGA-FV-A2QQ-01A-11R-A22L-07,LIHC,80.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-29354.0,Alive,TUMOR FREE,729.0,,[Not Available],,,,,[Not Available],,R0,0.0,729.0,0.0,729.0,0.0,729.0,0.0,729.0,
TCGA-DD-AADF-01A-11R-A41C-07,LIHC,64.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2011.0,[Not Available],-23614.0,Dead,TUMOR FREE,,115.0,[Not Available],,,,,[Not Available],,R0,1.0,115.0,0.0,115.0,0.0,115.0,0.0,115.0,
TCGA-DD-A4NV-01A-11R-A311-07,LIHC,61.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2007.0,[Not Available],-22438.0,Alive,TUMOR FREE,2398.0,,[Not Available],,,,,[Not Available],,R0,0.0,2398.0,0.0,2398.0,0.0,2398.0,0.0,2398.0,
TCGA-DD-AAVW-01A-11R-A41C-07,LIHC,35.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-12986.0,Alive,TUMOR FREE,2317.0,,[Not Available],,,,,[Not Available],,R0,0.0,2317.0,0.0,2317.0,0.0,2317.0,0.0,2317.0,
TCGA-BC-A8YO-01A-11R-A37K-07,LIHC,66.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-24189.0,Alive,WITH TUMOR,562.0,,[Not Available],Locoregional Recurrence,Liver,,220.0,[Not Available],,R0,0.0,562.0,0.0,562.0,1.0,220.0,1.0,220.0,
TCGA-MI-A75G-01A-11R-A32O-07,LIHC,63.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-23284.0,Alive,TUMOR FREE,698.0,,[Not Available],,,,,[Not Available],,R0,0.0,698.0,0.0,698.0,0.0,698.0,0.0,698.0,
TCGA-DD-A11B-01A-11R-A131-07,LIHC,73.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2005.0,[Not Available],-26857.0,Dead,TUMOR FREE,,14.0,[Not Available],,,,,[Not Available],,RX,1.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-QA-A7B7-01A-11R-A32O-07,LIHC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-17636.0,Alive,WITH TUMOR,94.0,,[Not Available],Locoregional Recurrence,Liver,,88.0,[Not Available],,RX,0.0,94.0,0.0,94.0,,,1.0,88.0,
TCGA-CC-A5UC-01A-11R-A28V-07,LIHC,63.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-23156.0,Dead,WITH TUMOR,,347.0,[Not Available],New Primary Tumor,Lung,,312.0,[Not Available],,R0,1.0,347.0,1.0,347.0,0.0,347.0,1.0,312.0,
TCGA-DD-AACD-01A-11R-A41C-07,LIHC,48.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2008.0,[Not Available],-17828.0,Dead,WITH TUMOR,,381.0,[Not Available],Locoregional Recurrence,Lung,,151.0,[Not Available],,R0,1.0,381.0,1.0,381.0,1.0,151.0,1.0,151.0,
TCGA-CC-A8HT-01A-11R-A36F-07,LIHC,74.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-27334.0,Dead,WITH TUMOR,,140.0,[Not Available],Locoregional Recurrence,,,83.0,[Not Available],,R0,1.0,140.0,1.0,140.0,1.0,83.0,1.0,83.0,
TCGA-DD-AAD0-01A-11R-A41C-07,LIHC,73.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-26781.0,Alive,WITH TUMOR,137.0,,[Not Available],Intrahepatic Recurrence,Liver,,47.0,[Not Available],,R0,0.0,137.0,0.0,137.0,1.0,47.0,1.0,47.0,
TCGA-G3-A25Y-01A-11R-A16W-07,LIHC,52.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2006.0,[Not Available],-19055.0,Dead,WITH TUMOR,,452.0,[Not Available],Locoregional Recurrence,Liver,,355.0,[Not Available],,R0,1.0,452.0,1.0,452.0,1.0,355.0,1.0,355.0,
TCGA-ED-A66X-01A-11R-A311-07,LIHC,35.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-12947.0,Alive,TUMOR FREE,406.0,,[Not Available],Intrahepatic Recurrence,Liver,,124.0,[Not Available],,R0,0.0,406.0,0.0,406.0,1.0,124.0,1.0,124.0,
TCGA-DD-AAD3-01A-11R-A41C-07,LIHC,43.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-15706.0,Alive,TUMOR FREE,1295.0,,[Not Available],,,,,[Not Available],,R0,0.0,1295.0,0.0,1295.0,0.0,1295.0,0.0,1295.0,
TCGA-CC-A7IE-01A-21R-A38B-07,LIHC,57.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-20985.0,Dead,WITH TUMOR,,217.0,[Not Available],New Primary Tumor,Lung,,169.0,[Not Available],,R0,1.0,217.0,1.0,217.0,0.0,217.0,1.0,169.0,
TCGA-DD-A1ED-01A-11R-A155-07,LIHC,68.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2006.0,[Not Available],-25039.0,Alive,TUMOR FREE,2301.0,,[Not Available],,,,,[Not Available],,R0,0.0,2301.0,0.0,2301.0,0.0,2301.0,0.0,2301.0,
TCGA-DD-AAE6-01A-11R-A41C-07,LIHC,59.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-21764.0,Alive,WITH TUMOR,141.0,,[Not Available],Intrahepatic Recurrence,Liver,,105.0,[Not Available],,R0,0.0,141.0,0.0,141.0,1.0,105.0,1.0,105.0,
TCGA-BW-A5NO-01A-11R-A27V-07,LIHC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-18510.0,Alive,TUMOR FREE,20.0,,[Not Available],,,,,[Not Available],,RX,0.0,20.0,0.0,20.0,,,0.0,20.0,
TCGA-CC-A9FV-01A-11R-A37K-07,LIHC,57.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-21044.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-G3-A7M7-01A-12R-A352-07,LIHC,65.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-24002.0,Alive,TUMOR FREE,361.0,,[Not Available],,,,,[Not Available],,R0,0.0,361.0,0.0,361.0,0.0,361.0,0.0,361.0,
TCGA-2Y-A9H8-01A-11R-A39D-07,LIHC,85.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-31322.0,Dead,WITH TUMOR,,633.0,[Not Available],Extrahepatic Recurrence,"Other, specify",Kidney,398.0,[Not Available],,R0,1.0,633.0,1.0,633.0,1.0,398.0,1.0,398.0,
TCGA-G3-A25Z-01A-11R-A16W-07,LIHC,58.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-21509.0,Alive,TUMOR FREE,655.0,,[Not Available],,,,,[Not Available],,R0,0.0,655.0,0.0,655.0,0.0,655.0,0.0,655.0,
TCGA-MR-A520-01A-11R-A266-07,LIHC,58.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-21398.0,Alive,TUMOR FREE,229.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,229.0,0.0,229.0,,,0.0,229.0,
TCGA-G3-A3CK-01A-11R-A213-07,LIHC,61.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-22462.0,Alive,TUMOR FREE,585.0,,[Not Available],,,,,[Not Available],,R0,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,
TCGA-ES-A2HS-01A-11R-A180-07,LIHC,80.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-29268.0,Dead,TUMOR FREE,,688.0,[Not Available],,,,,[Not Available],,R0,1.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,
TCGA-DD-A4NS-01A-11R-A311-07,LIHC,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2005.0,[Not Available],-22638.0,Dead,WITH TUMOR,,2456.0,[Not Available],Extrahepatic Recurrence,Bone,,893.0,[Not Available],,R0,1.0,2456.0,1.0,2456.0,1.0,893.0,1.0,893.0,
TCGA-G3-A7M8-01A-11R-A33R-07,LIHC,31.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-11527.0,Alive,TUMOR FREE,430.0,,[Not Available],,,,,[Not Available],,RX,0.0,430.0,0.0,430.0,,,0.0,430.0,
TCGA-DD-AACT-01A-11R-A41C-07,LIHC,69.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-25292.0,Alive,TUMOR FREE,1562.0,,[Not Available],,,,,[Not Available],,R0,0.0,1562.0,0.0,1562.0,0.0,1562.0,0.0,1562.0,
TCGA-2Y-A9HB-01A-11R-A39D-07,LIHC,66.0,MALE,[Not Evaluated],Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-24359.0,Alive,TUMOR FREE,260.0,,[Not Available],,,,,[Not Available],,R0,0.0,260.0,0.0,260.0,0.0,260.0,0.0,260.0,
TCGA-BW-A5NQ-01A-11R-A27V-07,LIHC,63.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-23353.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,RX,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-ED-A7PZ-01A-11R-A33R-07,LIHC,61.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-22601.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,R0,0.0,6.0,0.0,6.0,0.0,6.0,0.0,6.0,
TCGA-DD-AACH-01A-11R-A41C-07,LIHC,69.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-25544.0,Dead,TUMOR FREE,,195.0,[Not Available],Intrahepatic Recurrence,Liver,,83.0,[Not Available],,R0,1.0,195.0,0.0,195.0,1.0,83.0,1.0,83.0,
TCGA-DD-A73E-01A-12R-A32O-07,LIHC,66.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-24377.0,Alive,TUMOR FREE,44.0,,[Not Available],,,,,[Not Available],,R0,0.0,44.0,0.0,44.0,0.0,44.0,0.0,44.0,
TCGA-CC-A7IK-01A-12R-A33R-07,LIHC,59.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-21552.0,Dead,WITH TUMOR,,262.0,[Not Available],Locoregional Recurrence,,,150.0,[Not Available],,R0,1.0,262.0,1.0,262.0,1.0,150.0,1.0,150.0,
TCGA-IR-A3LF-01A-21R-A22U-07,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Adenocarcinoma of the Usual Type,G2,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23721.0,Alive,TUMOR FREE,2949.0,,,,,,,Complete Remission/Response,,,0.0,2949.0,0.0,2949.0,0.0,2949.0,0.0,2949.0,
TCGA-LP-A5U2-01A-11R-A28H-07,CESC,30.0,FEMALE,ASIAN,[Not Available],Stage IIIB,Endocervical Adenocarcinoma of the Usual Type,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11049.0,Alive,TUMOR FREE,9.0,,,,,,,Complete Remission/Response,,,0.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,
TCGA-C5-A1M7-01A-11R-A13Y-07,CESC,37.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13808.0,Alive,TUMOR FREE,1409.0,,,,,,,Complete Remission/Response,,,0.0,1409.0,0.0,1409.0,0.0,1409.0,0.0,1409.0,
TCGA-Q1-A73O-01A-11R-A32P-07,CESC,37.0,FEMALE,[Not Evaluated],[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13601.0,Alive,TUMOR FREE,428.0,,,,,,,Complete Remission/Response,,,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,
TCGA-ZJ-AAXT-01A-11R-A42T-07,CESC,54.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2009.0,[Unknown],-19847.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-JW-A852-01A-11R-A352-07,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15682.0,Dead,WITH TUMOR,,252.0,Cervical Cancer,New Primary Tumor,,Breast,153.0,Complete Remission/Response,,,1.0,252.0,1.0,252.0,0.0,252.0,1.0,153.0,
TCGA-EK-A3GM-01A-11R-A213-07,CESC,65.0,FEMALE,WHITE,[Not Available],Stage IIA,Endocervical Type of Adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23879.0,Alive,,0.0,,,,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-C5-A1BM-01A-11R-A13Y-07,CESC,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1997.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28815.0,Dead,TUMOR FREE,,2520.0,,,,,,Complete Remission/Response,,,1.0,2520.0,0.0,2520.0,0.0,2520.0,0.0,2520.0,
TCGA-VS-A8EG-01A-11R-A36F-07,CESC,36.0,FEMALE,[Unknown],[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,GX,2011.0,Peri (6-12 months since last menstrual period),-13166.0,Alive,TUMOR FREE,1386.0,,,,,,,Complete Remission/Response,,,0.0,1386.0,0.0,1386.0,0.0,1386.0,0.0,1386.0,
TCGA-LP-A5U3-01A-11R-A28H-07,CESC,40.0,FEMALE,ASIAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14698.0,Alive,TUMOR FREE,25.0,,,,,,,Complete Remission/Response,,,0.0,25.0,0.0,25.0,0.0,25.0,0.0,25.0,
TCGA-C5-A1M8-01A-21R-A13Y-07,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2001.0,Indeterminate (neither Pre or Postmenopausal),-15848.0,Alive,TUMOR FREE,919.0,,,,,,,Complete Remission/Response,,,0.0,919.0,0.0,919.0,0.0,919.0,0.0,919.0,
TCGA-EX-A8YF-01A-11R-A37O-07,CESC,44.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16258.0,Alive,WITH TUMOR,473.0,,,Locoregional Recurrence,"Other, specify",Vagina,396.0,Complete Remission/Response,,,0.0,473.0,0.0,473.0,1.0,396.0,1.0,396.0,
TCGA-DG-A2KH-01A-21R-A22U-07,CESC,25.0,FEMALE,[Not Evaluated],[Not Available],Stage IB1,Adenosquamous,GX,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9209.0,Alive,,34.0,,,,,,,[Unknown],,,0.0,34.0,0.0,34.0,,,0.0,34.0,
TCGA-2W-A8YY-01A-11R-A37O-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-C5-A8XK-01A-11R-A37O-07,CESC,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,G3,2000.0,[Not Available],-11268.0,Alive,TUMOR FREE,3039.0,,,,,,,[Not Available],,,0.0,3039.0,0.0,3039.0,,,0.0,3039.0,
TCGA-EA-A5ZE-01A-11R-A28H-07,CESC,54.0,FEMALE,ASIAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Peri (6-12 months since last menstrual period),-19868.0,Alive,TUMOR FREE,829.0,,,Distant Metastasis,"Other, specify","Lymph node, inguinal",425.0,Complete Remission/Response,,,0.0,829.0,0.0,829.0,1.0,425.0,1.0,425.0,
TCGA-DR-A0ZL-01A-11R-A10U-07,CESC,53.0,FEMALE,ASIAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19384.0,Alive,TUMOR FREE,2669.0,,,,,,,Complete Remission/Response,,,0.0,2669.0,0.0,2669.0,0.0,2669.0,0.0,2669.0,
TCGA-VS-A9UC-01A-11R-A42T-07,CESC,32.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Peri (6-12 months since last menstrual period),-11790.0,Alive,WITH TUMOR,825.0,,,,,,,Stable Disease,,,0.0,825.0,0.0,825.0,,,0.0,825.0,
TCGA-FU-A3NI-01A-11R-A21T-07,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16533.0,Dead,TUMOR FREE,,638.0,,,,,,[Not Available],,,1.0,638.0,0.0,638.0,,,0.0,638.0,
TCGA-EA-A5O9-01A-11R-A28H-07,CESC,39.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14472.0,Alive,TUMOR FREE,788.0,,,,,,,Complete Remission/Response,,,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,
TCGA-C5-A1MN-01A-11R-A14Y-07,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15499.0,Dead,TUMOR FREE,,1245.0,,,,,,Complete Remission/Response,,,1.0,1245.0,0.0,1245.0,0.0,1245.0,0.0,1245.0,
TCGA-VS-A8QC-01A-11R-A37O-07,CESC,51.0,FEMALE,WHITE,[Not Available],Stage IVA,Cervical Squamous Cell Carcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-18743.0,Dead,WITH TUMOR,,350.0,Cervical Cancer,Distant Metastasis,,Liver,263.0,Progressive Disease,,,1.0,350.0,1.0,350.0,,,1.0,263.0,
TCGA-EK-A2RO-01A-11R-A18M-07,CESC,59.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21844.0,Alive,WITH TUMOR,2.0,,,,,,,[Not Available],,,0.0,2.0,0.0,2.0,,,0.0,2.0,
TCGA-EK-A3GN-01A-11R-A213-07,CESC,47.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2005.0,[Not Available],-17425.0,Alive,WITH TUMOR,27.0,,,,,,,[Not Available],,,0.0,27.0,0.0,27.0,,,0.0,27.0,
TCGA-JW-A5VL-01A-11R-A28H-07,CESC,37.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G1,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13604.0,Alive,TUMOR FREE,474.0,,,,,,,Complete Remission/Response,,,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,
TCGA-EK-A2RJ-01A-11R-A18M-07,CESC,51.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2009.0,[Not Available],-18664.0,Alive,TUMOR FREE,53.0,,,,,,,[Not Available],,,0.0,53.0,0.0,53.0,,,0.0,53.0,
TCGA-ZJ-AAXI-01A-11R-A42T-07,CESC,67.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Unknown],-24497.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-ZJ-AB0H-01A-11R-A42T-07,CESC,48.0,FEMALE,[Unknown],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,[Not Available],2006.0,[Unknown],-17869.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-ZJ-A8QO-01A-11R-A37O-07,CESC,73.0,FEMALE,[Unknown],[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,[Not Available],2007.0,[Unknown],-26723.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-C5-A2LZ-01A-11R-A213-07,CESC,65.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24059.0,Dead,WITH TUMOR,,3046.0,Cervical Cancer,Distant Metastasis,,,2893.0,Complete Remission/Response,,,1.0,3046.0,1.0,3046.0,1.0,2893.0,1.0,2893.0,
TCGA-BI-A0VR-01A-11R-A10U-07,CESC,53.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19473.0,Alive,TUMOR FREE,1505.0,,,,,,,[Not Available],,,0.0,1505.0,0.0,1505.0,,,0.0,1505.0,
TCGA-C5-A1BE-01B-11R-A13Y-07,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23727.0,Dead,WITH TUMOR,,2094.0,Cervical Cancer,,,,1674.0,Complete Remission/Response,,,1.0,2094.0,1.0,2094.0,1.0,1674.0,1.0,1674.0,
TCGA-DG-A2KM-01A-11R-A180-07,CESC,46.0,FEMALE,[Not Evaluated],[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2008.0,[Unknown],-16808.0,Alive,TUMOR FREE,1946.0,,,,,,,Complete Remission/Response,,,0.0,1946.0,0.0,1946.0,0.0,1946.0,0.0,1946.0,
TCGA-FU-A3EO-01A-11R-A213-07,CESC,55.0,FEMALE,WHITE,[Not Available],Stage IIB,Endocervical Type of Adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20207.0,Alive,TUMOR FREE,490.0,,,,,,,Complete Remission/Response,,,0.0,490.0,0.0,490.0,0.0,490.0,0.0,490.0,
TCGA-C5-A7CJ-01A-11R-A32P-07,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IIA,Cervical Squamous Cell Carcinoma,G2,2002.0,[Not Available],-15652.0,Dead,TUMOR FREE,,3097.0,,,,,,[Not Available],,,1.0,3097.0,0.0,3097.0,,,0.0,3097.0,
TCGA-DS-A5RQ-01A-11R-A28H-07,CESC,80.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29526.0,Alive,TUMOR FREE,512.0,,,,,,,Complete Remission/Response,,,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,
TCGA-ZX-AA5X-01A-11R-A42T-07,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23440.0,Alive,WITH TUMOR,119.0,,,,,,,[Not Applicable],,,0.0,119.0,0.0,119.0,,,0.0,119.0,
TCGA-IR-A3LI-01A-11R-A32Y-07,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IVB,Endocervical Type of Adenocarcinoma,G2,2005.0,Peri (6-12 months since last menstrual period),-17741.0,Alive,TUMOR FREE,2493.0,,,,,,,Complete Remission/Response,,,0.0,2493.0,0.0,2493.0,,,0.0,2493.0,
TCGA-JW-A5VH-01A-11R-A28H-07,CESC,53.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19423.0,Dead,WITH TUMOR,,100.0,Cervical Cancer,Distant Metastasis,"Other, specify",Brain,94.0,Progressive Disease,,,1.0,100.0,1.0,100.0,,,1.0,94.0,
TCGA-C5-A7CG-01A-11R-A32P-07,CESC,55.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1997.0,[Not Available],-20242.0,Alive,TUMOR FREE,6408.0,,,,,,,[Not Available],,,0.0,6408.0,0.0,6408.0,,,0.0,6408.0,
TCGA-C5-A901-01A-11R-A37O-07,CESC,44.0,FEMALE,WHITE,[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,G2,2000.0,[Not Available],-16186.0,Alive,TUMOR FREE,518.0,,,,,,,[Not Available],,,0.0,518.0,0.0,518.0,,,0.0,518.0,
TCGA-MA-AA3Y-01A-11R-A38B-07,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17795.0,Alive,TUMOR FREE,542.0,,,,,,,Complete Remission/Response,,,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,
TCGA-C5-A905-01A-11R-A37O-07,CESC,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1994.0,[Not Available],-13584.0,Alive,TUMOR FREE,4879.0,,,,,,,[Not Available],,,0.0,4879.0,0.0,4879.0,,,0.0,4879.0,
TCGA-MA-AA3W-01A-11R-A38B-07,CESC,54.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20066.0,Alive,TUMOR FREE,685.0,,,,,,,Complete Remission/Response,,,0.0,685.0,0.0,685.0,0.0,685.0,0.0,685.0,
TCGA-VS-A9UV-01A-11R-A42T-07,CESC,74.0,FEMALE,[Unknown],[Not Available],Stage IVA,Cervical Squamous Cell Carcinoma,GX,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27348.0,Dead,WITH TUMOR,,104.0,Cervical Cancer,,,,,[Unknown],,,1.0,104.0,1.0,104.0,,,1.0,104.0,
TCGA-VS-A9UQ-01A-21R-A42T-07,CESC,32.0,FEMALE,[Unknown],[Not Available],Stage IB,Mucinous Adenocarcinoma of Endocervical Type,G2,2011.0,Peri (6-12 months since last menstrual period),-11853.0,Alive,TUMOR FREE,1263.0,,,Distant Metastasis,"Other, specify",Ovary,561.0,Complete Remission/Response,,,0.0,1263.0,0.0,1263.0,1.0,561.0,1.0,561.0,
TCGA-Q1-A5R2-01A-11R-A28H-07,CESC,64.0,FEMALE,WHITE,[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23523.0,Alive,TUMOR FREE,499.0,,,,,,,[Not Applicable],,,0.0,499.0,0.0,499.0,,,0.0,499.0,
TCGA-C5-A7UE-01A-11R-A33Z-07,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2001.0,[Not Available],-16473.0,Alive,TUMOR FREE,4738.0,,,,,,,Complete Remission/Response,,,0.0,4738.0,0.0,4738.0,0.0,4738.0,0.0,4738.0,
TCGA-VS-A9UD-01A-11R-A42T-07,CESC,73.0,FEMALE,WHITE,[Not Available],Stage IIIA,Cervical Squamous Cell Carcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26815.0,Alive,TUMOR FREE,739.0,,,,,,,Complete Remission/Response,,,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,
TCGA-FU-A3HZ-01A-11R-A213-07,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IIA2,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23565.0,Alive,TUMOR FREE,1103.0,,,,,,,Complete Remission/Response,,,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,
TCGA-HM-A6W2-06A-22R-A33Z-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-FU-A3WB-01A-11R-A22U-07,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IIA2,Cervical Squamous Cell Carcinoma,G2,2012.0,[Unknown],-15833.0,Alive,TUMOR FREE,491.0,,,,,,,Complete Remission/Response,,,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,
TCGA-VS-A9UT-01A-11R-A42T-07,CESC,72.0,FEMALE,ASIAN,[Not Available],Stage IB,Mucinous Adenocarcinoma of Endocervical Type,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26603.0,Alive,TUMOR FREE,482.0,,,,,,,Complete Remission/Response,,,0.0,482.0,0.0,482.0,0.0,482.0,0.0,482.0,
TCGA-VS-A9V4-01A-12R-A42T-07,CESC,63.0,FEMALE,WHITE,[Not Available],Stage IVA,Mucinous Adenocarcinoma of Endocervical Type,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23334.0,Dead,WITH TUMOR,,132.0,Cervical Cancer,New Primary Tumor,,Sigmoid colon,100.0,[Unknown],,,1.0,132.0,1.0,132.0,,,1.0,100.0,
TCGA-EK-A2RK-01A-11R-A18M-07,CESC,67.0,FEMALE,WHITE,[Not Available],Stage IA2,Cervical Squamous Cell Carcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24541.0,Alive,,13.0,,,,,,,[Not Available],,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-VS-A954-01A-11R-A38B-07,CESC,67.0,FEMALE,[Unknown],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24498.0,Alive,TUMOR FREE,1714.0,,,,,,,Complete Remission/Response,,,0.0,1714.0,0.0,1714.0,0.0,1714.0,0.0,1714.0,
TCGA-ZJ-AAXB-01A-11R-A42T-07,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IB2,Endocervical Adenocarcinoma of the Usual Type,G3,2009.0,[Unknown],-15492.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-Q1-A6DT-01A-11R-A32P-07,CESC,55.0,FEMALE,WHITE,[Not Available],Stage I,Cervical Squamous Cell Carcinoma,GX,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20286.0,Dead,WITH TUMOR,,275.0,Cervical Cancer,,,,,[Not Available],,,1.0,275.0,1.0,275.0,,,1.0,275.0,
TCGA-VS-A94X-01A-11R-A38B-07,CESC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Not Evaluated],-14955.0,Dead,WITH TUMOR,,506.0,Cervical Cancer,,,,,Partial Remission/Response,,,1.0,506.0,1.0,506.0,,,1.0,506.0,
TCGA-EA-A3HQ-01A-11R-A213-07,CESC,60.0,FEMALE,WHITE,[Not Available],Stage II,Cervical Squamous Cell Carcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21966.0,Alive,TUMOR FREE,1136.0,,,,,,,Complete Remission/Response,,,0.0,1136.0,0.0,1136.0,0.0,1136.0,0.0,1136.0,
TCGA-MA-AA3Z-01A-11R-A38B-07,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15762.0,Alive,TUMOR FREE,595.0,,,,,,,Complete Remission/Response,,,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,
TCGA-EA-A3HS-01A-11R-A213-07,CESC,35.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G1,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13117.0,Alive,TUMOR FREE,959.0,,,,,,,Complete Remission/Response,,,0.0,959.0,0.0,959.0,0.0,959.0,0.0,959.0,
TCGA-ZJ-AAX8-01A-11R-A42T-07,CESC,58.0,FEMALE,[Unknown],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2009.0,[Unknown],-21481.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-EA-A439-01A-11R-A24H-07,CESC,50.0,FEMALE,ASIAN,[Not Available],Stage IIA1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18529.0,Alive,TUMOR FREE,965.0,,,Locoregional Recurrence,Cervix,,316.0,Complete Remission/Response,,,0.0,965.0,0.0,965.0,1.0,316.0,1.0,316.0,
TCGA-EA-A43B-01A-81R-A32Y-07,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15871.0,Alive,TUMOR FREE,791.0,,,,,,,Complete Remission/Response,,,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,
TCGA-C5-A7UH-01A-11R-A352-07,CESC,55.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2003.0,[Not Available],-20189.0,Alive,TUMOR FREE,3988.0,,,,,,,[Not Available],,,0.0,3988.0,0.0,3988.0,,,0.0,3988.0,
TCGA-EA-A4BA-01A-21R-A26T-07,CESC,49.0,FEMALE,WHITE,[Not Available],Stage IB2,Endocervical Type of Adenocarcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17995.0,Alive,TUMOR FREE,755.0,,,,,,,Complete Remission/Response,,,0.0,755.0,0.0,755.0,0.0,755.0,0.0,755.0,
TCGA-Q1-A73R-01A-11R-A33Z-07,CESC,45.0,FEMALE,WHITE,[Not Available],Stage I,Endocervical Type of Adenocarcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16701.0,Alive,TUMOR FREE,567.0,,,,,,,Complete Remission/Response,,,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,
TCGA-VS-A9U6-01A-11R-A42T-07,CESC,52.0,FEMALE,WHITE,[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,GX,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19109.0,Alive,WITH TUMOR,1320.0,,,Distant Metastasis,,Diaphragm,711.0,Stable Disease,,,0.0,1320.0,0.0,1320.0,,,1.0,711.0,
TCGA-EA-A3HT-01A-61R-A21T-07,CESC,68.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G1,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25138.0,Alive,TUMOR FREE,954.0,,,,,,,Complete Remission/Response,,,0.0,954.0,0.0,954.0,0.0,954.0,0.0,954.0,
TCGA-ZJ-AAXJ-01A-11R-A42T-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-IR-A3LH-01A-21R-A213-07,CESC,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIA1,Cervical Squamous Cell Carcinoma,G4,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18118.0,Alive,TUMOR FREE,2394.0,,,,,,,Complete Remission/Response,,,0.0,2394.0,0.0,2394.0,0.0,2394.0,0.0,2394.0,
TCGA-EK-A2PL-01A-11R-A18M-07,CESC,36.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-13384.0,Alive,WITH TUMOR,13.0,,,,,,,[Not Available],,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-EX-A1H6-01B-11R-A22U-07,CESC,38.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14214.0,Alive,TUMOR FREE,241.0,,,,,,,Complete Remission/Response,,,0.0,241.0,0.0,241.0,0.0,241.0,0.0,241.0,
TCGA-VS-A9U5-01A-11R-A42T-07,CESC,57.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Peri (6-12 months since last menstrual period),-21149.0,Alive,TUMOR FREE,1535.0,,,,,,,Complete Remission/Response,,,0.0,1535.0,0.0,1535.0,0.0,1535.0,0.0,1535.0,
TCGA-EK-A2RN-01A-12R-A213-07,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16487.0,Alive,WITH TUMOR,71.0,,,,,,,[Not Available],,,0.0,71.0,0.0,71.0,,,0.0,71.0,
TCGA-Q1-A73P-01A-11R-A32P-07,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G1,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16450.0,Alive,TUMOR FREE,483.0,,,,,,,Complete Remission/Response,,,0.0,483.0,0.0,483.0,0.0,483.0,0.0,483.0,
TCGA-VS-A9UZ-01A-11R-A42T-07,CESC,61.0,FEMALE,WHITE,[Not Available],Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2009.0,Peri (6-12 months since last menstrual period),-22344.0,Alive,TUMOR FREE,2044.0,,,,,,,Complete Remission/Response,,,0.0,2044.0,0.0,2044.0,0.0,2044.0,0.0,2044.0,
TCGA-EK-A2GZ-01A-11R-A180-07,CESC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23599.0,Alive,WITH TUMOR,383.0,,,,,,,[Not Available],,,0.0,383.0,0.0,383.0,,,0.0,383.0,
TCGA-4J-AA1J-01A-21R-A38B-07,CESC,31.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11611.0,Alive,TUMOR FREE,542.0,,,,,,,Complete Remission/Response,,,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,
TCGA-UZ-A9PX-01A-11R-A42S-07,KIRP,73.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-26663.0,Alive,TUMOR FREE,1981.0,,[Not Available],,,,308.0,Complete Remission/Response,,,0.0,1981.0,0.0,1981.0,1.0,308.0,1.0,308.0,
TCGA-2Z-A9JT-01A-11R-A42S-07,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-26128.0,Alive,TUMOR FREE,684.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,684.0,0.0,684.0,0.0,684.0,0.0,684.0,
TCGA-SX-A7SL-01A-11R-A355-07,KIRP,74.0,MALE,[Not Evaluated],Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-27063.0,Alive,TUMOR FREE,823.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,
TCGA-B9-4114-01A-01R-1193-07,KIRP,49.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-17989.0,Alive,WITH TUMOR,857.0,,[Not Available],,,,637.0,[Not Available],,,0.0,857.0,0.0,857.0,,,1.0,637.0,
TCGA-5P-A9JY-01A-11R-A42S-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-IA-A83S-01A-11R-A355-07,KIRP,81.0,MALE,WHITE,[Discrepancy],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2003.0,[Not Available],-29677.0,Dead,,,2609.0,[Not Available],,,,,[Unknown],,,1.0,2609.0,,2609.0,,,0.0,2609.0,
TCGA-SX-A7SR-01A-12R-A36F-07,KIRP,66.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-24237.0,Alive,TUMOR FREE,805.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,805.0,0.0,805.0,0.0,805.0,0.0,805.0,
TCGA-A4-7732-01A-11R-2139-07,KIRP,55.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-20226.0,Alive,TUMOR FREE,582.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,582.0,0.0,582.0,0.0,582.0,0.0,582.0,
TCGA-BQ-5885-01A-11R-1592-07,KIRP,63.0,MALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-23173.0,Alive,TUMOR FREE,921.0,,[Not Available],,,,,[Not Available],,,0.0,921.0,0.0,921.0,,,0.0,921.0,
TCGA-BQ-5891-01A-11R-1592-07,KIRP,57.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-20945.0,Alive,TUMOR FREE,29.0,,[Not Available],,,,,[Not Available],,,0.0,29.0,0.0,29.0,,,0.0,29.0,
TCGA-A4-A6HP-01A-11R-A31O-07,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-24447.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-GL-A59T-01A-21R-A28H-07,KIRP,46.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-17142.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-MH-A856-01A-11R-A355-07,KIRP,54.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-20006.0,Alive,TUMOR FREE,947.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,947.0,0.0,947.0,0.0,947.0,0.0,947.0,
TCGA-J7-8537-01A-11R-2404-07,KIRP,37.0,FEMALE,ASIAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-13628.0,Dead,WITH TUMOR,,321.0,[Not Available],,,,220.0,Complete Remission/Response,,,1.0,321.0,1.0,321.0,1.0,220.0,1.0,220.0,
TCGA-2Z-A9J8-01A-11R-A42S-07,KIRP,50.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-18498.0,Alive,WITH TUMOR,2790.0,,[Not Available],,,,506.0,Complete Remission/Response,,,0.0,2790.0,0.0,2790.0,1.0,506.0,1.0,506.0,
TCGA-AL-7173-01A-11R-2139-07,KIRP,72.0,FEMALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-26326.0,Alive,WITH TUMOR,2060.0,,[Not Available],,,,332.0,Progressive Disease,,,0.0,2060.0,0.0,2060.0,,,1.0,332.0,
TCGA-SX-A7SQ-01A-12R-A36F-07,KIRP,48.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-17696.0,Alive,TUMOR FREE,1266.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1266.0,0.0,1266.0,0.0,1266.0,0.0,1266.0,
TCGA-B9-4115-01A-01R-1193-07,KIRP,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-19571.0,Alive,TUMOR FREE,803.0,,[Not Available],,,,,[Not Available],,,0.0,803.0,0.0,803.0,,,0.0,803.0,
TCGA-B1-A654-01A-11R-A31O-07,KIRP,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-15721.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-IZ-A6M9-01A-11R-A31O-07,KIRP,63.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-23149.0,Alive,TUMOR FREE,376.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,
TCGA-A4-8310-01A-11R-2404-07,KIRP,58.0,MALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-21312.0,Alive,TUMOR FREE,780.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,780.0,0.0,780.0,0.0,780.0,0.0,780.0,
TCGA-5P-A9JW-01A-11R-A42S-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-P4-AAVK-01A-11R-A42S-07,KIRP,74.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-27073.0,Alive,WITH TUMOR,1590.0,,[Not Available],,,,232.0,Complete Remission/Response,,,0.0,1590.0,0.0,1590.0,1.0,232.0,1.0,232.0,
TCGA-B3-4103-01A-02R-1351-07,KIRP,56.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-20708.0,Alive,TUMOR FREE,930.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,
TCGA-B9-A8YI-01A-21R-A37K-07,KIRP,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-28917.0,Alive,TUMOR FREE,374.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,374.0,0.0,374.0,0.0,374.0,0.0,374.0,
TCGA-UZ-A9PV-01A-11R-A42S-07,KIRP,65.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-23741.0,Alive,TUMOR FREE,1444.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1444.0,0.0,1444.0,0.0,1444.0,0.0,1444.0,
TCGA-BQ-7061-01A-11R-1965-07,KIRP,83.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-30662.0,Alive,TUMOR FREE,218.0,,[Not Available],,,,,[Not Available],,,0.0,218.0,0.0,218.0,,,0.0,218.0,
TCGA-P4-A5EB-01A-11R-A28H-07,KIRP,83.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-30395.0,Alive,TUMOR FREE,3015.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3015.0,0.0,3015.0,0.0,3015.0,0.0,3015.0,
TCGA-AL-A5DJ-01A-11R-A26U-07,KIRP,54.0,FEMALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-20079.0,Dead,WITH TUMOR,,1498.0,[Not Available],,,,,Progressive Disease,,,1.0,1498.0,1.0,1498.0,,,1.0,1498.0,
TCGA-BQ-7058-01A-11R-1965-07,KIRP,81.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-29856.0,Dead,WITH TUMOR,,343.0,[Not Available],,,,50.0,[Not Available],,,1.0,343.0,1.0,343.0,,,1.0,50.0,
TCGA-UZ-A9PP-01A-11R-A42S-07,KIRP,60.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-21915.0,Alive,TUMOR FREE,3010.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3010.0,0.0,3010.0,0.0,3010.0,0.0,3010.0,
TCGA-BQ-7048-01A-11R-1965-07,KIRP,64.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2003.0,[Not Available],-23460.0,Alive,WITH TUMOR,2839.0,,[Not Available],,,,229.0,[Not Available],,,0.0,2839.0,0.0,2839.0,,,1.0,229.0,
TCGA-HE-A5NL-01A-11R-A26U-07,KIRP,51.0,MALE,[Not Evaluated],Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-18913.0,Alive,TUMOR FREE,767.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,767.0,0.0,767.0,0.0,767.0,0.0,767.0,
TCGA-GL-7966-01A-11R-2204-07,KIRP,28.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-10428.0,Alive,WITH TUMOR,112.0,,[Not Available],,,,,[Not Available],,,0.0,112.0,0.0,112.0,,,0.0,112.0,
TCGA-UZ-A9PQ-01A-11R-A42S-07,KIRP,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-21550.0,Dead,WITH TUMOR,,2624.0,[Not Available],,,,2148.0,Complete Remission/Response,,,1.0,2624.0,1.0,2624.0,1.0,2148.0,1.0,2148.0,
TCGA-GL-8500-01A-11R-2404-07,KIRP,63.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-23338.0,Alive,TUMOR FREE,841.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,841.0,0.0,841.0,0.0,841.0,0.0,841.0,
TCGA-BQ-7050-01A-11R-1965-07,KIRP,53.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-19550.0,Alive,TUMOR FREE,1864.0,,[Not Available],,,,,[Not Available],,,0.0,1864.0,0.0,1864.0,,,0.0,1864.0,
TCGA-GL-7773-01A-11R-A32Z-07,KIRP,63.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-23239.0,Alive,TUMOR FREE,393.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,
TCGA-B1-A47O-01A-11R-A24Z-07,KIRP,54.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-19823.0,Alive,TUMOR FREE,842.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,
TCGA-A4-7583-01A-11R-A32Z-07,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-21962.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,[Not Available],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-B9-4116-01A-02R-1351-07,KIRP,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-27692.0,Alive,TUMOR FREE,627.0,,[Not Available],,,,,[Not Available],,,0.0,627.0,0.0,627.0,,,0.0,627.0,
TCGA-BQ-7053-01A-11R-1965-07,KIRP,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-20837.0,Alive,TUMOR FREE,1516.0,,[Not Available],,,,,[Not Available],,,0.0,1516.0,0.0,1516.0,,,0.0,1516.0,
TCGA-B9-A5W8-01A-11R-A28H-07,KIRP,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-18440.0,Alive,TUMOR FREE,524.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,
TCGA-UN-AAZ9-01A-11R-A38C-07,KIRP,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-27851.0,Alive,TUMOR FREE,548.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,548.0,0.0,548.0,0.0,548.0,0.0,548.0,
TCGA-A4-A5Y0-01A-11R-A31O-07,KIRP,61.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-22341.0,Alive,TUMOR FREE,252.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,252.0,0.0,252.0,0.0,252.0,0.0,252.0,
TCGA-P4-AAVL-01A-11R-A42S-07,KIRP,85.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-31082.0,Dead,WITH TUMOR,,487.0,[Not Available],,,,41.0,Complete Remission/Response,,,1.0,487.0,1.0,487.0,1.0,41.0,1.0,41.0,
TCGA-UZ-A9PS-05A-11R-A42S-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-Y8-A897-01A-11R-A36F-07,KIRP,68.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-25047.0,Alive,TUMOR FREE,549.0,,[Not Available],,,,450.0,Complete Remission/Response,,,0.0,549.0,0.0,549.0,1.0,450.0,1.0,450.0,
TCGA-DW-7834-01A-11R-2139-07,KIRP,53.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2001.0,[Not Available],-19660.0,Alive,TUMOR FREE,3950.0,,[Not Available],,,,,[Not Available],,,0.0,3950.0,0.0,3950.0,,,0.0,3950.0,
TCGA-B3-3925-01A-02R-1351-07,KIRP,52.0,MALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-19224.0,Alive,TUMOR FREE,1029.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1029.0,0.0,1029.0,0.0,1029.0,0.0,1029.0,
TCGA-B3-3926-01A-02R-1351-07,KIRP,59.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-21876.0,Alive,TUMOR FREE,883.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,
TCGA-5P-A9KH-01A-11R-A42S-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-UZ-A9PS-01A-11R-A42S-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-B3-A6W5-01A-12R-A33Z-07,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-15945.0,Alive,TUMOR FREE,309.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,309.0,0.0,309.0,0.0,309.0,0.0,309.0,
TCGA-DW-7836-01A-11R-2139-07,KIRP,55.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-20269.0,Alive,TUMOR FREE,1093.0,,[Not Available],,,,,[Not Available],,,0.0,1093.0,0.0,1093.0,,,0.0,1093.0,
TCGA-BQ-5892-01A-11R-1592-07,KIRP,51.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-18785.0,Alive,TUMOR FREE,364.0,,[Not Available],,,,,[Not Available],,,0.0,364.0,0.0,364.0,,,0.0,364.0,
TCGA-SX-A71S-01A-11R-A33Z-07,KIRP,66.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-24211.0,Alive,TUMOR FREE,1504.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1504.0,0.0,1504.0,0.0,1504.0,0.0,1504.0,
TCGA-A4-A4ZT-01A-11R-A26U-07,KIRP,71.0,FEMALE,WHITE,Stage I,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-26058.0,Alive,TUMOR FREE,516.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,
TCGA-B9-A8YH-01A-11R-A37K-07,KIRP,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-19051.0,Alive,TUMOR FREE,532.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,
TCGA-KV-A6GE-01A-11R-A31O-07,KIRP,65.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-23979.0,Alive,TUMOR FREE,885.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,
TCGA-G7-6790-01A-11R-1965-07,KIRP,57.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-21169.0,Alive,TUMOR FREE,1575.0,,[Not Available],,,,1558.0,[Not Available],,,0.0,1575.0,0.0,1575.0,,,1.0,1558.0,
TCGA-G7-6795-01A-11R-1965-07,KIRP,56.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-20478.0,Alive,TUMOR FREE,1194.0,,[Not Available],,,,,[Not Available],,,0.0,1194.0,0.0,1194.0,,,0.0,1194.0,
TCGA-AL-3473-01A-01R-1193-07,KIRP,55.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-20104.0,Alive,TUMOR FREE,1906.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1906.0,0.0,1906.0,0.0,1906.0,0.0,1906.0,
TCGA-BQ-5893-01A-11R-1592-07,KIRP,61.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-22320.0,Dead,WITH TUMOR,,241.0,[Not Available],,,,188.0,[Not Available],,,1.0,241.0,1.0,241.0,,,1.0,188.0,
TCGA-B9-4117-01A-02R-1351-07,KIRP,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-17622.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,[Not Available],,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-5P-A9KF-01A-11R-A42S-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-WN-AB4C-01A-11R-A42S-07,KIRP,60.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],,Alive,WITH TUMOR,1188.0,,[Not Available],,,,1157.0,Complete Remission/Response,,,0.0,1188.0,0.0,1188.0,1.0,1157.0,1.0,1157.0,
TCGA-G7-A8LE-01A-11R-A36F-07,KIRP,62.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-22810.0,Alive,TUMOR FREE,2453.0,,[Not Available],,,,1447.0,Complete Remission/Response,,,0.0,2453.0,0.0,2453.0,1.0,1447.0,1.0,1447.0,
TCGA-B1-5398-01A-02R-1592-07,KIRP,73.0,MALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-26820.0,Alive,TUMOR FREE,1251.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1251.0,0.0,1251.0,0.0,1251.0,0.0,1251.0,
TCGA-5P-A9JU-01A-11R-A42S-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-DZ-6135-01A-11R-1965-07,KIRP,45.0,MALE,[Not Available],Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-16468.0,Alive,TUMOR FREE,2269.0,,[Not Available],,,,,[Discrepancy],,,0.0,2269.0,0.0,2269.0,,,0.0,2269.0,
TCGA-MH-A854-01A-11R-A355-07,KIRP,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-22804.0,Alive,TUMOR FREE,536.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,536.0,0.0,536.0,0.0,536.0,0.0,536.0,
TCGA-4A-A93W-01A-11R-A37K-07,KIRP,66.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-24117.0,Alive,TUMOR FREE,4.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4.0,0.0,4.0,0.0,4.0,0.0,4.0,
TCGA-EV-5902-01A-11R-1592-07,KIRP,58.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-21344.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,[Not Available],,,0.0,578.0,0.0,578.0,,,0.0,578.0,
TCGA-IA-A83W-01A-11R-A355-07,KIRP,70.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2003.0,[Not Available],-25678.0,Dead,TUMOR FREE,,2043.0,[Not Available],,,,1408.0,Complete Remission/Response,,,1.0,2043.0,0.0,2043.0,1.0,1408.0,1.0,1408.0,
TCGA-2Z-A9JO-01A-11R-A42S-07,KIRP,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-20466.0,Alive,TUMOR FREE,949.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,949.0,0.0,949.0,0.0,949.0,0.0,949.0,
TCGA-F9-A7Q0-01A-11R-A36F-07,KIRP,37.0,FEMALE,ASIAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-13523.0,Alive,TUMOR FREE,398.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,
TCGA-P4-AAVO-01A-11R-A42S-07,KIRP,69.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-25354.0,Alive,TUMOR FREE,2400.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2400.0,0.0,2400.0,0.0,2400.0,0.0,2400.0,
TCGA-SX-A7SP-01A-11R-A355-07,KIRP,66.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-24382.0,Dead,TUMOR FREE,,496.0,[Not Available],,,,,Complete Remission/Response,,,1.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-2Z-A9JK-01A-11R-A42S-07,KIRP,50.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-18540.0,Alive,WITH TUMOR,1186.0,,[Not Available],,,,324.0,Stable Disease,,,0.0,1186.0,0.0,1186.0,,,1.0,324.0,
TCGA-AB-2861-03A-01T-0736-13,LAML,76.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-27940.0,Dead,[Not Available],,0.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,0.0,,,,,,,
TCGA-AB-2856-03A-01T-0736-13,LAML,63.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-23317.0,Dead,[Not Available],,150.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,150.0,,,,,,,
TCGA-AB-2812-03A-01T-0734-13,LAML,25.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],,[Not Available],2004.0,[Not Available],-9253.0,Dead,[Not Available],,366.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,366.0,,,,,,,
TCGA-AB-2885-03A-01T-0735-13,LAML,71.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-26176.0,Dead,[Not Available],,214.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,214.0,,,,,,,
TCGA-AB-2982-03B-01T-0748-13,LAML,29.0,FEMALE,[Not Available],[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-10807.0,Alive,[Not Available],150.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,150.0,0.0,,,,,,
TCGA-AB-2944-03A-01T-0740-13,LAML,48.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2010.0,[Not Available],-17622.0,Dead,[Not Available],,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,,,,,,,,
TCGA-AB-2986-03A-01T-0734-13,LAML,31.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-11596.0,Dead,[Not Available],,212.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,212.0,,,,,,,
TCGA-AB-2818-03A-01T-0734-13,LAML,62.0,FEMALE,ASIAN,[Not Available],[Not Available],,[Not Available],2002.0,[Not Available],-22707.0,Dead,[Not Available],,303.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,303.0,,,,,,,
TCGA-AB-2966-03A-01T-0734-13,LAML,57.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-20880.0,Dead,[Not Available],,854.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,854.0,,,,,,,
TCGA-AB-2985-03A-01T-0734-13,LAML,81.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-29890.0,Dead,[Not Available],,273.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,273.0,,,,,,,
TCGA-AB-2811-03B-01T-0760-13,LAML,81.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2002.0,[Not Available],-29766.0,Dead,[Not Available],,243.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,243.0,,,,,,,
TCGA-AB-2854-03A-01T-0734-13,LAML,51.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2003.0,[Not Available],-18809.0,Dead,[Not Available],,366.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,366.0,,,,,,,
TCGA-AB-2836-03A-01T-0736-13,LAML,35.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-12904.0,Dead,[Not Available],,518.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,518.0,,,,,,,
TCGA-AB-2963-03A-01T-0734-13,LAML,56.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2002.0,[Not Available],-20485.0,Dead,[Not Available],,1642.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,1642.0,,,,,,,
TCGA-AB-2876-03A-01T-0734-13,LAML,45.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-16648.0,Alive,[Not Available],1219.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1219.0,0.0,,,,,,
TCGA-AB-2903-03A-01T-0734-13,LAML,76.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-27971.0,Dead,[Not Available],,0.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,0.0,,,,,,,
TCGA-AB-3000-03A-01T-0736-13,LAML,25.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-9251.0,Alive,[Not Available],1249.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1249.0,0.0,,,,,,
TCGA-AB-2889-03A-01T-0735-13,LAML,55.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-20150.0,Alive,[Not Available],304.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,304.0,0.0,,,,,,
TCGA-AB-2806-03A-01T-0734-13,LAML,46.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2002.0,[Not Available],-16892.0,Dead,[Not Available],,945.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,945.0,,,,,,,
TCGA-AB-2994-03A-01T-0735-13,LAML,25.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-9436.0,Alive,[Not Available],1798.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1798.0,0.0,,,,,,
TCGA-AB-2937-03A-01T-0734-13,LAML,36.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-13149.0,Dead,[Not Available],,215.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,215.0,,,,,,,
TCGA-AB-2979-03B-01T-0760-13,LAML,30.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-11262.0,Alive,[Not Available],671.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,671.0,0.0,,,,,,
TCGA-AB-2912-03A-01T-0734-13,LAML,63.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-23345.0,Dead,[Not Available],,274.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,274.0,,,,,,,
TCGA-AB-2981-03B-01T-0748-13,LAML,35.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-13027.0,Alive,[Not Available],487.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,487.0,0.0,,,,,,
TCGA-AB-2965-03A-01T-0734-13,LAML,60.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-22006.0,Dead,[Not Available],,335.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,335.0,,,,,,,
TCGA-AB-2967-03A-01T-0734-13,LAML,58.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-21214.0,Alive,[Not Available],1035.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1035.0,0.0,,,,,,
TCGA-AB-2868-03A-01T-0736-13,LAML,77.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2002.0,[Not Available],-28216.0,Dead,[Not Available],,151.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,151.0,,,,,,,
TCGA-AB-2877-03A-01T-0735-13,LAML,60.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-21946.0,Alive,[Not Available],638.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,638.0,0.0,,,,,,
TCGA-AB-2904-03A-01T-0734-13,LAML,65.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-23833.0,Dead,[Not Available],,517.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,517.0,,,,,,,
TCGA-AB-2825-03A-01T-0736-13,LAML,31.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-11384.0,Dead,[Not Available],,212.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,212.0,,,,,,,
TCGA-AB-2927-03A-01T-0740-13,LAML,88.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-32326.0,Dead,[Not Available],,90.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,90.0,,,,,,,
TCGA-AB-2991-03A-01T-0735-13,LAML,40.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2004.0,[Not Available],-14885.0,Alive,[Not Available],1826.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1826.0,0.0,,,,,,
TCGA-AB-2835-03A-01T-0736-13,LAML,48.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-17624.0,Alive,[Not Available],1673.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1673.0,0.0,,,,,,
TCGA-AB-2843-03A-01T-0736-13,LAML,77.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2004.0,[Not Available],-28275.0,Dead,[Not Available],,215.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,215.0,,,,,,,
TCGA-AB-3008-03A-01T-0736-13,LAML,22.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-8159.0,Dead,[Not Available],,822.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,822.0,,,,,,,
TCGA-AB-2952-03B-01T-0760-13,LAML,60.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-22188.0,Dead,[Not Available],,31.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,31.0,,,,,,,
TCGA-AB-2858-03A-01T-0736-13,LAML,75.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2004.0,[Not Available],-27547.0,Dead,[Not Available],,577.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,577.0,,,,,,,
TCGA-AB-2950-03A-01T-0735-13,LAML,34.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-12693.0,Alive,[Not Available],306.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,306.0,0.0,,,,,,
TCGA-AB-2808-03A-01T-0734-13,LAML,23.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2002.0,[Not Available],-8521.0,Alive,[Not Available],2861.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,2861.0,0.0,,,,,,
TCGA-AB-2870-03A-01T-0735-13,LAML,76.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-27787.0,Dead,[Not Available],,153.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,153.0,,,,,,,
TCGA-AB-2970-03A-01T-0734-13,LAML,34.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-12569.0,Dead,[Not Available],,305.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,305.0,,,,,,,
TCGA-AB-2833-03A-01T-0734-13,LAML,77.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2002.0,[Not Available],-28308.0,Dead,[Not Available],,456.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,456.0,,,,,,,
TCGA-AB-2821-03A-01T-0735-13,LAML,64.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-23527.0,Dead,[Not Available],,822.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,822.0,,,,,,,
TCGA-AB-2992-03A-01T-0735-13,LAML,32.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2003.0,[Not Available],-11839.0,Dead,[Not Available],,1706.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,1706.0,,,,,,,
TCGA-AB-2886-03A-01T-0735-13,LAML,26.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-9497.0,Alive,[Not Available],181.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,181.0,0.0,,,,,,
TCGA-AB-2881-03A-01T-0735-13,LAML,48.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-17808.0,Alive,[Not Available],393.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,393.0,0.0,,,,,,
TCGA-AB-2869-03A-01T-0735-13,LAML,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-23679.0,Alive,[Not Available],243.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,243.0,0.0,,,,,,
TCGA-AB-2996-03A-01T-0735-13,LAML,74.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-27364.0,Alive,[Not Available],1581.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1581.0,0.0,,,,,,
TCGA-AB-2865-03A-01T-0736-13,LAML,75.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-27486.0,Dead,[Not Available],,61.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,61.0,,,,,,,
TCGA-AB-2816-03A-01T-0734-13,LAML,57.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2003.0,[Not Available],-20939.0,Dead,[Not Available],,245.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,245.0,,,,,,,
TCGA-AB-2956-03A-01T-0740-13,LAML,61.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-22523.0,Dead,[Not Available],,183.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,183.0,,,,,,,
TCGA-AB-2888-03B-01T-0748-13,LAML,57.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-20879.0,Alive,[Not Available],334.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,334.0,0.0,,,,,,
TCGA-AB-2900-03A-01T-0735-13,LAML,70.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-25627.0,Dead,[Not Available],,184.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,184.0,,,,,,,
TCGA-AB-3012-03A-01T-0736-13,LAML,53.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2004.0,[Not Available],-19543.0,Alive,[Not Available],1887.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1887.0,0.0,,,,,,
TCGA-AB-2969-03A-01T-0734-13,LAML,55.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-20331.0,Alive,[Not Available],1127.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1127.0,0.0,,,,,,
TCGA-AB-2933-03A-01T-0734-13,LAML,58.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-21396.0,Dead,[Not Available],,122.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,122.0,,,,,,,
TCGA-AB-2823-03A-01T-0736-13,LAML,61.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-22522.0,Dead,[Not Available],,0.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,0.0,,,,,,,
TCGA-AB-2983-03A-01T-0734-13,LAML,45.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-16589.0,Dead,[Not Available],,335.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,335.0,,,,,,,
TCGA-AB-2867-03A-01T-0734-13,LAML,66.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2002.0,[Not Available],-24257.0,Dead,[Not Available],,184.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,184.0,,,,,,,
TCGA-AB-2883-03A-01T-0734-13,LAML,60.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-22067.0,Alive,[Not Available],730.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,730.0,0.0,,,,,,
TCGA-AB-2810-03A-01T-0736-13,LAML,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],,[Not Available],2002.0,[Not Available],-27971.0,Dead,[Not Available],,31.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,31.0,,,,,,,
TCGA-AB-2939-03A-01T-0740-13,LAML,72.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-26512.0,Alive,[Not Available],455.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,455.0,0.0,,,,,,
TCGA-AB-2897-03A-01T-0735-13,LAML,50.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-18413.0,Alive,[Not Available],243.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,243.0,0.0,,,,,,
TCGA-AB-2941-03A-01T-0740-13,LAML,73.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-26998.0,Dead,[Not Available],,0.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,0.0,,,,,,,
TCGA-AB-2972-03A-01T-0734-13,LAML,82.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-30134.0,Dead,[Not Available],,30.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,30.0,,,,,,,
TCGA-AB-2842-03A-01T-0734-13,LAML,65.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2004.0,[Not Available],-23741.0,Dead,[Not Available],,0.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,0.0,,,,,,,
TCGA-AB-2878-03A-01T-0734-13,LAML,47.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-17501.0,Dead,[Not Available],,365.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,365.0,,,,,,,
TCGA-AB-2990-03B-01T-0748-13,LAML,51.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-18962.0,Alive,[Not Available],457.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,457.0,0.0,,,,,,
TCGA-AB-3007-03A-01T-0736-13,LAML,35.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-13029.0,Alive,[Not Available],1581.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,1581.0,0.0,,,,,,
TCGA-AB-2959-03A-01T-0734-13,LAML,71.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-26114.0,Dead,[Not Available],,489.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,489.0,,,,,,,
TCGA-AB-2977-03B-01T-0760-13,LAML,71.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-26053.0,Dead,[Not Available],,31.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,31.0,,,,,,,
TCGA-AB-2866-03A-01T-0736-13,LAML,67.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-24684.0,Dead,[Not Available],,153.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,153.0,,,,,,,
TCGA-AB-2998-03A-01T-0735-13,LAML,68.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-24837.0,Dead,[Not Available],,31.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,31.0,,,,,,,
TCGA-AB-2840-03A-01T-0734-13,LAML,74.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2003.0,[Not Available],-27243.0,Dead,[Not Available],,28.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,28.0,,,,,,,
TCGA-AB-2893-03A-01T-0734-13,LAML,45.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2006.0,[Not Available],-16617.0,Dead,[Not Available],,212.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,212.0,,,,,,,
TCGA-AB-2839-03A-01T-0734-13,LAML,51.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2003.0,[Not Available],-18963.0,Dead,[Not Available],,486.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,486.0,,,,,,,
TCGA-AB-2909-03A-01T-0744-13,LAML,22.0,MALE,ASIAN,[Not Available],[Not Available],,[Not Available],2009.0,[Not Available],-8220.0,Alive,[Not Available],30.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,30.0,0.0,,,,,,
TCGA-AB-2916-03A-01T-0734-13,LAML,48.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2007.0,[Not Available],-17866.0,Alive,[Not Available],882.0,,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,0.0,882.0,0.0,,,,,,
TCGA-AB-3002-03A-01T-0736-13,LAML,68.0,MALE,WHITE,[Not Available],[Not Available],,[Not Available],2005.0,[Not Available],-25171.0,Dead,[Not Available],,1431.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,1431.0,,,,,,,
TCGA-AB-2987-03A-01T-0734-13,LAML,75.0,FEMALE,WHITE,[Not Available],[Not Available],,[Not Available],2008.0,[Not Available],-27667.0,Dead,[Not Available],,184.0,[Not Available],[Not Available],[Not Available],[Not Available],,[Not Available],,,1.0,184.0,,,,,,,
TCGA-06-0184-01A-01R-1849-01,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-23317.0,Dead,WITH TUMOR,,2126.0,[Not Available],,[Not Applicable],[Not Applicable],1276.0,[Not Available],,,1.0,2126.0,1.0,2126.0,,,1.0,1276.0,
TCGA-27-2524-01A-01R-1850-01,GBM,56.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-20555.0,Dead,WITH TUMOR,231.0,231.0,[Not Available],,,,,[Not Available],,,1.0,231.0,1.0,231.0,,,1.0,231.0,
TCGA-27-1835-01A-01R-1850-01,GBM,53.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-19444.0,Dead,WITH TUMOR,648.0,648.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],157.0,[Not Available],,,1.0,648.0,1.0,648.0,,,1.0,157.0,
TCGA-26-5139-01A-01R-1850-01,GBM,65.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-23782.0,Alive,WITH TUMOR,48.0,,[Not Available],,,,,[Not Available],,,0.0,48.0,0.0,48.0,,,0.0,48.0,
TCGA-06-2567-01A-01R-1849-01,GBM,65.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-23759.0,Dead,WITH TUMOR,133.0,133.0,[Not Available],,,,,[Not Available],,,1.0,133.0,1.0,133.0,,,1.0,133.0,
TCGA-28-5216-01A-01R-1850-01,GBM,52.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-19239.0,Alive,TUMOR FREE,415.0,,[Not Available],,,,,[Not Available],,,0.0,415.0,0.0,415.0,,,0.0,415.0,
TCGA-06-0168-01A-01R-1849-01,GBM,59.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-21776.0,Dead,WITH TUMOR,579.0,598.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],461.0,[Not Available],,,1.0,598.0,1.0,598.0,,,1.0,461.0,
TCGA-32-1980-01A-01R-1850-01,GBM,72.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-26467.0,Dead,WITH TUMOR,36.0,36.0,[Not Available],,,,,[Not Available],,,1.0,36.0,1.0,36.0,,,1.0,36.0,
TCGA-76-4932-01A-01R-1850-01,GBM,50.0,FEMALE,WHITE,[Not Available],[Not Applicable],Treated primary GBM,[Not Available],2006.0,[Not Available],-18433.0,Dead,WITH TUMOR,1458.0,1458.0,[Not Available],,,,,[Not Available],,,1.0,1458.0,1.0,1458.0,,,1.0,1458.0,
TCGA-06-2557-01A-01R-1849-01,GBM,76.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-27980.0,Dead,WITH TUMOR,33.0,33.0,[Not Available],,,,,[Not Available],,,1.0,33.0,1.0,33.0,,,1.0,33.0,
TCGA-06-0141-01A-01R-1849-01,GBM,62.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2000.0,[Not Available],-22926.0,Dead,WITH TUMOR,280.0,313.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],145.0,[Not Available],,,1.0,313.0,1.0,313.0,,,1.0,145.0,
TCGA-06-0211-01B-01R-1849-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-06-0210-01A-01R-1849-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-26-5136-01B-01R-1850-01,GBM,78.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-28496.0,Dead,WITH TUMOR,,577.0,[Not Available],,,,,[Unknown],,,1.0,577.0,1.0,577.0,,,1.0,577.0,
TCGA-14-1823-01A-01R-1849-01,GBM,58.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-21384.0,Dead,WITH TUMOR,543.0,543.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],140.0,[Not Available],,,1.0,543.0,1.0,543.0,,,1.0,140.0,
TCGA-15-0742-01A-01R-1850-01,GBM,65.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-24050.0,Dead,,,419.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],232.0,[Not Available],,,1.0,419.0,,419.0,,,1.0,232.0,
TCGA-41-2572-01A-01R-1850-01,GBM,67.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-24505.0,Dead,WITH TUMOR,406.0,406.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],122.0,[Not Available],,,1.0,406.0,1.0,406.0,,,1.0,122.0,
TCGA-26-5133-01A-01R-1850-01,GBM,59.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-21560.0,Alive,TUMOR FREE,452.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],370.0,[Not Available],,,0.0,452.0,0.0,452.0,,,1.0,370.0,
TCGA-06-2570-01A-01R-1849-01,GBM,21.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-7936.0,Alive,TUMOR FREE,958.0,,[Not Available],,,,,[Not Available],,,0.0,958.0,0.0,958.0,,,0.0,958.0,
TCGA-19-1390-01A-01R-1850-01,GBM,63.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-23063.0,Dead,,772.0,772.0,[Not Available],,,,,[Not Available],,,1.0,772.0,,772.0,,,0.0,772.0,
TCGA-28-5208-01A-01R-1850-01,GBM,52.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-19053.0,Dead,WITH TUMOR,,544.0,[Not Available],,[Not Applicable],[Not Applicable],148.0,Progressive Disease,,,1.0,544.0,1.0,544.0,,,1.0,148.0,
TCGA-12-3650-01A-01R-1849-01,GBM,46.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-17138.0,Dead,WITH TUMOR,333.0,333.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],239.0,[Not Available],,,1.0,333.0,1.0,333.0,,,1.0,239.0,
TCGA-16-0846-01A-01R-1850-01,GBM,85.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-31111.0,Dead,WITH TUMOR,119.0,119.0,[Not Available],,,,,[Not Available],,,1.0,119.0,1.0,119.0,,,1.0,119.0,
TCGA-12-5299-01A-02R-1849-01,GBM,56.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-20463.0,Dead,WITH TUMOR,98.0,98.0,[Not Available],,,,,[Not Available],,,1.0,98.0,1.0,98.0,,,1.0,98.0,
TCGA-32-1982-01A-01R-1850-01,GBM,76.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-27764.0,Dead,WITH TUMOR,142.0,142.0,[Not Available],,,,,[Not Available],,,1.0,142.0,1.0,142.0,,,1.0,142.0,
TCGA-06-0174-01A-01R-1849-01,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-19824.0,Dead,WITH TUMOR,67.0,98.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],47.0,[Not Available],,,1.0,98.0,1.0,98.0,,,1.0,47.0,
TCGA-19-2619-01A-01R-1850-01,GBM,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-20159.0,Alive,WITH TUMOR,294.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],146.0,[Not Available],,,0.0,294.0,0.0,294.0,,,1.0,146.0,
TCGA-06-0125-01A-01R-1849-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-19-2624-01A-01R-1850-01,GBM,51.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-18891.0,Dead,TUMOR FREE,5.0,5.0,[Not Available],,,,,[Not Available],,,1.0,5.0,0.0,5.0,,,0.0,5.0,
TCGA-06-0156-01A-03R-1849-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-06-0190-02A-01R-2005-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-06-5413-01A-01R-1849-01,GBM,67.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-24477.0,Alive,WITH TUMOR,268.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],195.0,[Not Available],,,0.0,268.0,0.0,268.0,,,1.0,195.0,
TCGA-27-1830-01A-01R-1850-01,GBM,57.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-21131.0,Dead,WITH TUMOR,146.0,154.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],124.0,[Not Available],,,1.0,154.0,1.0,154.0,,,1.0,124.0,
TCGA-12-5295-01A-01R-1849-01,GBM,60.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-22161.0,Dead,WITH TUMOR,399.0,454.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],399.0,[Not Available],,,1.0,454.0,1.0,454.0,,,1.0,399.0,
TCGA-27-2528-01A-01R-1850-01,GBM,62.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-22867.0,Dead,WITH TUMOR,480.0,480.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],72.0,[Not Available],,,1.0,480.0,1.0,480.0,,,1.0,72.0,
TCGA-26-5134-01A-01R-1850-01,GBM,74.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-27111.0,Alive,TUMOR FREE,167.0,,[Not Available],,,,,[Not Available],,,0.0,167.0,0.0,167.0,,,0.0,167.0,
TCGA-06-0158-01A-01R-1849-01,GBM,73.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-26856.0,Dead,WITH TUMOR,166.0,329.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],90.0,[Not Available],,,1.0,329.0,1.0,329.0,,,1.0,90.0,
TCGA-06-0187-01A-01R-1849-01,GBM,69.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-25318.0,Dead,WITH TUMOR,801.0,828.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],531.0,[Not Available],,,1.0,828.0,1.0,828.0,,,1.0,531.0,
TCGA-06-0649-01B-01R-1849-01,GBM,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-26796.0,Dead,WITH TUMOR,62.0,64.0,[Not Available],,,,,[Not Available],,,1.0,64.0,1.0,64.0,,,1.0,64.0,
TCGA-06-0211-01A-01R-1849-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-28-5207-01A-01R-1850-01,GBM,71.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-25975.0,Dead,WITH TUMOR,275.0,343.0,[Not Available],,,,,[Not Available],,,1.0,343.0,1.0,343.0,,,1.0,343.0,
TCGA-06-5414-01A-01R-1849-01,GBM,61.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-22527.0,Alive,WITH TUMOR,273.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],167.0,[Not Available],,,0.0,273.0,0.0,273.0,,,1.0,167.0,
TCGA-06-5412-01A-01R-1849-01,GBM,78.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-28762.0,Dead,WITH TUMOR,138.0,138.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],88.0,[Not Available],,,1.0,138.0,1.0,138.0,,,1.0,88.0,
TCGA-14-1034-01A-01R-1849-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-26-1442-01A-01R-1850-01,GBM,43.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-15950.0,Alive,WITH TUMOR,953.0,,[Not Available],,,,,[Not Available],,,0.0,953.0,0.0,953.0,,,0.0,953.0,
TCGA-28-2510-01A-01R-1850-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-06-0744-01A-01R-1849-01,GBM,66.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-24471.0,Dead,WITH TUMOR,,1426.0,[Not Available],,[Not Applicable],[Not Applicable],1277.0,[Not Available],,,1.0,1426.0,1.0,1426.0,,,1.0,1277.0,
TCGA-12-0619-01A-01R-1849-01,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-21920.0,Dead,WITH TUMOR,316.0,1062.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],203.0,[Not Available],,,1.0,1062.0,1.0,1062.0,,,1.0,203.0,
TCGA-28-2514-01A-02R-1850-01,GBM,45.0,MALE,ASIAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-16737.0,Alive,,160.0,,[Not Available],,,,,[Not Available],,,0.0,160.0,0.0,160.0,,,0.0,160.0,
TCGA-06-5418-01A-01R-1849-01,GBM,75.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-27584.0,Dead,WITH TUMOR,83.0,83.0,[Not Available],,,,,[Not Available],,,1.0,83.0,1.0,83.0,,,1.0,83.0,
TCGA-06-5858-01A-01R-1849-01,GBM,45.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-16662.0,Alive,WITH TUMOR,187.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],97.0,[Not Available],,,0.0,187.0,0.0,187.0,,,1.0,97.0,
TCGA-76-4929-01A-01R-1850-01,GBM,76.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-27831.0,Dead,WITH TUMOR,111.0,111.0,[Not Available],,,,,[Not Available],,,1.0,111.0,1.0,111.0,,,1.0,111.0,
TCGA-28-5218-01A-01R-1850-01,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-23096.0,Dead,,128.0,157.0,[Not Available],,,,,[Not Available],,,1.0,157.0,,157.0,,,0.0,157.0,
TCGA-06-5415-01A-01R-1849-01,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-22213.0,Alive,WITH TUMOR,260.0,,[Not Available],,,,,[Not Available],,,0.0,260.0,0.0,260.0,,,0.0,260.0,
TCGA-06-0743-01A-01R-1849-01,GBM,69.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-25434.0,Dead,WITH TUMOR,,803.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],176.0,[Not Available],,,1.0,803.0,1.0,803.0,,,1.0,176.0,
TCGA-06-2563-01A-01R-1849-01,GBM,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-26643.0,Alive,WITH TUMOR,932.0,,[Not Available],,[Not Applicable],[Not Applicable],554.0,[Not Available],,,0.0,932.0,0.0,932.0,,,1.0,554.0,
TCGA-06-5416-01A-01R-1849-01,GBM,23.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-8533.0,Alive,WITH TUMOR,204.0,,[Not Available],,,,,[Not Available],,,0.0,204.0,0.0,204.0,,,0.0,204.0,
TCGA-14-0789-01A-01R-1849-01,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-20050.0,Dead,,342.0,342.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],105.0,[Not Available],,,1.0,342.0,,342.0,,,1.0,105.0,
TCGA-02-2485-01A-01R-1849-01,GBM,53.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-19494.0,Alive,WITH TUMOR,470.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],186.0,[Not Available],,,0.0,470.0,0.0,470.0,,,1.0,186.0,
TCGA-32-1970-01A-01R-1850-01,GBM,59.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-21613.0,Dead,WITH TUMOR,468.0,468.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],408.0,[Not Available],,,1.0,468.0,1.0,468.0,,,1.0,408.0,
TCGA-06-0129-01A-01R-1849-01,GBM,30.0,MALE,ASIAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-11284.0,Dead,WITH TUMOR,989.0,1024.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],148.0,[Not Available],,,1.0,1024.0,1.0,1024.0,,,1.0,148.0,
TCGA-06-2565-01A-01R-1849-01,GBM,59.0,MALE,ASIAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-21559.0,Dead,WITH TUMOR,,506.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],178.0,[Not Available],,,1.0,506.0,1.0,506.0,,,1.0,178.0,
TCGA-41-2571-01A-01R-1850-01,GBM,89.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-32612.0,Dead,WITH TUMOR,26.0,26.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],26.0,[Not Available],,,1.0,26.0,1.0,26.0,,,1.0,26.0,
TCGA-06-0221-02A-11R-2005-01,GBM,31.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2000.0,[Not Available],-11333.0,Dead,WITH TUMOR,548.0,603.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],260.0,[Not Available],,,1.0,603.0,1.0,603.0,,,1.0,260.0,
TCGA-19-4065-02A-11R-2005-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-14-0736-02A-01R-2005-01,GBM,49.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1999.0,[Not Available],-18219.0,Dead,WITH TUMOR,460.0,460.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],128.0,[Not Available],,,1.0,460.0,1.0,460.0,,,1.0,128.0,
TCGA-32-4213-01A-01R-1850-01,GBM,47.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-17237.0,Alive,WITH TUMOR,604.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],353.0,[Not Available],,,0.0,604.0,0.0,604.0,,,1.0,353.0,
TCGA-02-2486-01A-01R-1849-01,GBM,64.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-23394.0,Dead,WITH TUMOR,,618.0,[Not Available],,,,,[Not Available],,,1.0,618.0,1.0,618.0,,,1.0,618.0,
TCGA-06-0750-01A-01R-1849-01,GBM,43.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-16018.0,Dead,WITH TUMOR,28.0,28.0,[Not Available],,,,,[Not Available],,,1.0,28.0,1.0,28.0,,,1.0,28.0,
TCGA-06-2559-01A-01R-1849-01,GBM,83.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-30580.0,Dead,WITH TUMOR,150.0,150.0,[Not Available],,,,,[Not Available],,,1.0,150.0,1.0,150.0,,,1.0,150.0,
TCGA-19-0957-02A-11R-2005-01,GBM,48.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-17714.0,Dead,WITH TUMOR,666.0,666.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],50.0,[Not Available],,,1.0,666.0,1.0,666.0,,,1.0,50.0,
TCGA-06-0130-01A-01R-1849-01,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-19812.0,Dead,WITH TUMOR,320.0,394.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],244.0,[Not Available],,,1.0,394.0,1.0,394.0,,,1.0,244.0,
TCGA-27-2519-01A-01R-1850-01,GBM,48.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-17715.0,Dead,WITH TUMOR,,550.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],256.0,[Not Available],,,1.0,550.0,1.0,550.0,,,1.0,256.0,
TCGA-19-1787-01B-01R-1850-01,GBM,48.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-17894.0,Dead,WITH TUMOR,385.0,385.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],308.0,[Not Available],,,1.0,385.0,1.0,385.0,,,1.0,308.0,
TCGA-27-2521-01A-01R-1850-01,GBM,34.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-12685.0,Dead,WITH TUMOR,,510.0,[Not Available],,,,,[Not Available],,,1.0,510.0,1.0,510.0,,,1.0,510.0,
TCGA-14-0781-01B-01R-1849-01,GBM,49.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-17903.0,Dead,WITH TUMOR,29.0,29.0,[Not Available],,,,,[Not Available],,,1.0,29.0,1.0,29.0,,,1.0,29.0,
TCGA-06-0210-02A-01R-2005-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-14-1829-01A-01R-1850-01,GBM,57.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-20929.0,Alive,WITH TUMOR,218.0,,[Not Available],,,,,[Not Available],,,0.0,218.0,0.0,218.0,,,0.0,218.0,
TCGA-06-5856-01A-01R-1849-01,GBM,58.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-21232.0,Dead,WITH TUMOR,114.0,114.0,[Not Available],,,,,[Not Available],,,1.0,114.0,1.0,114.0,,,1.0,114.0,
TCGA-32-2615-01A-01R-1850-01,GBM,62.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-22916.0,Dead,WITH TUMOR,485.0,485.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],131.0,[Not Available],,,1.0,485.0,1.0,485.0,,,1.0,131.0,
TCGA-F5-6811-01A-11R-1830-07,READ,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-26575.0,Alive,TUMOR FREE,979.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,
TCGA-AH-6644-01A-21R-1830-07,READ,73.0,MALE,WHITE,[Not Available],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-26892.0,Alive,TUMOR FREE,838.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,838.0,0.0,838.0,0.0,838.0,0.0,838.0,
TCGA-CI-6624-01C-11R-1830-07,READ,53.0,FEMALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-19419.0,Alive,,1466.0,,[Not Available],,,,,[Unknown],,,0.0,1466.0,0.0,1466.0,,,0.0,1466.0,
TCGA-AG-A00C-01A-01R-A002-07,READ,49.0,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-18201.0,Alive,TUMOR FREE,183.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,
TCGA-AF-5654-01A-01R-1660-07,READ,73.0,FEMALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-26738.0,Dead,TUMOR FREE,,512.0,[Not Available],,,,,[Not Available],,,1.0,512.0,0.0,512.0,,,0.0,512.0,
TCGA-AG-A023-01A-01R-A00A-07,READ,62.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2005.0,[Not Available],-22830.0,Dead,WITH TUMOR,,1581.0,[Not Available],,,,822.0,[Not Available],,,1.0,1581.0,1.0,1581.0,,,1.0,822.0,
TCGA-AH-6903-01A-11R-1928-07,READ,46.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-17030.0,Alive,TUMOR FREE,592.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,592.0,0.0,592.0,0.0,592.0,0.0,592.0,
TCGA-DY-A1DD-01A-21R-A155-07,READ,77.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],1999.0,[Not Available],-28159.0,Dead,,1741.0,1741.0,[Not Available],,,,,[Not Available],,,1.0,1741.0,,1741.0,,,0.0,1741.0,
TCGA-BM-6198-01A-11R-1736-07,READ,73.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-26837.0,Alive,TUMOR FREE,646.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,646.0,0.0,646.0,0.0,646.0,0.0,646.0,
TCGA-AG-A008-01A-01R-A002-07,READ,50.0,FEMALE,[Not Available],Stage I,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-18416.0,Alive,TUMOR FREE,424.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,
TCGA-EI-6882-01A-11R-1928-07,READ,59.0,MALE,WHITE,Stage IIA,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-21682.0,Alive,TUMOR FREE,262.0,,[Not Available],,,,,[Not Available],,,0.0,262.0,0.0,262.0,,,0.0,262.0,
TCGA-AG-3582-01A-01R-0821-07,READ,75.0,MALE,[Not Available],Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-27636.0,Dead,WITH TUMOR,,1096.0,[Not Available],,,,,[Not Available],,,1.0,1096.0,1.0,1096.0,,,1.0,1096.0,
TCGA-G5-6641-01A-11R-A32Z-07,READ,67.0,MALE,WHITE,Stage IIIA,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-24486.0,Alive,TUMOR FREE,804.0,,[Not Available],,,,,[Not Available],,,0.0,804.0,0.0,804.0,,,0.0,804.0,
TCGA-AG-4008-01A-01R-1119-07,READ,63.0,MALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-23192.0,Alive,TUMOR FREE,518.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,
TCGA-AG-3893-01A-01R-1119-07,READ,74.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-27272.0,Alive,TUMOR FREE,1065.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1065.0,0.0,1065.0,0.0,1065.0,0.0,1065.0,
TCGA-DC-6156-01A-11R-1660-07,READ,62.0,MALE,WHITE,Stage IVA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-22706.0,Alive,WITH TUMOR,943.0,,[Not Available],,,,30.0,[Not Applicable],,,0.0,943.0,0.0,943.0,,,1.0,30.0,
TCGA-F5-6864-01A-11R-1928-07,READ,74.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-27058.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-AH-6547-01A-11R-1830-07,READ,79.0,FEMALE,WHITE,[Not Available],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-29030.0,Dead,TUMOR FREE,,76.0,[Not Available],,,,,Complete Remission/Response,,,1.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,
TCGA-AG-A02N-01A-11R-A083-07,READ,67.0,MALE,[Not Available],Stage II,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2005.0,[Not Available],-24687.0,Alive,WITH TUMOR,1885.0,,[Not Available],,,,,[Not Available],,,0.0,1885.0,0.0,1885.0,,,0.0,1885.0,
TCGA-EI-6917-01A-11R-1928-07,READ,33.0,MALE,WHITE,Stage IIIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-12113.0,Alive,TUMOR FREE,531.0,,[Not Available],,,,,[Not Available],,,0.0,531.0,0.0,531.0,,,0.0,531.0,
TCGA-AG-3575-01A-01R-0821-07,READ,51.0,MALE,[Not Available],Stage II,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2006.0,[Not Available],-18932.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,[Not Available],,,0.0,365.0,0.0,365.0,,,0.0,365.0,
TCGA-F5-6702-01A-11R-1830-07,READ,71.0,MALE,WHITE,Stage IVA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-26123.0,Alive,WITH TUMOR,452.0,,[Not Available],,,,368.0,Progressive Disease,,,0.0,452.0,0.0,452.0,,,1.0,368.0,
TCGA-AG-A01W-01A-21R-A083-07,READ,67.0,FEMALE,[Not Available],Stage II,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2004.0,[Not Available],-24745.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-AG-3726-01A-02R-0905-07,READ,63.0,FEMALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2006.0,[Not Available],-23345.0,Alive,TUMOR FREE,243.0,,[Not Available],,,,,[Not Available],,,0.0,243.0,0.0,243.0,,,0.0,243.0,
TCGA-EI-6883-01A-31R-1928-07,READ,63.0,MALE,WHITE,Stage IIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-23268.0,Alive,TUMOR FREE,350.0,,[Not Available],,,,,[Not Available],,,0.0,350.0,0.0,350.0,,,0.0,350.0,
TCGA-AG-4007-01A-01R-1119-07,READ,87.0,MALE,[Not Available],Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-31776.0,Alive,WITH TUMOR,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-AG-3608-01A-01R-0826-07,READ,79.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-29008.0,Alive,TUMOR FREE,485.0,,[Not Available],,,,,[Not Available],,,0.0,485.0,0.0,485.0,,,0.0,485.0,
TCGA-DC-6157-01A-11R-1660-07,READ,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-17807.0,Alive,TUMOR FREE,1581.0,,[Not Available],,,,,[Not Applicable],,,0.0,1581.0,0.0,1581.0,,,0.0,1581.0,
TCGA-AF-6136-01A-11R-1830-07,READ,72.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-26490.0,Alive,WITH TUMOR,741.0,,[Not Available],,,,199.0,Progressive Disease,,,0.0,741.0,0.0,741.0,,,1.0,199.0,
TCGA-AG-A002-01A-01R-A002-07,READ,35.0,MALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-13090.0,Alive,TUMOR FREE,638.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,638.0,0.0,638.0,0.0,638.0,0.0,638.0,
TCGA-AG-3598-01A-01R-0826-07,READ,69.0,MALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-25324.0,Alive,TUMOR FREE,1522.0,,[Not Available],,,,,[Not Available],,,0.0,1522.0,0.0,1522.0,,,0.0,1522.0,
TCGA-EI-6507-01A-11R-1736-07,READ,60.0,MALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-22176.0,Alive,TUMOR FREE,607.0,,[Not Available],,,,,[Not Available],,,0.0,607.0,0.0,607.0,,,0.0,607.0,
TCGA-AG-3611-01A-01R-0826-07,READ,72.0,MALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-26420.0,Alive,TUMOR FREE,424.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,
TCGA-AG-3578-01A-01R-0821-07,READ,76.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2007.0,[Not Available],-27851.0,Alive,TUMOR FREE,974.0,,[Not Available],,,,,[Not Available],,,0.0,974.0,0.0,974.0,,,0.0,974.0,
TCGA-AG-3898-01A-01R-1119-07,READ,61.0,MALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2006.0,[Not Available],-22492.0,Alive,WITH TUMOR,1461.0,,[Not Available],,,,,[Not Available],,,0.0,1461.0,0.0,1461.0,,,0.0,1461.0,
TCGA-AG-3727-01A-01R-0905-07,READ,78.0,FEMALE,[Not Available],Stage III,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2006.0,[Not Available],-28641.0,Alive,WITH TUMOR,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-DC-6155-01A-11R-1660-07,READ,31.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-11381.0,Alive,TUMOR FREE,425.0,,[Not Available],,,,,[Not Available],,,0.0,425.0,0.0,425.0,,,0.0,425.0,
TCGA-AG-3605-01A-01R-0826-07,READ,85.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-31078.0,Alive,WITH TUMOR,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-AG-3594-01A-02R-0821-07,READ,77.0,MALE,[Not Available],Stage IIA,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2007.0,[Not Available],-28277.0,Dead,WITH TUMOR,,61.0,[Not Available],,,,,[Not Available],,,1.0,61.0,1.0,61.0,,,1.0,61.0,
TCGA-DC-6154-01A-31R-1928-07,READ,57.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-21093.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,[Not Available],,,0.0,365.0,0.0,365.0,,,0.0,365.0,
TCGA-AG-3601-01A-01R-0826-07,READ,68.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-24837.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-DY-A1DG-01A-11R-A32Y-07,READ,75.0,MALE,WHITE,Stage IVA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2000.0,[Not Available],-27396.0,Dead,,,1566.0,[Not Available],,,,592.0,[Not Available],,,1.0,1566.0,,1566.0,,,1.0,592.0,
TCGA-AG-A036-01A-12R-A083-07,READ,71.0,MALE,[Not Available],Stage III,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2002.0,[Not Available],-26206.0,Alive,TUMOR FREE,3562.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3562.0,0.0,3562.0,0.0,3562.0,0.0,3562.0,
TCGA-AG-3599-01A-02R-0826-07,READ,70.0,MALE,[Not Available],Stage I,[Not Applicable],[Not Available],[Not Available],2007.0,[Not Available],-25749.0,Alive,TUMOR FREE,366.0,,[Not Available],,,,,[Not Available],,,0.0,366.0,0.0,366.0,,,0.0,366.0,
TCGA-CL-5918-01A-11R-1660-07,READ,90.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-32873.0,Alive,TUMOR FREE,218.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,218.0,0.0,218.0,0.0,218.0,0.0,218.0,
TCGA-AF-6655-01A-11R-1830-07,READ,66.0,MALE,WHITE,Stage IIIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-24417.0,Alive,TUMOR FREE,609.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,609.0,0.0,609.0,0.0,609.0,0.0,609.0,
TCGA-AH-6549-01A-11R-1830-07,READ,66.0,MALE,WHITE,[Not Available],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-24337.0,Alive,TUMOR FREE,532.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,
TCGA-AG-A02X-01A-01R-A00A-07,READ,77.0,MALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-28399.0,Alive,WITH TUMOR,1247.0,,[Not Available],,,,,[Not Available],,,0.0,1247.0,0.0,1247.0,,,0.0,1247.0,
TCGA-AG-3881-01A-01R-0905-07,READ,83.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],[Not Available],[Not Available],2008.0,[Not Available],-30467.0,Alive,TUMOR FREE,579.0,,[Not Available],,,,,[Not Available],,,0.0,579.0,0.0,579.0,,,0.0,579.0,
TCGA-AG-3593-01A-01R-0821-07,READ,72.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-26480.0,Alive,TUMOR FREE,1035.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1035.0,0.0,1035.0,0.0,1035.0,0.0,1035.0,
TCGA-AG-3581-01A-01R-0821-07,READ,63.0,MALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-23345.0,Alive,TUMOR FREE,215.0,,[Not Available],,,,,[Not Available],,,0.0,215.0,0.0,215.0,,,0.0,215.0,
TCGA-F5-6810-01A-11R-1830-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCGA-AG-A025-01A-01R-A00A-07,READ,62.0,FEMALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2006.0,[Not Available],-22952.0,Alive,WITH TUMOR,1520.0,,[Not Available],,,,,[Not Available],,,0.0,1520.0,0.0,1520.0,,,0.0,1520.0,
TCGA-AF-A56N-01A-12R-A39D-07,READ,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2012.0,[Not Available],-17480.0,Alive,TUMOR FREE,360.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,360.0,0.0,360.0,0.0,360.0,0.0,360.0,
TCGA-EF-5831-01A-01R-1660-07,READ,72.0,MALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-26331.0,Alive,TUMOR FREE,127.0,,[Not Available],,,,,[Not Applicable],,,0.0,127.0,0.0,127.0,,,0.0,127.0,
TCGA-EI-6509-01A-11R-1736-07,READ,53.0,MALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-19666.0,Alive,WITH TUMOR,517.0,,[Not Available],Metastatic,,,90.0,[Not Available],,,0.0,517.0,0.0,517.0,,,1.0,90.0,
TCGA-DC-5337-01A-01R-1660-07,READ,69.0,MALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-25202.0,Alive,TUMOR FREE,792.0,,[Not Available],,,,,[Unknown],,,0.0,792.0,0.0,792.0,,,0.0,792.0,
TCGA-DC-6683-01A-11R-1830-07,READ,43.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-15918.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,[Not Applicable],,,0.0,762.0,0.0,762.0,,,0.0,762.0,
TCGA-EI-6885-01A-11R-1928-07,READ,57.0,FEMALE,WHITE,Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-21140.0,Alive,WITH TUMOR,415.0,,[Not Available],Locoregional Disease,,,295.0,[Not Available],,,0.0,415.0,0.0,415.0,,,1.0,295.0,
TCGA-AG-4005-01A-01R-1119-07,READ,64.0,MALE,[Not Available],Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-23407.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-AG-3909-01A-01R-1119-07,READ,69.0,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-25537.0,Alive,TUMOR FREE,608.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,
TCGA-AG-3890-01A-01R-1119-07,READ,62.0,MALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-22950.0,Alive,TUMOR FREE,518.0,,[Not Available],,,,,[Not Available],,,0.0,518.0,0.0,518.0,,,0.0,518.0,
TCGA-AG-3732-01A-11R-1660-07,READ,78.0,FEMALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2005.0,[Not Available],-28521.0,Alive,TUMOR FREE,1003.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1003.0,0.0,1003.0,0.0,1003.0,0.0,1003.0,
TCGA-AG-3882-01A-01R-0905-07,READ,66.0,FEMALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-24198.0,Alive,TUMOR FREE,608.0,,[Not Available],,,,,[Not Available],,,0.0,608.0,0.0,608.0,,,0.0,608.0,
TCGA-AG-3612-01A-01R-0826-07,READ,55.0,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-20242.0,Alive,TUMOR FREE,608.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,
TCGA-DC-6160-01A-11R-1660-07,READ,68.0,MALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-24990.0,Alive,TUMOR FREE,1339.0,,[Not Available],,,,,[Not Applicable],,,0.0,1339.0,0.0,1339.0,,,0.0,1339.0,
TCGA-AH-6897-01A-11R-1928-07,READ,48.0,MALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-17536.0,Alive,TUMOR FREE,804.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0,
TCGA-AG-3885-01A-01R-0905-07,READ,71.0,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-26145.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-AG-3896-01A-01R-1119-07,READ,85.0,FEMALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-31046.0,Alive,WITH TUMOR,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-G5-6235-01A-11R-1736-07,READ,72.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-26348.0,Alive,TUMOR FREE,1696.0,,[Not Available],,,,1042.0,[Not Available],,,0.0,1696.0,0.0,1696.0,,,1.0,1042.0,
TCGA-DY-A1DC-01A-31R-A155-07,READ,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2000.0,[Not Available],-26436.0,Dead,,,1258.0,[Not Available],Locoregional Disease,,,630.0,[Not Available],,,1.0,1258.0,,1258.0,,,1.0,630.0,
TCGA-AG-3574-01A-01R-0821-07,READ,89.0,FEMALE,[Not Available],Stage II,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2005.0,[Not Available],-32781.0,Dead,WITH TUMOR,,1096.0,[Not Available],,,,,[Not Available],,,1.0,1096.0,1.0,1096.0,,,1.0,1096.0,
TCGA-AG-3592-01A-02R-1736-07,READ,68.0,MALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-25141.0,Alive,TUMOR FREE,1035.0,,[Not Available],,,,,[Not Available],,,0.0,1035.0,0.0,1035.0,,,0.0,1035.0,
TCGA-AG-3580-01A-01R-0821-07,READ,67.0,MALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-24775.0,Alive,TUMOR FREE,244.0,,[Not Available],,,,,[Not Available],,,0.0,244.0,0.0,244.0,,,0.0,244.0,
TCGA-AG-3892-01A-01R-1119-07,READ,57.0,FEMALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-20880.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,
TCGA-DC-4745-01A-01R-A32Z-07,READ,49.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-17958.0,Alive,TUMOR FREE,639.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,
TCGA-EI-6513-01A-21R-1736-07,READ,59.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-21776.0,Alive,TUMOR FREE,497.0,,[Not Available],,,,,[Not Available],,,0.0,497.0,0.0,497.0,,,0.0,497.0,
TCGA-DC-6682-01A-11R-1830-07,READ,57.0,MALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-21062.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,[Not Applicable],,,0.0,762.0,0.0,762.0,,,0.0,762.0,
TCGA-AG-3602-01A-02R-0826-07,READ,66.0,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-24350.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-AG-3591-01A-01R-1736-07,READ,66.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-24167.0,Alive,TUMOR FREE,1035.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1035.0,0.0,1035.0,0.0,1035.0,0.0,1035.0,
TCGA-OR-A5L5-01A-11R-A29S-07,ACC,77.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-28270.0,Alive,TUMOR FREE,1317.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1317.0,0.0,1317.0,0.0,1317.0,0.0,1317.0,
TCGA-OR-A5LG-01A-11R-A29S-07,ACC,46.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-16875.0,Alive,WITH TUMOR,1589.0,,[Not Available],Distant Metastasis,Lung,,1393.0,Complete Remission/Response,,,0.0,1589.0,0.0,1589.0,1.0,1393.0,1.0,1393.0,
TCGA-OR-A5JK-01A-11R-A29S-07,ACC,49.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-18214.0,Alive,TUMOR FREE,1497.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1497.0,0.0,1497.0,,,0.0,1497.0,
TCGA-OR-A5JO-01A-11R-A29S-07,ACC,26.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2005.0,[Not Available],-9547.0,Alive,TUMOR FREE,1194.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1194.0,0.0,1194.0,0.0,1194.0,0.0,1194.0,
TCGA-P6-A5OG-01A-22R-A29S-07,ACC,45.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-16659.0,Dead,WITH TUMOR,,383.0,[Not Available],Distant Metastasis,Lung,,11.0,Complete Remission/Response,,,1.0,383.0,1.0,383.0,,,1.0,11.0,
TCGA-OR-A5KV-01A-11R-A29S-07,ACC,17.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2003.0,[Not Available],-6250.0,Alive,TUMOR FREE,3878.0,,[Not Available],Distant Metastasis,Lung,,1116.0,Complete Remission/Response,,,0.0,3878.0,0.0,3878.0,1.0,1116.0,1.0,1116.0,
TCGA-OR-A5K3-01A-11R-A29S-07,ACC,53.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical Carcinoma- Oncocytic Type,[Not Available],2005.0,[Not Available],-19375.0,Alive,TUMOR FREE,3465.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3465.0,0.0,3465.0,0.0,3465.0,0.0,3465.0,
TCGA-OR-A5JM-01A-11R-A29S-07,ACC,25.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-9359.0,Dead,WITH TUMOR,,562.0,[Not Available],Distant Metastasis,Liver,,72.0,Progressive Disease,,,1.0,562.0,1.0,562.0,,,1.0,72.0,
TCGA-OR-A5K1-01A-11R-A29S-07,ACC,48.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-17596.0,Alive,TUMOR FREE,3289.0,,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,826.0,Complete Remission/Response,,,0.0,3289.0,0.0,3289.0,1.0,826.0,1.0,826.0,
TCGA-OR-A5LK-01A-11R-A29S-07,ACC,62.0,MALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical Carcinoma- Oncocytic Type,[Not Available],2007.0,[Not Available],-22919.0,Alive,TUMOR FREE,2740.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2740.0,0.0,2740.0,0.0,2740.0,0.0,2740.0,
TCGA-OR-A5JJ-01A-11R-A29S-07,ACC,65.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-24082.0,Dead,WITH TUMOR,,490.0,[Not Available],,,,,Progressive Disease,,,1.0,490.0,1.0,490.0,,,1.0,490.0,
TCGA-OR-A5JQ-01A-11R-A29S-07,ACC,26.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical Carcinoma- Myxoid Type,[Not Available],2006.0,[Not Available],-9667.0,Alive,TUMOR FREE,1103.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,
TCGA-OR-A5L6-01A-11R-A29S-07,ACC,60.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-22057.0,Alive,TUMOR FREE,861.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,861.0,0.0,861.0,0.0,861.0,0.0,861.0,
TCGA-OR-A5K6-01A-11R-A29S-07,ACC,56.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-20657.0,Alive,WITH TUMOR,1493.0,,[Not Available],Distant Metastasis,Liver,,391.0,Complete Remission/Response,,,0.0,1493.0,0.0,1493.0,1.0,391.0,1.0,391.0,
TCGA-OR-A5LP-01A-11R-A29S-07,ACC,37.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-13574.0,Alive,TUMOR FREE,1857.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1857.0,0.0,1857.0,0.0,1857.0,0.0,1857.0,
TCGA-OR-A5J3-01A-11R-A29S-07,ACC,23.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-8624.0,Alive,WITH TUMOR,2091.0,,[Not Available],Distant Metastasis,Lung,,53.0,Complete Remission/Response,,,0.0,2091.0,0.0,2091.0,1.0,53.0,1.0,53.0,
TCGA-OR-A5J2-01A-11R-A29S-07,ACC,44.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2004.0,[Not Available],-16090.0,Dead,WITH TUMOR,,1677.0,[Not Available],Distant Metastasis,Soft Tissue,,289.0,Progressive Disease,,,1.0,1677.0,1.0,1677.0,,,1.0,289.0,
TCGA-OR-A5JX-01A-11R-A29S-07,ACC,50.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-18402.0,Alive,TUMOR FREE,950.0,,[Not Available],,,,,[Not Available],,,0.0,950.0,0.0,950.0,,,0.0,950.0,
TCGA-OR-A5JY-01A-31R-A29S-07,ACC,68.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-25190.0,Dead,WITH TUMOR,,552.0,[Not Available],Distant Metastasis,Liver,,75.0,Progressive Disease,,,1.0,552.0,1.0,552.0,,,1.0,75.0,
TCGA-OR-A5J9-01A-11R-A29S-07,ACC,22.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-8175.0,Alive,WITH TUMOR,1352.0,,[Not Available],Distant Metastasis,Lung,,414.0,Complete Remission/Response,,,0.0,1352.0,0.0,1352.0,1.0,414.0,1.0,414.0,
TCGA-OR-A5LN-01A-11R-A29S-07,ACC,31.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-11414.0,Alive,TUMOR FREE,2342.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2342.0,0.0,2342.0,0.0,2342.0,0.0,2342.0,
TCGA-OU-A5PI-01A-12R-A29S-07,ACC,53.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-19492.0,Alive,WITH TUMOR,1171.0,,[Not Available],Distant Metastasis,Lung,,351.0,Stable Disease,,,0.0,1171.0,0.0,1171.0,,,1.0,351.0,
TCGA-OR-A5KT-01A-11R-A29S-07,ACC,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-16217.0,Alive,TUMOR FREE,2895.0,,[Not Available],Distant Metastasis,"Other, specify",Pancreas,2099.0,Complete Remission/Response,,,0.0,2895.0,0.0,2895.0,1.0,2099.0,1.0,2099.0,
TCGA-OR-A5LA-01A-11R-A29S-07,ACC,52.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-19242.0,Alive,TUMOR FREE,719.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,
TCGA-OR-A5K9-01A-11R-A29S-07,ACC,61.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2002.0,[Not Available],-22596.0,Dead,WITH TUMOR,,344.0,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,236.0,[Not Available],,,1.0,344.0,1.0,344.0,,,1.0,236.0,
TCGA-PK-A5HB-01A-11R-A29S-07,ACC,63.0,MALE,[Unknown],[Not Available],[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2003.0,[Not Available],-23293.0,Alive,WITH TUMOR,1293.0,,[Not Available],Distant Metastasis,Lung,,213.0,[Not Available],,,0.0,1293.0,0.0,1293.0,,,1.0,213.0,
TCGA-OR-A5JF-01A-11R-A29S-07,ACC,69.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2007.0,[Not Available],-25502.0,Alive,TUMOR FREE,2015.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2015.0,0.0,2015.0,0.0,2015.0,0.0,2015.0,
TCGA-OR-A5JV-01A-11R-A29S-07,ACC,55.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-20319.0,Alive,TUMOR FREE,2023.0,,[Not Available],New Primary Tumor,Lymph Node(s),,953.0,Complete Remission/Response,,,0.0,2023.0,0.0,2023.0,0.0,2023.0,1.0,953.0,
TCGA-OR-A5J1-01A-11R-A29S-07,ACC,58.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-21496.0,Dead,WITH TUMOR,,1355.0,[Not Available],Distant Metastasis,Peritoneal Surfaces,,754.0,Complete Remission/Response,,,1.0,1355.0,1.0,1355.0,1.0,754.0,1.0,754.0,
TCGA-OR-A5LC-01A-11R-A29S-07,ACC,71.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-26084.0,Dead,WITH TUMOR,,159.0,[Not Available],Distant Metastasis,Lung,,50.0,Progressive Disease,,,1.0,159.0,1.0,159.0,,,1.0,50.0,
TCGA-PK-A5HA-01A-11R-A29S-07,ACC,63.0,MALE,[Unknown],Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-23345.0,Alive,TUMOR FREE,1201.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1201.0,0.0,1201.0,0.0,1201.0,0.0,1201.0,
TCGA-OR-A5KO-01A-11R-A29S-07,ACC,39.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-14606.0,Alive,WITH TUMOR,1414.0,,[Not Available],Distant Metastasis,Lung,,541.0,Progressive Disease,,,0.0,1414.0,0.0,1414.0,,,1.0,541.0,
TCGA-OR-A5J5-01A-11R-A29S-07,ACC,30.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-11171.0,Dead,WITH TUMOR,,365.0,[Not Available],Locoregional Recurrence,"Other, specify",vena cava thrombus,50.0,Progressive Disease,,,1.0,365.0,1.0,365.0,,,1.0,50.0,
TCGA-OR-A5K4-01A-11R-A29S-07,ACC,64.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-23481.0,Alive,TUMOR FREE,1082.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1082.0,0.0,1082.0,0.0,1082.0,0.0,1082.0,
TCGA-P6-A5OF-01A-11R-A29S-07,ACC,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-20106.0,Dead,WITH TUMOR,,207.0,[Not Available],Distant Metastasis,Lung,,143.0,[Unknown],,,1.0,207.0,1.0,207.0,,,1.0,143.0,
TCGA-OR-A5LR-01A-11R-A29S-07,ACC,30.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-11261.0,Alive,TUMOR FREE,853.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,853.0,0.0,853.0,0.0,853.0,0.0,853.0,
TCGA-OR-A5JR-01A-11R-A29S-07,ACC,45.0,MALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2002.0,[Not Available],-16604.0,Alive,TUMOR FREE,3688.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3688.0,0.0,3688.0,0.0,3688.0,0.0,3688.0,
TCGA-OR-A5JZ-01A-11R-A29S-07,ACC,60.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-22218.0,Alive,WITH TUMOR,822.0,,[Not Available],Distant Metastasis,Liver,,247.0,Progressive Disease,,,0.0,822.0,0.0,822.0,,,1.0,247.0,
TCGA-OR-A5KX-01A-11R-A29S-07,ACC,25.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-9298.0,Alive,WITH TUMOR,1364.0,,[Not Available],Distant Metastasis,Bone,,62.0,Progressive Disease,,,0.0,1364.0,0.0,1364.0,,,1.0,62.0,
TCGA-PK-A5H8-01A-11R-A29S-07,ACC,42.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2004.0,[Not Available],-15373.0,Alive,TUMOR FREE,3623.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3623.0,0.0,3623.0,0.0,3623.0,0.0,3623.0,
TCGA-PA-A5YG-01A-11R-A29S-07,ACC,51.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-18926.0,Alive,TUMOR FREE,756.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,756.0,0.0,756.0,0.0,756.0,0.0,756.0,
TCGA-PK-A5H9-01A-11R-A29S-07,ACC,27.0,FEMALE,ASIAN,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-10173.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-OR-A5KZ-01A-11R-A29S-07,ACC,42.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-15594.0,Dead,WITH TUMOR,,125.0,[Not Available],Locoregional Recurrence,"Other, specify",abdomen,36.0,Progressive Disease,,,1.0,125.0,1.0,125.0,,,1.0,36.0,
TCGA-OR-A5JE-01A-11R-A29S-07,ACC,17.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2005.0,[Not Available],-6455.0,Dead,WITH TUMOR,,2105.0,[Not Available],Locoregional Recurrence,,,477.0,[Unknown],,,1.0,2105.0,1.0,2105.0,,,1.0,477.0,
TCGA-OR-A5L4-01A-11R-A29S-07,ACC,48.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-17819.0,Alive,TUMOR FREE,967.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,967.0,0.0,967.0,0.0,967.0,0.0,967.0,
TCGA-OR-A5LT-01A-11R-A29S-07,ACC,57.0,MALE,[Not Evaluated],Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-21032.0,Alive,TUMOR FREE,549.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,549.0,0.0,549.0,0.0,549.0,0.0,549.0,
TCGA-OR-A5JL-01A-11R-A29S-07,ACC,36.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-13155.0,Alive,TUMOR FREE,2056.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2056.0,0.0,2056.0,0.0,2056.0,0.0,2056.0,
TCGA-OR-A5LS-01A-11R-A29S-07,ACC,34.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-12663.0,Alive,TUMOR FREE,1096.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,
TCGA-OR-A5JA-01A-11R-A29S-07,ACC,53.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2004.0,[Not Available],-19436.0,Dead,WITH TUMOR,,922.0,[Not Available],,,,,[Not Available],,,1.0,922.0,1.0,922.0,,,1.0,922.0,
TCGA-OR-A5JC-01A-11R-A29S-07,ACC,37.0,MALE,WHITE,[Not Available],[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2001.0,[Not Available],-13862.0,Dead,,,1750.0,[Not Available],,,,,[Not Available],,,1.0,1750.0,,1750.0,,,0.0,1750.0,
TCGA-OR-A5J8-01A-11R-A29S-07,ACC,66.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-24266.0,Dead,WITH TUMOR,,579.0,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,530.0,Complete Remission/Response,,,1.0,579.0,1.0,579.0,1.0,530.0,1.0,530.0,
TCGA-OR-A5JS-01A-11R-A29S-07,ACC,65.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-24017.0,Alive,WITH TUMOR,383.0,,[Not Available],Distant Metastasis,Lung,,166.0,[Not Available],,,0.0,383.0,0.0,383.0,,,1.0,166.0,
TCGA-OR-A5JP-01A-11R-A29S-07,ACC,40.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-14667.0,Alive,TUMOR FREE,464.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,464.0,0.0,464.0,0.0,464.0,0.0,464.0,
TCGA-OR-A5J7-01A-11R-A29S-07,ACC,30.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-11279.0,Dead,WITH TUMOR,,490.0,[Not Available],Locoregional Recurrence,Retroperitoneal lymph nodes,,162.0,Progressive Disease,,,1.0,490.0,1.0,490.0,,,1.0,162.0,
TCGA-OR-A5L9-01A-11R-A29S-07,ACC,53.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-19526.0,Alive,TUMOR FREE,871.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,871.0,0.0,871.0,0.0,871.0,0.0,871.0,
TCGA-OR-A5LJ-01A-11R-A29S-07,ACC,54.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2005.0,[Not Available],-20069.0,Dead,WITH TUMOR,,1105.0,[Not Available],Distant Metastasis,Lung,,98.0,Progressive Disease,,,1.0,1105.0,1.0,1105.0,,,1.0,98.0,
TCGA-OR-A5LH-01A-11R-A29S-07,ACC,36.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2005.0,[Not Available],-13182.0,Dead,WITH TUMOR,,2385.0,[Not Available],,,,,Progressive Disease,,,1.0,2385.0,1.0,2385.0,,,1.0,2385.0,
TCGA-OR-A5LM-01A-11R-A29S-07,ACC,23.0,MALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-8735.0,Alive,TUMOR FREE,1858.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1858.0,0.0,1858.0,0.0,1858.0,0.0,1858.0,
TCGA-OR-A5LE-01A-11R-A29S-07,ACC,14.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],1997.0,[Not Available],-5383.0,Dead,WITH TUMOR,,662.0,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,265.0,[Unknown],,,1.0,662.0,1.0,662.0,,,1.0,265.0,
TCGA-OR-A5JG-01A-11R-A29S-07,ACC,61.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-22390.0,Dead,WITH TUMOR,,541.0,[Not Available],,,,,[Not Available],,,1.0,541.0,1.0,541.0,,,1.0,541.0,
TCGA-OR-A5J6-01A-31R-A29S-07,ACC,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-10839.0,Alive,TUMOR FREE,2703.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2703.0,0.0,2703.0,0.0,2703.0,0.0,2703.0,
TCGA-OR-A5LD-01A-11R-A29S-07,ACC,52.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],1998.0,[Not Available],-19111.0,Dead,WITH TUMOR,,1197.0,[Not Available],Distant Metastasis,Lung,,444.0,[Unknown],,,1.0,1197.0,1.0,1197.0,,,1.0,444.0,
TCGA-OR-A5JI-01A-11R-A29S-07,ACC,22.0,MALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-8177.0,Alive,TUMOR FREE,2331.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2331.0,0.0,2331.0,0.0,2331.0,0.0,2331.0,
TCGA-OR-A5JT-01A-11R-A29S-07,ACC,65.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-23794.0,Alive,WITH TUMOR,907.0,,[Not Available],,,,,Stable Disease,,,0.0,907.0,0.0,907.0,,,0.0,907.0,
TCGA-OR-A5KU-01A-11R-A29S-07,ACC,37.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-13559.0,Alive,TUMOR FREE,4673.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4673.0,0.0,4673.0,0.0,4673.0,0.0,4673.0,
TCGA-OR-A5JW-01A-11R-A29S-07,ACC,47.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-17513.0,Alive,TUMOR FREE,2202.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2202.0,0.0,2202.0,0.0,2202.0,0.0,2202.0,
TCGA-OR-A5JD-01A-11R-A29S-07,ACC,57.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical Carcinoma- Oncocytic Type,[Not Available],2005.0,[Not Available],-20989.0,Alive,TUMOR FREE,3038.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3038.0,0.0,3038.0,0.0,3038.0,0.0,3038.0,
TCGA-OR-A5LO-01A-11R-A29S-07,ACC,61.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-22370.0,Dead,WITH TUMOR,,2405.0,[Not Available],Distant Metastasis,Lung,,153.0,Complete Remission/Response,,,1.0,2405.0,1.0,2405.0,1.0,153.0,1.0,153.0,
TCGA-OR-A5JB-01A-11R-A29S-07,ACC,52.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-19172.0,Dead,,,551.0,[Not Available],,,,,[Unknown],,,1.0,551.0,,551.0,,,0.0,551.0,
TCGA-OR-A5L3-01A-11R-A29S-07,ACC,67.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-24763.0,Alive,TUMOR FREE,4628.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4628.0,0.0,4628.0,0.0,4628.0,0.0,4628.0,
TCGA-OR-A5L8-01A-11R-A29S-07,ACC,36.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-13472.0,Alive,TUMOR FREE,885.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,
TCGA-OR-A5KY-01A-11R-A29S-07,ACC,23.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-8745.0,Dead,WITH TUMOR,,391.0,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,178.0,Progressive Disease,,,1.0,391.0,1.0,391.0,,,1.0,178.0,
TCGA-OR-A5K8-01A-11R-A29S-07,ACC,39.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-14435.0,Alive,TUMOR FREE,749.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,749.0,0.0,749.0,0.0,749.0,0.0,749.0,
TCGA-OR-A5LL-01A-11R-A29S-07,ACC,75.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2007.0,[Not Available],-27607.0,Dead,WITH TUMOR,,1613.0,[Not Available],Distant Metastasis,Liver,,213.0,Complete Remission/Response,,,1.0,1613.0,1.0,1613.0,1.0,213.0,1.0,213.0,
TCGA-OR-A5LB-01A-11R-A29S-07,ACC,59.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-21565.0,Dead,WITH TUMOR,,1204.0,[Not Available],Distant Metastasis,Liver,,611.0,Progressive Disease,,,1.0,1204.0,1.0,1204.0,,,1.0,611.0,
TCGA-OR-A5K5-01A-11R-A29S-07,ACC,59.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-21907.0,Dead,WITH TUMOR,,498.0,[Not Available],Distant Metastasis,Lung,,108.0,Progressive Disease,,,1.0,498.0,1.0,498.0,,,1.0,108.0,
TCGA-OR-A5K2-01A-11R-A29S-07,ACC,32.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-11970.0,Dead,WITH TUMOR,,994.0,[Not Available],Distant Metastasis,Lung,,97.0,Progressive Disease,,,1.0,994.0,1.0,994.0,,,1.0,97.0,
TCGA-OR-A5K0-01A-11R-A29S-07,ACC,69.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-25400.0,Alive,WITH TUMOR,1029.0,,[Not Available],Distant Metastasis,Lung,,659.0,Progressive Disease,,,0.0,1029.0,0.0,1029.0,,,1.0,659.0,
TCGA-OR-A5KW-01A-11R-A29S-07,ACC,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-20328.0,Alive,TUMOR FREE,2076.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2076.0,0.0,2076.0,0.0,2076.0,0.0,2076.0,
TCGA-KL-8341-01A-11R-2315-07,KICH,41.0,MALE,ASIAN,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-15045.0,Dead,WITH TUMOR,,754.0,[Not Available],,,,175.0,[Unknown],,,1.0,754.0,1.0,754.0,,,1.0,175.0,
TCGA-KL-8337-01A-11R-2315-07,KICH,26.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-9819.0,Alive,TUMOR FREE,1364.0,,[Not Available],,,,,[Unknown],,,0.0,1364.0,0.0,1364.0,,,0.0,1364.0,
TCGA-KL-8324-01A-11R-2315-07,KICH,67.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2000.0,[Not Available],-24650.0,Alive,TUMOR FREE,4676.0,,[Not Available],,,,,[Not Available],,,0.0,4676.0,0.0,4676.0,,,0.0,4676.0,
TCGA-KO-8409-01A-11R-2315-07,KICH,69.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-25419.0,Alive,TUMOR FREE,3180.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3180.0,0.0,3180.0,0.0,3180.0,0.0,3180.0,
TCGA-KN-8433-01A-11R-2315-07,KICH,46.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2008.0,[Not Available],-17108.0,Alive,TUMOR FREE,341.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,
TCGA-KM-8442-01A-11R-2315-07,KICH,38.0,MALE,[Unknown],Stage II,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-14212.0,Alive,TUMOR FREE,1437.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1437.0,0.0,1437.0,,,0.0,1437.0,
TCGA-KL-8325-01A-11R-2315-07,KICH,56.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2000.0,[Not Available],-20768.0,Dead,TUMOR FREE,,725.0,[Not Available],,,,,[Not Available],,,1.0,725.0,0.0,725.0,,,0.0,725.0,
TCGA-KL-8326-01A-11R-2315-07,KICH,69.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2001.0,[Not Available],-25267.0,Alive,TUMOR FREE,3322.0,,[Not Available],,,,,[Unknown],,,0.0,3322.0,0.0,3322.0,,,0.0,3322.0,
TCGA-KM-8639-01A-11R-2403-07,KICH,67.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-24640.0,Alive,TUMOR FREE,953.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,953.0,0.0,953.0,0.0,953.0,0.0,953.0,
TCGA-KL-8345-01A-11R-2315-07,KICH,75.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2008.0,[Not Available],-27412.0,Alive,TUMOR FREE,1665.0,,[Not Available],,,,,[Unknown],,,0.0,1665.0,0.0,1665.0,,,0.0,1665.0,
TCGA-KN-8435-01A-11R-2315-07,KICH,59.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-21891.0,Alive,TUMOR FREE,3498.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3498.0,0.0,3498.0,0.0,3498.0,0.0,3498.0,
TCGA-KO-8405-01A-11R-2315-07,KICH,29.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-10671.0,Alive,TUMOR FREE,3056.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3056.0,0.0,3056.0,0.0,3056.0,0.0,3056.0,
TCGA-KO-8416-01A-11R-2315-07,KICH,41.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-15261.0,Alive,TUMOR FREE,2752.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2752.0,0.0,2752.0,0.0,2752.0,0.0,2752.0,
TCGA-KN-8434-01A-11R-2315-07,KICH,65.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-23934.0,Alive,TUMOR FREE,1797.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1797.0,0.0,1797.0,0.0,1797.0,0.0,1797.0,
TCGA-KL-8343-01A-11R-2315-07,KICH,72.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-26562.0,Dead,WITH TUMOR,,2172.0,[Not Available],,,,,[Unknown],,,1.0,2172.0,1.0,2172.0,,,1.0,2172.0,
TCGA-KN-8428-01A-11R-2315-07,KICH,71.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-26252.0,Dead,WITH TUMOR,,1590.0,[Not Available],,,,478.0,Stable Disease,,,1.0,1590.0,1.0,1590.0,,,1.0,478.0,
TCGA-KL-8340-01A-11R-2315-07,KICH,34.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-12696.0,Alive,TUMOR FREE,2024.0,,[Not Available],,,,,[Unknown],,,0.0,2024.0,0.0,2024.0,,,0.0,2024.0,
TCGA-KL-8331-01A-11R-2315-07,KICH,48.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-17710.0,Alive,TUMOR FREE,3010.0,,[Not Available],,,,,[Unknown],,,0.0,3010.0,0.0,3010.0,,,0.0,3010.0,
TCGA-KM-8443-01A-11R-2315-07,KICH,57.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-21183.0,Alive,TUMOR FREE,1520.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1520.0,0.0,1520.0,0.0,1520.0,0.0,1520.0,
TCGA-KN-8432-01A-11R-2315-07,KICH,86.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2010.0,[Not Available],-31591.0,Alive,,76.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,
TCGA-KL-8329-01A-11R-2315-07,KICH,57.0,FEMALE,ASIAN,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2003.0,[Not Available],-20972.0,Alive,TUMOR FREE,2752.0,,[Not Available],,,,,[Unknown],,,0.0,2752.0,0.0,2752.0,,,0.0,2752.0,
TCGA-KL-8338-01A-11R-2315-07,KICH,51.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-18667.0,Alive,TUMOR FREE,2633.0,,[Not Available],,,,,[Unknown],,,0.0,2633.0,0.0,2633.0,,,0.0,2633.0,
TCGA-KN-8437-01A-11R-2315-07,KICH,42.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-15475.0,Alive,TUMOR FREE,3068.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3068.0,0.0,3068.0,0.0,3068.0,0.0,3068.0,
TCGA-KO-8404-01A-11R-2315-07,KICH,78.0,MALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-28705.0,Dead,WITH TUMOR,,325.0,[Not Available],,,,148.0,Progressive Disease,,,1.0,325.0,1.0,325.0,,,1.0,148.0,
TCGA-KN-8418-01A-11R-2315-07,KICH,41.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2002.0,[Not Available],-15086.0,Alive,TUMOR FREE,3935.0,,[Not Available],,,,,[Not Available],,,0.0,3935.0,0.0,3935.0,,,0.0,3935.0,
TCGA-KL-8323-01A-21R-2315-07,KICH,57.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2000.0,[Not Available],-20849.0,Dead,WITH TUMOR,,1158.0,[Not Available],,,,758.0,[Unknown],,,1.0,1158.0,1.0,1158.0,,,1.0,758.0,
TCGA-KM-8439-01A-11R-2315-07,KICH,30.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2011.0,[Not Available],-11266.0,Alive,WITH TUMOR,708.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,708.0,0.0,708.0,,,0.0,708.0,
TCGA-KL-8346-01A-11R-2315-07,KICH,62.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2008.0,[Not Available],-22651.0,Alive,TUMOR FREE,1897.0,,[Not Available],,,,,[Unknown],,,0.0,1897.0,0.0,1897.0,,,0.0,1897.0,
TCGA-KN-8425-01A-11R-2315-07,KICH,53.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-19692.0,Alive,TUMOR FREE,3179.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3179.0,0.0,3179.0,0.0,3179.0,0.0,3179.0,
TCGA-KN-8436-01A-11R-2315-07,KICH,62.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-22997.0,Alive,TUMOR FREE,1288.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,
TCGA-KN-8431-01A-11R-2315-07,KICH,35.0,FEMALE,[Not Evaluated],Stage II,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-13043.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,[Not Available],,,0.0,588.0,0.0,588.0,,,0.0,588.0,
TCGA-KN-8426-01A-11R-2315-07,KICH,50.0,MALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-18345.0,Alive,WITH TUMOR,108.0,,[Not Available],,,,,Progressive Disease,,,0.0,108.0,0.0,108.0,,,0.0,108.0,
TCGA-KN-8419-01A-11R-2315-07,KICH,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-15769.0,Alive,TUMOR FREE,714.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,
TCGA-KN-8423-01A-11R-2315-07,KICH,44.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-16335.0,Alive,TUMOR FREE,788.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,
TCGA-KL-8330-01A-11R-2315-07,KICH,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2003.0,[Not Available],-16250.0,Alive,TUMOR FREE,3304.0,,[Not Available],,,,,[Unknown],,,0.0,3304.0,0.0,3304.0,,,0.0,3304.0,
TCGA-KN-8430-01A-11R-2315-07,KICH,75.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-27467.0,Dead,WITH TUMOR,,,[Not Available],,,,,[Unknown],,,1.0,,1.0,,,,1.0,,
TCGA-KL-8332-01A-11R-2315-07,KICH,55.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-20128.0,Alive,TUMOR FREE,2582.0,,[Not Available],,,,,[Unknown],,,0.0,2582.0,0.0,2582.0,,,0.0,2582.0,
TCGA-KL-8334-01A-11R-2315-07,KICH,37.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-13602.0,Alive,TUMOR FREE,2949.0,,[Not Available],,,,,[Unknown],,,0.0,2949.0,0.0,2949.0,,,0.0,2949.0,
TCGA-KM-8476-01A-11R-2315-07,KICH,47.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2002.0,[Not Available],-17240.0,Alive,TUMOR FREE,3745.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3745.0,0.0,3745.0,0.0,3745.0,0.0,3745.0,
TCGA-KN-8421-01A-11R-2315-07,KICH,47.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-17524.0,Alive,TUMOR FREE,2674.0,,[Not Available],,,,,[Not Available],,,0.0,2674.0,0.0,2674.0,,,0.0,2674.0,
TCGA-KL-8342-01A-11R-2315-07,KICH,45.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-16550.0,Alive,TUMOR FREE,2248.0,,[Not Available],,,,,[Unknown],,,0.0,2248.0,0.0,2248.0,,,0.0,2248.0,
TCGA-KN-8427-01A-11R-2315-07,KICH,54.0,MALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-19854.0,Alive,TUMOR FREE,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-KM-8440-01A-11R-2315-07,KICH,37.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-13860.0,Alive,TUMOR FREE,1366.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1366.0,0.0,1366.0,0.0,1366.0,0.0,1366.0,
TCGA-KL-8339-01A-11R-2315-07,KICH,67.0,MALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-24545.0,Dead,WITH TUMOR,,855.0,[Not Available],,,,64.0,[Not Evaluated],,,1.0,855.0,1.0,855.0,,,1.0,64.0,
TCGA-KO-8408-01A-11R-2315-07,KICH,47.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-17299.0,Dead,TUMOR FREE,,507.0,[Not Available],,,,46.0,[Not Available],,,1.0,507.0,0.0,507.0,,,1.0,46.0,
TCGA-KN-8422-01A-11R-2315-07,KICH,28.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-10303.0,Alive,TUMOR FREE,775.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,
TCGA-KO-8415-01A-11R-2315-07,KICH,44.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-16395.0,Alive,TUMOR FREE,2939.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2939.0,0.0,2939.0,0.0,2939.0,0.0,2939.0,
TCGA-KL-8336-01A-11R-2315-07,KICH,51.0,FEMALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-18821.0,Dead,WITH TUMOR,,920.0,[Not Available],,,,47.0,[Unknown],,,1.0,920.0,1.0,920.0,,,1.0,47.0,
TCGA-KO-8407-01A-11R-2315-07,KICH,42.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-15407.0,Alive,TUMOR FREE,2820.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2820.0,0.0,2820.0,0.0,2820.0,0.0,2820.0,
TCGA-KN-8429-01A-11R-2315-07,KICH,38.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-13903.0,Alive,TUMOR FREE,2650.0,,[Not Available],,,,1989.0,Complete Remission/Response,,,0.0,2650.0,0.0,2650.0,1.0,1989.0,1.0,1989.0,
TCGA-KO-8403-01A-11R-2315-07,KICH,49.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-18171.0,Alive,TUMOR FREE,3208.0,,[Not Available],,,,,[Not Available],,,0.0,3208.0,0.0,3208.0,,,0.0,3208.0,
TCGA-KO-8417-01A-11R-2315-07,KICH,30.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-11139.0,Alive,TUMOR FREE,2815.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2815.0,0.0,2815.0,0.0,2815.0,0.0,2815.0,
TCGA-KM-8477-01A-11R-2315-07,KICH,56.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-20491.0,Alive,TUMOR FREE,1553.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1553.0,0.0,1553.0,0.0,1553.0,0.0,1553.0,
TCGA-KL-8328-01A-11R-2315-07,KICH,60.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2003.0,[Not Available],-21976.0,Alive,TUMOR FREE,3127.0,,[Not Available],,,,,[Not Evaluated],,,0.0,3127.0,0.0,3127.0,,,0.0,3127.0,
TCGA-KL-8335-01A-11R-2315-07,KICH,67.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-24832.0,Alive,TUMOR FREE,2815.0,,[Not Available],,,,,[Unknown],,,0.0,2815.0,0.0,2815.0,,,0.0,2815.0,
TCGA-KO-8406-01A-11R-2315-07,KICH,17.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-6556.0,Alive,TUMOR FREE,3145.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3145.0,0.0,3145.0,0.0,3145.0,0.0,3145.0,
TCGA-KL-8327-01A-11R-2315-07,KICH,46.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2001.0,[Not Available],-17121.0,Alive,TUMOR FREE,4169.0,,[Not Available],,,,,[Unknown],,,0.0,4169.0,0.0,4169.0,,,0.0,4169.0,
TCGA-KM-8441-01A-11R-2315-07,KICH,61.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2011.0,[Not Available],-22303.0,Alive,WITH TUMOR,876.0,,[Not Available],,,,876.0,Complete Remission/Response,,,0.0,876.0,0.0,876.0,1.0,876.0,1.0,876.0,
TCGA-KO-8410-01A-11R-2315-07,KICH,74.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-27084.0,Alive,TUMOR FREE,3136.0,,[Not Available],,,,,[Not Available],,,0.0,3136.0,0.0,3136.0,,,0.0,3136.0,
TCGA-KN-8424-01A-11R-2315-07,KICH,42.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-15384.0,Alive,TUMOR FREE,1983.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1983.0,0.0,1983.0,0.0,1983.0,0.0,1983.0,
TCGA-KO-8413-01A-11R-2315-07,KICH,46.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-17067.0,Alive,TUMOR FREE,3038.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3038.0,0.0,3038.0,0.0,3038.0,0.0,3038.0,
TCGA-KL-8344-01A-11R-2315-07,KICH,51.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-18742.0,Alive,TUMOR FREE,876.0,,[Not Available],,,,,[Unknown],,,0.0,876.0,0.0,876.0,,,0.0,876.0,
TCGA-KM-8438-01A-11R-2315-07,KICH,45.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2000.0,[Not Available],-16683.0,Alive,WITH TUMOR,4622.0,,[Not Available],,,,2317.0,Complete Remission/Response,,,0.0,4622.0,0.0,4622.0,1.0,2317.0,1.0,2317.0,
TCGA-KO-8414-01A-11R-2315-07,KICH,50.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-18502.0,Alive,TUMOR FREE,3212.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3212.0,0.0,3212.0,0.0,3212.0,0.0,3212.0,
TCGA-KL-8333-01A-11R-2315-07,KICH,69.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-25229.0,Alive,TUMOR FREE,2991.0,,[Not Available],,,,,[Unknown],,,0.0,2991.0,0.0,2991.0,,,0.0,2991.0,
TCGA-KO-8411-01A-11R-2315-07,KICH,58.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-21371.0,Alive,TUMOR FREE,3958.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3958.0,0.0,3958.0,0.0,3958.0,0.0,3958.0,
TCGA-N5-A4R8-01A-11R-A28V-07,UCS,65.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24102.0,Dead,,,3115.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3115.0,,3115.0,0.0,3115.0,0.0,3115.0,
TCGA-N9-A4PZ-01A-22R-A28V-07,UCS,77.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28211.0,Dead,WITH TUMOR,,667.0,[Not Available],Locoregional Recurrence,Pelvis,,487.0,Complete Remission/Response,,,1.0,667.0,1.0,667.0,1.0,487.0,1.0,487.0,
TCGA-N6-A4VC-01A-11R-A28V-07,UCS,83.0,FEMALE,WHITE,[Not Applicable],Stage III,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30643.0,Dead,WITH TUMOR,,597.0,[Not Available],Distant Metastasis,Lung,,171.0,Progressive Disease,,,1.0,597.0,1.0,597.0,,,1.0,171.0,
TCGA-N8-A4PP-01A-11R-A28V-07,UCS,88.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32415.0,Dead,WITH TUMOR,,611.0,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,149.0,Partial Remission/Response,,,1.0,611.0,1.0,611.0,,,1.0,149.0,
TCGA-N7-A59B-01A-11R-A28V-07,UCS,69.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25360.0,Alive,TUMOR FREE,827.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,
TCGA-N9-A4Q4-01A-11R-A28V-07,UCS,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22575.0,Alive,,1089.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1089.0,0.0,1089.0,0.0,1089.0,0.0,1089.0,
TCGA-NF-A4X2-01A-11R-A28V-07,UCS,59.0,FEMALE,WHITE,[Not Applicable],Stage II,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21908.0,Alive,TUMOR FREE,81.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,81.0,0.0,81.0,0.0,81.0,0.0,81.0,
TCGA-NF-A4WU-01A-11R-A28V-07,UCS,59.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21901.0,Alive,TUMOR FREE,298.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,298.0,0.0,298.0,0.0,298.0,0.0,298.0,
TCGA-N9-A4Q8-01A-31R-A28V-07,UCS,68.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25185.0,Dead,WITH TUMOR,,481.0,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,215.0,Complete Remission/Response,,,1.0,481.0,1.0,481.0,1.0,215.0,1.0,215.0,
TCGA-ND-A4WA-01A-12R-A28V-07,UCS,90.0,FEMALE,ASIAN,[Not Applicable],Stage IC,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Dead,TUMOR FREE,,714.0,[Not Available],,,,,Complete Remission/Response,,,1.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,
TCGA-N5-A4RS-01A-11R-A28V-07,UCS,65.0,FEMALE,WHITE,[Not Applicable],Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23893.0,Dead,WITH TUMOR,,911.0,[Not Available],Distant Metastasis,Lung,,427.0,Complete Remission/Response,,,1.0,911.0,1.0,911.0,1.0,427.0,1.0,427.0,
TCGA-N8-A4PM-01A-11R-A28V-07,UCS,73.0,FEMALE,WHITE,[Not Applicable],Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26971.0,Alive,WITH TUMOR,829.0,,[Not Available],Locoregional Recurrence,Lymph Node(s),,524.0,Complete Remission/Response,,,0.0,829.0,0.0,829.0,1.0,524.0,1.0,524.0,
TCGA-NA-A4QY-01A-11R-A28V-07,UCS,62.0,FEMALE,WHITE,[Not Applicable],Stage III,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22756.0,Dead,WITH TUMOR,,114.0,[Not Available],,,,,[Not Available],,,1.0,114.0,1.0,114.0,,,1.0,114.0,
TCGA-N6-A4VE-01A-11R-A28V-07,UCS,84.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30794.0,Dead,WITH TUMOR,,291.0,[Not Available],Distant Metastasis,Bone,,275.0,Progressive Disease,,,1.0,291.0,1.0,291.0,,,1.0,275.0,
TCGA-NG-A4VU-01A-11R-A28V-07,UCS,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23323.0,Dead,WITH TUMOR,,442.0,[Not Available],Progression of Disease,Pelvis,,281.0,Progressive Disease,,,1.0,442.0,1.0,442.0,,,1.0,281.0,
TCGA-N8-A56S-01A-11R-A28V-07,UCS,75.0,FEMALE,WHITE,[Not Applicable],Stage IB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27519.0,Dead,WITH TUMOR,,371.0,[Not Available],Progression of Disease,Lung,,199.0,Stable Disease,,,1.0,371.0,1.0,371.0,,,1.0,199.0,
TCGA-NA-A4QW-01A-11R-A28V-07,UCS,61.0,FEMALE,WHITE,[Not Applicable],Stage IIA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22588.0,Alive,TUMOR FREE,2457.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2457.0,0.0,2457.0,0.0,2457.0,0.0,2457.0,
TCGA-N7-A4Y0-01A-12R-A28V-07,UCS,65.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23983.0,Dead,WITH TUMOR,,771.0,[Not Available],Progression of Disease,"Other, specify",retroperitoneum,281.0,[Unknown],,,1.0,771.0,1.0,771.0,,,1.0,281.0,
TCGA-N9-A4Q3-01A-11R-A28V-07,UCS,65.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24031.0,Alive,WITH TUMOR,1672.0,,[Not Available],Distant Metastasis,Lung,,735.0,Complete Remission/Response,,,0.0,1672.0,0.0,1672.0,1.0,735.0,1.0,735.0,
TCGA-N8-A4PQ-01A-11R-A28V-07,UCS,76.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27772.0,Alive,TUMOR FREE,572.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,
TCGA-N9-A4Q7-01A-11R-A28V-07,UCS,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25419.0,Alive,TUMOR FREE,604.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,604.0,0.0,604.0,0.0,604.0,0.0,604.0,
TCGA-NF-A5CP-01A-12R-A28V-07,UCS,90.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871.0,Dead,WITH TUMOR,,167.0,[Not Available],Progression of Disease,"Other, specify","systemic, lung",106.0,Progressive Disease,,,1.0,167.0,1.0,167.0,,,1.0,106.0,
TCGA-NG-A4VW-01A-11R-A28V-07,UCS,74.0,FEMALE,WHITE,[Not Applicable],Stage IC,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27326.0,Dead,WITH TUMOR,,949.0,[Not Available],Distant Metastasis,Lung,,937.0,Complete Remission/Response,,,1.0,949.0,1.0,949.0,1.0,937.0,1.0,937.0,
TCGA-N8-A4PI-01A-21R-A28V-07,UCS,71.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26270.0,Dead,WITH TUMOR,,810.0,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,255.0,Partial Remission/Response,,,1.0,810.0,1.0,810.0,,,1.0,255.0,
TCGA-N5-A4RU-01A-31R-A28V-07,UCS,54.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20025.0,Dead,WITH TUMOR,,1526.0,[Not Available],Locoregional Recurrence,Pelvis,,253.0,Complete Remission/Response,,,1.0,1526.0,1.0,1526.0,1.0,253.0,1.0,253.0,
TCGA-ND-A4WF-01A-11R-A28V-07,UCS,77.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28398.0,Dead,WITH TUMOR,,167.0,[Not Available],,,,,Progressive Disease,,,1.0,167.0,1.0,167.0,,,1.0,167.0,
TCGA-N8-A4PL-01A-11R-A28V-07,UCS,82.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30069.0,Dead,WITH TUMOR,,418.0,[Not Available],Locoregional Recurrence,Lymph Node(s),,138.0,Progressive Disease,,,1.0,418.0,1.0,418.0,,,1.0,138.0,
TCGA-N6-A4V9-01A-11R-A28V-07,UCS,59.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,[Unknown],-21677.0,Alive,TUMOR FREE,979.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,
TCGA-N5-A59E-01A-11R-A28V-07,UCS,62.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22650.0,Dead,WITH TUMOR,,447.0,[Not Available],Locoregional Recurrence,Abdomen,,354.0,Complete Remission/Response,,,1.0,447.0,1.0,447.0,,,1.0,354.0,
TCGA-N6-A4VG-01A-31R-A28V-07,UCS,77.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28428.0,Alive,WITH TUMOR,1574.0,,[Not Available],Locoregional Recurrence,Lymph Node(s),,493.0,Partial Remission/Response,,,0.0,1574.0,0.0,1574.0,,,1.0,493.0,
TCGA-NF-A4WX-01A-11R-A28V-07,UCS,61.0,FEMALE,[Unknown],[Not Applicable],Stage IV,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22407.0,Alive,TUMOR FREE,452.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,452.0,0.0,452.0,,,0.0,452.0,
TCGA-NA-A4QV-01A-11R-A28V-07,UCS,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26379.0,Alive,TUMOR FREE,4269.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4269.0,0.0,4269.0,0.0,4269.0,0.0,4269.0,
TCGA-N5-A59F-01A-11R-A28V-07,UCS,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23826.0,Dead,WITH TUMOR,,361.0,[Not Available],Locoregional Recurrence,Pelvis,,274.0,Complete Remission/Response,,,1.0,361.0,1.0,361.0,1.0,274.0,1.0,274.0,
TCGA-NA-A4QX-01A-11R-A28V-07,UCS,60.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22264.0,Dead,WITH TUMOR,833.0,838.0,[Not Available],Distant Metastasis,Pelvis,,566.0,[Not Available],,,1.0,838.0,1.0,838.0,,,1.0,566.0,
TCGA-NA-A4R0-01A-11R-A28V-07,UCS,80.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29449.0,Dead,WITH TUMOR,,541.0,[Not Available],,,,,[Not Available],,,1.0,541.0,1.0,541.0,,,1.0,541.0,
TCGA-N8-A4PN-01A-11R-A28V-07,UCS,68.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25064.0,Alive,TUMOR FREE,812.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,812.0,0.0,812.0,0.0,812.0,0.0,812.0,
TCGA-NA-A4R1-01A-11R-A28V-07,UCS,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27688.0,Dead,WITH TUMOR,,203.0,[Not Available],,,,,[Not Available],,,1.0,203.0,1.0,203.0,,,1.0,203.0,
TCGA-N7-A4Y8-01A-11R-A28V-07,UCS,72.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26650.0,Dead,WITH TUMOR,,378.0,[Not Available],Progression of Disease,"Other, specify",Pleural effusion,187.0,Partial Remission/Response,,,1.0,378.0,1.0,378.0,,,1.0,187.0,
TCGA-N8-A4PO-01A-11R-A28V-07,UCS,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24124.0,Alive,WITH TUMOR,781.0,,[Not Available],Distant Metastasis,Bone,,158.0,Progressive Disease,,,0.0,781.0,0.0,781.0,,,1.0,158.0,
TCGA-N9-A4Q1-01A-11R-A28V-07,UCS,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25791.0,Dead,WITH TUMOR,,2043.0,[Not Available],Distant Metastasis,"Other, specify",Pleural surface,1839.0,Complete Remission/Response,,,1.0,2043.0,1.0,2043.0,1.0,1839.0,1.0,1839.0,
TCGA-N7-A4Y5-01A-12R-A28V-07,UCS,87.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32058.0,Dead,WITH TUMOR,,8.0,[Not Available],,,,,Progressive Disease,,,1.0,8.0,1.0,8.0,,,1.0,8.0,
TCGA-N5-A4RM-01A-11R-A28V-07,UCS,62.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22886.0,Dead,WITH TUMOR,,148.0,[Not Available],Locoregional Recurrence,Pelvis,,144.0,Progressive Disease,,,1.0,148.0,1.0,148.0,,,1.0,144.0,
TCGA-N5-A4RA-01A-11R-A28V-07,UCS,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23359.0,Dead,,,1591.0,[Not Available],,,,,[Unknown],,,1.0,1591.0,,1591.0,,,0.0,1591.0,
TCGA-NA-A5I1-01A-21R-A28V-07,UCS,80.0,FEMALE,WHITE,[Not Applicable],Stage IIIB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2006.0,[Not Available],-29329.0,Dead,WITH TUMOR,,2680.0,[Not Available],Distant Metastasis,Pelvis,,2553.0,Complete Remission/Response,,,1.0,2680.0,1.0,2680.0,1.0,2553.0,1.0,2553.0,
TCGA-QN-A5NN-01A-11R-A28V-07,UCS,55.0,FEMALE,ASIAN,[Not Applicable],Stage IB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20318.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-ND-A4W6-01A-11R-A28V-07,UCS,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24835.0,Dead,WITH TUMOR,,317.0,[Not Available],,,,,Progressive Disease,,,1.0,317.0,1.0,317.0,,,1.0,317.0,
TCGA-N5-A4RD-01A-11R-A28V-07,UCS,69.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25413.0,Dead,WITH TUMOR,,142.0,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,75.0,Progressive Disease,,,1.0,142.0,1.0,142.0,,,1.0,75.0,
TCGA-N5-A4RF-01A-11R-A28V-07,UCS,68.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25041.0,Alive,TUMOR FREE,1806.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1806.0,0.0,1806.0,0.0,1806.0,0.0,1806.0,
TCGA-N6-A4VF-01A-31R-A28V-07,UCS,51.0,FEMALE,WHITE,[Not Applicable],Stage IB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Peri (6-12 months since last menstrual period),-18806.0,Dead,TUMOR FREE,,522.0,[Not Available],,,,,[Not Available],,,1.0,522.0,0.0,522.0,,,0.0,522.0,
TCGA-N5-A4RN-01A-12R-A28V-07,UCS,71.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26054.0,Alive,WITH TUMOR,1053.0,,[Not Available],Locoregional Recurrence,Pelvis,,570.0,Complete Remission/Response,,,0.0,1053.0,0.0,1053.0,,,1.0,570.0,
TCGA-QM-A5NM-01A-11R-A28V-07,UCS,67.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24781.0,Alive,WITH TUMOR,587.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,153.0,[Unknown],,,0.0,587.0,0.0,587.0,,,1.0,153.0,
TCGA-N5-A4RJ-01A-11R-A28V-07,UCS,61.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22341.0,Dead,WITH TUMOR,,550.0,[Not Available],Distant Metastasis,Lymph Node(s),,287.0,Complete Remission/Response,,,1.0,550.0,1.0,550.0,,,1.0,287.0,
TCGA-N5-A4RO-01A-11R-A28V-07,UCS,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24823.0,Dead,WITH TUMOR,,685.0,[Not Available],Progression of Disease,Lymph Node(s),,407.0,Progressive Disease,,,1.0,685.0,1.0,685.0,,,1.0,407.0,
TCGA-N5-A4RV-01A-21R-A28V-07,UCS,62.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22978.0,Alive,TUMOR FREE,2042.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2042.0,0.0,2042.0,0.0,2042.0,0.0,2042.0,
TCGA-N6-A4VD-01A-11R-A28V-07,UCS,81.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29658.0,Dead,WITH TUMOR,,112.0,[Not Available],Distant Metastasis,Liver,,49.0,Progressive Disease,,,1.0,112.0,1.0,112.0,,,1.0,49.0,
TCGA-N5-A4RT-01A-11R-A28V-07,UCS,69.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25386.0,Alive,TUMOR FREE,2485.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2485.0,0.0,2485.0,0.0,2485.0,0.0,2485.0,
TCGA-ND-A4WC-01A-21R-A28V-07,UCS,83.0,FEMALE,ASIAN,[Not Applicable],Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30434.0,Alive,TUMOR FREE,766.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,
